<SEC-DOCUMENT>0000355019-23-000044.txt : 20230928
<SEC-HEADER>0000355019-23-000044.hdr.sgml : 20230928
<ACCEPTANCE-DATETIME>20230928152718
ACCESSION NUMBER:		0000355019-23-000044
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230928
DATE AS OF CHANGE:		20230928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		231289120

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>fonar_10-k.htm
<DESCRIPTION>FONAR CORPORATION FORM 10-K AT JUNE 30, 2023
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:FONR="http://fonar.com/20230630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_FONR_fonar.com_20230630 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20220701_20230630 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0204" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:StockIssuedToEmployeesUnderStockBonusPlansValue" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0336" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0338" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:LossOnDispositionOfFixedAssets" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0728" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0762" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0840" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl0843" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl0928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl0930" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1087" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="xdx2ixbrl1199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="xdx2ixbrl1205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-06-30_custom_NotePayable2Member" id="xdx2ixbrl1245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_custom_NotePayable2Member" id="xdx2ixbrl1247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" id="xdx2ixbrl1300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement" contextRef="From2022-07-01to2023-06-30" id="xdx2ixbrl1348" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2022-06-30" id="xdx2ixbrl1389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2022-06-30" id="xdx2ixbrl1392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" id="xdx2ixbrl1397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" id="xdx2ixbrl1410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_DE" id="xdx2ixbrl1601" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_AE" id="xdx2ixbrl1605" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_PR" id="xdx2ixbrl1607" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1663" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember" id="xdx2ixbrl1666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember" id="xdx2ixbrl1671" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2020-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1678" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20230630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-01to2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-08_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-08_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-08_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-08_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember1131540968">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassANonVotingPreferredMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember1131541015">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-25</xbrli:startDate>
        <xbrli:endDate>2022-09-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-05_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-072015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-07</xbrli:startDate>
        <xbrli:endDate>2015-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NotePayable1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_NotePayable2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-02-282016-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-02-28</xbrli:startDate>
        <xbrli:endDate>2016-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ABillingCompanyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_BensonhurstMRILimitedPartnershipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-292023-07-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-29</xbrli:startDate>
        <xbrli:endDate>2023-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-012023-08-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>FONR:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001511" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1513" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="Fact001515" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="Fact001547" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1549" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="Fact001551" toRefs="Footnote001576"></ix:relationship>
  <ix:relationship fromRefs="Fact001648" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="Fact001654" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="Fact001658" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1662" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1666" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="Fact001670" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="Fact001674" toRefs="Footnote001681"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1678" toRefs="Footnote001681"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="text-align: center; width: 60%; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SECURITIES
  AND EXCHANGE COMMISSION</span></td>
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">WASHINGTON,
  D.C. 20549</span></td>
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FORM
  </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><b><span id="xdx_903_edei--DocumentType_c20220701__20230630_zIbUvkNC8EU5"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:DocumentType">10-K</ix:nonNumeric></span></b><span style="font-style: normal; font-weight: normal"></span></span></td>
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_904_edei--DocumentAnnualReport_c20220701__20230630_zmCnu26WBQm2"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span>&#160;ANNUAL
  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;For
  the fiscal year ended </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><b><span id="xdx_90B_edei--DocumentPeriodEndDate_c20220701__20230630_zKNmYwoTNFz"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_906_edei--CurrentFiscalYearEndDate_c20220701__20230630_zG1ewE4q2Uqc"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, 2023</ix:nonNumeric></span></b><span style="font-style: normal; font-weight: normal"></span></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; width: 100%; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">OR</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_edei--DocumentTransitionReport_c20220701__20230630_z8hRe0AxU2g6"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span>&#160;TRANSITION
  REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
  the transition period from _____________ to _____________</span></td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commission
  File No. <span id="xdx_904_edei--EntityFileNumber_c20220701__20230630_z3qfVw70A1Ci"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></span></td>
  </tr>
</table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<img src="fonar_logo.jpg" alt="" style="height: 30px; width: 200px" /></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="text-align: center; width: 60%; vertical-align: top"><span id="xdx_901_edei--EntityRegistrantName_c20220701__20230630_z78yXH2LQOoc" style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><b><span id="xdx_905_edei--EntityRegistrantName_c20220701__20230630_z1QIwUfhV5Sl"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></b><span style="font-style: normal; font-weight: normal"></span></span></td>
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="border-top: Black 1pt solid; text-align: center; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Exact
  name of registrant as specified in its charter)</span></td>
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-transform: uppercase; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20220701__20230630_zUJTGiyKz6Ef"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20220701__20230630_zZ4UXC4mBFJk"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(State
    of incorporation)</span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(IRS
    Employer Identification Number)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; width: 45%; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_edei--EntityAddressAddressLine1_c20220701__20230630_zkAq5sBLDFi4"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20220701__20230630_znRFgtJFXhKf"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20220701__20230630_zotHbWZIqwti"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt; width: 45%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_904_edei--EntityAddressPostalZipCode_c20220701__20230630_zvy8u31gWl09"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Address
    of principal executive offices)</span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Zip
    Code)</span></td></tr>
  </table>


<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="text-align: center; width: 60%; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;
  <span id="xdx_90B_edei--CityAreaCode_c20220701__20230630_zHq2Ser13IW4"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_901_edei--LocalPhoneNumber_c20220701__20230630_zYyZg2k9GXQk"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></td>
  <td style="width: 20%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
  <td style="border-top: Black 1pt solid"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Registrant's
  Telephone Number, including area code)</span></td>
  <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
</table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Securities
Registered pursuant to Section 12(b) of the Act</span></p>

<p style="margin-bottom: 0pt; text-align: center"></p>

<p style="margin-bottom: 0pt; text-align: center"></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="5" style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center"></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; width: 38%; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Title
    of Each Class</span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif; width: 7%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt; width: 22%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Trading
    Symbol(s)</span></td>
    <td style="width: 7%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt; width: 26%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Exchange
    Registered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--Security12bTitle_c20220701__20230630_zdckRZ2uDGNl"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:Security12bTitle">Common
    Stock, $.0001 par value</ix:nonNumeric></span></span></td><td style="font: 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: middle; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_edei--TradingSymbol_c20220701__20230630_zKZAoOM9OS91"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 11pt Arial, Helvetica, Sans-Serif; vertical-align: middle; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_edei--SecurityExchangeName_c20220701__20230630_zY4hgFRDgyAi"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Securities
Registered pursuant to Section 12(g) of the Act</span></p>

<p style="margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">None&#160;</span></p>
<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744;&#160;<span id="xdx_90F_edei--EntityWellKnownSeasonedIssuer_c20220701__20230630_z46gPCJzVGaj"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;
..</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744;&#160;<span id="xdx_90F_edei--EntityVoluntaryFilers_c20220701__20230630_z5ziiAXrVRcj"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746; .</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_903_edei--EntityCurrentReportingStatus_c20220701__20230630_zknPuaFUFHR7"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#9746; No &#9744; .</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has submitted electronically and posted on its corporate website, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files). <span id="xdx_902_edei--EntityInteractiveDataCurrent_c20220701__20230630_z8w1yzkIqe34"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#9746; No &#9744;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer and &#8220;smaller reporting company&#8221;
in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; width: 33%; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Large
    accelerated filer&#160;&#9744;</span></td>
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; width: 34%; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accelerated
    filer&#160;&#160;&#9744;</span></td>
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; width: 33%; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--EntityFilerCategory_c20220701__20230630_zuDLXzxuZMf1"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span>&#160;&#160;&#9746;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Smaller
    reporting company&#160;&#160;<span id="xdx_900_edei--EntitySmallBusiness_c20220701__20230630_z9cvWmH6yDr3"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Emerging
    Growth Company&#160;&#160;<span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20220701__20230630_z4eJsz0u8gnb"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;&#9744; <span id="xdx_90B_edei--EntityShellCompany_c20220701__20230630_zaqVv1khyky5"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;&#160;.</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
aggregate market value of the shares of Common Stock held by non-affiliates as of December 31, 2022 based on the closing price of $16.75
per share on such date as reported on the NASDAQ System, was approximately <span id="xdx_90C_edei--EntityPublicFloat_iI_pn5n6_c20221231_zr2fdpYTeex3">$<ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">106.2</ix:nonFraction></span> million. The other outstanding classes do not have
a readily determinable market value.</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of September 8, 2023<span style="line-height: 115%"></span>, <span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20230908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQaUEcrnPjd7"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-09-08_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></span> shares of Common Stock, <span id="xdx_906_edei--EntityCommonStockSharesOutstanding_iI_c20230908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zI7BXCfZI9sh"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-09-08_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span> shares of Class B Common Stock,
<span id="xdx_90B_edei--EntityCommonStockSharesOutstanding_iI_c20230908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2CpgIhBpyCf"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-09-08_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span> shares of Class C Common Stock and <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20230908__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z1W2gOBEjYZf"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-09-08_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span> shares of Class A Non-voting Preferred Stock of the registrant were outstanding.</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_909_edei--DocumentFinStmtErrorCorrectionFlag_c20220701__20230630_zayy5iHvXmj6" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt:booleanfalse" name="dei:DocumentFinStmtErrorCorrectionFlag">No</ix:nonNumeric></span></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">DOCUMENTS
INCORPORATED BY REFERENCE</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NONE</span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">TABLE
OF CONTENTS</span></p>

<p style="font: 11pt/150% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 11%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 2%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 10%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 67%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FORM
    10-K ITEMS</span></td>
    <td style="vertical-align: bottom; width: 1%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top; width: 8%; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PAGE</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    I</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    1.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Item_1">Business</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    1A.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#RiskFactors">Risk Factors</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    1B.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#UnresolvedStaffComments">Unresolved Staff Comments</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    2.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Properties">Properties</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    3.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#LegalProceedings">Legal Proceedings</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    4.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Mine_Safety">Mine Safety Disclosures</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    II</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    5.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Stockholder_Matters">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    6.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Reserved">[Reserved]</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">31</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    7.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#MDA">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">31</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    7A.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#QualitativeDisclosures">Quantitative and Qualitative Disclosures About Market Risk.</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    8.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#FinancialStatements">Financial Statements and Supplementary Data</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    9.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#CautionaryNote">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">81</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    9A.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#ControlsAndProcedures">Controls and Procedures</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">81</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    9B.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Information">Other Information</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">82</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    9C.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Disclosure">Disclosures Regarding Foreign Jurisdictions that Prevent Inspections</a></span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">82</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    III</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    10.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#DirectorsAndExecutiveOfficers">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">82</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    11.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#ExecutiveCompensation">Executive Compensation</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">86</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    12.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#SecurityOwnership">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">88</span></td></tr>
  <tr style="vertical-align: top">
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    13.</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#CertainRelationships">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    14.</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Accounting">Principal Accountant Fees and Services</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">91</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
    IV</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Item
    15.<span style="line-height: 150%">&#160;</span></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Exhibits">Exhibits and Financial Statement Schedules</a></span></td>
    <td style="vertical-align: bottom; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; vertical-align: top; line-height: 150%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">92</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
I</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Business"></span><span id="Item_"></span><span id="Item_1"></span>ITEM
1. BUSINESS&#9;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">GENERAL</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
Corporation, sometimes referred to as the &#8220;Company&#8221; or &#8220;FONAR&#8221;, is a Delaware corporation which was incorporated
on July 17, 1978. Our address is 110 Marcus Drive, Melville, New York 11747 and our telephone number is 631-694-2929. FONAR also maintains
a website at www.fonar.com. FONAR provides copies of its filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and
8-K and amendments to these reports to stockholders on request.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
conduct our business in two segments. Our medical equipment segment is conducted directly through FONAR. Our physician management and
diagnostic services segment is conducted through our subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;). HMCA provides
management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance
consulting, purchasing, IT services, hiring, conducting interviews and managing personnel, storage of medical records, office space,
equipment, repair, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging.
In addition to acting as a management company, HMCA owns and operates five diagnostic imaging facilities in Florida, where the corporate
practice of medicine is permitted.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging scanners, also referred to as
&#8220;MRI&#8221; or &#8220;MR&#8221; scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities,
other medical conditions and injuries. FONAR&#8217;s founders built the first MRI scanner in 1977 and FONAR introduced the first commercial
MRI scanner in 1980. FONAR is also the originator of the iron-core non-superconductive and permanent magnet MRI technology.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR&#8217;s
iron frame technology made FONAR the originator of &#8220;open&#8221; MRI scanners. We introduced the first &#8220;open&#8221; MRI in
1980. Since that time we have concentrated on further application of our &#8220;open&#8221; MRI, introducing most recently the Upright&#174;
Multi-Position&#8482;&#8221; MRI scanner (also referred to as the &#8220;Upright&#174;&#8221; or &#8220;Stand-Up&#174;&#8221; MRI scanner)
and the FONAR 360&#8482; MRI scanner. The FONAR 360&#8482; MRI is not presently being marketed.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 16 to the Consolidated Financial Statements for separate financial information regarding our medical equipment and physician and
diagnostic management services segments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CAUTIONARY
NOTE REGARDING FORWARD LOOKING STATEMENTS.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Certain
statements made in this Annual Report on Form 10-K are &#8220;forward-looking statements&#8221;, within the meaning of the Private Securities
Litigation Reform Act of 1995, regarding the plans and objectives of Management for future operations. Such statements involve known
and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements
are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions
involving the expansion of business. These assumptions involve judgments with respect to, among other things, future economic, competitive
and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which
are beyond our control. Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the
assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this Annual
Report will prove to be accurate. In light of the significant uncertainties inherent in our forward-looking statements, the inclusion
of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">MEDICAL
EQUIPMENT SEGMENT</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PRODUCTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI scanner is the product we are presently promoting.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI is a &#8220;whole-body&#8221; MRI, meaning that it can be used to scan virtually any part of the body.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI differs from conventional MRI scanners in that it is not limited to scanning patients in the recumbent posture. For
example, patients can be scanned while sitting, standing, bending, or lying down.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI is also, by design, a non-claustrophobic MRI scanner. The Upright&#174; MRI employs a dipole magnet whose magnetic field
orientation is transverse to the axis of the patient&#8217;s body. The gap between the poles of the magnet is the space into which the
patient is placed. Because the magnetic field direction is horizontal and transverse to the body, a patient who is scanned seated or
standing has an unobstructed view out of the gap of the magnet. In typical installations, patients watch television while being scanned,
without the aid of special glasses with mirrors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
fact that the patient space is unobstructed permits scanning in a variety of postures that cannot be duplicated in conventional MRI scanners.
Most conventional MRI scanners in use today employ solenoidal super-conducting magnets whose magnetic field orientation is along the
axis of the patient&#8217;s body, which must be placed into the bore of the scanner in either a supine or prone posture. Our experience
is that when presented with a choice between being scanned lying down in a tunnel-like enclosure or seated in an open MRI, most patients
will choose the latter.</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI facilitates patient scanning in a variety of postures thanks to a unique, three-axis patient handling system. The motorized
patient table, or bed, can be rotated to any angle between 0 (horizontal) and 84 degrees (nearly vertical). Unlike a conventional recumbent
MRI patient table, which can only move into or out of the scanner&#8217;s bore, the Upright&#174; MRI bed can be translated with two degrees
of freedom, in/out and up/down. User-friendly software allows the scanner operator to move the anatomical region of interest precisely
to the center of the magnet using a cursor placed on a localizer image. Anatomically true image orientation is assured, regardless of
the rotation angle of the bed, via computer read-back of the table&#8217;s position. A seat can be hooked onto the bed in a variety of
locations, or removed, as needed. Transpolar VersaRests&#8482; and other devices can be used to keep the patient comfortable and motionless
throughout the scanning process.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">IMAGE
QUALITY AND FIELD STRENGTH</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Most
commercially available MRI scanners range in magnetic field strength from about 0.2 T (Tesla) to 7.0 T, and open MRI scanners range from
about 0.2 T to 1.2 T.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Field
strength is an important characteristic of MRI scanners, but not the only one. Higher field strengths generally provide higher signal-to-noise
ratios (SNR) on account of the Boltzmann distribution, but SNR is not the only determinant of image quality. For example, the spin-lattice
relaxation time T1 that characterizes the nuclear magnetic resonance (NMR) signal increases with field strength, decreasing the difference
in T1 values between tissues that is an essential contributor to contrast in images. For example, grey/white matter contrast in the brain
falls off rapidly above about 1.0 T, and some studies have shown that optimal tissue contrast occurs in the mid-field region, down to
0.2 T. Imaging bandwidth, receiver coil design, pulse sequence design, and scan parameters significantly affect image quality. Indeed,
researchers and MRI vendors are pushing the boundaries of MRI technology in both directions, that is, to very low (1 &#8211; 199 mT)
and very high (7.0 T and above) field strengths for a variety of technical and diagnostic reasons. For instance, one advantage of lower
field strengths is that image artifacts arising from metallic implants such as surgical screws diminish as field strength decreases.
This is particularly important for surgeons referring their postoperative patients for diagnostic imaging studies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI operates at a mid-field strength of 0.6 T and enjoys wide acceptance in the radiological community. The scanner is diagnostically
versatile and equipped with a broad range of clinically proven imaging protocols that produce images of exceptional quality, and a fully-featured,
robust, and user-friendly software interface.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">DIAGNOSTIC
ADVANTAGES OF POSITIONAL MRI</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Apart
from its attractiveness as an open, non-claustrophobic, general-purpose MRI, the Upright&#174; MRI can deliver diagnostically relevant
information that correlates with patient posture.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
example, a variety of injuries to and pathologies of the spine, such as spondylolisthesis (&#8220;slipped disc&#8221;), may go undetected
in the recumbent posture, but manifest themselves when the patient is scanned in a normal, weight-bearing (&#8220;physiological&#8221;)
position, such as seated, or seated in forward flexion, extension, or standing.</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI has demonstrated its value for patients suffering from scoliosis, who typically undergo regular x-ray exams over a course
of years. A study by the National Cancer Institute (2000) of 5,466 women with scoliosis reported a 70% increase in breast cancer resulting
from 24.7 chest x-rays received on average over the course of their treatment. Prior to the advent of the Upright&#174; MRI, the x-ray
machine was the only imaging modality that could evaluate the condition because the patient must be imaged standing. FONAR has developed
an RF receiver coil and a 3D scanning protocol that for the first time allows scoliosis patients to obtain diagnostic, multi-slice images
of their spines while standing, without the risks associated with radiation, and with the soft-tissue-contrast benefits of MRI over x-ray.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
utility of upright, weight-bearing MRI is not limited to the spine. For example, approximately one in a thousand people (some 200,000
to 500,000 in the US) have a congenital condition known as Chiari malformation, an abnormality of the brain at the junction with the
spine at the base of the skull. In people with Chiari malformation, the lowest lying structures of the brain, the tonsils of the cerebellum,
descend into and become entrapped by the foramen magnum, the circular bony opening at the base of the skull where the spinal cord exits.
While most of these individuals are asymptomatic, many suffer from more severe forms of the syndrome (e.g., type II or Arnold-Chiari
syndrome), in which brain stem compression results in severe neurological symptoms. The Chiari syndrome is also called Cerebellar Tonsillar
Ectopia (CTE) because of the displacement (ectopia) of the cerebellar tonsils. Classic symptoms of Chiari syndrome include the &#8220;drop
attack,&#8221; in which the afflicted individual unexpectedly experiences an explosive rush at the base of the brain that runs down the
body to the extremities, causing the patient to collapse in a temporary neuromuscular paralysis. These symptoms subside when the patient
is lying down. Conventional lie-down MRI scanners cannot make an adequate evaluation of the pathology since this pathology is most visible
and the symptoms are most acute when the patient is scanned in the upright, weight-bearing position (Brain Injury 2010, 24 (7-8) 988-994).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
the body, the Upright&#174; MRI is being utilized in a variety of ways, for example to image pelvic organ prolapse in the standing posture,
inguinal hernias, defecation in the sitting posture (utilizing cine MRI), and the prostate in the sitting posture (utilizing a flat,
multi-channel receiver coil on top of which the patient simply sits).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PRODUCT
MARKETING</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR&#8217;s
principal marketing efforts in the medical equipment segment have been focused on the Upright&#174; MRI, which we believe is a unique
product. We expect to focus on the Upright&#174; MRI going forward.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
principal markets for the Company&#8217;s scanners are private diagnostic imaging centers and hospital outpatient imaging facilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
use internal personnel and independent manufacturer&#8217;s representatives for domestic and foreign sales.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR&#8217;s
marketing strategy has been designed to reach key purchasing decision makers with information concerning the Upright&#174; MRI. This has
led to many inquiries and some sales of the Upright&#174; MRI scanner and is intended to increase FONAR&#8217;s presence in the medical
equipment market. FONAR focuses primarily on four target audiences: neurosurgeons, orthopedic surgeons, radiologists, and general physicians.</span></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
advertising for FONAR and HMCA reinforces the unique value provided by the FONAR Upright&#174; MRI scanner. We have increased internet
awareness of our product by driving patient traffic to the HMCA scanning centers we manage via the FONAR website as well as through websites
for each HMCA location. These websites give prospective customers of Upright&#174; MRI scanners a view of operating Upright&#174; MRI centers
and highlight the benefits of using the Upright&#174; MRI scanner. A complete list of the sites managed by HMCA can be found at HMCA&#8217;s
website, www.hmca.com.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SERVICE
AND UPGRADES FOR MRI SCANNERS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
is generated from the installed base in two principal areas, namely, service and upgrades. Service and maintenance revenues from our
external installed base were approximately $7.5 million in fiscal 2023 and $7.7 million in fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
expect to maintain service revenues at present levels or better, based on the demonstrated longevity of the Upright&#174; MRI scanner
and continued customer satisfaction with the product. Critical to this longevity and customer satisfaction is the stream of software
improvements and hardware upgrades that FONAR has delivered over the years to keep the scanners competitive with the latest technology
in the marketplace. We also anticipate that our installed base of scanners will generate income from upgrades in future fiscal years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">RESEARCH
AND DEVELOPMENT</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the fiscal year ended June 30, 2023, we incurred expenditures of $1,567,749, none of which were capitalized, on research and development,
as compared to $1,494,181, none of which were capitalized, during the fiscal year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development activities have focused principally on software improvements to the user interface of the MRI scanner. The Windows-based
Sympulse&#8482; platform controls all of the functions of the Upright&#174; scanner except those of the versatile, multi-position patient
table. Separate, dedicated, motion-control software is used to maneuver the Upright&#174; bed, and development of this software is ongoing
as well.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">While
software improvements to the user interface are important in their own right, significant value is added to the MRI scanner by the modification
of existing protocols for examining various parts of the body, and the development of new protocols that utilize new underlying capabilities
of the pulse sequence software. Over time, FONAR users have become accustomed to the steady improvement in the recommended clinical protocols
that accompany new software releases. More significantly, in recent years we have seen increasing adoption of FONAR-recommended clinical
protocols over those developed on site. This is a testament to the superior image quality they produce in attractively short scan times.&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
development of clinically practical scan protocols and software depends on close contact between research and development scientists
and engineers, and end users. That close contact is facilitated in part by the relationship with HMCA and the scanning centers. In addition
to that collaboration, R&amp;D staff have pursued a variety of novel and Upright&#174; MRI-specific research projects. It is anticipated
that these will ultimately lead to new applications that are made available to existing customers as upgrade add-ons to their machines.
For example, phase-contrast imaging techniques originally developed for angiography have recently been applied to cerebro-spinal fluid
(CSF) flow. Analysis of CSF flow in upright and recumbent postures may prove to be of significant value in the evaluation of a variety
of disorders and lead to a better understanding of human physiology.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">BACKLOG</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
backlog of unfilled orders at September 8, 2023 was approximately $608,000, as compared to $844,000 at September 8, 2022. It is expected
that the existing backlog of orders will be filled during the 2023 fiscal year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PATENTS
AND LICENSES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
currently have numerous patents in effect which relate to the technology and components of our MRI scanners. We believe that these patents,
and the know-how we have developed, are material to our business.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">One
of our patents, issued in the name of Dr. Damadian and licensed to FONAR, was United States patent No. 3,789,832, Apparatus and Method
for Detecting Cancer in Tissue, also referred to in this report as the &#8220;1974 Patent&#8221;. The 1974 Patent was the first MRI patent
issued by the United States Patent Office. The development of our MRI scanners has been based upon the 1974 Patent, and we believe that
the 1974 Patent was the first of its kind to utilize MR to scan the human body and to detect cancer. The 1974 Patent was extended beyond
its original 17-year term and expired in February, 1992. A number of FONAR&#8217;s existing patents specifically relate to protecting
FONAR&#8217;s position in the Upright MRI market. The patents further enhance Dr. Damadian&#8217;s pioneer patent, the 1974 Patent, that
initiated the MRI industry and provided the original invention of MRI scanning. The terms of the patents in FONAR&#8217;s portfolio extend
to various times.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have significantly enhanced our patent position within the industry and now possess a substantial patent portfolio which provides us,
under the aegis of United States patent law, &#8220;the exclusive right to make, use and sell&#8221; many of the scanner features which
FONAR pioneered and which are now incorporated in most MRI scanners sold by the industry. As of June 30, 2023, 225 patents had been issued
to FONAR, and approximately 8 patents were pending. Two new patents were issued in fiscal year 2023. One patent describes an equipment
calibration system for ultrasound equipment used to non-invasively measure intracranial pressure. The other described a method for identifying
the presence and amount of vascular congestion using MRI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
also have patent cross-licensing agreements with other MRI manufacturers. We have not licensed, however, any technology relating to Upright&#174;
MRI scanning.</span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PRODUCT
COMPETITION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">MRI
SCANNERS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
faces competition for MRI product sales from companies such as Siemens, General Electric, Hitachi, Philips, Canon, and United Imaging.
Each of these is primarily focused on the high-field (1.0 T and above) marketplace, though some have produced open MRI scanners for imaging
in the recumbent posture. None of these firms has so far introduced an open, upright MRI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
recent years Paramed and Esaote have introduced MRI scanners aimed at the upright, weight-bearing MRI market. Their success in the US
has so far been limited. We believe that the higher field strength and larger dimensions of the FONAR Upright&#174; MRI magnet, together
with the greater variety of patient positioning possibilities afforded by the FONAR Upright&#174; MRI bed, give us a competitive advantage
over the products introduced by these companies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Most
of our competitors have marketing and financial resources more substantial than those available to us. They have in the past, and may
in the future, heavily discount the sales price of their scanners.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">OTHER
IMAGING MODALITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR&#8217;s
MRI scanners also compete with other diagnostic imaging systems, all of which are based upon the ability of some form of energetic wave
to penetrate human tissue and be detected by either photographic film or electronic devices for presentation on a display monitor. Three
different kinds of energy waves &#8211; x-ray, gamma, and sound &#8211; are used in medical imaging techniques that compete with MRI,
the first two of which involve exposing the patient to potentially harmful radiation. These other imaging modalities compete with MRI
products on the basis of cost, space requirements, and specific clinical applications.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">X-rays
are the most common energy source used in imaging the body and are employed in three imaging modalities: conventional x-ray systems,
computerized tomography (CT), and digital radiography. None of these enjoy the exquisite soft-tissue contrast of MRI, but they do offer
high resolution imaging in certain applications and high speed of image acquisition.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Nuclear
medicine systems, which are based upon the detection of photons (gamma radiation) generated by radioactive pharmaceuticals introduced
into the body, are used to provide information concerning soft tissue and internal body organs and particularly to examine organ function
over time.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ultrasound
systems emit, detect, and process high frequency sound waves reflected from organ boundaries and tissue interfaces to generate images
of soft tissue and internal body organs. Although the images are substantially less detailed than those obtainable with x-rays or MRI,
ultrasound is generally considered harmless and therefore has found applications in imaging the pregnant uterus and the breast, to name
two.</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">X-ray
(including CT), nuclear medicine, and ultrasound compete with the MRI scanners by offering significantly lower price and space requirements.
However, history has shown that the superior tissue contrast characteristics of MRI have secured its place as the diagnostic imaging
modality of choice for a wide variety of pathologies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">GOVERNMENT
REGULATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA
Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Food and Drug Administration in accordance with Title 21 of the Code of Federal Regulations regulates the manufacturing and marketing
of FONAR&#8217;s MRI scanners. The regulations can be classified as either pre-market or post-market. The pre-market requirements include
obtaining marketing clearance, proper device labeling, establishment registration and device listing. Once the products are on the market,
FONAR must comply with post-market surveillance controls. These requirements include the Quality Systems Regulation, or &#8220;QSR&#8221;,
also known as Current Good Manufacturing Practices or CGMPs, and Medical Device Reporting, also referred to as MDR regulations. The QSR
is a quality assurance requirement that covers the design, packaging, labeling and manufacturing of a medical device. The MDR regulation
is an adverse event-reporting program.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Classes
of Products</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Under
the Medical Device Amendments of 1976 to the Federal Food, Drug and Cosmetic Act, all medical devices are classified by the FDA into
one of three classes. A Class I device is subject only to general controls, such as labeling requirements and manufacturing practices;
a Class II device must comply with certain performance standards established by the FDA; and a Class III device must obtain pre-market
approval from the FDA prior to commercial marketing. FONAR&#8217;s products are Class II devices. Class II devices are subject to &#8220;General
Controls&#8221;; General Controls include:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Establishment
                                            registration of companies which are required to register under 21 CFR Part 807.20, such as
                                            manufacturers, distributors, re-packagers and re-labelers.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
                                            device listing with FDA of devices to be marketed.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
                                            devices in accordance with the Current Good Manufacturing Practices Quality System Regulation
                                            in 21 CFR Part 820.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Labeling
                                            devices in accordance with labeling regulations in 21 CFR Part 801 or 809.</span></td></tr></table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.25in; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Submission
                                            of a Premarket Notification, pursuant to 510(k), before marketing a device.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition to complying with general controls, Class II devices are also subject to special controls. Special controls may include special
labeling requirements, guidance documents, mandatory performance standards and post-market surveillance.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
October 3, 2000 FONAR received FDA clearance for the Upright&#174; MRI under the name &#8220;Indomitable&#8221;.</span></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Premarketing
Submission</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Each
person who wants to market Class I, II and some III devices intended for human use in the U.S. must submit a 510(k) to FDA at least 90
days before marketing unless the device is exempt from 510(k) requirements. A 510(k) is a pre-marketing submission made to FDA to demonstrate
that the device to be marketed is as safe and effective, that is, substantially equivalent, SE, to a legally marketed device that is
not subject to pre-market approval, PMA. Applicants must compare their 510(k) device to one or more similar devices currently on the
U.S. market and make and support their substantial equivalency claims.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
FDA is committed to a 90-day clearance after submission of a 510(k), provided the 510(k) is complete and there is no need to submit additional
information or data.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
510(k) is essentially a brief statement and description of the product. As FONAR&#8217;s scanner products are Class II products, there
are no pre-market data requirements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">An
investigational device exemption, also referred to as IDE, allows the investigational device to be used in a clinical study pending FDA
clearance in order to collect safety and effectiveness data required to support the Premarket Approval, also referred to as PMA, application
or a Premarket Notification pursuant to 510(k), submission to the FDA. Clinical studies are most often conducted to support a PMA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the most part, however, we have not found it necessary to utilize IDE&#8217;s. The standard 90 day clearance for our new MRI scanner
products classified as Class II products makes the IDE unnecessary, particularly in view of the time and effort involved in compiling
the information necessary to support an IDE.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Quality
System Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Quality Management System is applicable to the design, manufacture, administration of installation and servicing of magnetic resonance
imaging scanner systems. The FDA has authority to conduct detailed inspections of manufacturing plants, to establish Good Manufacturing
Practices which must be followed in the manufacture of medical devices, to require periodic reporting of product defects and to prohibit
the exportation of medical devices that do not comply with the law.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Device Reporting Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturers
must report all MDR reportable events to the FDA. Each manufacturer must review and evaluate all complaints to determine whether the
complaint represents an event which is required to be reported to FDA. Section 820.3(b) of the Quality Systems regulation defines a complaint
as, &#8220;any written, electronic or oral communication that alleges deficiencies related to the identity, quality, durability, reliability,
safety, effectiveness, or performance of a device after it is released for distribution.&#8221;&#160;</span></p>


<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
report is required when a manufacturer becomes aware of information that reasonably suggests that one of their marketed devices has or
may have caused or contributed to a death, serious injury, or has malfunctioned and that the device or a similar device marketed by the
manufacturer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Malfunctions
are not reportable if they are not likely to result in a death, serious injury or other significant adverse event experience.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
malfunction which is or can be corrected during routine service or device maintenance still must be reported if the recurrence of the
malfunction is likely to cause or contribute to a death or serious injury if it were to recur.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have established and maintained written procedures for implementation of the MDR regulation. These procedures include internal systems
that:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">provide
for timely and effective identification, communication and evaluation of adverse</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">events;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">provide
a standardized review process and procedures for determining whether or not an</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">event
is reportable; and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">provide
procedures to insure the timely transmission of complete reports.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">These
procedures also include documentation and record keeping requirements for information that was evaluated to determine if an event
was reportable;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">all
medical device reports and information submitted to the FDA;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">any
information that was evaluated during preparation of annual certification reports; and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">systems
that ensure access to information that facilitates timely follow up and inspection by</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA
Enforcement</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA
may take the following actions to enforce the MDR regulation:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA-Initiated
or Voluntary Recalls</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recalls
are regulatory actions that remove a hazardous, potentially hazardous, or a misbranded product from the marketplace. Recalls are also
used to convey additional information to the user concerning the safe use of the product. Either FDA or the manufacturer can initiate
recalls.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
are three classifications, i.e., I, II, or III, assigned by the Food and Drug Administration to a particular product recall to indicate
the relative degree of health hazard presented by the product being recalled.&#160;</span></p>


<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
I</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Is
a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse
health consequences or death.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
II</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Is
a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences
or where the probability of serious adverse health consequences is remote.&#8195;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
III</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Is
a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif; background-color: white">FONAR
has initiated six voluntary recalls, which occurred between 1987-2016.&#160; Five of the recalls were Class II and one was Class III.
The recalls involved making minor corrections to the product in the field. Frequently, corrections which are made at the site of the
device are called field corrections as opposed to recalls.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Civil
Money Penalties</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
FDA, after an appropriate hearing, may impose civil money penalties for violations of the FD&amp;C Act that relate to medical devices.
In determining the amount of a civil penalty, FDA will take into account the nature, circumstances, extent, and gravity of the violations,
the violator&#8217;s ability to pay, the effect on the violator&#8217;s ability to continue to do business, and any history of prior
violations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Warning
Letters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FDA
issues written communications to a firm, indicating that the firm may incur more severe sanctions if the violations described in the
letter are not corrected. Warning letters are issued to cause prompt correction of violations that pose a hazard to health or that involve
economic deception. The FDA generally issues the letters before pursuing more severe sanctions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Seizure</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
seizure is a civil court action against a specific quantity of goods which enables the FDA to remove these goods from commercial channels.
After seizure, no one may tamper with the goods except by permission of the court. The court usually gives the owner or claimant of the
seized merchandise approximately 30 days to decide a course of action. If they take no action, the court will recommend disposal of the
goods. If the owner decides to contest the government&#8217;s charges, the court will schedule the case for trial. A third option allows
the owner of the goods to request permission of the court to bring the goods into compliance with the law. The owner of the goods is
required to provide a bond or, security deposit, to assure that they will perform the orders of the court, and the owner must pay for
FDA supervision of any activities by the company to bring the goods into compliance.</span></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Citation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
citation is a formal warning to a firm of intent to prosecute the firm if violations of the FD&amp;C Act are not corrected. It provides
the firm an opportunity to convince FDA not to prosecute.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Injunction</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">An
injunction is a civil action filed by FDA against an individual or company. Usually, FDA files an injunction to stop a company from continuing
to manufacture, package or distribute products that are in violation of the law.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prosecution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prosecution
is a criminal action filed by FDA against a company or individual charging violation of the law for past practices.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
and Export Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
obtain approvals as necessary in connection with the sales of our products in foreign countries. In some cases, FDA approval has been
sufficient for foreign sales as well. Our standard practice has been to require either the distributor or the customer to obtain any
such foreign approvals or licenses which may be required.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legally
marketed devices that comply with the requirements of the Food Drug &amp; Cosmetic Act require a Certificate to Foreign Government issued
by the FDA for export. Other devices that do not meet the requirements of the FD&amp;C Act but comply with the laws of a foreign government
require a Certificate of Exportability issued by the FDA. All products which we sell have FDA clearance and would fall into the first
category.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
governments have differing requirements concerning the import of medical devices into their respective jurisdictions. The European Union&#8217;s
new medical device regulation, EU 2017/745 went into effect on May 25, 2021, and contains significant changes from the prior European
regulatory scheme. We have applied to the Notified Body, TUV-SUD, to perform a Conformity Assessment of our technical documentation and
our Quality Management System.&#160; We (optimistically) expect to have this completed by end of our third quarter, March 30, 2024.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
countries require that their own testing laboratories perform an evaluation of our devices. This requires that we must bring the foreign
agency&#8217;s personnel to the USA to perform the evaluation at our expense before exporting.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Some
countries, including many in Latin America and Africa, have very few regulatory requirements, beyond FDA clearance.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">To
date, FONAR has been able to comply with all foreign regulatory requirements applicable to its export sales.&#160;</span></p>


<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PHYSICIAN
AND DIAGNOSTIC SERVICES MANAGEMENT BUSINESS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Health
Diagnostics Management, LLC (HDM) is owned by Health Management Corporation of America (70.8%) and investors (29.2%). Health Management
Corporation of America is owned 100% by FONAR Corporation. During the fiscal year 2022, the Company purchased non-controlling interests
from the minority shareholders for $546,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HDM
operates under the assumed name &#8220;Health Management Company of America&#8221; (&#8220;HMCA&#8221;).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
combined business (HDM and Health Management Corporation of America) will be referred to as &#8220;HMCA&#8221; for all periods before
and after July 1, 2015, unless otherwise indicated.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
provides comprehensive non-medical management services to diagnostic imaging facilities. These services include administrative services,
billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring,
conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment,
repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth
and marketing strategies.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2023, HMCA managed a total of 41 MRI scanners of which twenty-four (24) scanners are located in New York and seventeen (17)
scanners are located in Florida. For the 2023 fiscal year, the revenues HMCA recognized from the MRI facilities has increased to $90.4
million from $89.4 million in fiscal 2022. Six of the facilities in Florida are owned by HMCA subsidiaries, where the corporate practice
of medicine is permitted.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
believe the utilization of FONAR Upright&#174; MRI scanning systems, which are produced under the protection of our patents, accounts
for the historically robust patient volume at the scanning facilities. During fiscal 2023, two scanners were installed in Casselberry,
Florida. We completed the consolidation of our two Manhattan centers into their new location in Midtown, removing the scanner previously
located at Avenue A. The extremity-only scanner at our Brooklyn location was deemed to be passed its useful life and was removed from
service.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
GROWTH STRATEGY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
growth strategy focuses on upgrading and expanding the existing facilities it manages and expanding the number of facilities it either
owns or manages for its clients, including new sites. In connection with improving the performance of the facilities, we have added high
field MRI scanners, extremity scanners and x-ray machines to the Upright&#174; MRI scanners at certain of the sites where such additional
diagnostic imaging modalities are expected to produce the greatest return.&#160;</span></p>


<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PHYSICIAN
AND DIAGNOSTIC MANAGEMENT SERVICES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
services to the facilities it manages encompass substantially all of their business operations. Each facility is controlled, however,
not by HMCA, but by the physician owner, or in the case of the six Florida sites owned by HMCA subsidiaries, by the medical director.
All medical services are performed by physicians and other medical personnel under the physician-owner&#8217;s supervision. HMCA is the
management company and performs services of a non-medical nature. These services include:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.
Offices and Equipment. HMCA identifies, negotiates leases for and/or provides office space and equipment to its clients. This includes
technologically sophisticated medical equipment. HMCA also provides improvements to leaseholds, assistance in site selection and advice
on improving, updating, expanding and adapting to new technology.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.
Personnel. HMCA staffs all the non-medical positions of its clients with its own employees, eliminating the client&#8217;s need to interview,
train and manage non-medical employees. HMCA processes the necessary tax, insurance and other documentation relating to employees.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.
Administrative. HMCA assists in the scheduling of patient appointments, purchasing of office and medical supplies and equipment and handling
of reporting, accounting, processing and filing systems. It prepares and files the physician portions of complex applications to enable
its clients to participate in managed care programs and to qualify for insurance reimbursement. HMCA assists the clients to implement
programs and procedures to ensure full and timely regulatory compliance and appropriate cost reimbursement under no-fault insurance and
Workers&#8217; Compensation guidelines, as well as compliance with other applicable governmental requirements and regulations, including
HIPAA and other privacy requirements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;4.
Billing and Collections. HMCA is responsible for the billing and collection of revenues from third-party payors including those governed
by No-Fault and Workers&#8217; Compensation statutes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.
Cost Saving Programs. Based on available volume discounts, HMCA seeks to assist in obtaining favorable pricing for office and medical
supplies, medical imaging film, equipment, contrast agents, such as gadolinuim, and magnavist and other inventory for its clients.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.
Diagnostic Imaging and Ancillary Services. HMCA can offer access to diagnostic imaging equipment through diagnostic imaging facilities
it manages. The Company is expanding the ancillary services offered in its network to include x-rays, and other MRI equipment such as
high-field (1.5 or 3.0 Tesla magnet strength) MRI scanners and extremity MRI scanners.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7.
Marketing Strategies. HMCA is responsible for developing and proposing marketing plans for its clients.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8.
Expansion Plans. HMCA assists the clients in developing expansion plans including the opening of new or replacement facilities where
appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
objective is to free physicians from as many non-medical duties as is practicable, allowing physicians to spend less time on business
and administrative matters and more time practicing medicine.</span></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
exceptions to this general model of operation are six of the facilities located in Florida. These Florida facilities are owned by limited
liability companies which, as our subsidiaries, conduct their operations directly and bill and collect their fees from the patients and
third-party payors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
facilities enter into contracts with third-party payors, including managed care companies. None of HMCA&#8217;s clients, however, participate
in any capitated plans or other risk sharing arrangements. Capitated plans are those HMO programs where the provider is paid a flat monthly
fee per patient.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
management fees payable by the facilities to HMCA are flat monthly fees. In fiscal 2023, the aggregate amount of active management fees
was $4,860,732 per month. In fiscal 2022, the aggregate amount of active management fees was $4,865,443 per month.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fees
under the management agreements are subject to adjustment by mutual agreement on an annual basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian currently owns three HMCA-managed MRI facilities in Florida. The facilities were owned by Dr. Damadian until his passing in
August of 2022. The fees for these three sites are flat monthly fees which are subject to adjustment by mutual agreement on an annual
basis. In fiscal 2023 and fiscal 2022, the aggregate monthly amount of management fees payable to HMCA by these sites was $995,825.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
six Florida facilities owned by HMCA subsidiaries directly bill their patients or the patients&#8217; insurance carriers. Patient fees
net of provision for bad debts were $29,793,993 in fiscal 2023 as compared to $29,582,238 in fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
had previously contracted with an outside billing company (located in Melville, New York) which performed billing and collection for
their clients&#8217; No-Fault and Workers&#8217; Compensation business. The Company had entered into a one year renewable agreement to
provide IT services to the billing company for a monthly fee of $23,884. This agreement was terminated on May 31, 2023. HMCA has been
handling these billing and collection services internally since the termination of this agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
MARKETING</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
marketing strategy is to expand the business and improve the facilities which it manages. HMCA is seeking to increase the number of locations
of those facilities where market conditions are promising and to promote growth of our clients&#8217; and Florida subsidiaries&#8217;
patient volume and revenue.&#160;</span></p>


<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">DIAGNOSTIC
IMAGING FACILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
imaging facilities managed by HMCA provide diagnostic imaging services to patients referred by physicians. The facilities are operated
in a manner which eliminates the admission and other administrative inconveniences of in-hospital diagnostic imaging services. Imaging
services are performed in an outpatient setting by trained medical technologists under the direction of physicians. Following diagnostic
procedures, the images are reviewed by the interpreting physicians who prepare reports of these tests and their findings. The vast majority
of reports for the New York facilities are transcribed by HMCA personnel and the remainder are outsourced to professional transcription
services. Reports for the Florida facilities are outsourced to professional transcription services.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
develops marketing programs and educational programs in an effort to establish and maintain referring physician relationships for our
clients and Florida subsidiaries.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
care providers are an important factor in the diagnostic imaging industry. To further its position, HMCA is seeking to expand the imaging
modalities offered at its managed and owned diagnostic imaging facilities. Four facilities in New York and eight facilities in Florida
have two or more MRI scanners. One facility in New York and two in Florida also perform X-rays. During fiscal 2023, a new location was
opened in Casselberry, Florida.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">REIMBURSEMENT</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
clients receive reimbursements for their services through Medicare, Medicaid, managed care, private commercial insurance, third-party
administrators, Workers&#8217; Compensation, No-Fault and other insurance.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Medicare program provides reimbursement for hospitalization, physician, diagnostic and certain other services to eligible persons 65
years of age and over and certain other individuals. Providers are paid by the federal government in accordance with regulations promulgated
by the Department of Health and Human Services, HSS, and generally accept the payment with nominal deductible and co-insurance amounts
required to be paid by the service recipient, as payment in full. Hospital inpatient services are reimbursed under a prospective payment
system. Hospitals receive a specific prospective payment for inpatient treatment services based upon the diagnosis of the patient.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Under
Medicare&#8217;s prospective payment system for hospital outpatient services, or OPPS, a hospital is paid for outpatient services on
a rate per service basis that varies according to the ambulatory payment classification group, or APC, to which the service is assigned
rather than on a hospital&#8217;s costs. Each year the Centers for Medicare and Medicaid Services, or CMS, publishes new APC rates that
are determined in accordance with the promulgated methodology.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Services
provided in non-hospital based freestanding facilities are paid under the Medicare Physician Fee Schedule, or MPFS. All of HMCA&#8217;s
clients are presently in this category. The MPFS is updated on an annual basis and sometimes modified more frequently.</span></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have experienced reimbursement reductions for radiology services provided to Medicare beneficiaries, including reductions pursuant to
the Deficit Reduction Act, or DRA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CMS&#8217;
2010 regulatory changes to the MPFS included a downward adjustment to services primarily involving the technical component rather than
the physician work component, by adjusting downward malpractice payments for these services. These adjustments have been phased in over
a four year period. For our fiscal year ended June 30, 2023, Medicare revenues represented approximately 2.9% of the revenues for HMCA&#8217;s
clients and subsidiaries as compared to 3.2% for the fiscal year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicaid</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Medicaid program is a jointly-funded federal and state program providing coverage for low-income persons. In addition to federally-mandated
basic services, the services offered and reimbursement methods vary from state to state. In many states, Medicaid reimbursement is patterned
after the Medicare program; however, an increasing number of states have established or are establishing payment methodologies intended
to provide healthcare services to Medicaid patients through managed care arrangements. In fiscal 2023, approximately 0.05% of the revenues
of HMCA&#8217;s clients were attributable to Medicaid, as compared to 0.07% in fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
Care and Private Insurance</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Health
Maintenance Organizations, or HMO&#8217;s, Preferred Provider Organizations, or PPOs, and other managed care organizations attempt to
control the cost of healthcare services by a variety of measures, including imposing lower payment rates, preauthorization requirements,
limiting services and mandating less costly treatment alternatives. Managed care contracting is competitive and reimbursement schedules
in many cases can be at or below Medicare reimbursement levels. Some managed care organizations have reduced or otherwise limited, and
other managed care organizations may reduce or otherwise limit, reimbursement in response to reductions in government reimbursement.
These reductions could have an adverse impact on our financial condition and results of operations. These reductions have been, and any
future reductions may be, similar to the reimbursement reductions previously proposed.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
COMPETITION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
physician and diagnostic management services field is highly competitive. A number of large hospitals have acquired medical practices
and this trend may continue. HMCA expects that more competition will develop. Many competitors have greater financial and other resources
than HMCA.&#160;</span></p>


<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">With
respect to the diagnostic imaging facilities managed by HMCA, the outpatient diagnostic imaging industry is highly competitive. Competition
focuses primarily on attracting physician referrals at the local market level and increasing referrals through relationships with managed
care organizations, as well as emphasizing to potential referral sources the advantages of Upright&#174; MRI scanning. HMCA believes that
principal competitors for the diagnostic imaging centers are hospitals and independent or management company-owned imaging centers. Competitive
factors include quality and timeliness of test results, ability to develop and maintain relationships with managed care organizations
and referring physicians, type and quality of equipment, facility location, convenience of scheduling and availability of patient appointment
times. HMCA believes that it will be able to effectively meet the competition in the outpatient diagnostic imaging industry with the
FONAR Upright&#174; MRI scanners and strategically placed high field MRI scanners at its facilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">GOVERNMENT
REGULATION APPLICABLE TO HMCA</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FEDERAL
REGULATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
healthcare industry is highly regulated and changes in laws and regulations can be significant. Changes in the law or new interpretation
of existing laws can have a material effect on our permissible activities, the relative costs associated with doing business and the
amount of reimbursement by government and other third-party payors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
False Claims Act</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
federal False Claims Act and, in particular, the False Claims Act&#8217;s &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; provisions
allow a private individual to bring actions in the name of the government alleging that a defendant has made false claims for payment
from federal funds. After the individual has initiated the lawsuit the government must decide whether to intervene in the lawsuit and
to become the primary prosecutor. If the government declines to join the lawsuit, the individual may choose to pursue the case alone,
although the government must be kept apprised of the progress of the lawsuit, and may intervene later. Whether or not the federal government
intervenes in the case, it will receive the majority of any recovery.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">When
an entity is determined to have violated the federal False Claims Act, it must pay three times the actual damages sustained by the government,
plus mandatory civil penalties for each separate false claim and the government&#8217;s attorneys&#8217; fees. Liability arises when
an entity knowingly submits, or causes someone else to submit, a false claim for reimbursement to the federal government. The False Claims
Act defines the term &#8220;knowingly&#8221; broadly, though simple negligence will not give rise to liability under the False Claims
Act. Examples of the other actions which may lead to liability under the False Claims Act are set forth below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Failure
to comply with the many technical billing requirements applicable to our Medicare and Medicaid business;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Failure
to comply with the prohibition against billing for services ordered or supervised by a physician who is excluded from any federal healthcare
program, or the prohibition against employing or contracting with any person or entity excluded from any federal healthcare program;</span></p>


<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Failure
to comply with the Medicare physician supervision requirements for the services we provide, or the Medicare documentation requirements
concerning physician supervision.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Fraud Enforcement and Recovery Act of 2009 expanded the scope of the False Claims Act by, among other things, broadening protections
for whistleblowers and creating liability for knowingly retaining a government overpayment, acting in deliberate ignorance of a government
overpayment or acting in reckless disregard of a government overpayment. The healthcare reform bills in the form of the Patient Protection
and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, &#8220;PPACA&#8221;) expanded
on changes made by the 2009 Fraud Enforcement and Recovery Act with regard to such &#8220;reverse false claims.&#8221; Under PPACA, the
knowing failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost
report is due, whichever is later, constitutes a violation of the False Claims Act. HMCA and its clients have never been sued under the
False Claims Act and believe they are in compliance with the law.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stark
Law</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Under
the federal Self-Referral Law, also referred to as the &#8220;Stark Law&#8221;, which is applicable to Medicare and Medicaid patients,
and the self-referral laws of various States, certain health practitioners, including physicians, chiropractors and podiatrists, are
prohibited from referring their patients for the provision of designated health services, including diagnostic imaging and physical therapy
services, to any entity with which they or their immediate family members have a financial relationship, unless the referral fits within
one of the specific exceptions in the statutes or regulations. The federal government has taken the position that a violation of the
federal Stark Law is also a violation of the Federal False Claims Act. Statutory exceptions under the Stark Law include, among others,
direct physician services, in-office ancillary services rendered within a group practice, space and equipment rental and services rendered
to enrollees of certain prepaid health plans. Some of these exceptions are also available under the State self-referral laws. HMCA believes
that it and its clients are in compliance with these laws.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Anti-kickback
Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
are subject to federal and state laws which govern financial and other arrangements between healthcare providers. These include the federal
anti-kickback statute which, among other things, prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration,
direct or indirect, in cash or in kind, in return for or to induce the referral of patients for items or services covered by Medicare,
Medicaid and certain other governmental health programs. Under PPACA, knowledge of the anti-kickback statute or the specific intent to
violate the law is not required. Violation of the anti-kickback statute may result in civil or criminal penalties and exclusion from
the Medicare, Medicaid and other federal healthcare programs, and according to PPACA, now provides a basis for liability under the False
Claims Act. In addition, it is possible that private parties may file &#8220;qui tam&#8221; actions based on claims resulting from relationships
that violate the anti-kickback statute, seeking significant financial rewards. Many states have enacted similar statutes, which are not
limited to items and services paid for under Medicare or a federally funded healthcare program. Neither HMCA nor its clients engage in
this practice.</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
fiscal 2023, approximately 2.9% of the revenues of HMCA&#8217;s clients were attributable to Medicare and 0.05% were attributable to
Medicaid. In fiscal 2022, approximately 3.2% of the revenues of HMCA&#8217;s clients were attributable to Medicare and 0.07% were attributable
to Medicaid.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deficit
Reduction Act (DRA)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
February 8, 2006, the President signed into law the DRA. Effective January 1, 2007, the DRA provides that Medicare reimbursement for
the technical component for imaging services (excluding diagnostic and screening mammography) performed in freestanding facilities will
be capped. Payment is the lesser of the Medicare Physician Fee Schedule or the Hospital Outpatient Prospective Payment System (OPPS)
rates. Implementation of these reimbursement reductions contained in the DRA has had an adverse effect on our business. We have been
able to counter this effect by increasing our clients&#8217; scan volumes through our vigorous marketing efforts and reducing our operating
expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
DRA also codified the reduction in reimbursement for multiple images on contiguous body parts previously announced by CMS, the agency
responsible for administering the Medicare program. In November 2005, CMS announced that it would pay 100% of the technical component
of the higher priced imaging procedure and 50% of the technical component of each additional imaging procedure for imaging procedures
involving contiguous body parts within a family of codes when performed in the same session. CMS had indicated that it would phase in
this 50% rate reduction over two years, so that the reduction was 25% for each additional imaging procedure in 2006 and another 25% reduction
in 2007. However, for services furnished on or after July 1, 2010, the PPACA requires the full 50% reduction to be implemented.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Health
Insurance Portability and Accountability Act</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Congress
enacted the Health Insurance Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect
the privacy and security of patients&#8217; individually identifiable healthcare information. HIPAA, among other things, amends existing
crimes and criminal penalties for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-governmental
healthcare benefit programs by means of false or fraudulent representations in connection with the delivery of healthcare services is
subject to a fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against
entities that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services
to federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business, financial
condition and results of operations.&#160;</span></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Further,
HIPAA requires healthcare providers and their business associates to maintain the privacy and security of individually identifiable protected
health information (&#8220;PHI&#8221;). HIPAA imposes federal standards for electronic transactions, for the security of electronic health
information and for protecting the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;),
signed into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business
associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2)
substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals,
DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition
on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties
that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per occurrence. In 2013
additional legal requirements were adopted to provide further protection for PHI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, many states have enacted comparable privacy and security statues or regulations that, in some cases, are most stringent than
HIPAA requirements. In those cases it may be necessary to modify our operations and procedures to comply with the more stringent state
laws, which may entail significant and costly changes for us. We believe that we are in compliance with such state laws and regulations.
However, if we fail to comply with applicable state laws and regulations, we could be subject to sanctions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
believe that we are in compliance with the current HIPAA requirements, as amended by HITECH, together with other legislation and regulations,
and comparable state laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot
guarantee that enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or
the interpretations of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards
may result in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs,
including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results
of operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Civil
Money Penalty Law and Other Federal Statutes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Civil Money Penalty, or CMP, law covers a variety of practices. It provides a means of administrative enforcement of the anti-kickback
statute, and prohibits false claims, claims for medically unnecessary services, violations of Medicare participating provider or assignment
agreements and other practices. The statute gives the Office of Inspector General of the HHS the power to seek substantial civil fines,
exclusion and other sanctions against providers or others who violate the CMP prohibitions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, in 1996, Congress created a new federal crime: healthcare fraud and false statements relating to healthcare matters. The healthcare
fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors.
A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs such as
the Medicare and Medicaid programs.</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Certificates
of Need</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Some
states require hospitals and certain other healthcare facilities and providers to obtain a certificate of need, or CON, or similar regulatory
approval prior to establishing certain healthcare operations or services, incurring certain capital projects and/or the acquisition of
major medical equipment including MRI and PET/CT systems. We are not operating in any such states.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
Protection and Affordable Care Act</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 23, 2010, President Obama signed into law healthcare reform legislation in the form of PPACA. The implementation of this law has
had a significant impact on the healthcare industry. Most of the provisions of PPACA are being phased in over time and can be conceptualized
as a broad framework not only to provide health insurance coverage to millions of Americans, but to fundamentally change the delivery
of care by bringing together elements of health information technology, evidence-based medicine, chronic disease management, medical
&#8220;homes,&#8221; care collaboration and shared financial risk in a way that will accelerate industry adoption and change. We are
unable to predict the full impact of PPACA at this time primarily due to the previous administration&#8217;s efforts to repeal and replace
the PPACA, or to utilize executive action to modify the Act&#8217;s provisions where possible.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
Regulation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition to the federal self-referral law and federal Anti-kickback statute, many States, including those in which HMCA and its clients
operate, have their own versions of self-referral and anti-kickback laws. These laws are not limited in their applicability, as are the
federal laws, to specific programs. HMCA believes that it and its clients are in compliance with these laws.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Various
States prohibit business corporations from practicing medicine. Various States, including New York, also prohibit the sharing of professional
fees or fee splitting. Consequently, in New York HMCA leases space and equipment to clients and provides clients with a range of non-medical
administrative and managerial services for agreed upon fees. Under Florida law a business entity can bill patients and third-party payors
directly if that entity is properly licensed through AHCA. All of the nine facilities in Florida are licensed healthcare clinics through
AHCA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
clients and subsidiaries generate revenue from patients covered by no-fault insurance and workers&#8217; compensation programs. For the
fiscal year ended June 30, 2023 approximately 58.4% of our clients&#8217; receipts were from patients covered by no-fault insurance and
approximately 8.6% of our client&#8217;s receipts were from patients covered by workers&#8217; compensation programs. For the fiscal
year ended June 30, 2022, approximately 57.7.% of HMCA&#8217;s clients&#8217; receipts were from patients covered by no-fault insurance
and approximately 8.6% of HMCA&#8217;s clients&#8217; receipts were from patients covered by workers&#8217; compensation programs. The
foregoing numbers do not include payments from third-party administrators. In the event that changes in these laws alter the fee structures
or methods of providing service, or impose additional or different requirements, HMCA could be required to modify its business practices
and services in ways that could be more costly to HMCA or in ways that decrease the revenues which HMCA receives from its clients.</span></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Compliance
Program</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
maintain a program to monitor compliance with federal and state laws and regulations applicable to the healthcare entities. The compliance
program includes the adoption of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees,
affiliates and others may report regulatory or ethical concerns. We believe that our compliance program meets the relevant standards
provided by the Office of Inspector General of the Department of Health and Human Services.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">An
important part of our compliance program consists of conducting periodic audits of various aspects of our operations and that of the
contracted radiology practices. We also assist our clients with educational programs designed to familiarize them with the regulatory
requirements and specific elements of our compliance program.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
believes that it and its clients are in compliance with applicable Federal, State and local laws. HMCA does not believe that such laws
will have any adverse material effect on its business.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">EMPLOYEES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
and HMCA had approximately &#160;&#160;561 employees as of September 12, 2023. This total number included employees engaged in production,
customer support, research and development, information technology, employees engaged in marketing and sales, billing and collection,
legal and compliance matters, as well as transcriptionists, Florida technologists, field service technicians and individuals in various
administrative positions. A significant number of employees were employed at the MRI facilities managed or owned by HMCA, primarily in
administrative positions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="RiskFactors"></span>ITEM
1A. RISK FACTORS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;An
investment in our securities is subject to various risks, the most significant of which are summarized below.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reduced
                                            Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted
                                            by HMCA. Our scanning center clients and the Florida facilities owned by HMCA are experiencing
                                            lower reimbursement rates from Medicare, other government programs and private insurance
                                            companies. To the extent possible, we counter these reductions by increasing scanning volume
                                            and controlling operating expenses. Inflation in the cost of both materials and labor have
                                            limited our ability to control our costs, negatively impacting our ability to maintain profitability
                                            in this business segment.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inflation
                                            and Increasing Interest Rates. Inflation has drastically increased our costs for both materials
                                            and labor. The Federal Reserve has increased interest rates substantially in an attempt to
                                            control inflation, which in turn has increased the cost of capital. Diagnostic imaging facilities
                                            require significant amounts of capital to operate, particularly in the context of opening
                                            new diagnostic imaging centers. These increased costs make it more difficult to achieve organic
                                            growth and extend the time that a new center takes to achieve profitability. Continued costs
                                            increases, coupled with reduced reimbursement rates, may threaten the profitability of our
                                            current operations and cause the cost of expansion to become prohibitively high.<br /></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Demand
                                            for MRI Scanners. The reduced margins have a negative effect on our sales of MRI scanners.
                                            With lower revenue projections, prospective customers demand lower prices for scanners. Although
                                            the reduced reimbursements may not affect foreign demand, a lower number of sales in the
                                            aggregate could reduce economies of scale and consequently, profit margins.</span></td></tr></table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
                                            Competition. Many if not most of our competing scanner manufacturers have significantly greater
                                            financial resources, production capacity, and other resources than we do. Such competitors
                                            would include General Electric, Siemens, Hitachi and Phillips. Although FONAR is the only
                                            company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner,
                                            potential customers must be convinced that the purchase of a FONAR scanner is their best
                                            choice. We believe that with time, that objective will be reached, particularly with customers
                                            scanning patients having neck, back, knee and various orthopedic issues who would benefit
                                            from being scanned in weight-bearing positions.</span></td></tr></table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dependence
                                            on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from
                                            fees charged for the diagnostic imaging services performed at the facilities. We depend on
                                            referrals of patients from unaffiliated physicians and other third parties to the facilities
                                            we manage or own for the services we perform. If these physicians and other third parties
                                            were to reduce the number of patients they refer or discontinue referring patients, scan
                                            volumes could decrease, which would reduce our net revenue and operating margins.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pressure
                                            to Control Healthcare Costs. One of the principal objectives of health maintenance organizations
                                            and preferred provider organizations is to control the cost of healthcare services. Healthcare
                                            providers participating in managed care plans may be required to refer diagnostic imaging
                                            tests to certain providers depending on the plan in which a covered patient is enrolled.
                                            In addition, managed care contracting has become very competitive. The expansion of health
                                            maintenance organizations, preferred provider organizations and other managed care organizations
                                            in New York or Florida could have a negative impact on the utilization and pricing of services
                                            performed at the facilities HMCA manages or owns to the extent these organizations exert
                                            control over patients&#8217; access to diagnostic imaging services, selections of the provider
                                            of such services and reimbursement rates for those services.</span></td></tr></table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Scanning
                                            Facility Competition. The market for diagnostic imaging services is highly competitive. The
                                            facilities we manage or own compete for patients on the basis of reputation, location and
                                            the quality of diagnostic imaging services. Groups of radiologists, established hospitals,
                                            clinics and other independent organizations that own and operate imaging equipment are the
                                            principal competitors.</span></td></tr></table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Eligibility
                                            Changes to Insurance Programs. Due to potential decreased availability of healthcare through
                                            private employers, the number of patients who are uninsured or participate in governmental
                                            programs may increase. Healthcare reform legislation will increase the participation of individuals
                                            in the Medicaid program in states that elect to participate in the expanded Medicaid coverage.
                                            A shift in payor mix from managed care and other private payors to government payors or an
                                            increase in the number of uninsured patients may result in a reduction in the rates of reimbursement
                                            or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease
                                            in net revenue. Policies now being offered under various insurance plans are expected to
                                            reduce demand for MRI scans as they become less affordable. Changes in the eligibility requirements
                                            for governmental programs such as the Medicaid program and state decisions on whether to
                                            participate in the expansion of such programs also could increase the number of patients
                                            who participate in such programs and the number of uninsured patients. Even for those patients
                                            who remain in private insurance plans, changes to those plans could increase patient financial
                                            responsibility, resulting in a greater risk of uncollectible receivables. These factors and
                                            events could have a material adverse effect on our business, financial condition, and results
                                            of operations.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
                                            and future changes in Florida Insurance Law. On March 24, 2023, Florida Governor Ron DeSantis
                                            signed into law House Bill 837. Dubbed the Tort Reform Act, the bill makes sweeping changes
                                            to Florida&#8217;s negligence laws, including reducing the statute of limitations, barring
                                            recovery for plaintiffs who are found to be 50% or greater at fault, and changing the rule
                                            of evidence regarding admissibility of the costs of prior and future medical treatment. The
                                            bill is viewed as a boon to insurance companies, and is largely aimed at reducing the cost
                                            of personal injury lawsuits to insurers operating in Florida&#8217;s motor vehicle and general
                                            liability markets. The full impact of the bill remains to be seen. Certain provisions of
                                            the bill are expected to negatively impact our reimbursement percentage and/or reimbursement
                                            rates. We expect that some percentage of our patients who are seeking treatment following
                                            motor vehicle accidents will not meet the new 51% threshold, and as a result we expect an
                                            increase in the percentage of uncollectible billings from those patients. We are unable to
                                            estimate what that percentage might be.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Further,
changes to the evidentiary admissibility rules may lead to a higher percentage of our billings being paid at commercial rates instead
of at the presently prevailing PIP schedule, a reduction in reimbursement of approximately 60%. These changes will negatively impact
our Florida diagnostic imaging facilities (both those we own and those we manage) with more unpaid bills, and lower reimbursement rates.
The full extent of those reductions are unclear at this time.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition to the above, Florida legislature continues to propose an outright repeal of Florida&#8217;s No-Fault law. SB 586 and its companion
statue H 429, again propose a repeal of Personal Injury Protection and replacing it with $25,000 Bodily Injury Coverage and Property
Damage Liability Coverage. We cannot predict whether Florida will continue to pursue the repeal of the No-Fault Law in light of the passage
of HB 837, and whether such efforts will be successful.</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
                                            and state privacy and information security laws. We must comply with numerous federal and
                                            state laws and regulations governing the collection, dissemination, access, use, security
                                            and privacy of PHI, including HIPAA and its implementing privacy and security regulations,
                                            as amended by the federal HITECH Act. If we fail to comply with applicable privacy and security
                                            laws, regulations and standards, properly maintain the integrity of our data, protect our
                                            proprietary rights to our systems, or defend against cybersecurity attacks, our business,
                                            reputation, results of operations, financial position and cash flows could be materially
                                            and adversely affected.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
security risks have significantly increased in recent years because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers,
terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and
storage of confidential, proprietary and other information in our computer systems and networks.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11.</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
                                            changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from
                                            adverse changes in general domestic and global economic conditions, including recession or
                                            economic slowdown and disruption of credit markets. Turbulence and uncertainty in the United
                                            States and international markets and economies may adversely affect our liquidity, financial
                                            condition, revenues, profitability and business operations generally.</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="UnresolvedStaffComments"></span>ITEM
1B. UNRESOLVED STAFF COMMENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">None.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Properties"></span>ITEM
2. PROPERTIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
and HMCA currently lease approximately 78,000 square feet of office and plant space at its principal offices in Melville, New York.
The term of the lease runs through November, 2026. Management believes that the premises will be adequate for its current needs.
HMCA also maintains office space for the Facilities owned by its subsidiaries in Florida and for its clients at the clients&#8217;
sites in New York and Florida under leases having various terms. HMCA owns the building for the client&#8217;s premises in
Tallahassee, Florida. The Company received approval from the Suffolk County Industrial Development Agency on February 29, 2016 of a 50%
property tax abatement, valued at $440,000, over a 10 year period commencing January, 2017.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="LegalProceedings"></span>ITEM
3. LEGAL PROCEEDINGS.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
are no material legal proceedings threatened or pending against the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Mine_Safety"></span>ITEM
4. MINE SAFETY DISCLOSURES.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br />
Not Applicable</span></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
II</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Stockholder_Matters"></span>ITEM
5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
Common Stock is traded on NASDAQ Capital Markets under the symbol FONR.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 12, 2023, we had approximately 996 stockholders of record of our Common Stock, 12 stockholders of record of our Class B Common
Stock, 3 stockholders of record of our Class C Common Stock and 1,155 stockholders of record of our Class A Non-voting Preferred Stock.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
the present time, the only class of our securities for which there is a market is the Common Stock.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
currently have a policy of retaining earnings to finance the development and expansion of our business. We expect to continue this policy
for the foreseeable future.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Performance
Graph</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following graph compares the Company&#8217;s cumulative total stockholder return on its Common Stock against industry and broad-market
indexes which have been compiled by the Nasdaq Global Index Group. The periods commence on June 28, 2019 for five years and end on June
30, 2023.. The graph assumes $100 is invested in FONAR Common Stock (NASDAQ: FONR), the Nasdaq Composite Total Return (Nasdaq Composite),
Nasdaq Health Care Management Services (Nasdaq Health), and Nasdaq Medical Equipment (Nasdaq Equipment). The comparisons in the graph
below are based on historical data and are not intended to forecast the possible future performance of the common stock.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Date</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    28, <br />
    2019</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2020</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 30%; padding-left: 5.4pt; text-indent: -5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONR
    Common Stock</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">99</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">82</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">71</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">79</span></td>
    <td style="width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-indent: -5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Nasdaq
    Composite</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">184</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">141</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">178</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-indent: -5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Nasdaq
    Health</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">114</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">58</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">193</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">185</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-indent: -5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Nasdaq
    Equipment</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">106</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">54</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">129</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">145</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">]&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<img src="fonar_graph.jpg" alt="" style="height: 262px; width: 670px" /></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Reserved"></span>ITEM
6. [Reserved]</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Not
applicable.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="MDA"></span>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">INTRODUCTION.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
was formed in 1978 to engage in the business of designing, manufacturing and selling MRI scanners. HMCA, a subsidiary of FONAR, provides
management services to diagnostic imaging facilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR&#8217;s
principal MRI product is its Upright&#174; MRI (also called Stand-Up&#174; MRI) scanner. The Upright&#174; MRI allows patients to be scanned
for the first time under weight-bearing conditions. The Stand-Up&#174; MRI is the only MRI capable of producing images in the weight-bearing
state.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
0.6 Tesla field strength, the Upright&#174; MRI is among the highest field open MRI scanners in the industry, offering non-claustrophobic
MRI together with high-field image quality. FONAR&#8217;s open MRI scanners were the first high field strength open MRI scanners in the
industry.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">HMCA
generates revenues from providing comprehensive management services, including development, administration, accounting, billing and collection
services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues are in the form
of fees which are earned under contracts with HMCA&#8217;s clients except for its six Florida subsidiaries which engage in the practice
of medicine, and bill and collect fees from patients, insurers and other third-party payors directly.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Since
March, 2020, the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international economies which
have adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company
has been able to navigate through these challenges and avoid any significant disruption of the business and the volume has risen back
to pre-COVID-19 levels. Although we are unable to predict if there will be additional consequences on our operations, the Company believes
with the positive cash flows, low debt and cash on hand, it will be able to continue operations going forward.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CRITICAL
ACCOUNTING POLICIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
discussion and analysis of financial condition and results of operations are based on our consolidated financial statements that were
prepared in accordance with U.S. generally accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing
financial statements. These estimates and assumptions affect various matters, including:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
disclosure of contingent assets and liabilities at the dates of the financial statements; and Our reported amounts of net revenue and
expenses in our consolidated statements of operations during the reporting periods.</span></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">These
estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control.
As a result, actual amounts could differ materially from these estimates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a
company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment,
often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent
periods. In the notes to our consolidated financial statements, we discuss our significant accounting policies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our
consolidated financial statements. We recognize revenue and related costs of revenue from sales contracts for our MRI scanners and major
upgrades, under the percentage-of-completion method. Under this method, we recognize revenue and related costs of revenue, as each sub-assembly
is completed. Amounts received in advance of our commencement of production are recorded as customer advances.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
continuously, qualitatively and quantitatively evaluate the realizability (including both positive and negative evidence) of the net
deferred tax assets and assess the valuation allowance periodically. Our evaluation considers the financial condition of the Company
and both the business conditions and regulatory environment of the industry. If future taxable income or other factors are not consistent
with our expectations, an adjustment to our allowance for net deferred tax assets may be required. For net deferred tax assets we consider
estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely
than not to be realized. Our ability to project future taxable income may be significantly affected by our ability to determine the impact
of regulatory changes which could adversely affect our future profits. As a result, the benefits of our net operating loss carry forwards
could expire before they are utilized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
June 30, 2022, the net deferred tax asset was valued at $12,842,478. At June 30, 2023, the net deferred tax asset was valued at $10,041,960.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use
the shorter of the assets useful lives or the lease term of the facility for which these assets are associated.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company provides for medical receivables that could become uncollectible by establishing an allowance for doubtful accounts in order
to adjust medical receivables to estimated net realizable value. In evaluating the collectability of medical receivables, the Company
considers a number of factors, including the age of the account, historical collection experiences, payor type, current economic conditions
and other relevant factors. There are various factors that impact collection trends, such as payor mix, changes in the economy, increase
burden on copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously
change and can have an impact on collection trends and the estimation process.</span></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
amortize our intangible assets, including patents, and capitalized software development costs, over the shorter of the contractual/legal
life or the estimated economic life. Our amortization life for patents and capitalized software development costs is 15 to 17 years and
5 years, respectively. Our amortization of the non-competition agreements entered into with certain individuals in connection with the
HDM transaction are depreciated over seven years, and customer relationships are amortized over 20 years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill
is recorded as a result of business combinations. Management evaluates goodwill, at a minimum, on an annual basis and whenever events
and changes in circumstances suggest that the carrying amount may not be recoverable. Impairment of goodwill is tested by comparing the
reporting unit&#8217;s carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit
is estimated using a combination of the income or discounted cash flows approach and the market approach, which uses comparable market
data. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed
to measure the amount of impairment loss, if any. Based on our test for goodwill impairment, we noted no impairment related to goodwill.
However, if estimates or the related assumptions change in the future, we may be required to record impairment charges to reduce the
carrying amount of goodwill.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
periodically assess the recoverability of long-lived assets, including property and equipment, intangibles and management agreements,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">RESULTS
OF OPERATIONS. FISCAL 2023 COMPARED TO FISCAL 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
fiscal 2023, we recognized net income of $12.1 million on revenues of $98.6 million, as compared to net income of $17.2 million on revenues
of $97.6 million for fiscal 2022. This represents an increase in revenues of 1.1%. Total costs and expenses increased by 10.9%. Our consolidated
operating results decreased by 32.8% to an operating income of $14.8 million for fiscal 2023 as compared to operating income of $22.0
million for fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Discussion
of Operating Results of Medical Equipment Segment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
2023 Compared to Fiscal 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues
attributable to our medical equipment segment increased by 0.5% to $8.3 million in fiscal 2023 from $8.2 million in fiscal 2022, with
product sales revenues increasing by 41.2% from $518,000 in fiscal 2022 to $732,000 in fiscal 2023. Service revenue decreased by 2.2%
from $7.7 million in fiscal 2022 to $7.5 million in fiscal 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Product
sales to unrelated parties increased by 41.2% from $518,000 in fiscal 2022 to $732,000 in fiscal 2023. There were no product sales to
related parties in fiscal 2023 or 2022.&#160;</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
believe that one of our principal challenges in achieving greater market penetration is attributable to the better name recognition and
larger sales forces of our larger competitors such as General Electric, Siemens, Hitachi, Philips and Toshiba.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, lower reimbursement rates have reduced the demand for our MRI products, resulting in lower sales volumes. As a result of fewer
sales, service revenues have decreased since as older scanners are taken out of service, there are fewer new scanners available to sign
service contracts.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
operating loss for the medical equipment segment increased from an operating loss of $4.6 million in fiscal 2022 to an operating loss
of $5.9 million in fiscal 2023. The losses are attributable most significantly to the fact that costs increased by a greater amount than
revenues. The increase in costs was primarily due to the increase in business activity which resulted in our increased revenues.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development expenses increased to $1.6 million in fiscal 2023 from $1.5 million in fiscal 2022. Our expenses for fiscal 2023 represented
continued research and development of various upgrades for the Upright&#174; MRI scanner.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Discussion
of Operating Results of Physician and Diagnostic Services Management Segment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
2023 Compared to Fiscal 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues
attributable to the Company&#8217;s physician and diagnostic services management segment, HMCA, increased to $90.4 million in fiscal
2023 as compared to $89.4 million in fiscal 2022. The increase in revenues was due to an increase of $212,000 of patient fees (net of
contractual allowances and discounts less provision for bad debts) from patient and third-party payors recognized by six of the facilities
in Florida. Management and other fees increased by $799,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cost
of revenues as a percentage of the related revenues for our physician and diagnostic services management segment increased from $47.1
million or 52.7% of related revenues for the year ended June 30, 2022 to $49.0 million, or 54.1% of related revenues for the year ended
June 30, 2023. The cost relating to these revenues increased more than the revenues.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
results of this segment decreased from operating income of $26.6 million in fiscal 2022 to operating income of $20.7 million in fiscal
2023. The decrease is due mainly to more reserves being taken on management fees. We believe that our efforts to expand and improve the
operation of our physician and diagnostic services management segment are directly responsible for the profitability of this segment
and our company as a whole.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the fiscal year ended June 30, 2023, 12.1% of total revenues were derived from contract with facilities that were owned by Dr. Raymond
V. Damadian until his passing, and currently owned by Timothy Damadian, the Chief Executive Officer of FONAR. 11.8% of total revenues
were derived from these contracts for the 2022 fiscal year. The agreements with these MRI facilities are for one-year terms which renew
automatically on an annual basis, unless terminated. The fees for these sites, which are located in Florida, are flat monthly fees.&#160;</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Discussion
of Certain Consolidated Results of Operations</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
2023 Compared to Fiscal 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
and investment income increased in 2023 compared to 2022. We recognized interest income of $1.2 million in 2023 as compared to $247,158
in fiscal 2022, representing an increase of 394.4%. This is due to the increase in the prime interest rate and the Company placing cash
in interest bearing accounts.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
expense of $50,131 was recognized in fiscal 2023, as compared to interest expense of $346,552 in fiscal 2022. The decrease in interest
expense is attributable to an assessment of additional taxes and interest in connection with a state income tax audit in fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
29.2% noncontrolling interest allocations of $2,751,000 and $4,793,000 for fiscal 2023 and fiscal 2022, respectively, have been calculated
by Income from operations, and adding depreciation and amortization net of miscellaneous losses and other income from the Physician and
Diagnostic Service Management segment (See Note 16).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">While
revenue increased by 1.1% selling, general and administrative expenses increased by 25.0% to $29.4 million in fiscal 2023 from $23.5
million in fiscal 2022. This increase in selling, general and administrative expenses was due to placing more reserves on management
fees and other receivables and from the impact of the COVID-19 virus as compared to fiscal 2022. It is too early to know how much of
these reserves will be recovered. FONAR also resolved certain sales tax liabilities during the year and was able to reverse accrued
interest and penalties of $55,000 and $119,000 for fiscal years ending 2023 and 2022 respectively which was recorded under selling,
general and administrative expenses in the prior year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from service and repair fees decreased from $7.7 million in fiscal 2022 to $7.5 million in fiscal 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Continuing
our tradition as the originator of MRI, we remain committed to maintaining our position as the leading innovator of the industry through
investing in research and development. In fiscal 2023 we continued our investment in the development of various upgrades for the UPRIGHT&#174;
MRI, with an investment of $1,567,749 in research and development, none of which was capitalized, as compared to $1,494,181, none of
which was capitalized, in fiscal 2022. The research and development expenditures were approximately 18.9% of revenues attributable to
our medical equipment segment and 1.5% of total revenues in 2023, and 18.2% of medical equipment segment revenues and 1.5% of total revenues
in fiscal 2022. This represented a 4.9% increase in research and development expenditures in fiscal 2023 as compared to fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the physician and diagnostic services management segment, HMCA, revenues increased to $90.4 million in fiscal 2023 as compared to $89.3
million in fiscal 2022. This is primarily attributable to an increase in patient scans resulting from our marketing efforts.</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
the fiscal year 2023 the Company recorded an income tax expense of $3.6 million compared with an income tax expense of $5.5 million
for 2022. The income tax benefits are attributable to the expected tax benefits associated with the projected realization and
utilization of our net operating losses in future periods. The Company has recorded a deferred tax asset of $10.0 million as of June
30, 2023, primarily relating to the tax benefits from the net operating loss carry forwards, allowance for doubtful accounts and tax
credits available to offset future taxable income. The utilization of these tax benefits is dependent on the Company generating future
taxable income and other factors. A partial valuation allowance will be maintained until evidence exists to support that it is no
longer needed, (principally related to research and development credits). Although the Company is expecting to generate taxable
income in future periods, we cannot accurately measure the full impact of the adoption of healthcare regulations, including the
impact of continuing changes in MRI scanning reimbursement rates, which could materially impact operations. A partial valuation
allowance will be maintained until evidence exists to support that it is no longer needed. As of June 30, 2023, the valuation
allowance was $364,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have been taking steps to improve HMCA revenues by our marketing efforts, which focus on the unique capability of our Upright&#174; MRI
scanners to scan patients in different positions. We have also been increasing the number of health insurance plans in which our clients
participate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
management fees are dependent on collection by our clients of fees from reimbursements from Medicare, Medicaid, private insurance, no
fault and workers&#8217; compensation carriers, self&#8211;pay and other third-party payors. The health care industry is experiencing
the effects of the federal and state governments&#8217; trend toward cost containment, as governments and other third-party payors seek
to impose lower reimbursement and utilization rates and negotiate reduced payment schedules with providers. The cost-containment measures,
consolidated with the increasing influence of managed-care payors and competition for patients, have resulted in reduced rates of reimbursement
for services provided by our clients from time to time. Our future revenues and results of operations may be adversely impacted by future
reductions in reimbursement rates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Certain
third-party payors have proposed and implemented changes in the methods and rates of reimbursement that have had the effect of substantially
decreasing reimbursement for diagnostic imaging services that HMCA&#8217;s clients provide. To the extent reimbursement from third-party
payors is reduced, it will likely have an adverse impact on the rates they pay us, as they would need to reduce the management fees they
pay HMCA to offset such decreased reimbursement rates. Furthermore, many commercial health care insurance arrangements are changing,
so that individuals bear greater financial responsibility through high deductible plans, co-insurance and higher co-payments, which may
result in patients delaying or foregoing medical procedures. More frequently, however, patients are scanned and we experience difficulty
in collecting deductibles and co-payments. We expect recent changes to the Florida insurance laws to result in less patients being reimbursed
through no-fault auto insurance, resulting in both lower reimbursement rates and a higher rate of uncollectible billings. We expect that
any further changes to the rates or methods of reimbursement for services, which reduce the reimbursement per scan of our clients may
partially offset the increases in scan volume we are working to achieve for our clients, and indirectly will result in a decline in our
revenues.</span></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
addition, the use of radiology benefit managers, or RBM&#8217;s has increased in recent years. It is common practice for health insurance
carriers to contract with RBMs to manage utilization of diagnostic imaging procedures for their insureds. In many cases, this leads to
lower utilization of imaging procedures based on a determination of medical necessity. The efficacy of RBMs is still a highly controversial
topic. We cannot predict whether the use of RBMs will negatively impact our business, but it is possible that our financial position
and results of operations could be negatively affected.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">LIQUIDITY
AND CAPITAL RESOURCES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash,
and cash equivalents increased by 5.2% from $48.7 million at June 30, 2022 to $51.3 million at June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
provided by operating activities for fiscal 2023 approximated $14.5 million. Cash provided by operating activities was attributable to
the net income of $12.1 million, depreciation and amortization of $4.5 million, provision for bad debts of $5.5 million, deferred income
tax expense benefit of $3.0 million which was offset by the increase in accounts, and medical and management fee receivables of $8.1
million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
used in investing activities for fiscal 2023 approximated $4.3 million. The cash used in investing activities was attributable to purchases
of property and equipment of $4.2 million and costs of patents of $120,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
used in financing activities for fiscal 2023 approximated $7.6 million. The principal uses of cash used in financing activities included
the repayment of borrowings and capital lease obligations of $37,000, purchase of treasury stock of $1.8 million and distributions to
non-controlling interests of $5.8 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
liabilities decreased by 6.3% during fiscal 2023, from approximately $53.1 million at June 30, 2022 to approximately $49.8 million at
June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At
June 30, 2023, we had working capital of approximately $110.0 million as compared to working capital of $101.9 million at June 30, 2022,
and stockholders&#8217; equity of $150.8 million at June 30, 2023 as compared to stockholders&#8217; equity of $146.2 million at June
30, 2022. For the year ended June 30, 2023, we realized a net income of $12.1 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
principal sources of liquidity are derived from revenues.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
business plan includes a program for manufacturing and selling our Upright&#174; MRI scanners. In addition, we are enhancing our revenue
by participating in the physician and diagnostic services management business through our subsidiary, HMCA and have upgraded the facilities
which it manages, most significantly by the replacement of the original MRI scanners with new Upright&#174; MRI scanners. As of June 30,
2023, HMCA manages a total of 41 MRI scanners of which 24 MRI scanners are located in New York and 17 are located in Florida. We have
also intensified our marketing activities through the hiring of additional marketers for HMCA&#8217;s clients.</span></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
business plan also calls for a continuing emphasis on providing our customers with enhanced equipment service and maintenance capabilities
and delivering state-of-the-art, innovative and high quality equipment upgrades at competitive prices. Fees for on-going service and
maintenance from our installed base of scanners were $7.7 million for the year ended June 30, 2022 and $7.5 million for the year ended
June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
order to promote profitability and to reduce demands on our cash and other liquid reserves, we maintain an aggressive program of cost
containment. Previously, these measures included consolidating HMCA&#8217;s office space with FONAR&#8217;s office space and reducing
the size of our workforce, compensation and benefits. We continue to attempt to contain expenses across the board, despite significant
increases in the cost of labor and materials as the result of inflation. The cost control efforts are intended to enable us to withstand
periods of low volumes of MRI scanner sales, by keeping expenditures at levels which can be supported by service revenues and HMCA revenues.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
economic credit conditions have contributed to a slower than optimal business environment. As a result our business may suffer, should
the credit markets not improve in the near future. The direct impact of these conditions is not fully known.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues
from HMCA have been the principal reason for our profitability, and we have so far been able to maintain and increase such revenues by
increasing the number of scans being performed by the sites we manage and those we own, notwithstanding reductions in reimbursement rates
from third-party payors. The likelihood and effect of any subsequent reductions is not fully known.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
expenditures for fiscal 2023 approximated $4.3 million. Capitalized patent costs were approximately $120,000. Purchases of property and
equipment were approximately $4.2 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
is has not committed to making any material capital expenditures in the 2024 fiscal year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company believes that its business plan has been responsible for the past five consecutive fiscal years of profitability (fiscal 2023,
fiscal 2022, fiscal 2021, fiscal 2020 and fiscal 2019) and that its capital resources will be adequate to support operations at current
levels through September 30, 2024.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. On September 26, 2022, the Board of Directors has approved up to $9
million to be repurchased under the plan which will be purchased on the open market at prevailing prices. During fiscal 2023, we repurchased
103,148 shares for $1.8 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
August 2023 the Company renewed their revolving credit agreement. The terms include borrowing limits of up to $10,000,000 and the agreement
was extended to November 15, 2023. The interest rate on unpaid principal remains at 4% along with certain financial covenants still applicable.</span></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="QualitativeDisclosures"></span>ITEM
7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company does not have any investments in marketable securities, foreign currencies, mutual funds, certificates of deposit or other fixed
rate instruments. All of our funds are in cash accounts or money market accounts which are liquid.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 10 to the consolidated Financial Statements for information on long-term debt.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ITEM
8.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="FinancialStatements"></span>FINANCIAL
STATEMENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS </span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PAGE.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 90%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#ReportOfAccountingFirm">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
    <td style="text-align: center; width: 10%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">40</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#BalanceSheet">CONSOLIDATED BALANCE SHEETS</a></span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">43</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">At June 30,
    2023 and 2022</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#IncomeStatement">CONSOLIDATED STATEMENTS OF INCOME</a></span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">46</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years
    Ended June 30</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
    2023</span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    2022</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#StockholderEquity">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</a></span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years
    Ended June 30, 2023 and 2022</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#CashFlow">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years
    Ended June 30, 2023 and 2022</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="#Notes">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">52</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><b><span id="ReportOfAccountingFirm"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">To the Shareholders and Board of Directors of </p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><b>FONAR Corporation and Subsidiaries</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">We have audited the accompanying consolidated balance
sheets of FONAR Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2023 and 2022, the related consolidated statements
of income, stockholders&#8217; equity and cash flows for each of the two years in the period ended June 30, 2023, and the related notes
(collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of June 30, 2023 and 2022, and the results of its operations and its cash
flows for each of the two years in the period ended June 30, 2023, in conformity with accounting principles generally accepted in the
United States of America.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><b>Basis for Opinion</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><b>&#160;</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">These financial statements are the responsibility
of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#34;PCAOB&#34;) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">We conducted our audits in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify">Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well
as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM (Continued)</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>&#160;</b></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">The critical audit matters communicated
below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated
to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved
our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our
opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate
opinions on the critical audit matters or on the accounts or disclosures to which they relate.</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><b><span style="text-decoration: underline">Medical Accounts Receivable Reserve &#8211; Refer to Note
3 to the financial statements </span></b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="text-decoration: underline">Critical Audit Matter Description </span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Medical accounts receivable is recorded
at net realizable value based on the estimated amounts the Company expects to receive from patients and third-party payers. Estimates
of&#160;contractual allowances under managed care, commercial, and governmental insurance plans are based upon the payment terms specified
in the related contractual agreements or as mandated under government payer programs. Management continually reviews the contractual allowance
estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care&#160;contractual
terms resulting from contract renegotiations and renewals. Receivables related to uninsured patients and uninsured copayment and deductible
amounts for patients who have health insurance coverage may have discounts applied. The Company also records estimated implicit price
concessions&#160;(based on historical experience) related to accounts to record the accounts receivable at the amount the Company expects
to collect from patients and third-party payers. &#160;This implied concession requires extensive judgment and subjective assumptions.
Implicit price concessions relate primarily to amounts due directly from patients and are based upon management&#8217;s assessment of
historical write-offs and expected net collections, business and economic conditions, trends in federal, state, and private employer health
care coverage, and other collection indicators. Auditing management&#8217;s estimate of the price concessions was complex and judgmental
due to the significant data inputs and subjective assumptions utilized in determining the net realizable value of accounts receivable.</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="text-decoration: underline">How the Critical Audit Matter Was Addressed in the Audit</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">Our audit procedures related to the net realizable value of
patient accounts receivable included the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We obtained an understanding, evaluated the design,
and tested the operating effectiveness of certain controls that address the risks of material misstatement relating to the measurement
of service fee revenue and receivables. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested informational technology general controls
around the Company&#8217;s billing system and associated database. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We evaluated management&#8217;s methodology and
related assumptions, including cash collections, by comparing actual results to management&#8217;s historical estimates. </span></td></tr></table>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM (Continued)</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b></b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the underlying data related to the recognition
of patient level charges and the subsequent activities, including cash collections and non-cash adjustments. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the contractual rates set forth by the
third-party payers which are input into the Company&#8217;s billing system and then billed to patients and/or third-party payers. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We tested the mathematical accuracy of the estimates
applied to period-end accounts receivable. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">We evaluated the appropriateness of the industry,
economic, and Company factors that were used in determining the net realizable value of patient accounts receivable. </span></td></tr></table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">&#160;</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><b><span style="text-decoration: underline">Management Fee Accounts Receivable Reserve &#160;&#8211;
Refer to Note 3 to the financial statements. </span></b></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt; text-align: justify">Management fee accounts receivable is related
to fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under management agreements. Payment
of the outstanding fees is dependent on the PCs ability to collect fees from third-party payers and patients because the management fees
are collateralized by the PCs accounts receivable. &#160;The Company records the management fee accounts receivables net of the estimated
implicit price concessions based on the PCs likelihood to collect on the accounts. &#160;Implicit price concessions on the PCs are estimated
by management in the same manner the patient accounts receivable are analyzed. This implied concession requires extensive judgment and
subjective assumptions. Implicit price concessions relate primarily to amounts due directly from patients and are based upon management&#8217;s
assessment of historical write-offs and expected net collections, business and economic conditions, trends in federal, state, and private
employer health care coverage, and other collection indicators. Auditing management&#8217;s estimate of the price concessions was complex
and judgmental due to the significant data inputs and subjective assumptions utilized in determining the net realizable value of accounts
receivable.</p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="text-decoration: underline">How the Critical Audit Matter Was Addressed in the Audit</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt">Our audit procedures related to the management fee accounts
receivable reserve are consistent with the audit procedures associated with the patient fee accounts receivable reserve. In addition,
we traced the management fees to the underlying agreements and the general ledger.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">/s/ Marcum <span style="font-variant: small-caps">llp</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p id="xdx_986_edei--AuditorName_c20220701__20230630_zPfE83OhEkr5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorName">Marcum <span style="font-variant: small-caps">llp</span></ix:nonNumeric></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">We have served as the Company&#8217;s auditor since 1990, such date takes
into account the merger of Tabb, Conigliaro, McGann, P.C. (&#8220;Tabb&#8221;) into another firm in approximately 2001 and the former
partners of Tabb joining Marcum LLP in 2002.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p id="xdx_98A_edei--AuditorFirmId_c20220701__20230630_zeMUgq1rp8Oh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorFirmId">688</ix:nonNumeric></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_90A_edei--AuditorLocation_c20220701__20230630_zdXcaQXmJZci"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" name="dei:AuditorLocation">New York, New York</ix:nonNumeric></span><br />
September 28, 2023<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="BalanceSheet"></span>CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">ASSETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_111_zMOVVsvtqQF7" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20230630" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_490_20220630" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    Assets:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_pp0p0_maACz581_z0gTSz4F7Yki" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    and cash equivalents</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,279,707</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,722,977</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--ShortTermInvestments_i01I_pp0p0_maACz581_zn8z0O527uVg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,799</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,326</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--AccountsReceivableServiceAndRepairFees_i01I_pp0p0_maACz581_zYj6Bqv5iaD7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; net of allowances for doubtful accounts of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_c20230630_pp0p0"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,593</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_c20220630_pp0p0"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,597</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">at
    June 30, 2023 and 2022, respectively</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,861,512</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,335,956</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--MedicalReceivable_i01I_pp0p0_maACz581_z6mqSuzTiq7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
    receivables &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,259,262</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,108,989</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagementAndOtherFees_i01I_pp0p0_maACz581_zI4CmF345Y8f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; net of allowances for doubtful accounts of $<span id="xdx_90B_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_pp0p0_c20230630_zgYLoXnzdfqh" title="Management and other receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,608,567</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    $<span id="xdx_905_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_pp0p0_c20220630_zPKxvQuP3pVg" title="Management and other receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,627,917</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">at
    June 30, 2023 and 2022, respectively</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,888,253</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,419,219</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_pp0p0_maACz581_zMufXS45Lwu6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $<span id="xdx_900_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_pp0p0_c20230630_zSgL40LRC7Hb" title="Related party receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,989,692</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    $<span id="xdx_907_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_pp0p0_c20220630_zUOvYVrs1gr3" title="Related party receivable allowances for doubtful accounts"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,686,893</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">at
    June 30, 2023 and 2022, respectively</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,161,870</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,602,561</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_pp0p0_maACz581_zpMaOktnibg3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,569,666</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,359,821</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_pp0p0_maACz581_z9BeVlroHnYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,607,768</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,104,325</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsCurrent_i01TI_pp0p0_mtACz581_maAz73J_z83T1wzejQPl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Current Assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,660,837</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,686,174</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--AccountsReceivableNetLongTerm_i01I_pp0p0_maAz73J_z6WhOti4xyph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; long term</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">710,085</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,871,890</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maAz73J_zGlQ9Yklriyh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax asset</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,041,960</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,842,478</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pp0p0_maAz73J_zB9O4OoFNgu9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,146,373</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,281,791</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pp0p0_maAz73J_zTP3KbZTtwra" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use-asset
    &#8211; operating leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,068,755</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,232,109</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_pp0p0_maAz73J_zH8HxSCIBnEd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use-asset
    &#8211; financing lease</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">729,229</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">928,109</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--Goodwill_i01I_pp0p0_maAz73J_zVrYX4YskYgc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,269,277</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,269,277</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_pp0p0_maAz73J_zFmuhBXMRnDj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    intangible assets &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherAssets_i01I_pp0p0_maAz73J_zo9j2ziBqnI6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">523,506</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">526,269</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Assets_i01TI_pp0p0_mtAz73J_z2rk6ATGSZqg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Assets</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,581,887</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,341,982</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">LIABILITIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesCurrentAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    Liabilities:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--LongTermDebtAndCapitalLeaseObligationCurrent_i01I_pp0p0_maLCzHpU_zInFp1gHPuh5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current
    portion of long-term debt </span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:LongTermDebtAndCapitalLeaseObligationCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,767</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:LongTermDebtAndCapitalLeaseObligationCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,078</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i01I_pp0p0_maLCzHpU_zQWMWiXvrCCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,579,240</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,551,269</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_i01I_pp0p0_maLCzHpU_zSvM5jygiS37" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,443,724</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,417,227</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_pp0p0_maLCzHpU_z2ZKRT6P0k2i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liability &#8211; current portion</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,905,484</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,880,129</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_pp0p0_maLCzHpU_zbWn7nHzmHFl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liability &#8211; current portion</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,597</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,140</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DeferredRevenueCurrent_i01I_pp0p0_maLCzHpU_zilTEwkgoN5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned
    revenue on service contracts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,832,184</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,288,766</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CustomerDeposits_i01I_pp0p0_maLCzHpU_zUGuRJWaW1Yh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">602,377</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">361,245</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesCurrent_i01TI_pp0p0_mtLCzHpU_maLzL4e_zFajRZx4HiTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Current Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,624,373</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,748,854</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesNoncurrentAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Term
    Liabilities:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredRevenueNoncurrent_i01I_pp0p0_maLNzmN4_zf9JhrjWbqpg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Unearned
    revenue on service contracts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">760,242</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,857,257</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_pp0p0_maLNzmN4_zjW4LTsUp0zg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax liability</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,758</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DueToRelatedPartyMedicalPractices_i01I_pp0p0_maLNzmN4_zCgfGrmEujrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Due
    to related party medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DueToRelatedPartyMedicalPractices" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">92,663</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DueToRelatedPartyMedicalPractices" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">92,663</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pp0p0_maLNzmN4_zKZs2SsrOZm9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liability &#8211; net of current portion</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,105,405</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,090,990</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_pp0p0_maLNzmN4_zuShN8pAtXS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liability &#8211; net of current portion</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">620,481</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">838,291</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--LongTermDebtAndCapitalLeaseObligation_i01I_pp0p0_maLNzmN4_zOTDIqIv3BT1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    debt and capital leases, less current portion</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:LongTermDebtAndCapitalLeaseObligation" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,075</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:LongTermDebtAndCapitalLeaseObligation" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,379</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherLiabilities_i01I_pp0p0_maLNzmN4_zgc0INSHp7P5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,750</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,541</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesNoncurrent_i01TI_pp0p0_mtLNzmN4_maLzL4e_zZUV8YvZaQn9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Long-Term Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,130,374</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,356,847</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_pp0p0_mtLzL4e_maLASEzOmC_z8RURK2Tyh43" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,754,747</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,105,701</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commitments,
Contingencies and Other Matters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">STOCKHOLDERS&#8217;
EQUITY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stockholders&#8217;
    Equity:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Class
    A non-voting preferred stock $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2023 and 2022, <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2023 and 2022</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--PreferredStockValue_pp0p0_maSEzK0u_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zuHyFCGkTVba" title="Preferred Stock Value" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--PreferredStockValue_pp0p0_maSEzK0u_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zJpzbc3xrbk3" title="Preferred Stock Value" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Preferred
    stock $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2023 and 2022, issued and outstanding &#8211; <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zAPhOF9FHe4k"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span></span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--PreferredStockValue_pp0p0_maSEzK0u_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zog2k34fucmb" title="Preferred Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0187">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PreferredStockValue_pp0p0_maSEzK0u_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_znGR9o9WXUc8" title="Preferred Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0189">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    stock $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2023 and 2022, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,462,524</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,565,853</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;issued
    at June 30, 2023 and 2022, respectively <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    <span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;outstanding
    at June 30, 2023 and 2022, respectively</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zAGd3lhLQtkj" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">647</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5rhqehqAe09" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">657</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    B convertible common stock (10 votes per share) $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2023 and 2022, <span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2023 and 2022</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpbqx9wGDfbj" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0204">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z3j9dPIJZ9j4" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0206">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C common stock (25 votes per share) $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">par
    value; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    authorized at June 30, 2023 and 2022, <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">issued
    and outstanding at June 30, 2023 and 2022</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFfKpKya3qYc" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_pp0p0_maSEzK0u_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlR0Ttrmppe7" title="Common Stock Value" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_maSEzK0u_z5PZnmSRar99" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid-in
    capital in excess of par value</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">182,612,518</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">184,531,535</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_pp0p0_maSEzK0u_zZqoyICAeys" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    deficit</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,190,981</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">33,566,757</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--TreasuryStockValue_iNI_pp0p0_di_msSEzK0u_zoLR7lV18UI7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    stock, at cost &#8211; <span id="xdx_906_eus-gaap--TreasuryStockCommonShares_iI_c20230630_zJ22SFYKZnx"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,463</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    <span id="xdx_909_eus-gaap--TreasuryStockCommonShares_iI_c20220630_zHC7gpkrlar"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,643</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
    of common stock at June 30, 2023 and 2022, respectively</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">515,820</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">675,390</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_iTI_pp0p0_mtSEzK0u_maSEIPAzkrg_znwzPq4fAG1k" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Fonar Corporation&#8217;s Stockholders&#8217; Equity</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,906,433</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,290,114</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--MinorityInterest_iI_pp0p0_maSEIPAzkrg_zwgCbg0eMcOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling
    interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,079,293</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,053,833</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iTI_pp0p0_mtSEIPAzkrg_maLASEzOmC_zETej0ObZ4Be" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Stockholders&#8217; Equity</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,827,140</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,236,281</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEzOmC_zkRsuoa8WEt1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Liabilities and Stockholders&#8217; Equity</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,581,887</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,341,982</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="IncomeStatement"></span>CONSOLIDATED
STATEMENTS OF INCOME</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zlhY03oUzW19" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF INCOME" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49B_20220701_20230630" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20210701_20220630" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40F_eus-gaap--RevenuesAbstract_iB" style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenues</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_pp0p0_maRzWgN_z6FHLXGkLA51" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue, net of contractual allowances and discounts</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,793,993</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,582,238</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ProductSalesNet_i01_pp0p0_maRzWgN_z8EqkGEJOhZ1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">731,607</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">517,939</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ServiceAndRepairFeesNet_i01_pp0p0_maRzWgN_zHgdLWQI4Lah" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,419,104</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,590,865</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_pp0p0_maRzWgN_zKhxpaTR52ng" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; related parties &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ManagementAndOtherFeesNet_i01_pp0p0_maRzWgN_zdK265DexTl5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,640,497</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,226,787</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_pp0p0_maRzWgN_zLAwTAN0lamj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; related party medical practices &#8211; net</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,949,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,564,316</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Revenues_i01T_pp0p0_mtRzWgN_maILFCOz3wL_zNtHzrNGKkh1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,645,101</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,592,145</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--CostsAndExpensesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    and Expenses</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--CostsRelatedToProductSales_i01_pp0p0_maCAEzH38_zv06neD7EOSa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">852,025</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">416,814</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CostsRelatedToServiceAndRepairFees_i01_pp0p0_maCAEzH38_zAd7nPDnsbD3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,033,967</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,991,069</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_pp0p0_maCAEzH38_zAMVIS6xCFD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees &#8211; related parties</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">44,983</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,344</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OtherCostOfOperatingRevenue_i01_pp0p0_maCAEzH38_zNqw50w3mugc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,183,166</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,307,819</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--CostsRelatedToManagementAndOtherFees_i01_pp0p0_maCAEzH38_zU1hTlQe99hl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,975,563</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,251,268</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_pp0p0_maCAEzH38_z4SVtnWu3LW4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related party medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,807,454</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,567,887</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ResearchAndDevelopmentExpense_i01_pp0p0_maCAEzH38_zmQJDuK6Pnpi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,567,749</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,494,181</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_pp0p0_maCAEzH38_zoetpe6R2nh4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Selling,
general and administrative expenses</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,390,932</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,512,581</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CostsAndExpenses_i01T_pp0p0_mtCAEzH38_msILFCOz3wL_zLnYTAt24Yql" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,855,839</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,584,963</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_pp0p0_mtILFCOz3wL_maILFCOzllv_zdMOhbK3N0m8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    from Operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,789,262</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,007,182</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    Income and (Expenses):</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--InterestExpense_iN_pp0p0_di_msILFCOzllv_zP72s7dERlG3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    expense</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,131</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">346,552</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--InvestmentIncomeNet_maILFCOzllv_zE4ioGNH7Rc4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Investment
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,222,176</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,158</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherNonoperatingIncomeExpense_maILFCOzllv_zlluZyhD8n6l" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    (expense) income</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">202,720</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">861,087</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pp0p0_mtILFCOzllv_maPLzdZe_zl5Lbo5o2FMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
    before provision for income taxes and noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,758,587</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,768,875</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_iN_pp0p0_di_msPLzdZe_zR1CFVZ8veg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,632,071</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,534,487</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_iT_pp0p0_mtPLzdZe_maNILznPG_zBxmhoeDVuNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,126,516</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,234,388</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pp0p0_di_msNILznPG_zXYYpKghuUg7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Noncontrolling Interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,750,740</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,793,482</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_iT_mtNILznPG_zbChxLNdLf4j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,375,776</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,440,906</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br />&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF INCOME (Continued)</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common&#160;Stockholders</span></td><td style="width: 8%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,801,974</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,690,796</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">427,666</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">559,072</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common&#160;Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,136</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">191,038</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.35</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.78</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.32</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.75</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211;&#160;Class C Common</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Diluted Shares Outstanding &#8211; Common Stockholders</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,666,880</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,681,713</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="StockholderEquity"></span>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
THE YEARS ENDED JUNE 30, 2023 AND 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_114_zFC47Ug3EGCh" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_custom--ClassANonVotingPreferredMember_zgjwPblUXPl2" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zEr9sCj0L1gj" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_z1fN6u2DfjL8" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Non-Voting Preferred</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Shares</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    Amount</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr id="xdx_431_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zE7ncYrFCTpe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2021</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYacUpVQ3pn1" title="Beginning Balance, Shares" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0328">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0330">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedToEmployeesUnderStockBonusPlansValue_zOlEqVNMVLAc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    issued to employees under stock bonus plans</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0332">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0333">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0334">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zEKf6rClKZJ3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0336">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0337">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0338">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_43D_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zB21d5OkwyXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2022</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zznxstO0e5K3" title="Beginning Balance, Shares" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember1131540968" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,210</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember1131540968" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_z4gYbm8slThl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0346">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0347">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0348">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockRepurchasedDuringPeriodValue_iNP3us-gaap--ProfitLoss_di_zVTrNiLdinre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0352">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--CancellationOfShares_iP3us-gaap--StockRepurchasedDuringPeriodValue_zRAxLjbuosu1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cancellation
    of shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0354">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--CancellationOfSharesShares_iP3custom--CancellationOfShares_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkOQu4bAajL3" title="Cancellation of shares, shares" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:CancellationOfSharesShares" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">103,328</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0356">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_ztqiytA0iwnf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0360">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0361">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_434_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zP3Rr20IN559" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20220701__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHQa1eA620ch" title="Ending Balance, Shares" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1131541015" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1131541015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zvBOySY7Z3a3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zPsJjT7dq9Se" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Paid-in
    Capital in Excess of Par Value</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td></tr>
  <tr id="xdx_437_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zsQvgWYZsqug" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2021</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,100,976</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,007,663</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_zaMAL79wL2z5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0373">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,440,906</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BuyoutOfNoncontrollingInterests_iP3us-gaap--ProfitLoss_zY8Mn2Cpd7e7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Buyout
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">569,441</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zUtTfVvebzne" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0379">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_43D_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zWg7szLRlP7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2022</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">184,531,535</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,566,757</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ProfitLoss_zt9zRbnRu5Ne" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0385">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,375,776</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zreB5MNVz9T8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0388">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0389">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--CancellationOfShares_zNQjcfNeLrw3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cancellation
    of shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,919,017</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0392">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_za9K3rCyXf24" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0394">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0395">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_434_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zvgMwnBg4Itc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,612,518</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,190,981</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FOR
THE YEARS ENDED JUNE 30, 2023 AND 2022</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zk8I8IdTKtU7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zUXG7Nsy2lN3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_4B8_zTtJjRnbRKbj" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling
    Interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr id="xdx_43D_c20210701__20220630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z2NUuqU8fSVb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    July 1, 2021</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,048,524</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,370,125</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ProfitLoss_zNiBZCnS1tNe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0404">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,793,482</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234,388</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--BuyoutOfNoncontrollingInterests_z5QrZ3yZaXag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Buyout
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0408">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,441</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">546,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pp0p0_di_zjVFB2dVnKDf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0412">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_43D_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zfYd2JCozSuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2022</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,390</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,053,833</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,236,281</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ProfitLoss_zfjb0n96LcJe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0420">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750,740</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,126,516</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pp0p0_di_zqZvNgKgaaR3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,759,457</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,759,457</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_ecustom--CancellationOfShares_zaL1WTmlE2g7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cancellation
    of shares</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,027</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0429">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0430">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_z6vcO5sXdeq6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,776,200</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,776,200</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_434_c20220701__20230630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zofrCdevxcL5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance,
    June 30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">515,820</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,079,293</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,827,140</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="CashFlow"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_112_ztqWmtgGkqmk" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_495_20220701__20230630_z5J6oHBwvDCi" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20210701__20220630_zQeyuKJWFrT4" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zUn0SQ1EdEvd" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    FLOWS FROM OPERATING ACTIVITIES</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_maNCPBUz57l_z1CJsKOuSRO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,126,516</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,234,388</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Adjustments
    to reconcile net income to net cash provided by operating activities:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherDepreciationAndAmortization_i01_pp0p0_maNCPBUz57l_zwJyRUiIAr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,540,135</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,535,236</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ProvisionForBadDebts_i01_pp0p0_maNCPBUz57l_zkdKP3nnvMCf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    for bad debts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,513,476</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,343,533</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_pp0p0_maNCPBUz57l_zhtJH8kGpMvj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    income tax - net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,979,550</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,893</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_pp0p0_maNCPBUz57l_zSWS2x2eaIt3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
    on right-of-use assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,264,818</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,131</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--LossOnDispositionOfFixedAssets_i01_pp0p0_maNCPBUz57l_zYBPl7JDgLWg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Loss
    on disposition of fixed assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:LossOnDispositionOfFixedAssets" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">213,244</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--GainOnForgivenessOfPppLoan_i01N_pp0p0_di_msNCPBUz57l_z44SlHcW3SB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Gain
    on forgiveness of PPP loan</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0464">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">700,764</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zijb3QscvLX8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Increase)
    decrease in operating assets, net:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInAccountReceivable_i01N_pp0p0_di_msNCPBUz57l_zpINh9fr3GTe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts,
    medical and management fee receivables</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInAccountReceivable" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,055,843</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInAccountReceivable" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,602,188</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInReceivables_i01N_pp0p0_di_msNCPBUz57l_zXOzIV65jRCc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,532</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">43,334</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInInventories_i01N_pp0p0_di_msNCPBUz57l_ztOF9NRVjsbk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">209,845</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">696,402</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_pp0p0_di_msNCPBUz57l_zSRvuAdl7Pob" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">438,911</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">90,638</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_pp0p0_di_msNCPBUz57l_z3ktON7EP2Q2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,763</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">129,411</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Increase
    (decrease) in operating liabilities, net:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInAccountPayable_i01_pp0p0_maNCPBUz57l_z2GorrVrPd38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInAccountPayable" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,685</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInAccountPayable" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">314,766</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_pp0p0_maNCPBUz57l_z4HrUiow3On9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,527,100</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,765,215</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40A_ecustom--IncreaseDecreaseInCustomerAdvance_i01_pp0p0_maNCPBUz57l_zo4Qxhh3Twih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    advances</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">241,132</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">369,856</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInOperatingLiability_i01_pp0p0_maNCPBUz57l_z8o8znScWnl6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInOperatingLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,862,814</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInOperatingLiability" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,437,743</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_pp0p0_di_msNCPBUz57l_zqEp9mXHi2ag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    lease liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,353</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,741</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInContractLiabilities_i01_pp0p0_maNCPBUz57l_zbGsrXWUsGy5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Contract
    liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,739</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInAccruedLiability_i01_pp0p0_maNCPBUz57l_zR0DEuwKEvn4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInAccruedLiability" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">64,791</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInAccruedLiability" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">64,790</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUz57l_maCCERCzKXv_zdGR8HK3e1Al" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH PROVIDED BY OPERATING ACTIVITIES</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,467,130</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,301,360</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CONSOLIDATED
STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Continued</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    FLOWS FROM INVESTING ACTIVITIES</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_pp0p0_di_msNCPBUzMaz_zm0Xx6kpWW5j" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchases
    of property and equipment</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,218,084</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,545,292</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsForProceedsFromShortTermInvestments_i01N_pp0p0_di_msNCPBUzMaz_zLFGqbaOsvJb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Proceeds
    of Short-term investment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">473</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_ecustom--PurchaseOfNoncontrollingInterests_i01N_pp0p0_di_msNCPBUzMaz_zkU5CWq8DX97" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0521">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">546,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_pp0p0_di_msNCPBUzMaz_zKoQH9X196yb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cost
    of patents</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,571</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,882</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_pp0p0_mtNCPBUzMaz_maCCERCzKXv_z1W2HbD7xkVg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH USED IN INVESTING ACTIVITIES</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,338,128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,179,323</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
                                 FLOWS FROM FINANCING ACTIVITIES:</span></p></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--RepaymentsOfNotesPayable_i01N_pp0p0_di_msNCPBUzVjg_zFgngws6fZWi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Repayment
    of borrowings and capital lease obligations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,615</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,239</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_i01N_pp0p0_di_msNCPBUzVjg_zRDXhdntwlB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury stock</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,759,457</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0537">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_pp0p0_di_msNCPBUzVjg_zMZM9AUQLefc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions
    to noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,776,200</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_pp0p0_mtNCPBUzVjg_maCCERCzKXv_zZG0F6UYZ8Eb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
    CASH USED IN FINANCING ACTIVITIES</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,572,272</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,859,471</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_pp0p0_mtCCERCzKXv_z3e4Biu7Er3i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NET
                                 INCREASE IN CASH AND CASH EQUIVALENTS</span></p></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,556,730</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,262,566</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_pp0p0_z138e7tYsjm8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    AND CASH EQUIVALENTS - BEGINNING OF YEAR</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,722,977</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">44,460,411</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">CASH
    AND CASH EQUIVALENTS - END OF YEAR</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,279,707</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,722,977</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
accompanying notes to consolidated financial statements.&#160;</span></p>


<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Notes"></span>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zb24H4oNzOPg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 - <span id="xdx_829_zVI3HShgHmqg">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zyRfdB1dpfaj" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_90E_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zIF9tsz0Z6Ta" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_90D_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_ze5MYLfKl9yh" title="The ownership interest of the original investors of HDM"><ix:nonFraction name="FONR:OwnershipInterestOfOriginalInvestorsOfHdm" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$<span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ClassBControllingInterestsMember_zxfXvVcP7nT" title="Purchase of interests from Class A ($)"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">giving
the Company a direct ownership interest of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zCF8eX6iEAVd" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and the investors&#8217; a <span id="xdx_90D_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zXyzXHfsd8lk" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and
recurrence of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and
the world economy in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing
global pandemic of COVID-19, the Company believes with the positive cash flows, low debt and cash on hand, it will be able to continue
operations going forward.&#160;</span></p>

<ix:exclude><p id="xdx_233_zKjOftAVIsFk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_ziJUpTQDFdJ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zjompmDsCVP5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z3scdL14PRM7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zfqU6YrGyKc7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zhDwn5jf1AXg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zxgTanfbVq5g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zkdxy9Houod2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_823_zghDXeiHcE16">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zKPD51EyDsj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_z2rB3dOQNvH5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84E_eus-gaap--UseOfEstimates_zYNxcUhninLk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_z91PjCxPXmI5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:InventoryWorkInProcessPolicy"><p id="xdx_84D_eus-gaap--InventoryWorkInProcessPolicy_z0V0V8zLQo7a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_864_zG49sAr63Pv8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgEZUz7RXum6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zTnmhmOHipkj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost less accumulated depreciation. Property and equipment purchased in
connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is
being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold
improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other
disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the
resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to
operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_903_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20220701__20230630_zeLPNbmPBPS" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,801,000</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zNT9P9lUPqp6" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,783,000</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2023 and 2022 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; line-height: 115%"><span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated Useful Life in Years for Property and Equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">13</ix:nonNumeric></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">9</ix:nonNumeric></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">28</ix:nonNumeric></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zGKQgXtsKCii" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br />&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z1wwkZBEv6Z5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zA1oHvbPJFvb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zbOuv55npvf4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zIVKXAeXGhad" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zjuSicQCvUR7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zJ4phP8ITDmb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zlkfJQy0SRJd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zfqKcL8M9ICf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ztEJLUScpIq2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zdtqua1BNY4f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwejWLpF1pIi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_863_zuAp1j69iZhd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zWhzHSiGQFa5" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="AsOf2023-06-30_us-gaap_IntellectualPropertyMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight-line basis over the length of the agreement (<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zLXimc2TXHK3" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1NqOvO07C2b" title="Finite-Lived Intangible Asset, Useful Life"><ix:nonNumeric contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zbdMXyNzL1v2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_zRiwosQZ2OI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually at the end of
each fiscal year and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting
unit level by comparing the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed
to measure the amount of impairment loss, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock"><p id="xdx_843_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zZNdzbsu7oca" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zrVI7zAtSWGk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805, &#8220;Business Combinations&#8221;, if the initial accounting for a business combination is incomplete by the end
of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the
acquisition date, the Company adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount
recognized for goodwill.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zQoPNqyqFtZk" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_za6i3mJcOuq7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z6jD3jjkhSq" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zLEW39ANOdo" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zMiIomJByJef" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z920Om8zkL09" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zxwoPlIBB9Q9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zxXvUCLXqvK3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjDCKZ9HVr8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_86B_z3irRoxrgEed" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span>Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2023, the Company has <span id="xdx_90A_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20230630_zu1GMVhlNeAg"><ix:nonFraction name="FONR:ManagementAgreementsWithCompanyTotalMedicalPractices" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">22</ix:nonFraction> </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which <span id="xdx_903_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20230630_z63iksoJVlj4"><ix:nonFraction name="FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">were
with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned
by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related medical
practices&#8221;) and <span id="xdx_90B_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20230630_zhF4TIENIJE4"><ix:nonFraction name="FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">19</ix:nonFraction></span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90B_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zdeKaV5lMUe8"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMinimum" contextRef="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,000</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to
$<span id="xdx_90D_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zZq9uyt4UDWi"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMaximum" contextRef="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">447,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad
debts for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of
Operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company currently recognizes revenue in accordance with the recognition accounting standard issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606
outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods
or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures
regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zriouhivCem2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zVg03yFv0X3f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.<br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zvLjJjH0H2b4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zVRnLtCwpmxg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zBYCoYvum6Ee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zNVFCmROjNCi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z5BvYuYOHCW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z4yPy5UPG7Y9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zqBcZrNLUSt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zaGXDw2VszDj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zOHQc9H4DGVi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z4FKmNZj68Kd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2023 and 2022 are summarized in the following table.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue - Net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" title="Net Patient Fee Revenue" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,124,646</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" title="Net Patient Fee Revenue" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,248,708</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" title="Net Patient Fee Revenue" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,063,846</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" title="Net Patient Fee Revenue" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,060,920</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" title="Net Patient Fee Revenue" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,670,019</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" title="Net Patient Fee Revenue" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,907,335</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-012023-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,935,482</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,365,275</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,793,993</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,582,238</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zvOUXNf3Jow5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_846_eus-gaap--ResearchAndDevelopmentExpensePolicy_zCcM57Igdj39" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_866_zwXLEwU83yx2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zBxcVxuBnXu" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z5FNGeZ78rL9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zlYCG1YxR7i7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z13Mdit4SdEf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zFOyq0c4mia3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zHh44DOj2wQj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zbLD0YZH8KA" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zTt8ScFxzute" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zcrvaUItXfcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86B_zhkPe3HTjppk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_pp0p0_c20220701__20230630_zKZkoEVBqYll"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">570,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_902_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zs0vwBzoQKZ5"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">634,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_z6lN7U5pAQx6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zbMIL87Ze1o6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:CustomerAdvancesPolicyTextBlock"><p id="xdx_848_ecustom--CustomerAdvancesPolicyTextBlock_zkYTUOYusfEg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_867_zNOLsjdj5iE" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z9PLWI0HYQEk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_zUzptieOT1t1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2023 and 2022, diluted EPS for common shareholders
includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_zmZ5QYUGnotk"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zz6aoGuAC2T4" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zOpJbbWy7366" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zKgaB16HGbvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z6EhYTmcFTR9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zV1OhPdrVJvh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;
&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z1XsCwLba5Ld" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zJf8gCf3hCF5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_zP1e1w62Dcni">Earnings
Per Share (Continued)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,375,776</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,801,974</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,136</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.43</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.35</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Weighted average shares outstanding" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,539,376</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Weighted average shares outstanding" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,666,880</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.32</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,440,906</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,690,796</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" title="Basic Numerator: Net Income Available to Common Stockholders" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,038</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Denominator: Weighted Average Shares Outstanding" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.78</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Basic Income Per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Weighted average shares outstanding" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,554,209</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Weighted average shares outstanding" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" title="Shares included upon conversion of Class C Common to calculate a diluted EPS" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,681,713</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zsQKPKfscQvj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z7UlH72Y2ptf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zGtEhgltwGti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zQFu66yFNWq5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zwpM12NnvE6h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zXSzsGEUNIXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zOLi54MraZ6k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zUzjJGbcZaGb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,203,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zWKnPKJ58vpa" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zJzW7Pqvhbv2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zY3Wn2jolIad" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zDkZ1AnQRHFl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zV5UOLUPCJN5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z5GbMkEoHpY9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zwcYEIMxUHRf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zVKbbl600Vsb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z5oVDwdOxaUe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zOvp50FpUZfj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
3 &#8211; <span id="xdx_824_zWN7Rf9LVOhi">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zeRFZ85er3ub" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zMLrI6H5uhEi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zLUbD2VGI8Ze" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zhQXeekoKUce" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z9tqGhy3EFo2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_230_z78CvjpMBHu" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zilkb33vHmS1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zsNTC5rEqxSf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years at June 30, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" id="xdx_881_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zYKHQPEvqGjc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt"></p>

 <span>Receivables - Non Current - Net</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 32%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td>
    <td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 2%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20230630_znrIcImoXpQh" title="2025" style="width: 24%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">620,230</ix:nonFraction></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ContractReceivableDueThreeToFourYears_c20230630_pp0p0" title="2026" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,012</ix:nonFraction></span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: top; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230630_pp0p0" title="Total non current receivables" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">760,242</ix:nonFraction></span></td>
    </tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third-party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s receivables from the related and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third-party
medical reimbursement organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90E_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20220701__20230630_zyTG4Ufu97ya"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zKye6CX3AiA4"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
respectively, of the PCs&#8217; 2023 and 2022 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zZFCgdivRcT7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zjqtYEzVsOz3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z3sEjqQnN4nk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zajvbDDgGMki" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_ztlY0Qv8VS93" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zsMQKzRd1u7e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zWo2K8Famt9j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zY1O8mYEes7b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zFBBEfyWhKP1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Net
revenues from management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zIZK7t0BMva5"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_906_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_zQ3TiOR2fnK2"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
of the consolidated net revenues for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number of our facilities for the years ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zNZKqR4isGYh" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zqVKDBtZsVzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Facilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_ziCbS5DEjBg7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210701__20220630_z0H7dxI6RRT6" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagedFacilitiesClosedDuringYear_zBb50vwk3Bhb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Integer">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0843">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zOl243Kc9hdl" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zFTieOtkWUUl" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_z2XTuD2Eqew8" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z5Qw7FZC3BX6" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zfz6jC7jwhB5" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zTSFHy9DMwjl" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p></ix:exclude></ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zhcCVkyy2ISa" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
                                            4 &#8211; <span id="xdx_82F_zQ7nP1d1W6A3">INVENTORIES</span></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying consolidated balance sheets consist of:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zxmn31fB1U3h" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_493_20230630_z5fnXPyLMjW7" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_498_20220630_z4LiPeIovZ21" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B2_zP8axrk5q5Ji" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzMGG_zx2JvSV1E76b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,346,300</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,125,805</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzMGG_zyWke2UcY5hc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">223,366</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,016</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzMGG_zlF8YCMD2fUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,569,666</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,359,821</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zKxnEGZ1QsGi" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
5 - <span id="xdx_82C_z1peDaeNis8i">PROPERTY AND EQUIPMENT</span></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2023 and 2022, is comprised of:&#160;&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zBjDgbuLNcne" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center; padding-left: 0.25in"><span id="xdx_8BE_zUkEImWg2N5f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property and Equipment</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zFE5I5Uydvgb" title="Property plant and equipment, gross" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,144,266</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z1hQgmHUEcle" title="Property plant and equipment, gross" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_custom_DiagnosticEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,304,258</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkxDNvzBNx93" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zTm3QR28b024" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zmdy1OLEJiDe" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zQX5ia2KuLw8" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0BCuCjUrr1" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,714,499</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsjOd8C50KZg" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,484,525</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvj5cLSAgUYk" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,650,041</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwgzcjF852Ia" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,087,581</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zKfnxmFnQee5" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zwHyepL5FNm8" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30_us-gaap_BuildingMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zbZ8fPWhLZA5" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,717,416</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630_zXKbrO6DAOLl" title="Property plant and equipment, gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,084,974</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zk62conpjdag" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,571,043</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20220630_z6rlq9wXJsWi" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,803,183</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zzlldLmaVQ3i" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,146,373</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220630_zv1Gk9Lf5794" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,281,791</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
and amortization of property and equipment for the years ended June 30, 2023 and 2022 was $<span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,148,544</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,113,640</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively. During fiscal year ended June 30 2022, the Company removed fully depreciated assets of $<span id="xdx_900_ecustom--DepreciatedAssetsWriteoff_pp0p0_c20220701__20230630_zCh3diTqmRed" title="Depreciated assets write-off"><ix:nonFraction name="FONR:DepreciatedAssetsWriteoff" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,737,918</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">that
related to a location that was previously closed.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zjUnxArkvbv6" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zhyA1bPLfcFl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zTlD6Yj9SKea" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zqtuWQWO9OI2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z0lgjE7a7s0l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_ztyYfbCTYehi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_827_zjIvlFRC88f">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of these practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zH9fVfdjztK" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
                                            of operating and financing lease payments</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Year
                                            Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease Payments</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,592,971</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,600,823</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,174,942</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,343</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,190,414</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,897</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDMy2mNDurQ4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,600,133</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,306,056</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0930">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscount_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBQW6Hr7QTbj" title="Present Value discount, Operating Lease" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,454,450</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zbNyy5gYETsk" title="Present Value discount, Financing Lease" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">57,848</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,010,889</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">838,078</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23C_zpZcekeyZSRg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 64 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_z4c8UDFFRBG2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zJNCpU4woAf3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zlk2bHXwcpRa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zgAmLeBiAUYb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zYjMWw9WoPlf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z0lVRmodUGBa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zM21wsKtC1I5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; OPERATING &amp; FINANCING LEASES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zckfhFOew0he" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zrImfJStlpKj" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B0_zKGhhdGBbs3h" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average Remaining Lease Term</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zk5uChC6bwS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">10.8</ix:nonNumeric></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zt5RrgC0pKdf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="AsOf2023-06-30" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">3.6</ix:nonNumeric></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Discount Rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_z5xM5K3cLNnh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_zC0uyTsGS8w1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
components of lease expense were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LeaseCostTableTextBlock_zxy39OwJ5OYj" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zyygSFR0RPUl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of Lease Expense</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_zGmMbeyWhzQ4" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210701__20220630_zucBadwZwugg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,887,390</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,668,199</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
                                    lease cost:</span></p></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zaUg4yKy4K5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,833</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,603</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCost_i01_pp0p0_zT0YjfaMdF4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">234,714</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,484</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
cash flow information related to leases as follows:&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9zePwdCb3Qh" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8BA_zgxLD6WvH0z4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20220701__20230630_zzzkPQ3GoYz1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20210701__20220630_zm3L7Omts6Ge" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_405_ecustom--OperatingCashFlowsFromOperatingLeases_zX6I191tFDq8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,577,578</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,133,369</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zGoPDcDi7xIi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zGY8GpFt41ua" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,902,584</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,900,074</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 65 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zrK4ESoSjqpc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><br />&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zh9saoufkwqh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p></ix:exclude>

<ix:exclude><p id="xdx_236_z9jb39rgM2ed" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zSY9n83T0yGl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zdIR7MAmS78l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zk3TIk9AGBAh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zc6P8aNp1N16" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXINrkF1i5H6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 - <span id="xdx_826_z71ABYwLJHhh">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, at June 30, 2023 and 2022 are comprised of:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zUIORFkxq0A2" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BB_zxXOUGIcS73d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets - Net</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" title="Other intangible assets - gross" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,004,847</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,452,345</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,332,774</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,150,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,150,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,900,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - gross" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,900,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,507,192</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" title="Other intangible assets - gross" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,387,621</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230630_pp0p0" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,075,327</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,683,736</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_c20230630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
estimated amortization of other intangible assets for the five years ending June 30, 2028 and thereafter is as follows:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjZ0zCHUktAi" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><p id="xdx_8BA_z8AOEZvCt3ih" style="margin-top: 0; margin-bottom: 0">Schedule Of Other Intangible Assets</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; width: 29%; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630_pp0p0" title="2024" style="width: 16%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">376,600</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2024" style="width: 16%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">176,600</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2024" style="width: 16%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630_pp0p0" title="2025" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,645</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2025" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,645</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2025" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630_pp0p0" title="2026" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">369,022</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2026" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,022</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2026" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630_pp0p0" title="2027" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">366,427</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2027" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,427</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2027" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630_pp0p0" title="2028" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">362,172</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="2028" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,172</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="2028" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630_pp0p0" title="Thereafter" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,585,999</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Thereafter" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">671,832</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Thereafter" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">914,167</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
                                            intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,517,698</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,914,167</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 66 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zdlDn7xfEWQ3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_zuAPXtzo4Oq9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zvfnp76AGrkh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z82XcwIbwaS1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zhEr3Y3K1Zgi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zIhdoe9oKzDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zoqhVHAEMOaa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zJny1IV3x0J3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 - OTHER INTANGIBLE ASSETS (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zlPoBrK33P95" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
weighted average amortization period for other intangible assets is <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220701__20230630_z6lgHxazj58l"><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10.3</ix:nonNumeric>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years
and they have no expected residual value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
related to the above intangible assets for the years ended June 30, 2023 and 2022 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zb0iXarH8vzc" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span id="xdx_8B1_zrayfMZnH9zf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Year Ended</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zIbCT4YdN9U5" title="Balance - Beginning of Year" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zYhsOIFManec" title="Balance - Beginning of Year" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,037,599</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zkRceRrU5th7" title="Amounts capitalized" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,571</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" title="Amounts capitalized" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">87,882</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20220701__20230630_zt3lWWpUAQ02" title="Software or patents written off" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1087">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" title="Software or patents written off" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1089">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AdjustmentForAmortization_c20220701__20230630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">391,591</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" title="Amortization" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">421,596</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zAxEzLTjDDy9" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zM7BcuwscN26" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,703,885</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">191,591</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">184,096</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of non-competition agreements for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,500</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:CapitalStockAndOptionsDisclosureTextblock"><p id="xdx_800_ecustom--CapitalStockAndOptionsDisclosureTextblock_zspzh5bc7i7b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_821_z9NzzPP1xRU8">CAPITAL STOCK</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_902_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zozgmjrlfAbj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" name="us-gaap:DividendsPayableNature">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B Common Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zCEjy4Yviq4l" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</ix:nonNumeric></span> <span id="xdx_901_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjzK1n5DxQAd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember" name="us-gaap:CommonStockVotingRights">Class
B common stock has 10 votes per share.</ix:nonNumeric></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziWlZyNwmc08"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of such
shares outstanding at June 30, 2023 and 2022.&#160;&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 67 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z70b65hjpV9i" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zweN8cyItj55" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zVjN8QdC6GQf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zAKpnTfJtnB6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zY8tWdzUxRe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zI0QZA6UPiv1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_234_z2JTUgjWZzm" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - CAPITAL STOCK (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zHH2tbKLB5o1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
C Common Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbKZqgOixFKh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" name="us-gaap:CommonStockVotingRights">The
Class C common stock has 25 votes per share</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
as compared to 10 votes per share for the Class B common stock and <span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxPRe9as5iW4"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" name="us-gaap:CommonStockVotingRights">one
vote per share for the common stock.</ix:nonNumeric></span></span> <span id="xdx_908_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzvFWlmhGrH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</ix:nonNumeric></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions. <span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlSZxxyUVxsc"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
A Non-Voting Preferred Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_90F_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zsS5rSJelvvc"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_PreferredClassAMember" name="us-gaap:CommonStockVotingRights">one
share of Class A non-voting preferred stock for every five shares of common stock.</ix:nonNumeric></span></span> <span id="xdx_901_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zknp5hxWcc3a" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_PreferredClassAMember" name="us-gaap:DividendsPayableNature">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next
$20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company
in connection with the enforcement of five of the Company&#8217;s patents in its patent lawsuits, less the revised special dividend
payable on the common stock with respect to one of the Company&#8217;s patents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
Bonus Plans</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the <span id="xdx_90C_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z44qqM8lbMj2" title="Shares registered"><ix:nonFraction name="FONR:SharesRegistered" contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares.
As of June 30, 2023, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z128fjIzEL8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,177</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2023 and 2022, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
were issued.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_z9Y314Qv7YG3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zMeFwv4qdbRj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zMvbg8fiDm5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_ztRVlJja2Kxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zd7bDMOiqBAg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0UEd2dt5TLh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zFraSr9P7TCk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - CAPITAL STOCK (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z9MDwbLjQxR5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zLJAo4WJgEi1"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to be repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company utilizes the cost method of accounting to value the treasury stock when repurchasing stock. Under this method, the shares are
valued at the price paid and recorded to treasury stock. When the treasury stock is cancelled, the par value of the stock is reduced
and the additional paid in capital is reduced for the remaining value based upon the original stock sale. For the year ended June 30,
2023, the Company purchased <span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zbVKgbP4955b" title="Purchase of treasury shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,148</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
at a cost of $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_zaUzvszQYkn6" title="Purchase of treasury stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,759,457</ix:nonFraction></span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and cancelled <span id="xdx_907_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zDbQcALXM2Ak" title="Cancellation of treasury shares"><ix:nonFraction name="FONR:CancellationOfTreasuryShares" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,328</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
valued at $<span id="xdx_901_ecustom--CancellationOfTreasuryStock_c20220701__20230630_zXX30Ms6m1I5" title="Cancellation of treasury stock"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,919,027</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zQO8lv4qtGig" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_828_zW1nhvcEn5Ah">CONTROLLING AND NONCONTROLLING INTERESTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
February 13, 2013, the Company entered into an agreement with outside investors to acquire a 50.5% controlling interest in a newly formed
limited liability company, Health Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM
there are two classes of members; Class A members and one Class B member. The Class A members have an ownership interest of <span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zITDnPqEL0ue" title="Ownership interest"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. The Class B member (HMCA) has an ownership of <span id="xdx_901_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zLQfxZl2D3l7"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $<span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zTpleUMySCWa" title="Contribution to HDM ($)"><ix:nonFraction name="FONR:ProceedsFromContributionsFromCompany" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,200,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to HDM
and the group of outside investors contributed $<span id="xdx_902_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_znd47uB9Rt6d"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,800,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for its
non-controlling membership interest.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 5, 2013, HDM purchased from Health Diagnostics, LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve
(<span id="xdx_90B_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zjFpaDEo1rb8"><ix:nonFraction name="FONR:PurchaseOfStandupMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">12</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
Stand-Up MRI Centers and two (<span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zxF20Bpatrel"><ix:nonFraction name="FONR:PurchaseOfOtherMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_902_ecustom--ConsiderationToOutsideInvestors_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zZofmKyMrlW2" title="HDM purchase price includes consideration to outside investors"><ix:nonFraction name="FONR:ConsiderationToOutsideInvestors" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.5</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to outside investors) aggregating $<span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z91ck1ngrdzi" title="HDM purchase from Health Diagnostics (HD) ($)"><ix:nonFraction name="FONR:TotalPurchasePrice" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35.9</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $<span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zzr61Ti8GMz7" title="HDM entered agreement for consulting and non-competition agreement ($)"><ix:nonFraction name="FONR:ConsiderationForNoncompetitionAndConsultingAgreements" contextRef="AsOf2013-03-05_custom_HDMMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.1</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business Combinations&#8221;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.</span></p>

<ix:exclude><!-- Field: Page; Sequence: 69 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zn2BFKOKTAVl" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;<br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z5pqOwc1V04b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zpmAyaSEA2X7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zm4pUJfdJ7Yb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zRte9xHxEYtb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zkPhd3Mx63k8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zGntWDy6Ico6" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; CONTROLLING AND NONCONTROLLING INTERESTS (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zAqR0ICsWar9" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;On
January 8, 2015, the Company purchased <span id="xdx_90A_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zBrMv2zTd845" title="Purchase of interests from Class A (%)"><ix:nonFraction name="FONR:EquityMethodInvestmentsOwnershipPercentage" contextRef="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the Class A members ownership interest at a cost of $<span id="xdx_90D_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMqOM4WFZj33" title="Purchase of interests from Class A ($)"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2015-01-072015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,971,094</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The Company has a <span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zJD348qEDs0c"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60.4</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests
for $<span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z3YlRtCCgXIi" title="Purchase of interests from Class A ($)"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">546,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">giving
the Company a direct ownership interest of <span id="xdx_90E_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zYWPdVYP12qe"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and the investors&#8217; a <span id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20220630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zWqpEQIKAZzg" title="Ownership interest"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2022-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
amount of each class of HDM members&#8217; equity as of June 30, 2023 and 2022 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zrJSsZorVLE2" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span id="xdx_8B2_zRSseaHm1Kld" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class A and B Members' Equity </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members' Equity</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,053,833</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,292,073</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,048,524</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Opening Members Equity" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,923,380</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share
    of Net Income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,750,740</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,513,540</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,793,482</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Share of Net Income" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,228,693</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Buyout
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zoqoPWuts0ca" title="Buyout of noncontrolling interests" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--BuyoutOfNoncontrollingInterestsValue_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Buyout of noncontrolling interests" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Buyout of noncontrolling interests" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,441</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Buyout of noncontrolling interests" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,776,200</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,023,800</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98D_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,822,232</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Distributions" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:Distributions" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,860,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending
    Members' Equity</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,079,293</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,781,813</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,053,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,292,073</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 70 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zj9iVdSkwxm2" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBI97KZ9xHF5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zDoJUCRAT587" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zFXJbDOmuhGj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkP0CmqI2X3a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_ztI4pm5yXpfa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:DebtAndCapitalLeaseDisclosuresTextBlock"><p id="xdx_807_ecustom--DebtAndCapitalLeaseDisclosuresTextBlock_z0LoIwYoBhe8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 - <span id="xdx_82F_zbRoeFU5NrFi">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt, notes payable and capital leases consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zEgujPxkPXbh" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zYWIKQ4Q2LZf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    Debt, Notes Payable and Capital Leases </span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRg68h9lrgK3"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-07-012023-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90B_ecustom--MonthlyPaymentPeriod_dtM_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z6nYhUl9NSwg"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_NotePayable1Member" format="ixt-sec:durmonth" name="FONR:MonthlyPaymentPeriod">240</ix:nonNumeric>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">monthly
    payments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-07-012023-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,472</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_904_ecustom--MaturityDate_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_NotePayable1Member" name="FONR:MaturityDate">October 2026</ix:nonNumeric></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_906_ecustom--BookValueOfBuilding_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zb0M1y52wIMk" title="Book Value Of Building"><ix:nonFraction name="FONR:BookValueOfBuilding" contextRef="AsOf2023-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,995</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2023.</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z49euvtnLP25" title="Long Term Debt Current" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">158,842</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zmO4ivBSS6Mh" title="Long Term Debt Current" style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30_custom_NotePayable1Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,457</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
    revolving credit note was extended to November 15, 2023. The Company can borrow up to $<span id="xdx_90B_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zlyEtRYYdf8b"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2022-07-012023-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000,000</ix:nonFraction>
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zUq2b70gTFZ"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2022-07-012023-06-30_custom_NotePayable2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zPxMifvXD5si" title="Long Term Debt Current" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zOFyzWKlQKOi" title="Long Term Debt Current" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LongTermDebtCurrent_c20230630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">158,842</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LongTermDebtCurrent_c20220630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,457</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20230630_pp0p0" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,767</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" title="Current portion of Long Term Debt, Notes Payable and Capital Leases" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,078</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20230630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">115,075</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,379</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_ze3NYm3Q0hF9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
maturities of debt over the next four years are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_znlr3sk58ur9" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BF_zCEqiJZQudaj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities of Long-term Debt</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 2%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 9%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_c20230630_pp0p0" title="2024" style="width: 43%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,767</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_c20230630_pp0p0" title="2025" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,002</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_c20230630_pp0p0" title="2026" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,448</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_c20230630_pp0p0" title="2027" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,625</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: right"></td><td style="padding-bottom: 2.5pt; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif; color: Black">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230630_zJJN50r1PrW6" title="Total long term debt" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,842</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 71 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_ztmRMGjYuWLj" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zlUFwEMiX8x" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_z2NMV9NnsOBf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zGjf93tuVCO2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zOeQRjO4tmY6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zLkDNGjO2QXj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
11 - <span id="xdx_82C_zt7Zbe5Qf9ne">INCOME TAXES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740, &#8220;Accounting for Income Taxes&#8221; prescribes a recognition threshold and a measurement attribute for
the financial statement recognition and measurement of tax positions taken or expected to be taken in a corporate tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences
between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation
are referred to as unrecognized benefits. A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable
is reduced) for an unrecognized tax benefit because it represents an enterprise&#8217;s potential future obligation to the taxing authority
for a tax position that was not recognized as a result of applying the provisions of ASC 740. The Company believes there are no
uncertain tax positions in prior year&#8217;s tax filings and therefore it has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net. Penalties if incurred would be recognized as a component of &#8220;Selling, general
and administrative&#8221; expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has recorded a deferred tax asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_pp0p0_c20230630_zmrqxfrXaEfl"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,041,960</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
a deferred tax liability of $<span id="xdx_90C_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_pp0p0_c20230630_z2xG5R9k0Qhj"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,758</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
of June 30, 2023, primarily relating to its net Federal operating loss carryforwards of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_pp0p0_c20230630_zghzAHzWQ2Vk"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,110,000</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $<span id="xdx_906_eus-gaap--OperatingIncomeLoss_pp0p0_c20220701__20230630_zT1rO3MCQ1J3"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,130,000</ix:nonFraction> </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
city operating loss carryforwards allowance for doubtful accounts and tax credits of approximately $<span id="xdx_90A_eus-gaap--OtherOperatingIncome_pp0p0_c20220701__20230630_z4v22By4iEN7"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,235,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2023, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15%&#160;corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#8217;s financial statements.&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 72 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zgkYhKi9a1z" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zcLxfPSesvU9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zUqqnICOzxwd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zvva1DC1x7o6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zG3jkXCfnlgk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zXtR9NfcOM96" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zZUIF9QTZRcf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to certain state net operating losses. A valuation allowance will be maintained until sufficient
positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2023, by approximately $<span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20230630_zEW2pqvqsLH9"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The valuation allowance decreased by approximately $<span id="xdx_905_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20220630_zizcqOtZTwT6"><ix:nonFraction name="us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">448,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">during
the year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
of the provision (benefit) for income taxes are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6y1hFTCOf9c" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_zysDaFNtEFVl" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of the provision for income taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20220701__20230630_z9bunqIZvHog" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210701__20220630_z2zyMGjQf8z1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zF1yzXEy8uz3" style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentFederalTaxExpenseBenefit_zsxb5kuS8NH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1300">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zZKXHI2RZ7f8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">652,522</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,440,594</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_z8HEcDRpBj1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">652,522</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,440,594</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqTyw3EjR307" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zvNDEJelDZX2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,770,980</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,935,921</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zRAwcBDX65A9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,569</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,972</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zFenrUvRYWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,979,549</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,893</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxExpensesBenefit_iT_pp0p0_mtITEBzXA8_z3mYrNiszNl2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncomeTaxExpensesBenefit" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,632,071</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncomeTaxExpensesBenefit" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,534,487</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 73 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zMwgmeiHPuU2" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zeSh2dHKkVr4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z0Y7OEi4uQhk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zoNuxIj94GY6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zNNGD0P67eR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zFEJdYWZAJH6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUZopEqPK21k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zB0ALcksBTy1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of the federal statutory income tax rate to the Company&#8217;s effective tax rate as reported is as follows:&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLo3Ld9h7Id4" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B6_zADvGj9GsS8b" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20220701__20230630_zRiACJwupoH7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20210701__20220630_zl40kX3RSMX7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z2XEbsfaH9Rk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zPahfCKGnEXe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.1</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.2</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zSXDrFLvbzs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling interest</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.5</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zWJ5JEKRwyP3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-indent: 10pt; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.8</ix:nonFraction></span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_z1B8EuDhvX1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left">)<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_401_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zN9Me9o5xBK4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">New
    York state audit settlement</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1348">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.5</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zDoc7tdj8dE1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.5</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.0</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zLs4Dx3JDR65" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zTQ4MMg0sHC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23.0</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.3</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2023, the Company has net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $9,110,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_pp0p0_c20230630_zAMoI9jdAnHb"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,981,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company was also under audit with New York State for income tax and was assessed additional taxes of $<span id="xdx_909_ecustom--AdditionalTaxes_pp0p0_c20220701__20230630_znYfcXKfGT3g" title="Additional Taxes"><ix:nonFraction name="FONR:AdditionalTaxes" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,014,071</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties. These amounts were paid during fiscal year ending June 30, 2022.&#160;&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 74 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zcPhyGhlteS9" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zIj923beTjl5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zuBksBYS7Zil" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zjGjXnpBwoWb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zSECsJsyOuW9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zJcBLGpPVw26" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zyEItVrE84Sl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zMUlUrnSdtrc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Significant
components of the Company&#8217;s deferred tax assets and liabilities at June 30, 2023 and 2022 are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zk4dlaBdlo01" summary="xdx: Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BC_zsDy1qosNeo8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of company&#8217;s deferred tax assets and liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20230630_zNlrWkjeE10l" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20220630_zri6mvKsALf8" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company&#8217;s Deferred Tax Assets and Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zzjHJa2JLYX6" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,360,809</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,239,903</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_z9rn4rbW8iO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,400</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,400</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zhzhjUe3grx" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,768,844</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,820,010</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zG6dQHgCxejg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,981,214</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,346,509</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z2Qv9VuIR4Pl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">Capitalized research and development</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">369,675</ix:nonFraction></td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="padding-left: -10pt; text-indent: 0pt; vertical-align: middle; font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1389">&#8212;</span> </td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zkzC1StgmEzb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0">Right of use assets and lease liabilities</p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,938</ix:nonFraction></td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1392">&#8212;</span></td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zdeBPhyTmRHe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">105,310</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,945</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_z6zPnbSFXrD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1397">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,576</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z4QhO76n5m7a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,406,190</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,284,343</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zpcVtWGmQfx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">364,230</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">441,865</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_zxOQxyhXKJ4l" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,041,960</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,842,478</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z85ERFvIt3qi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt">Property and equipment and depreciation</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,007</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1410">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMjpPTLPLpF8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">243,751</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_z5kmTeiwww35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">394,758</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,726</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zVGmIoVll3rf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,647,203</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,626,752</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_803_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zM3qi7ptRmqi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - <span id="xdx_825_zEr90BR8vToi">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
in other current liabilities are the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zkBqSaGxKSv2" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_z7Ev5TRSKybd" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of other current liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20230630_zMSbXzPsoTO3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_494_20220630_zaXLycoP2Lzg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,413,044</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,652,173</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">193,041</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">248,702</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,353</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">382,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,207</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,707</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120,000</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,971</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,167</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,534</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">59,516</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">573,574</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">854,962</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,443,724</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,417,227</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 75 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zXyQzezjKrvk" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zdpgXQlGi5Al" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zPQyuTJWlXD6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zbdNiep3WHBh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zWU6Vtne8VLd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zntCE5L5gqtc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
13 - <span id="xdx_82D_zWXnxBvOICL3">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leases</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Rent
expense for operating leases approximated $<span id="xdx_909_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zLQ2pV2k4kPk" title="Operating Leases, Rent Expense"><ix:nonFraction name="FONR:LeaseAndRentalExpenses" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,887,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20210701__20220630_zkRKv5AGqn3i" title="Operating Leases, Rent Expense"><ix:nonFraction name="FONR:LeaseAndRentalExpenses" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,668,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company received approval from the Suffolk County Industrial Development Agency on February 29, 2016 of a <span id="xdx_905_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_zZwwlKxQ7Brd" title="Property Tax Abatement From Suffolk County IDA"><ix:nonFraction name="FONR:PropertyTaxAbatementFromSuffolkCountyIda" contextRef="From2016-02-282016-02-29" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
property tax abatement, valued at $<span id="xdx_90B_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zvABCvhoTFLf" title="Property Tax Abatement"><ix:nonFraction name="FONR:PropertyTaxAbatement" contextRef="From2016-02-282016-02-29" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">440,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
over a 10 year period commencing January 2017.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Employee
Benefit Plans</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has a non-contributory 401(k) Plan (the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $<span id="xdx_907_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zBF3MZhy5To8"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,523</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20210701__20220630_zeUoP5iWtYGj"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">employer
contributions to the Plan for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal counsel,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20220701__20230630_zOVsqVuRUbqe" title="Liability for individual claims"><ix:nonFraction name="FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2023
and 2022, the Company had approximately $<span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20230630_zZwyV47UBw4f"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20220630_ziUtQve0x3U5"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the consolidated balance sheets.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_z3RF3wX0pQf8" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zDfM1IEnoiZ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zwtEiGBCECwl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zWBp6HWQavI2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zfP9j8QImf98" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zyHs7XCgknzc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
13 - COMMITMENTS AND CONTINGENCIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4HUvyj7n3Gb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zfjOnR9EJ8Tf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z0PpLRjmGaF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_801_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGNTfroZi4zl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
14 - <span id="xdx_82E_zHfNFZoQEyB9">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022 the Company paid $<span id="xdx_90B_eus-gaap--InterestPaidNet_pp0p0_c20220701__20230630_zdwzZBvH1Vdj"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,132</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_909_eus-gaap--InterestPaidNet_pp0p0_c20210701__20220630_zqPfaa25zVq7"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">617,029</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for interest,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022 the Company paid $<span id="xdx_905_eus-gaap--IncomeTaxesPaid_pp0p0_c20220701__20230630_zwoBRzrbRP0a"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,439,507</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--IncomeTaxesPaid_pp0p0_c20210701__20220630_zJ0Oyc6iTVF5"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,408,145</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for income
taxes, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and
penalties in the amount of $<span id="xdx_902_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20220701__20230630_ztv4LP7ipUFh" title="Selling, General and Administrative Expenses"><ix:nonFraction name="FONR:SellingGeneralAndAdministrativeExpenses" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,000</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_907_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20210701__20220630_zePjJScfVwX3" title="Selling, General and Administrative Expenses"><ix:nonFraction name="FONR:SellingGeneralAndAdministrativeExpenses" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,000</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, which has been recorded under selling, general and administrative expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z45ey6Nlcw02" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
15 &#8211; <span id="xdx_82C_zZUHxSktMUtg">RELATED PARTY TRANSACTIONS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90B_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--ABillingCompanyMember_zDJXJOPyuz2b" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_ABillingCompanyMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was terminated on May 31, 2023.</ix:nonNumeric></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90D_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zduaEdq4gFV1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonNumeric contextRef="From2022-07-012023-06-30_custom_BensonhurstMRILimitedPartnershipMember" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</ix:nonNumeric></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zW9LRVpTfK28" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zJTSoRwmE42" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zsjDzJt4Joo7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zR4nPPODv0I4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zLMQYT5B1dRk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zanA7qWHO3Tl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
16 - <span id="xdx_821_z4FuE9q21gw8">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company provides segment data in accordance with the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise
and Related Information&#8221;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
Segment Financial Information&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zPXG9kSLthP7" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BD_z7C7hc2iLLAb" style="display: none; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summarized segment financial information</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2023:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zpNMwgWqh7Yk" title="Total Revenues - Net" style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,260,711</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zHxTupVuDJLj" title="Total Revenues - Net" style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,384,390</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220701__20230630_zAknCGKJZkla" title="Total Revenues - Net" style="width: 11%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,645,101</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zOsO6rfotIJc" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001511" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">985,833</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pdp0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zsNxiO6YETy5" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1513">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630_fKg_____zqbSeMrwjba" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-01to2023-06-30" id="Fact001515" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">985,833</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zXR0iSaDwHle" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,875,126</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zzdpLLifZtZ6" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,664,388</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630_zMTWT84bXrD2" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,789,262</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zojxEEEyBLJ9" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,720</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zuariS2sOssi" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,276,415</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630_zkZ9Uq6ZYsTj" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,540,135</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zfnR5AVfUzx8" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,892,807</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpgqVsDleOJl" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,153,612</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsNet_pp0p0_c20230630_zua5IeHhZe0l" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">201,046,419</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zhUVKAqmpuS6" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,571</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zlX9m0tmAvI7" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,218,084</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630_zqQ064GXbR3j" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,337,655</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2022:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zKMglThxge42" title="Total Revenues - Net" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,218,804</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrLkiYhx9D06" title="Total Revenues - Net" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,373,341</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20210701__20220630_zff7EAGeLXB8" title="Total Revenues - Net" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">97,592,145</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjMeTghUhDJd" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" id="Fact001547" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">965,417</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zGFoe4ufuqcc" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1549">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zhfeDEwGjne9" title="Intersegment net revenues" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-06-30" id="Fact001551" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">965,417</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_znVhOlhMnb52" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,604,305</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zCPs6OXoGRH" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,611,487</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630_zEsuSmoDlGRi" title="(Loss) Income from operations" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,007,182</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zbnqxGhQCkWe" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">263,559</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zYsxlOYyuZPk" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,271,677</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630_zaiNd5lWe1th" title="Depreciation and amortization" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,535,236</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zkqm6FASk111" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,182,037</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_z5MnKSAJphW5" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,159,945</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_iI_pp0p0_c20220630_zrAoywIBuDE1" title="Total identifiable assets" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,341,982</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zTFPZgfjNJK5" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">258,271</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyJqfV4JvZX2" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,374,903</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630_zyvDM4bzTfDi" title="Capital expenditures" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,633,174</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td id="xdx_F0F_zsV6KE79uDZ3" style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F13_z6TxoJTiISs8" style="width: 97%"><ix:footnote id="Footnote001576" xml:lang="en-US"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation&#160;</span></ix:footnote></td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A5_zsYVRsSlZHW5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 78 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zXKvvqbGwvLf" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkkjgXdfGGLh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zkmCxdZmVBx4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zjLYctSgzSb7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zmte24wH8276" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z2dkmrpN4age" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
16 - SEGMENT AND RELATED INFORMATION (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z89XaUtxoN2g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
Product Sales</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to <span id="xdx_901_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_z0Jfn3udqT0g" title="Export Sales Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.1</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_905_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_zcecMvPwN9O8" title="Export Sales Of Medical Equipment Percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.9</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of product sales revenues to third parties for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:ExportProductSalesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExportProductSalesTableTextBlock_z6ygtRfCAElb" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B8_zs0G1fu2rRTi" style="display: none; font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of export product sales</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_za70KzLBfi0h" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_DO" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8212;</ix:nonFraction></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zUeCyfTz5bmg" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_DO" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.0</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zwnWaRixp2og" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zTHPj4mKQYC" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_z0MpxSKF60P" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zBG1YMht5atc" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1601">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zm8LSOFJqNJh" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-012023-06-30_country_AE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.7</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--AE_zjMl2sPcl006" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1605">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zwvZKNJcZT64" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1607">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zn1o5GS82Are" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">36.3</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630_zP7xHOq0WGd9" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14.1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630_zpmnKRLlyyLi" title="Foreign Product Sales" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48.9</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_z4r5uN0Ubweg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service and Repair Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to <span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zUfwWckzmopi"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.4</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zRkIWqrtPDol"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.4</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of consolidated net service and repair fees for the years ended June 30, 2023 and 2022 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service Repair Fees&#160;&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="FONR:ExportServiceRevenuesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ExportServiceRevenuesTableTextBlock_zNTdDnFBKgw6" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BA_zyn3KRxz8kA8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of foreign service and repair fees</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
                                            the Years</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ended
                                            June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zWUC5N2rrnsc" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="width: 12%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zy7sTtLtgDP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_PR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.5</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_zHUz06fBicM6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z78GlqwOwOw7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_CH" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zZrDG1mOzLI9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zglZ5NQ90vac" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_DE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zlzbL7PYSnO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zqjVBH7xRhAj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_GB" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zTtkp2daEkCl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_AE" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zmEraVSvsot2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_DO" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zxVyjjJPlBU3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_CA" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.6</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zqY4i9Xq6jKk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_zYEf2OBkL3j4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_GR" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zvIX1pLJR5Y7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-012023-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.9</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zcznXqKAwZb3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30_country_AU" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zcKtHCqor8u2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2022-07-01to2023-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.4</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zghWVedLFHNh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2021-07-012022-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.4</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company does not have any material assets outside of the United States.&#160;&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 79 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zCD3NtoZ33gl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_znvm7T1wTyZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zfO7KF4zPDCj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zrYILisIHjE8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">JUNE
30, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zO5BMen1cFl7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zK945sHnKjNg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"><p id="xdx_802_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zMEsVSSw2E4i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
17 &#8211; <span id="xdx_829_zOIphTVYkgNa">ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2023 and 2022 respectively:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summary
of Allowance For Doubtful Accounts&#160;&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zN2psGB4q6hf" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8B1_zPUNyCV9PLBf" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summary of allowance for doubtful accounts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br /> June 30, 2022</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br /> June 30, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3c84wGytPAa" title="Beginning Balance" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,597</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zWFykp0lXNj8" title="Additions (Included in provision for bad debts)" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember" id="Fact001648" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,000</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7BvZoNcapV4" title="Deductions" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,004</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zJTLa3X6CNul" title="Ending Balance" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,593</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zmYFaJiJZALj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,627,917</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zqKUaRQqYYq1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001654" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,007,382</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zXNQJ2KuLf5e" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,026,732</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zIRFpZFP48ai" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,608,567</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzh3AqMjv2sk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,686,893</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zPxmExHv0NVk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001658" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,451,094</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zJnui7QrFv33" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,148,295</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zO8tH05rN7l1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,989,692</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zeAHTCre7yWa" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zjYx5Y9qzGK9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1662">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zHSiDs9z0Dr4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1663">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEwr4pfZiX6c" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zme0piRnKc98" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">442,270</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z5gsunDsB1ac" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1666">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zamy9Xu4zwI" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">237,673</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zWt8BHrJqjHa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,597</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBq1gGJMhCw3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,786,878</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zMvpsGLiuAE9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001670" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">841,039</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zeyGJP1zUmFl" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1671">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNJyZMlxPOVj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,627,917</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zP5xUMx3gkm2" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,184,399</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zolmLfsiOFca" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001674" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">502,494</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzSvguOHpRUk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1675">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zqIEfuVrH8Gk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,686,893</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zcVaBiwFQY25" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zc79CWS3III1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1678">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEMrAKCt0vcb" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1679">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zkCgSPaWDJk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td id="xdx_F0B_zvbAfRny9CW4" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td id="xdx_F11_zPa1oeg5ikXa" style="padding-left: 11pt; text-align: justify"><ix:footnote id="Footnote001681" xml:lang="en-US"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
    in provision for bad debts.</span></ix:footnote></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zjDDdhSgWOpe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zKjxFtBaELZa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
18 &#8211; <span id="xdx_824_zM6hgVunp0P2">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 31, 2023, <span id="xdx_909_eus-gaap--BroadcastersLicenseAgreementCommitmentsDescription_c20230729__20230731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyvLNlVUCQTc"><ix:nonNumeric contextRef="From2023-07-292023-07-31_us-gaap_SubsequentEventMember" name="us-gaap:BroadcastersLicenseAgreementCommitmentsDescription">the
Company entered into a software license agreement for a term of 3 years at a cost of $1,260,000. The effective date of the agreement
is October 1, 2023.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
August 2023 the Company amended their revolving credit agreement. The agreement was extended to November 15, 2023.&#160;The interest
rate on borrowings remains at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230801__20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcY6vAQyqhQ4"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-08-012023-08-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
along with certain financial covenants.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of August 31, 2023, the Company repurchased <span id="xdx_90C_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znypzzQ2uwsg"><ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" contextRef="AsOf2023-08-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">27,844</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
at a cost of $<span id="xdx_905_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5nnRU49yCw9"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2023-08-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">469,372</ix:nonFraction>
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
was authorized under the stock repurchase plan adopted in September 2022.</span></p>

<ix:exclude><!-- Field: Page; Sequence: 80 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>


    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_81A_zFee4nqFQXy1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="CautionaryNote"></span>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
have been no disagreements with our independent registered public accounting firm or other matters requiring disclosure under Regulation
S-K, Item 304(b).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="ControlsAndProcedures"></span>ITEM
9A. CONTROLS AND PROCEDURES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Evaluation
of Disclosure Controls and Procedures</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of the end of the period covered by this Annual Report on Form 10-K, we performed an evaluation under the supervision of and with the
participation of management, including our Principal Executive Officer and our Acting Principal Financial Officer, of the design and
effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act
of 1934 as amended (the &#8220;Exchange Act&#8221;). Based upon that evaluation, our Principal Executive Officer and Acting Principal
Financial Officer concluded, as of the end of the period covered by this Annual Report that our disclosure controls and procedures were
effective.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management&#8217;s
Report on Internal Control Over Financial Reporting</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting, as is defined in the Exchange
Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of our
financial reporting and the preparation of financial statements for external reporting purposes in accordance with GAAP.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal
Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO-2013). Based on this
evaluation, our management concluded that our internal control over financial reporting was effective at June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Based
on the COSO criteria, management concluded that our internal controls were effective to prevent material misstatements of the Company&#8217;s
annual or interim financial statements for the fiscal year ending June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Changes
in Internal Controls over Financial Reporting</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the
most recent fiscal quarter and year ended June 30, 2023 that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.</span></p>

<!-- Field: Page; Sequence: 81 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Information"></span>Item
9B. OTHER INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">None.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Disclosure"></span>Item
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">None.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
III</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="DirectorsAndExecutiveOfficers"></span>ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Directors
serve from the date of their election until the next annual meeting of stockholders and until their successors are elected and qualify.
During fiscal 2022, with the exception of Dr. Raymond V. Damadian, who did not receive any fees for serving as a director, each director
receives a base fee of $20,000 per annum for his or her service as a director, with greater amounts for additional services on the Board
of Directors. Officers serve at the discretion of the Board of Directors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
majority of our board of directors is composed of independent directors: consisting of, Ronald G. Lehman, Richard E. Turk and Jessica
Maher. The outside directors also serve as the members of the audit committee, which is a standing committee of the board of directors
having a charter describing its responsibilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">We
have adopted a code of ethics applicable to, among other personnel, our principal executive officer, principal financial officer, controllers
and persons performing similar functions. The code is designed to deter wrongdoing and to promote: 1. honest and ethical conduct, including
the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; 2. full, fair, accurate,
timely and understandable disclosure in reports and documents that we file or submit to the Securities and Exchange Commission and in
other public communications we make; 3. compliance with applicable governmental laws, rules and regulations; 4. the prompt internal reporting
of violations of the code to an appropriate person or persons identified in the code and 5. accountability for adherence to the code.
We will provide a copy of the code to any person who requests a copy. A person may request a copy by writing to FONAR Corporation, 110
Marcus Drive, Melville, New York 11747, to the attention of the Legal Department or Investor Relations.&#160;</span></p>


<!-- Field: Page; Sequence: 82 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
officers and directors of the Company are set forth below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 35%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian</span></td>
    <td style="vertical-align: top; width: 10%; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">59</span></td>
    <td style="width: 55%; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
                                            of the Board, President,</span></p>
                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
                                            Executive Officer and Treasurer</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    B. Bonanni</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">68</span></td>
    <td style="text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
                                    Vice President, Chief Operating Officer and</span></p>
                                    <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">acting
                                    Principal Financial Officer</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
                                    J.V. Chan</span></p></td>
    <td style="vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">85</span></td>
    <td style="vertical-align: top; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
                                    J. Lehman</span></p></td>
    <td style="vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47</span></td>
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
    E. Turk</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39</span></td>
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Jessica
    Maher</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26</span></td>
    <td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian has been the Chairman of the Board and Treasurer of FONAR since September 7, 2022 and the President and Chief Executive Officer
of FONAR since February 11, 2016. From 2010 to 2016 he served as an independent consultant, with a focus on the Company&#8217;s MRI facility
management business. Timothy Damadian began his career at FONAR in 1985, installing MRI scanners and components for FONAR customers.
Over the course of the following 16 years, he held positions of increasing authority, eventually becoming Vice President of Operations.
In 1997, Timothy Damadian was appointed President of the newly formed Health Management Corporation of America (HMCA), a wholly-owned
subsidiary of FONAR that was formed to manage medical and diagnostic imaging offices. In 2001, Timothy Damadian left FONAR to form Integrity
Healthcare Management, Inc., a diagnostic imaging management company that would eventually manage MRI scanning centers in New York and
Florida. The company was a success and was sold to Health Diagnostics, LLC in 2007. Mr. Damadian returned to FONAR as a consultant in
2010. He also serves as a Manager of Health Diagnostics Management, LLC, which are subsidiaries of HMCA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
B. Bonanni has served as Chief Operating Officer (COO) and Executive Vice President (EVP) for FONAR Corporation since June 27, 2016.
In September 2022, he was appointed to fill the position of acting Principal Financial Officer. Prior to his appointment as COO, Mr.
Bonanni had served the Company as Vice President since 1989, during which time he oversaw general operations, research and development,
manufacturing, service, sales, finance, accounting and regulatory compliance. Prior to 1989, Mr. Bonanni held the title of Vice President
of Production and Engineering from the time of FONAR&#8217;s initial public offering in 1981. Mr. Bonanni joined the Company as an electrical
engineer in 1978. He holds a Bachelor of Electrical Engineering degree from Manhattan College.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan has been a Director of FONAR since October 1987 and Secretary of FONAR since January 2008. Mrs. Chan was employed from 1992
through 1997 by Raymond V. Damadian, M.D. MR Scanning Centers Management Company and since 1997 by HMCA, as &#8220;site inspector,&#8221;
in which capacity she is responsible for supervising and implementing standard procedures and policies for MRI scanning centers. From
1989 to 1994 Mrs. Chan was employed by St. Matthew&#8217;s and St. Timothy&#8217;s Neighborhood Center, Inc., as the director of volunteers
in the &#8220;Meals on Wheels&#8221; program, a program which cares for the elderly.</span></p>


<!-- Field: Page; Sequence: 83 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">From
approximately 1983 to 1989, Mrs. Chan was President of the Claudette Penot Collection, a retail mail-order business specializing in women&#8217;s
apparel and gifts. Mrs. Chan practiced and taught in the field of nursing until 1973, when her son was born. She received a Bachelor
of Science degree in nursing from Cornell University in 1960.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
G. Lehman has been a Director of FONAR since April, 2012, when he was unanimously appointed by the remaining four Directors to fill the
vacancy resulting from the death of former Director Robert Djerejian. From October, 2009 to the present, Mr. Lehman has served as Managing
Director of Investment Banking with Bruderman Brothers, LLC, a private New York-based broker-dealer registered with the Securities and
Exchange Commission and which is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection
Corporation (SIPC). Mr. Lehman directly manages all facets of the firm&#8217;s transaction processes, from deal origination, to sourcing
capital, to negotiating deal structures, through documentation and closing. The firm provides buy and sell-side advisory, capital raising,
and consulting services to lower middle-market companies. Mr. Lehman specializes in advising healthcare services companies and has recently
completed several recapitalizations in the industry. He also participates in the firm&#8217;s merchant banking investments and oversees
many of these assignments. From May, 2008 to October, 2009, Mr. Lehman served as Senior Vice President of Acquisitions at Health Diagnostics,
LLC, where he managed the company&#8217;s acquisition and corporate finance activities. From March, 2000 to May, 2008, Mr. Lehman worked
for various Bruderman entities as a buy and sell-side advisor and as a principal in several private equity transactions. From September,
1998 to March, 2000, Mr. Lehman worked at Deutsche Bank Securities, Inc. and last held the position of Associate in their Global Custody
Group. Mr. Lehman graduated from Columbia University with a B.A. in 1998.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
E. Turk has been a Director of FONAR since June, 2020, when he was appointed to fill the vacancies on the Board of Directors and Audit
Committee of the Board of Directors resulting from the death of his predecessor, Robert J. Janoff. Mr. Turk is the Chief Financial Officer
of PRISM Vision Group, a private equity-backed, multi-location, outpatient comprehensive eye care practice headquartered in Union, New
Jersey. Mr. Turk joined PRISM in November, 2018 as the Chief Development Officer and became CFO in March 2021. Mr. Turk has helped PRISM
expand from a single-specialty (retina) provider with 17 locations and 21 physicians to a comprehensive, vertically-integrated, multi-specialty,
eye care organization with approximately 190 physicians and more than 90 locations across New Jersey, Pennsylvania, Delaware, Virginia,
Washington, DC, and Maryland. Prior to his tenure at PRISM, Mr. Turk was employed by Professional Physical Therapy, a private equity-backed
outpatient physical and occupational therapy company headquartered in Uniondale, New Jersey with more than 180 locations across New York,
New Jersey, Connecticut, Massachusetts and New Hampshire. During his four years at Professional Physical Therapy, Mr. Turk sourced, analyzed,
and completed 32 acquisitions comprised of 116 clinics, expanding the company&#8217;s services and adding three states. From 2007 to
2014, Mr. Turk was employed by Bruderman Brothers, a broker dealer involved in investment banking, merchant banking, investment advisory,
and consulting for lower middle market companies ($10M-$250M of enterprise value) in a variety of industries, including healthcare. Mr.
Turk was Vice President of Bruderman Brothers from 2011 to 2014. Mr. Turk graduated from Columbia University in 2007.</span></p>


<!-- Field: Page; Sequence: 84 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Jessica
Maher has been a Director of FONAR since March 2023, when she was appointed to fill the vacancies on the Board of Directors and Audit
Committee resulting from the resignation of her predecessor, John Collins. Mrs. Maher is a staff accountant at Ives &amp; Sultan, LLP
in Woodbury, New York, where she is responsible for preparing audited financial statements for various clients, overseeing audit testing
areas, audits of 401(k) plans, and personal and company tax returns. Mrs. Maher holds a Bachelor of Science in Accounting with a minor
in Accounting Information Systems, and a Master of Science in Accounting from Fairfield University in Fairfield, Connecticut. During
her early undergraduate years, Mrs. Maher worked for Tritech Healthcare Management in Melville, New York, where she reviewed patient
files, insurance, charts and documents to ensure that the services provided by clients were being properly billed. In her senior year,
Mrs. Maher interned at Northwell Health in Westbury, New York, where she supported the financial reporting team for two hospitals, reported
into accounts receivable software, and analyzed patient billing records to identify overpayments. Mrs. Maher&#8217;s first position out
of college was with PriceWaterhouseCoopers in Melville, New York, where she was assigned to two private equity clients, was responsible
for a variety of the audit areas, and assisted managers in reviewing financial statements, footnote disclosures, and audit opinions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Board
    Diversity Matrix as of September 12, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 64%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Number of Directors</span></td>
    <td style="border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 18%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Part
    I:&#160;&#160;Gender Identity</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Female</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Male</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Directors</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Part
    II: Demographic Background</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">White</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="border-top: Black 1pt solid; vertical-align: bottom; background-color: White">
    <td colspan="4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Board
    Diversity Matrix as of September 15, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Number of Directors</span></td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Part
    I: Gender Identity</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Female</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Male</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Did
    not disclose gender</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; width: 30%; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Directors</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; width: 20%; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; width: 20%; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt; width: 30%; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Part
    II: Demographic Background</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">White</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Did
    Not Disclose Demographic Background 1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director
    with Disabilities</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td></tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 85 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="ExecutiveCompensation"></span>ITEM
11. EXECUTIVE COMPENSATION.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">With
the exception of the Chief Executive Officer and the Chairman of the Board of Directors, the compensation of the Company&#8217;s executive
officers is based on a combination of salary and bonuses based on performance. The Chief Executive Officer and the Chairman of the Board
have no understandings with the Company with respect to bonuses, options or other incentives; they are not subject to our general policy
later discussed.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Board of Directors does not have a compensation Committee. The Chief Executive Officer and the Chief Operating Officer participate in
the determination of compensation for the Company&#8217;s management and other employees.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;The
Board of Directors has established an audit committee. The members of the committee are Ronald G. Lehman, Richard E. Turk and Jessica
Maher.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
compensation policy includes a combination of salary, commissions, bonuses, stock bonuses and stock options, designed to incentivize
our employees. There is no universal plan applicable to all of our employees. The fixed and variable components of our employees&#8217;
compensation tend to be individualized, based on a combination of the employees&#8217; performance, responsibilities and position, our
assessment of how best to motivate a person in such a position and the needs and preferences of the particular employees, as negotiated
between employees and their supervisors or management.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;There
is set forth in the following Summary Compensation Table the compensation provided by us during fiscal 2023, 2022 and 2021 to our Principal
Executive Officer, and our acting Principal Financial Officer. There is set forth in the following Outstanding Equity Awards Table and
Director Compensation Table the required information.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">I.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SUMMARY
                                            COMPENSATION TABLE</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Reflects
information up to end of Fiscal 2023)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and All Other Principal Position</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Year</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Salary<br />
    ($)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    Bonuses<br /> ($)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    Awards<br /> ($)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Compensation ($)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(a)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(b)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(c)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(d)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(e)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(f)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,900</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,900</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President,
    Principal</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Officer</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,553</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">329,353</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
    of the Board,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">458,895</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasurer
    and</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">153,095</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">458,895</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principal
    Financial Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    Bonanni</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">143,416</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">449,216</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Operating Officer and</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">148,572</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">305,800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">454,372</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Vice President</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2021</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,496</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">152,931</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">298,969</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"></p>

<!-- Field: Page; Sequence: 86 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">II.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">OUTSTANDING
                                            EQUITY AWARDS AT FISCAL YEAR-END</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Number
    Of Securities Underlying Unexercised Options (#) Exercisable</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Option
    Exercise Price ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Option Exercise
    Expiration Date</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(a)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(b)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(c)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 22%; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Raymond
    V. Damadian, Chairman of the Board, Treasurer and Principal Financial Officer</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 19%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 19%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 21%; text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian, President and Principal Executive Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    Bonanni, Chief Operating Officer, Executive Vice President and acting Principal Financial Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">N/A</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.25in; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">III</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">DIRECTOR
                                            COMPENSATION</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table shows the compensation paid to the Directors for fiscal 2023:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fees
    earned in pad <br />in cash ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
    awards ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Option
    awards ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-equity
    incentive plan compen- <br />sation</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Nonqualified
    deferred compen- <br />sation earnings <br />($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
    other compen- <br />sation ($)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    <br />($)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(a)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(b)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(c)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(d)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(e)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(f)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(g)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(h)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 37%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A.
    Claudette J.V. Chan</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">38,880</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">58,880</span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">B.
    Ronald G. Lehman</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">60,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">80,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">C.
    Richard E. Turk</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,000</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">D.
    Jessica Maher</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,423</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,423</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">E.
    John Collins</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,384</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">44,038</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">59,423</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">EMPLOYEE
COMPENSATION PLANS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
adopted its 2010 Stock Bonus Plan, on June 28, 2010. This Plan permits FONAR to issue an aggregate of 2,000,000 shares of common stock
of FONAR as bonus or compensation. As of June 30, 2023, 450,177 shares were available for issuance.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 87 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="SecurityOwnership"></span>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number and percentage of shares of FONAR&#8217;s securities held by each director, by each person known
by us to own in excess of five percent of FONAR&#8217;s voting securities and by all officers and directors as a group as of September
1, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and Address of Beneficial Owner (1) </span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: middle"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shares
    Beneficially Owned</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Percent</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class</span></p></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian, as trustee of the Fonar Class C Trust</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">c/o
    FONAR Corporation, Melville, New York</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,447</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">99.98</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Kayne
    Anderson Rudnick</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Investment
    Management LLC</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1800
    Avenue of the Stars, 2nd Floor</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Los
    Angeles, CA 90067</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">628,700</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9.75</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dimensional
    Fund Advisors LP</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building
    One</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6300
    Bee Cave Road</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Austin,
    Texas 78746</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">409,855</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.35</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
    Vanguard Group, Inc.</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100
    Vanguard Boulevard</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Malvern,
    PA 19355-2331</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">373,859</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.80</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
    of the Board, President</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Executive Officer and Treasurer</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 62%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 15%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">42,700</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 2%"></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 14%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; font-family: Arial, Helvetica, Sans-Serif; text-align: center; width: 1%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">800</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
    </tr>
  </table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 88 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Continued:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Name
    and Address of Beneficial Owner (1) </span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Shares
    Beneficially Owned</span></td><td style="padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Percent</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    B. Bonanni,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Vice President,</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Operating Officer and acting <br />Principal Financial Officer</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 54%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="width: 6%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 15%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">54,253</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 6%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 15%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; width: 2%; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,285</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
    Chan</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director
    and Secretary</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">106</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
    G. Lehman</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,330</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
    E. Turk</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Jessica
    Maher</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: middle; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;All
    Officers and Directors as a Group (6 persons)</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">101,389</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(3)</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.50</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,447</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">99.98</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    A Preferred</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,117</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">*</td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*
Less than one percent</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>










<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black" />

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.
Address provided for each beneficial owner owning more than five percent of the voting securities of FONAR.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 89 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="CertainRelationships"></span>ITEM
13.&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to HMCA&#8217;s management agreements with its clients, HMCA provides comprehensive non-medical management and administrative services,
including billing and collection of accounts, payroll and accounts payable processing, office facilities, supplies and utilities. Under
the management agreements, HMCA also provides service for the FONAR Upright&#174; MRI scanners through FONAR. In total, as of September
11, 2023, 22 of our clients had management agreements with HMCA. Six sites in Florida are owned and operated directly by HMCA subsidiaries.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
fees charged under the management agreements are flat fees charged on a monthly basis. These fees ranged from $84,000 to $447,000 per
month in fiscal 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian, the Chairman of the Board, President, Chief Executive Officer and Treasurer of the Company during the 2023 fiscal year owned
three of the imaging facilities in Florida managed by HMCA. The facilities were owned by Dr. Raymond Damadian until his death in August
2022. Those facilities paid HMCA flat rate monthly fees ranging from $245,535 to $411,589 per month during fiscal 2023. These fees are
renegotiable on an annual basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the fiscal years ended June 30, 2023 and June 30, 2022, the net revenues received by HMCA from the imaging facilities owned by Timothy
Damadian and previously by Dr. Damadian were approximately $11.9 million, and $11.6 million, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian, the Chairman of the Board, President, Chief Executive Officer and Treasurer of FONAR, was one of the owners of a billing company
that performed billing and collection services for No-Fault and Workers&#8217; Compensation claims on behalf of HMCA&#8217;s clients.
The monthly fee charged to HMCA was $85,000. These services were terminated on January 1, 2021.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
June 1, 2017, the Company also entered into a one year renewable agreement to provide IT services to the billing company for a monthly
fee of $23,884. Timothy Damadian is also a Manager of Health Management Company of America. The agreement was renewed on June 1, 2022
and terminated on May 31, 2023, The Company billed them $191,072 in the fiscal year ended June 30, 2023 and $286,608 in the fiscal year
ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
Damadian sold his ownership interest in the billing company on May 31, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
Lehman, a Director of FONAR, holds a .0378% interest in Health Management Company of America&#8217;s Class A membership interests.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
J.V. Chan, a Director and the Secretary of FONAR, owns a .0378% interest in Health Management Company of America&#8217;s Class A Membership
interests.&#160;</span></p>


<!-- Field: Page; Sequence: 90 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Accounting"></span>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Audit
Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
aggregate fees billed by Marcum LLP for the audit of our annual consolidated financial statements for the fiscal year ended June 30,
2023 and the reviews of the financial statements included in our Forms 10-Q for the fiscal year ended June 30, 2023 were $374,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
aggregate fees billed by Marcum LLP for the audit of our annual financial statements for the fiscal year ended June 30, 2022 and the
reviews of the financial statements included in our Forms 10-Q for the fiscal year ended June 30, 2022 were $379,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Audit
Related Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for the fiscal years ended June 30, 2023 or June 30, 2022 for services related to the Audit or review
of our financial statements that are not included under the caption &#8220;Audit Fees&#8221;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for the fiscal years ended June 30, 2023 or June 30, 2022 for designing, operating, supervising or implementing
any of our financial information systems or any hardware or software systems for our financial information</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for tax compliance, tax advice and tax planning in the fiscal year ended June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees billed by Marcum LLP for tax compliance, tax advice and tax planning in the fiscal year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
Other Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">No
fees were billed by Marcum LLP for any other services during the fiscal years ended June 30, 2023 and June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Since
January 1, 2003, the audit committee has adopted policies and procedures for pre-approving all non-audit work performed by the auditors.
Specifically, the committee must pre-approve the use of the auditors for all such services. The audit committee has pre-approved all
non-audit work since that time and in making its determination has considered whether the provision of such services was compatible with
the independence of the auditors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
audit committee believes that the provision by Marcum LLP of services in addition to audit services in previous years were compatible
with maintaining their independence.&#160;</span></p>


<!-- Field: Page; Sequence: 91 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">PART
IV</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="Exhibits"></span>ITEM
15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">a)
FINANCIAL STATEMENTS AND SCHEDULES&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following consolidated financial statements are included in Part II, Item 8.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Report
of Independent Registered Public Accounting Firm</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Balance Sheets as at June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Income for the Years Ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Stockholders&#8217; Equity for the Years Ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Consolidated
Statements of Cash Flows for the Years Ended June 30, 2023 and 2022 .</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
to Consolidated Financial Statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
required by schedules called for under Regulation S-X is either not applicable or is included in the consolidated financial statements
or notes to the consolidated financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">b)
&#160;&#160;&#160;&#160;&#160;&#160;&#160;REPORTS ON FORM 8-K</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501922000050/fonar_8-k.htm" style="-sec-extract: exhibit">1. Registrant's Report on Form 8-K: Item 2.02, Results of Operations and Financial Condition for Fiscal Year ended June 30, 2022, reported September 27, 2022. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify; background-color: white"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501923000014/fonar_8k.htm" style="-sec-extract: exhibit">2. Registrants Report on Form 8-K: Item 5.02, Departure of Directors or Certain Officers, reported March 20, 2023. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify; background-color: white"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501923000034/fonar_8-k.htm" style="-sec-extract: exhibit">3. Registrants Report on Form 8-K: Item 5.07, Submission of Matters to a Vote of Security Holders, at the annual meeting of stockholders, reported on May 22, 2023. Commission File No. 0-10248.</a></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">c)</span></td><td style="text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">EXHIBITS</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -18pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.1
Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s registration
statement on Form S-1,Commission File No. 33-13365.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-95-000015.txt">3.2
Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s
registration statement on Form S-8, Commission File No. 33-62099.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501901500018/ex0403.txt">3.3
Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 4.3
to the Registrant&#8217;s registration statement on Form S-3, Commission File No. 333-63782.</a></span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>


<!-- Field: Page; Sequence: 92 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"></p><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501903000019/x033.txt">3.4
Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.3
of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.5
By-Laws, as amended, of the Registrant incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s registration statement on Form
S-1, Commission File No. 33-13365.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.1
Specimen Common Stock Certificate incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-1,
Commission File No. 33-13365.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.2
Specimen Class B Common Stock Certificate incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s registration statement on
Form S-1, Commission File No. 33-13365.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.1
License Agreement between the Registrant and Raymond V. Damadian incorporated by reference to Exhibit 10 (e) to Form 10-K for the fiscal
year ended June 30, 1983, Commission File No. 0-10248.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000036.txt">10.2
Stock Purchase Agreement, dated July 31, 1997, by and between U.S. Health Management Corporation, Raymond V. Damadian, M.D. MR Scanning
Centers Management Company and Raymond V. Damadian, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Form 8-K, July
31, 1997, commission File No: 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000029.txt">10.3
Merger Agreement and Supplemental Agreement dated June 17, 1997 and Letter of Amendment dated June 27, 1997 by and among U.S. Health
Management Corporation and Affordable Diagnostics Inc. et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K,
June 30, 1997, Commission File No: 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000004.txt">10.4
Stock Purchase Agreement dated March 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Giovanni Marciano,
Glenn Muraca et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, March 20, 1998, Commission File No: 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000013.txt">10.5
Stock Purchase Agreement dated August 20, 1998 by and among Health Management Corporation of America, Fonar Corporation, Stuart Blumberg
and Steven Jonas, incorporated by reference to Exhibit 2 to the Registrant&#8217;s 8-K, September 3, 1998, Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501902000016/x99.txt">10.6
2002 Incentive Stock Option Plan incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8,
Commission File No.: 333-96557.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501905000018/x2-50801.txt">10.7
Asset Purchase Agreement dated July 28, 2005 among Health Plus Management Services, L.L.C., Health Management Corporation of America,
Dynamic Healthcare Management, Inc. and Fonar Corporation, incorporated by reference to Exhibit 2 to the Registrant&#8217;s Form 8-K,
August 2, 2005, Commission File No. 0-10248.</a></span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501908000021/x10.txt">10.8
Partnership Interest Purchase Agreement dated September 29, 2008 by and between Diagnostic Management, LLC and Raymond V. Damadian, M.D.
MR Scanning Centers Management Company, incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended June 30, 2008.
Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; background-color: white"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center; background-color: white"></p><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501910000014/x99.txt">10.9
2010 Stock Bonus Plan, incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission
File No. 333-168771.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501911000020/fonar10x.txt">10.10
Operating Agreement for Imperial Management Services, LLC, incorporated by reference to Exhibit 10.37 to Form 10-K for the fiscal year
ended June 30, 2011. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.11
Operating Agreement for Health Diagnostics Management, LLC, incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year
ended June 30, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm">10.12
Modification to Operating Agreement for Health Diagnostics Management, LLC., See Exhibits. incorporated by reference to Exhibit 10.38
to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000007/fonar_exhibit-10.htm">10.13
Purchase Agreement dated March 5, 2013 among Health Diagnostics Management, LLC, Health Diagnostics, LLC and others. Incorporated by
reference to Exhibit 10.1 to the Registrant&#8217;s Form 8-K filed March 11, 2013. Commission File No. 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501904000028/x141.txt">14.1
Code of Ethics, incorporated by reference to Exhibit 14.1 of Registrant&#8217;s Form 10-K for the fiscal year ended June 30, 2004, Commission
File No.: 0-10248.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-21.htm">21.1 Subsidiaries of the Registrant. See Exhibits.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-23.htm">23.1 Independent Registered Public Accounting Firms Report. See Exhibits.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">31.1 Section 302 Certification. See Exhibits.</a></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><a href="fonar_exhibit-32.htm"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">32.1 Section 906 Certification. See Exhibits.</span></a>&#160;</p>



<!-- Field: Page; Sequence: 94 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">SIGNATURES.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
    CORPORATION</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"></td><td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 33%; font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dated:
    September 28, 2023</span></td><td style="width: 1%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 32%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">By:</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 33%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;/s/Timothy
    Damadian</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    Damadian,</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
    of the Board of Directors</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Executive Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President
    and Treasurer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">By</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Luciano
    B. Bonanni</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Luciano
    B. Bonanni</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Executive
    Vice President, Chief Operating Officer and Acting Principal Financial Officer</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 26%; font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Signature</span></td><td style="width: 10%; font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; width: 28%; font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt; vertical-align: bottom"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Title</span></td><td style="width: 10%; font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 26%; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Date</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/
    Timothy R. Damadian</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chairman
    of the Board of Directors</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    28, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Timothy
    R. Damadian</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Chief
    Executive Officer</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">President
    and Treasurer</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Claudette
    J.V. Chan</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    28, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Claudette
    J.V. Chan</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Ronald
    G. Lehman</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    28, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ronald
    G. Lehman</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Richard
    E. Turk</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    28, 2023&#160;&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Richard
    E. Turk</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">/s/Jessica
    Maher</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Director</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">September
    28, 2023&#160;&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Jessica
    Maher</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<!-- Field: Page; Sequence: 95 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--  
       -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
MZ-G\'_\ @I2C_AWY^QG_ -&T>#__  4I7D!_X+K?\$\0<?\ "P-=_P#"7NO_
M (FE_P"'ZO\ P3Q/3XA:Y_X2]U_\31]=X<_GI?\ DH?ZK^+_ /T"XW[JQ[MX
M._9+_9T^$FJMXS^%_P &?#FA:Q#;2)!J-C8+'(@9<$;AV/>OS;^(W_!"']H3
MXE?$+6_'^I_M"^$&GUG5)[R4RI,6S)(S8/TSC\*^UKS]NKX,?M4_LD_%#Q]^
MSOX@U&[3P_H-W#<32V$MM)',;9G7:' )X[BOPR'C[XVXR/&OBSTYU.Z_^*KY
M_B3%Y/&E1BZ7M(.\ERNROL]EKLS]5\&N'N/JV+S&K2Q_U2O!PIS5:FJDVM9)
M>_).-M[>:/MYO^#>KX[8^7]H/P9_W[FJ73O^#>CXV/J$$>H?M >$3 TRB?R(
MI2^S(SM]\=*^'/\ A/\ XV_]#KXL_P#!G=?_ !5>X?\ !-SQ'\4_$?[</PXT
MKQ#XL\236;^(HVGBNM0N&C8 $X8,V",CO7S6%JY#B<5"DL))<S2UF^OR/V/.
ML#XIY3D^(QKS^E)4H3G98>";Y8MV3YGJ[=C]A_V>O^"?7[*_[/?A6VT#PG\'
M="NKF&)5N-6U6P2YN;A]HRQ>0$C)SP,"O1Q\$/@^!C_A5/AG_P $-O\ _$5T
MED7,1WYSNJ:OUNGA,/1@H0@DEY+_ "/X,Q><9KF&)EB,3B)SG)ZR<FVWZMG*
M_P#"D/@]_P!$I\,_^"&W_P#B*/\ A2/P@'3X4>&/_!#;_P#Q%=515^QH_P J
M^Y'/]<QG_/R7WL\I^+/[%7[+_P 9O#\WA[QW\#?#4\4L943VVEQP319[K)&H
M8'\:_.#QW_P;U?$P>-M4/@;XZ^&[?16OI&TJ#4XY?/CMRQ*+(1P6"X!(ZXK]
M<KC/DMCKBOQ8_P""X&N_$CP[^W1=1>%?$FNVMM/X8L)&BTZ^G2/=^\7.$8#.
M *^6XHPV64L''$5Z'/9VT?*]?-'[9X)YOQMC<_J93EF9_5XS@YOVD?:P]UK:
M,G:+=]U;169T)_X-ZOCKV_:"\&?]\34L7_!OC\>[:5;F#]H;P>DD3!DDC2;*
M,#P1[YKX?_X3_P"-O_0Z^+/_  9W7_Q5'_"??&X]/&WBSKU_M.Y_^*KX+ZYD
M,=5@Y_\ @;_R/Z@ED'BHXO\ XR"B_P#N6ATU_F9_2+X"M/$.G?#[2K#Q=J,%
MYJL&E0QZE>6V?+GG6("1USV+ D?6OYI_'?/CC63_ -16X_\ 1K5^^/\ P2ZU
MK7->_8 ^'FH^);JYN+W^QYDFFO'9I&VW$JC<6Y/ '6OP/\=C/CG61_U%KG_T
M8U?0<:557P6%J)6NF_PB?EOT<\#/+.)L]P<I*3IRA"Z5D^6=572Z)VT1DUI^
M%O!7C#QQ>3:?X,\*ZCJT]O;-<7$.G6;S-'"N-TC! 2%&1D]!FLP'(S7V7_P0
MEOU@_;QM],DP8[_PGJ,,D;='&(VP1W^[7Q.786.-Q]+#MVYVE<_H_BW.ZO#?
M#.+S6E!3E0@Y\KT3MJU=;:7/C3GN"/K17VY_P6+_ ."?$_[-/Q*?XX?#31C_
M ,(5XFO&,\<"?)IEXQR8R/X4?DKVSD>E?$=/,,!7RW%RP]9:K\5T:#A3B;+>
M+\AHYK@I7A46JZQE]J,NS3T?W['M?[!?[8WBO]BOX]V'Q(TEY)]&NRMKXFTH
M-\MW:%ADX_OI]Y3ZC'0FOZ OA=\2?!OQ7\!Z;\1_ .KQW^D:O:I<65S"P(9&
M X/H1T([$5_,E@'J*^_?^"*G_!0P_!7QU'^S#\6]=*>%O$%Q_P 2"\N'^33K
MYCQ&2>D<G3V;!Z$D?4\(9[]3K_4ZS]R3T\G_ )'XAX^^&3XBRY\09;"^)HQ]
M^*6M2FNOG*'3JXW71'[)*P8;A7X-_P#!::T%I_P4-\9# _>063_G;(:_>&U<
M20*ZG((XQ7X9_P#!<O3?L/\ P4&U^4C'VG1M/E'_ (#J/Z5]+QQ&^3I_WXGY
M!]&JHH>(%2/>A/\ ]*@?']7O#(SXDT\'_G^B_P#0Q5&KWAC_ )&73O\ K^A_
M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
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H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fonar_graph.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_graph.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0@Z17AI9@  34T *@    @  @$2  ,
M   !  $  .H<  <   @,    )@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH **** "BBB@
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M.854MN82;?G7@\8\D^*G[/WB[X+_ /!([]N2^TCX=_$CX-_LZ>(KGPQ-\/O
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M5) >.5'C=3RKHRD @BM#SL,.H% $E%-$P)IOGKGK0!)133*N:;O!Z?C2Y@)
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M<TRQ.G6L,.[*Q*$STSBKA^4"D(R>HJKNUB>79CZ***"@HHHH **** "BBB@
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MP%#X\USP+X>O]7M9O%!TA66\\0:3&Q,^EK.DJ/;+<'8KRJ6/EATVD.:^"O\
M@FE\'OCO^UO^T]X#^)GQ$^&OAWX0^"_@KXO^(-]"B>(H-<UC7M6U75+^&ZM
M\*A([6UDDFC8DYEDMDD4%74I];?\%?-3_:*3]E-='_9I\)WGB;QGXCU*'3]3
MN++7K'1;[1]+*NUS/:W%XXCCN6"K%')MD,9E\P(2@K7$6<5;?^OP(A_$E;0^
M:OV6/V2OAA^PS_P6$T7X>_LN_P!MZ/X7M/".H7OQC\.0:]=ZKHNE.XA.C2/]
MJDE,=_*YF(0/O\@;MJHY9_)_A=_P3N\-_MV?\$]_$O[8GB;Q%XVC_:.\06VN
M^+_"_B^V\17MNW@Q+6>Z^PV-K;QR"!;:..!$92C%M\N&&[CZ*_X)<WWQR^ .
ML^'_ (8W7[#/_"E_AU?3W5YKWC&?XPZ5XFU"6[:.25KR[2.,7-Y<3SA$9RQ*
M^8N-J(%'G*?L\_MF?LX_ ;Q9^RG\.?A=X)\0?#;79M4T_P ,?%BZ\6V]G'X5
MT?49IY3#=:65^TSW-NL\J*T7[L_NN& 85$^;2*?O6T?YA'5MO;\PU;3;/_@M
M/\>_@%\._BU<:Q<_#&Z^!FG_ !8\0>&;"_GTRU\2:K?S100K<O;NKF* I,ZH
MK+AW!R<8KVW_ ()4>#/^&3_VI_VA?V<-'U?7-2^'/PW;0->\&VFJ7LM[+H%G
MJEK<&33XYI&+M!'-:,8PQ) D(R3DG$^./[&_Q9_8C^)'P?\ B=^SKX-T?XM7
M'P\^'D7PLU[P;J.M0:!<ZWI4#126EU;WDH,,4L4L<A99,J4E8*,C(]._X)G_
M +/_ ,4M&^(/Q:^-7QLT?1?"?Q&^,M[I^/"VEWZZC#X6TO3[=H;2T>Z4!9IL
MRS/(R93<^5P#@7!IIK[_ %(UZ^5O(]Y7]H[P_M_Y!_CW_P (?6O_ )$K/\-?
MM>>"?&FG27FCMXOU:SAN[FPDGL_!VL3QI<6T\EO<0EEM2!)%/%+$Z'E)(W5@
M&4@>G+R.E?/_ /P343_C'7Q']W_DJOQ'[?\ 4[Z[0:'H7_#2'AW_ *!_C_\
M\(;6_P#Y$H_X:0\._P#0/\?_ /A#:W_\B5WNSV7\J-GLOY4 <%_PTAX=_P"@
M?X__ /"&UO\ ^1*/^&D/#O\ T#_'_P#X0VM__(E=[L]E_*C9[+^5 '!?\-(>
M'?\ H'^/_P#PAM;_ /D2C_AI#P[_ - _Q_\ ^$-K?_R)7>[/9?RHV>R_E0!P
M7_#2'AW_ *!_C_\ \(;6_P#Y$H_X:0\._P#0/\?_ /A#:W_\B5WNSV7\J-GL
MOY4 <%_PTAX=_P"@?X__ /"&UO\ ^1*/^&D/#O\ T#_'_P#X0VM__(E=[L]E
M_*C9[+^5 '!?\-(>'?\ H'^/_P#PAM;_ /D2C_AI#P[_ - _Q_\ ^$-K?_R)
M7>[/9?RHV>R_E0!P7_#2'AW_ *!_C_\ \(;6_P#Y$H_X:0\._P#0/\?_ /A#
M:W_\B5WNSV7\J-GLOY4 <%_PTAX=_P"@?X__ /"&UO\ ^1*/^&D/#O\ T#_'
M_P#X0VM__(E=[L]E_*C9[+^5 '!?\-(>'?\ H'^/_P#PAM;_ /D2C_AI#P[_
M - _Q_\ ^$-K?_R)7>[/9?RHV>R_E0!P7_#2'AW_ *!_C_\ \(;6_P#Y$H_X
M:0\._P#0/\?_ /A#:W_\B5WNSV7\J-GLOY4 >5>!OVS_  )\2]%FU'0?^$XU
M2QM]0O=*EFA\#ZX52ZLKJ6SNHCFT^]%<031M_M1GK6Q_PTAX=_Z!_C__ ,(;
M6_\ Y$KSW_@FHG_&.OB/[O\ R57XC]O^IWUVO?\ 9[+^5 '!?\-(>'?^@?X_
M_P#"&UO_ .1*/^&D/#O_ $#_ !__ .$-K?\ \B5WNSV7\J-GLOY4 <%_PTAX
M=_Z!_C__ ,(;6_\ Y$H_X:0\._\ 0/\ '_\ X0VM_P#R)7>[/9?RHV>R_E0!
MP7_#2'AW_H'^/_\ PAM;_P#D2C_AI#P[_P! _P ?_P#A#:W_ /(E=[L]E_*C
M9[+^5 ' _P##2'A[_H'^/O\ PAM;_P#D2C_AH_P[_P! [Q]_X0VM_P#R)7?;
M/9?RHV>R_E0!P?\ PTAX>_Z!_C[_ ,(;6_\ Y$H/[2'A['_(/\??^$-K?_R)
M7>;/9?RHV>R_E0!P1_:.\/'_ )AWCW_PAM;_ /D2D_X:.\/?] [Q]_X0^M__
M ")7?;/9?RHV>R_E0!P/_#2'A[_H'^/O_"&UO_Y$H_X:/\._] [Q]_X0VM__
M ")7?;/9?RHV>R_E0!P7_#1_A[_H&^/?_"&UO_Y$I/\ AH_P]C_D'>/O_"&U
MO_Y$KOMGLOY4;/9?RH X'_AH_P ._P#0.\??^$-K?_R)2_\ #1_A[_H&^/?_
M  AM;_\ D2N]POM^5& ?X1Q0!Y38_MG>!=0^(&I^%8/^$VD\0Z/I]IJM[8KX
M'UOS;:UNY+J*WE;_ $3&V1[*Z4<]86]L[7_#1_AW_H&^/?\ PAM;_P#D2O._
MARH_X>F_&/@?\DJ\!_\ IW\95] %5% ' _\ #1WA_/\ R#O'O_A#:W_\B4?\
M-'^'?^@=X^_\(;6__D2N^V>R_E1L]E_*@#@O^&C?#O\ T#O'W_A#:W_\B4G_
M  T?X=_Z!WC[_P (;6__ )$KOMGLOY4;/9?RH X,_M(^'P/^0=X]_P#"&UO_
M .1*;_PT?X=_Z!WC[_PAM;_^1*[[9[+^5&SV7\J .!'[1WA[_H'>/?\ PAM;
M_P#D2C_AH_P[_P! [Q]_X0VM_P#R)7?;/9?RHV>R_E0!P/\ PT?X=_Z!WC[_
M ,(;6_\ Y$H_X:/\/8_Y!WC[_P (;6__ )$KOMGLOY4;/9?RH X$_M'^'2!_
MQ+O'W_A#:W_\B4?\-'^'?^@=X^_\(;6__D2N^V>R_E1L]E_*@#@_^&D?#W_0
M/\??^$-K?_R)2?\ #1_A_P#Z!_C[_P (?6__ )$KO=@QT'Y4;5SVI70'!?\
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M?_95?B/_ .IOKM,#Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M869:^C>/:D_[YK.62X=[*WS#E1\YG]F;XK:2@-G\6+RX9>0+B!L'_OIGIO\
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M1_\ U-]=KZ KY_\ ^":?_)NOB/\ [*K\1_\ U-]=H ^@**** "BBB@ HHHH
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MHH ***3=[&@ V_3\J,?3\J-V?6AFP.>* $#9/2AQQFFAP.X]::\V>.I[4N5
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M<HU*G6R['H1EE^#5HKVD_/2*_P SXH\ _P#!+?QA\=/$%KXB^/?CS4_% /\
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M<-HA,DB+MY.3TKX.N?VZ/V@OVDY3'\+?A//H>DWQ"6VL:V"H"'EIAN**."N
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M90!] 4444 %#'"FBB@".$-M^8@G.2:DIH?YL8IU !1110 4444 -/*5\W?\
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M6U%VFLH6*XPJ/S+@' 9^ $4K&AKZPT3PO8^&[&*UT^SM[*VA41I%#$J(B@
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M #-;@^]2XP::TU)% P*^?_\ @FG_ ,FZ^(_^RJ_$?_U-]=KZ KY__P"":?\
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MKFK:?IJ29,?VF=8S)@9(4$Y8X[ >GJ*\;\3?MTVWB&^;3? .@ZIXJU)B0)#
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M5Q)N#,S')F8$ +\TOJ< [0G;3R&+][&U')]D:*@EK49YQ8_MI_#OPWKG]@_
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MX1Y98W>W'8DFYDR?;8?PI4_99_:V\>-L\1?&K0M%M9/F/]CV^)8\\;?D@A/
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M0 4444 %%%% !1110 4444 %?/\ \1O^4IOP;_[)5X\_]._@ROH"OG_XC?\
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MO#?Q@UGP?X0U7^P_$OQ'T?PC+>^"_#=\K[)+>ZOU8%6C<JK%(W +  ]2)O\
M@EQX1TOP%^U7^V-HN@:98Z+I.D^/]+MK*QL;9+>VM8D\.Z:%2.-0$1 . J@
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MON__ )6T =]17 _V]\3_ /H4? ?_ (5]W_\ *VC^WOB?_P!"CX#_ /"ON_\
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MH^ __"ON_P#Y6T =]17 _P!O?$__ *%'P'_X5]W_ /*VC^WOB?\ ]"CX#_\
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M6."%0 0/D#=2<_4TNFQW,++)'&P8892H(/Z=/PKP[_@FH ?V=/$?_95?B/\
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MXI^ -QJOD\3/HLTK[CZJL8N./^!'\*^V=H8>AJ-H1SD#]>*?UZ#^.$7^!/\
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MO2WQ;W/B+4>5&8-,*CD9_P"6C)6*?^"TW@/5)%CT?P=\0M49F\M2EA"%<D<
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M/CUX"_;Z^%MO\0M8U1/%7A[PIKUQH\\0B38);O1BQC,"JL@.Q0<L_P RE3G
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MX:-\/C_F'^/O_"&UK_Y$H [ZBN!'[1WA\_\ ,/\ 'W_A#ZU_\B4G_#1_A_\
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M ,(?6_\ Y$H_X:/\/_\ 0/\ 'W_A#ZW_ /(E '?T5P'_  T?X?\ ^@?X^_\
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M?X?_ .@?X^_\(?6__D2@#OZ*X#_AH_P__P! _P ??^$/K?\ \B4?\-'^'_\
MH'^/O_"'UO\ ^1* ._HK@1^T=X?/_,/\??\ A#ZU_P#(E'_#1OA__H'^/O\
MPA]:_P#D2@#OJ*X'_AH[P_\ ] _Q]_X0VM?_ ")2?\-'^'_^@?X^_P#"'UO_
M .1* ._HK@?^&CO#_P#T#_'W_A#:U_\ (E)_PTAX=_Z!_C__ ,(;6_\ Y$H
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M  __ - WQ]_X0^M?_(M '?5\_P#Q&_Y2F_!O_LE7CS_T[^#*]!_X:/\ #_\
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MX%:'\3M0&C>$_$7_  EUCXDM;O4&1I8;2\2V56LI)41M@<L2X9< *S"'XO\
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MZ0BQ,]_=WMPICMHCYT:IO7+NVW@UD?#O_@LAX9?]D[XJ?$#XD^!_%GPU\7?
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M\01^+-*\8:A#<:?!?V-@MY%/IMO'"L=C$S[QY48X7:"S"O8]%_X(<?"'P_\
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M_CCXA:GXGE\6'XBV6CM\/]3O8XI+RSUFU$<D\A@;RW"0KO\ )9<G<X">T?\
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MQ2\)ZU>:6FA>)+#PEXIFT73_ !KIR,Q2TU-(AOFB =E(1XRRG#$@#&E\"_\
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M5:_,):Q:WT*7_!)$VI;]J[[=]F.L_P#"]_$XU+>%\SR2+;[-YG^S]F,6W/\
M#COFK?\ P0&*M_P2V\!^1M.F'4M?.E^7_J_L/]MW_P!FV?['D[-OMBK'[5O_
M  1-^&7[57QNUGQTWC+XQ?#?4?%T$5KXPL? OBM]%T[QO#&HC6/4H51O.'E9
MC)4HQ4\G.#7I7B?]E>;P-JGP!T+X9-K'@_P3\,-6:*]TO2M6^QZ;)I2:5=01
MP7,'+7?[]K;:I/# RL25 9P6O,]VDO2W44TW:W1W]=+6/4OC#X<\'^*OAMJE
MKX^TWPWJ?A&WB%[J46OV\,VFI' PG$TRS QA8VC63<WW"@;(VYKXOT;Q?JG_
M  6!_:,^&?BCPMH]]HG[-OP=\2)XNL/%&IV[V=]\0]:MX98K7^S8'4.NEQ"X
M=GN9 IG?"1KM1G/TW^W/^QIH'[?G[,?B3X3^*-<\5>'?#WBL0QW]UX=NX;6_
M,<<R2F-7EBE0(Y0*X*'<I8<9S7SQ\&_^"'D/P8\?>&-<M?VL/VUM:MO"M_:W
ML.B:M\3Q<:1?);R(ZVUQ;BU4/;N$"/&",H2,C-*$;S;?3;U[CG\&F_4O?\$D
M?LOF?M7?;_L_]L_\+V\3_P!I[]HE\G;;?9O,]%^S&+;G^''O7EG_  3%^,?P
ME_99_P""1'PU^+'Q*BT*ULO">K>(K'P=J)TQ+W4UBO-;O8K>STM41IV>XA6)
M!%#RZH-WRJ2/9/VJO^")?PS_ &J_C;J_CO\ X33XQ_#?4O%]O#:>+['P+XK?
M1=.\;PQ)Y:)J4(C;SAY68B5*,48@G.")/VL/^"*_PY_:CT'X0Z7IOC;XM_"#
M3_@;;2VOA*'X=Z]#HYL \4</F>8]O-)YJQQ[ ZLK8DDR3O)I6?Q=TE;M;JBM
M&_+5_?T%_8:^$?C[XQ_M1>,/VF?B;X;F^'UYXM\.6OA'P=X.G=3J6D:!%</=
MB;5-N56_GGE+F%&(MT C+,^\CS6P_97^'?[(G_!7[]GCPO\ #?PGI/A+1?\
MA7OC*YFCM59I;R9KK1]TT\SEI9Y6[R2LSGN3@8]J_8Q_X)B_\,9_%*[\4?\
M#0?[3OQ6^V:;)IITGXB^.O[<TN#?+%)YZ0^1'B=?*VA\G"R2#'S9'J?B[]E'
MP_XT_:G\&_%R[O=83Q)X'T34M!L+6*6);&6"^>V>5I4,9<N#:Q[2KJ!ELALC
M&CTE'EV7^3,K/EDNK^[H>ICI1110:!1101D4 1NV/6O%?&O[8/PV\2Z+\9_#
MMOXJL(]8^$>FN?%UO=));#15ELS<1R.TJJKQF(AMZ%E'()!!%>U%?E-?,?[5
M?_!&W]FG]MSXQ6/C[XH?"?1?%'B[3TCC74#>7=DUTL9!1;E+>6-+D* %'GK)
M\OR_=XK.4;^Z]FG<<6EKU/A_]CO5K?PIX9_X)1R:E,MC%>>'=;LX7F_=J\TV
M@CRH\GC<_11_%P!G-<K_ ,%%?$VF_$BQ_P""G,&BZS;W7V:T\ Z5/<V4HE^Q
MW,9V21Y4\/&YPRY!5U*G!! _4#]J+_@GW\&_VT/@AIOPW^)7@/1_$7@K1Y(9
M=.TU&EL5TUH5*1?9Y+=XY( J$H!&RC82OW3BN9T/_@DY^SWX5^&7C#P9I/PS
MTS2/"_CRSTVPUS3=/OKNU@O(=..;0 1RJ8V5LLSQ[6D8EI"Y)-*4.9W?G^+3
M_0SY;*\=]+_+_ASY#L/V$_!__!-G_@JC^SOJWPGNO&%KJ'Q<TGQ-8>.GU7Q%
M?ZO)XSGM=-6Z@O+LSRMNG$P9CM"J2YVJF.?SW^&_PU^*7[2O[/6L?M$7O[,^
MO>+/BC<2ZAJJ?'<_M+V/A]_"EPD\A4)I\THALK>USL^RW R$W*67<-O]#7C/
M]GGPC\0OBIX)\:ZQI/VOQ-\.FO'\/7GVJ:/^SS=P>1<?NU<1R;XOE_>*VWJN
M#S7SY\3/^"$O[)?QA^/\WQ0\1?!+POJ7C"\NS?74QGNXK.^G+,S2SV4<JVLS
MLS%G:2)BY)+;CS6E-M3YI>?W7O\ D$5:'+UT^>EF>\_LQ^,==\?_ +-7@'7O
M%,5G%XDUKPWI]_JR6=S!=6PNI;:-YO*E@=X9$WEMK1.Z$8*LP()^$_\ @J#X
M;^$G_!27]A#7_CIX=^/GBC1/"?PUTV^GATYKA8_"FI:G8RM(MMK.C7MONN9#
M<1QQB&95<_N]BG>-_P"DMK81V5K'!#&L4,*A$C10JHHX"@=  .,"OEKX@_\
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M*<;:]Z_;#_8%^$/[?GPZM?"OQ=\#Z;XRT73[@7-HDTLUK/9R8P3#<0/'-%D
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M^*%U+48;5KYX397%N5A614+9EC4?>D08!SSTQ7K2:_9D?\?$//O7Y/?LN?\
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M"VN)K-(%2*588U 9KAG=N8A4KX%;=M:^5KZ"CK-WT23]=['ZG>&O^"CWP/\
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MV?Q2^'=U\0+>5X9?#$/B2SDUB-T&YU-H)/.!4 D@ID#D\5^+O[%UGX3\ ?\
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M=BHQO?HMO/>Q^F7QV_:\UCX?_MA?L[^!?#ZZ!J?A7XR'7&O[Y@\TPCL].%U
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M3XYK<VDSJ6MV65W<M&06)^8D  ;RC:S>W7[[: I7NNNEOF?>?C'_ (*7> _
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MX'S+@\=:@U#]ESX:ZM\/]<\)W7P]\#7'A;Q/?RZGK.C2:%:M8:M=RN'DN+B
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M].E*1@4;*6RL/K?J.HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110
J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>fonar_exhibit-21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 21.1 Subsidiaries of the Registrant</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Imperial Management
Services, LLC (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Health Diagnostic
Management, LLC d/b/a Health Management Company of America (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Health Management
Corporation of America (Delaware)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Fair Haven Services,
Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">HMCM, Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Raymond V. Damadian,
M.D. MR Scanning Center Management Company (Delaware)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Dynamic Services,
Inc. (New York)</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">Central Health Care
Management Company, Inc. (Delaware)</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>fonar_exhibit-23.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">Exhibit 23.1&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">Independent Registered Public Accounting
Firm&rsquo;s Consent</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We consent to the incorporation by reference in the
Registration Statement of FONAR Corporation and Subsidiaries on Form S-8 File No. 333-168771 of our report dated September 28, 2023, with
respect to our audits of the consolidated financial statements of FONAR Corporation and Subsidiaries as of June 30, 2023 and 2022 and
for the two years ended June 30, 2023, which report is included in this Annual Report on Form 10-K of FONAR Corporation and Subsidiaries
for the year ended June 30, 2023.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">/s/ Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Marcum <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">New York, New York</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">September 28, 2023</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>6
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 31.1</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">CERTIFICATION</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">I, Timothy R. Damadian certify that:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">I, Luciano Bonanni, certify that:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">1.I have reviewed this annual report on Form 10-K of
Fonar Corporation;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2.Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements made, not misleading with respect to the period covered by this annual report; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">3.Based on my knowledge, the financial statements,
and other financial information, included in this annual report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">4.I am responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financialreporting
(as defined in Exchange Act Rules 13a-15(f) and 15(f)for the registrant and I have:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the
period in which this report is being prepared;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">b) Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance
regarding the reliability of financial statements for external purposes in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">c) Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and
procedures as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">d) Disclosed in this report any change in the
registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the
registrant&rsquo;s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">5.I have disclosed, based on my most recent evaluation
of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of
directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">a) all significant deficiencies and material
weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial data; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify">b) any fraud, whether or not material, that
involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Date: September 28, 2023</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Timothy R. Damadian</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Timothy R. Damadian,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">President and Principal Executive
Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Luciano Bonanni</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Luciano Bonanni,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive Vice President, COO and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Acting Principal Financial Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 32.1</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In connection with the Annual Report of Fonar Corporation
and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10K for the fiscal year ended June 30, 2023, as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian, President and Chief Executive Officer of the Company, and
I, Luciano Bonanni, Executive Vice President, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley
Act of 2002, that:</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Timothy R. Damadian</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Timothy R. Damadian,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">President and Principal Executive
Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">/s/ Luciano Bonanni</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Luciano Bonanni,</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive Vice President, COO and</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">Acting Principal Financial Officer</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Date:September 28, 2023</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">A signed original of this written statement required
by Section 906 has been provided to Fonar Corporation and will be retained by Fonar Corporation and furnished to the Securities and Exchange
Commission or its staff upon request.</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>fonr-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOaWH+aP9wZ936ekhsGR4bXmKXyMpnzTeDiHJnDsWEcUA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:FONR="http://fonar.com/20230630" elementFormDefault="qualified" targetNamespace="http://fonar.com/20230630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
          <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" id="ConsolidatedStatementsOfStockholdersEquity">
          <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" id="DescriptionOfBusinessAndLiquidityAndCapitalResources">
          <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
          <link:definition>00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
          <link:definition>00000010 - Disclosure - INVENTORIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000011 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
          <link:definition>00000012 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
          <link:definition>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStock" id="CapitalStock">
          <link:definition>00000014 - Disclosure - CAPITAL STOCK</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" id="ControllingAndNoncontrollingInterests">
          <link:definition>00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" id="Long-termDebtNotesPayableAndCapitalLeases">
          <link:definition>00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000017 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>00000018 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
          <link:definition>00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000021 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
          <link:definition>00000022 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" id="AllowanceForDoubtfulAccounts">
          <link:definition>00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000024 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
          <link:definition>00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>00000028 - Disclosure - INVENTORIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
          <link:definition>00000030 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
          <link:definition>00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" id="ControllingAndNoncontrollingInterestsTables">
          <link:definition>00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" id="Long-termDebtNotesPayableAndCapitalLeasesTables">
          <link:definition>00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000034 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
          <link:definition>00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" id="AllowanceForDoubtfulAccountsTables">
          <link:definition>00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" id="DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative">
          <link:definition>00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" id="SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details">
          <link:definition>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" id="SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1">
          <link:definition>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/EarningsPerShareContinuedDetails" id="EarningsPerShareContinuedDetails">
          <link:definition>00000041 - Disclosure - Earnings Per Share (Continued) (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
          <link:definition>00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
          <link:definition>00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
          <link:definition>00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
          <link:definition>00000046 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" id="PropertyAndEquipment-PropertyAndEquipmentDetails">
          <link:definition>00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
          <link:definition>00000049 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" id="OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails">
          <link:definition>00000050 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" id="OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails">
          <link:definition>00000051 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" id="OperatingFinancingLeases-RelatedToLeasesDetails">
          <link:definition>00000052 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
          <link:definition>00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" id="OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details">
          <link:definition>00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" id="OtherIntangibleAssets-ScheduleOfIntangleAssets-Details">
          <link:definition>00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
          <link:definition>00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" id="CapitalStockDetailsNarrative">
          <link:definition>00000057 - Disclosure - CAPITAL STOCK (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" id="ControllingAndNoncontrollingInterests-HdmMembersEquityDetails">
          <link:definition>00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" id="ControllingAndNoncontrollingInterestsDetailsNarrative">
          <link:definition>00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" id="Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details">
          <link:definition>00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" id="Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details">
          <link:definition>00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" id="IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails">
          <link:definition>00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" id="IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails">
          <link:definition>00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" id="IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details">
          <link:definition>00000064 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000065 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
          <link:definition>00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
          <link:definition>00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" id="SegmentAndRelatedInformation-SumarizedSegments-Details">
          <link:definition>00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" id="SegmentAndRelatedInformation-ForeignProductSales-Details">
          <link:definition>00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" id="SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details">
          <link:definition>00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" id="SegmentAndRelatedInformationDetailsNarrative">
          <link:definition>00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" id="AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails">
          <link:definition>00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredMember" name="ClassANonVotingPreferredMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ControllingInterestMember" name="ControllingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassBControllingInterestsMember" name="ClassBControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticImagingFacilityMember" name="DiagnosticImagingFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMember" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMedicalPracticesMember" name="RelatedPartiesMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipmentMember" name="DiagnosticEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" name="ResearchDeveopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_N2010StockBonusPlanMember" name="N2010StockBonusPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAControllingInterestsMember" name="ClassAControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMEquityMember" name="HDMEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable1Member" name="NotePayable1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotePayable2Member" name="NotePayable2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ABillingCompanyMember" name="ABillingCompanyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BensonhurstMRILimitedPartnershipMember" name="BensonhurstMRILimitedPartnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" name="ManufacturingAndServicingOfMedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableMember" name="ManagementAndOtherFeesReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" name="ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LongTermDebtAndCapitalLeaseObligationCurrent" name="LongTermDebtAndCapitalLeaseObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DueToRelatedPartyMedicalPractices" name="DueToRelatedPartyMedicalPractices" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LongTermDebtAndCapitalLeaseObligation" name="LongTermDebtAndCapitalLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" name="ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" name="RelatedPartyReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterests" name="BuyoutOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfShares" name="CancellationOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfSharesShares" name="CancellationOfSharesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" name="StockIssuedToEmployeesUnderStockBonusPlansValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LossOnDispositionOfFixedAssets" name="LossOnDispositionOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnForgivenessOfPppLoan" name="GainOnForgivenessOfPppLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInAccountReceivable" name="IncreaseDecreaseInAccountReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInAccountPayable" name="IncreaseDecreaseInAccountPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInOperatingLiability" name="IncreaseDecreaseInOperatingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInContractLiabilities" name="IncreaseDecreaseInContractLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInAccruedLiability" name="IncreaseDecreaseInAccruedLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfNoncontrollingInterests" name="PurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureCapitalStockAbstract" name="DisclosureCapitalStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalStockAndOptionsDisclosureTextblock" name="CapitalStockAndOptionsDisclosureTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" name="DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DebtAndCapitalLeaseDisclosuresTextBlock" name="DebtAndCapitalLeaseDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" name="AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesPolicyTextBlock" name="CustomerAdvancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" name="EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportProductSalesTableTextBlock" name="ExportProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportServiceRevenuesTableTextBlock" name="ExportServiceRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" name="OwnershipInterestOfOriginalInvestorsOfHdm" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestorsOwnershipInterest" name="InvestorsOwnershipInterest" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageSharesOutstandingBasic" name="WeightedAverageSharesOutstandingBasic" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" name="IncrementalCommonSharesAttributableToConversionOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" name="ManagementAgreementsWithCompanyTotalMedicalPractices" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" name="ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" name="ScannersWithManagementWithCompanyLocatedInNewYorkState" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMinimum" name="ContractualFeesForServicesRenderedMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMaximum" name="ContractualFeesForServicesRenderedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" name="NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" name="TotalFacilitiesOwnedOrManagedAtBeginningOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedByInternalDevelopment" name="ManagedFacilitiesAddedByInternalDevelopment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesClosedDuringYear" name="ManagedFacilitiesClosedDuringYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" name="TotalFacilitiesOwnedOrManagedAtEndOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciatedAssetsWriteoff" name="DepreciatedAssetsWriteoff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AmountsCapitalized" name="AmountsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareOrPatentsWrittenOff" name="SoftwareOrPatentsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesRegistered" name="SharesRegistered" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryShares" name="CancellationOfTreasuryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryStock" name="CancellationOfTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OpeningMembersEquity" name="OpeningMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShareOfNetIncome" name="ShareOfNetIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterestsValue" name="BuyoutOfNoncontrollingInterestsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Distributions" name="Distributions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EndingMembersEquity" name="EndingMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentOwnershipPercentages" name="EquityMethodInvestmentOwnershipPercentages" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProceedsFromContributionsFromCompany" name="ProceedsFromContributionsFromCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfStandupMriCenters" name="PurchaseOfStandupMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfOtherMriCenters" name="PurchaseOfOtherMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationToOutsideInvestors" name="ConsiderationToOutsideInvestors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchasePrice" name="TotalPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" name="ConsiderationForNoncompetitionAndConsultingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentsOwnershipPercentage" name="EquityMethodInvestmentsOwnershipPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MonthlyPaymentPeriod" name="MonthlyPaymentPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaturityDate" name="MaturityDate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BookValueOfBuilding" name="BookValueOfBuilding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredIncomeTaxExpensesBenefit" name="DeferredIncomeTaxExpensesBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncomeTaxExpensesBenefit" name="IncomeTaxExpensesBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" name="EffectiveIncomeTaxRateReconciliationNysAuditSettlement" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" name="DeferredTaxAssetsInRightUseAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AdditionalTaxes" name="AdditionalTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LeaseAndRentalExpenses" name="LeaseAndRentalExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatementFromSuffolkCountyIda" name="PropertyTaxAbatementFromSuffolkCountyIda" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyTaxAbatement" name="PropertyTaxAbatement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" name="StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SellingGeneralAndAdministrativeExpenses" name="SellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignProductSales" name="ForeignProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignServiceAndRepairFees" name="ForeignServiceAndRepairFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportSalesOfMedicalEquipmentPercentage" name="ExportSalesOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" name="ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsAdditions" name="AllowanceForDoubtfulAccountsAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsDeductions" name="AllowanceForDoubtfulAccountsDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>fonr-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20230630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20230630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20230630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:href="fonr-20230630.xsd#EarningsPerShareContinuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20230630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20230630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20230630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DueToRelatedPartyMedicalPractices" xlink:label="loc_FONRDueToRelatedPartyMedicalPractices" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRDueToRelatedPartyMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligation" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LossOnDispositionOfFixedAssets" xlink:label="loc_FONRLossOnDispositionOfFixedAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRLossOnDispositionOfFixedAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountReceivable" xlink:label="loc_FONRIncreaseDecreaseInAccountReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInAccountReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountPayable" xlink:label="loc_FONRIncreaseDecreaseInAccountPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInAccountPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInOperatingLiability" xlink:label="loc_FONRIncreaseDecreaseInOperatingLiability" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInOperatingLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccruedLiability" xlink:label="loc_FONRIncreaseDecreaseInAccruedLiability" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInAccruedLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000011 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000012 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000014 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000018 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000022 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000028 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000030 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:title="00000041 - Disclosure - Earnings Per Share (Continued) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000046 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000049 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000050 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="00000051 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="00000052 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000057 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncomeTaxExpensesBenefit" xlink:label="loc_FONRIncomeTaxExpensesBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRIncomeTaxExpensesBenefit" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000064 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>fonr-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20230630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20230630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20230630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:href="fonr-20230630.xsd#EarningsPerShareContinuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20230630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20230630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20230630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_70" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_70" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_70" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_70" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_70" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_70" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_70" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_70" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_70" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_70" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_70" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_70" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_70" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_70" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_70" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_70" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_70" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_70" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_70" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_70" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_70" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_70" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_70" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_70" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_70" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_70" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_70" xlink:type="arc" order="62" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DueToRelatedPartyMedicalPractices" xlink:label="loc_FONRDueToRelatedPartyMedicalPractices_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRDueToRelatedPartyMedicalPractices_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligation" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligation_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="47" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_90" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassANonVotingPreferredMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfShares" xlink:label="loc_FONRCancellationOfShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfShares_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfSharesShares" xlink:label="loc_FONRCancellationOfSharesShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfSharesShares_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000011 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000012 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000014 - Disclosure - CAPITAL STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000018 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000022 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000028 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000030 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassBControllingInterestsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FONRControllingInterestMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:title="00000041 - Disclosure - Earnings Per Share (Continued) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_100" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000046 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="loc_FONRDepreciatedAssetsWriteoff_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_FONRDepreciatedAssetsWriteoff_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000049 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000050 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="00000051 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="00000052 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_40" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000057 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock_120" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="loc_FONRMonthlyPaymentPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMonthlyPaymentPeriod_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations_90" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000064 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DO" xlink:label="loc_countryDO_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA" xlink:label="loc_countryCA_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AE" xlink:label="loc_countryAE_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR" xlink:label="loc_countryPR_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR" xlink:label="loc_countryPR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="loc_countryCH_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB" xlink:label="loc_countryGB_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AE" xlink:label="loc_countryAE_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DO" xlink:label="loc_countryDO_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA" xlink:label="loc_countryCA_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GR" xlink:label="loc_countryGR_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU" xlink:label="loc_countryAU_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees_180" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions_220" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BroadcastersLicenseAgreementCommitmentsDescription" xlink:label="loc_us-gaapBroadcastersLicenseAgreementCommitmentsDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBroadcastersLicenseAgreementCommitmentsDescription_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_40" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>fonr-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="FONR_ClassANonVotingPreferredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredMember" xlink:to="FONR_ClassANonVotingPreferredMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredMember_lbl" xml:lang="en-US">Class A non-voting Preferred [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassCCommonStockMember" xlink:label="FONR_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ControllingInterestMember" xlink:label="FONR_ControllingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ControllingInterestMember_lbl" xml:lang="en-US">Controlling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="FONR_ClassBControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBControllingInterestsMember" xlink:to="FONR_ClassBControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassBControllingInterestsMember_lbl" xml:lang="en-US">Class B Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="FONR_DiagnosticImagingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticImagingFacilityMember_lbl" xml:lang="en-US">Diagnostic Imaging Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMember" xlink:label="FONR_RelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMember" xlink:to="FONR_RelatedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMember_lbl" xml:lang="en-US">Related Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="FONR_RelatedPartiesMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMedicalPracticesMember" xlink:to="FONR_RelatedPartiesMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMedicalPracticesMember_lbl" xml:lang="en-US">Related Parties Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="FONR_DiagnosticEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipmentMember_lbl" xml:lang="en-US">Diagnostic Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research Deveopment And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other Revenue Source [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="FONR_N2010StockBonusPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_N2010StockBonusPlanMember_lbl" xml:lang="en-US">N 2010 Stock Bonus Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">Health Diagnostics Management, LLC (HDM) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="FONR_ClassAControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAControllingInterestsMember" xlink:to="FONR_ClassAControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAControllingInterestsMember_lbl" xml:lang="en-US">Class A Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsByNameAxis" xlink:to="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xml:lang="en-US">Other Ownership Interests Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMEquityMember" xlink:label="FONR_HDMEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMEquityMember_lbl" xml:lang="en-US">H D M Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable1Member" xlink:label="FONR_NotePayable1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable1Member_lbl" xml:lang="en-US">Note Payable 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable2Member" xlink:label="FONR_NotePayable2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotePayable2Member_lbl" xml:lang="en-US">Note Payable 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ABillingCompanyMember" xlink:label="FONR_ABillingCompanyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ABillingCompanyMember" xlink:to="FONR_ABillingCompanyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ABillingCompanyMember_lbl" xml:lang="en-US">A Billing Company [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xml:lang="en-US">Bensonhurst M R I Limited Partnership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:to="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManufacturingAndServicingOfMedicalEquipmentMember_lbl" xml:lang="en-US">Manufacturing And Servicing Of Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DO" xlink:label="country_DO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DO" xlink:to="country_DO_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DO_lbl" xml:lang="en-US">DOMINICAN REPUBLIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AE" xlink:label="country_AE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AE" xlink:to="country_AE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AE_lbl" xml:lang="en-US">UNITED ARAB EMIRATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR" xlink:label="country_PR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="country_CH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US">SWITZERLAND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GR" xlink:label="country_GR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GR" xlink:to="country_GR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GR_lbl" xml:lang="en-US">GREECE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="FONR_ManagementAndOtherFeesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableMember" xlink:to="FONR_ManagementAndOtherFeesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableMember_lbl" xml:lang="en-US">Management And Other Fees Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableMember_lbl" xml:lang="en-US">Notes Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowances for doubtful accounts of $198,593 and $204,597 at June 30, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $12,608,567 and $16,627,917 at June 30, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $3,989,692 and $4,686,893 at June 30, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:to="FONR_LongTermDebtAndCapitalLeaseObligationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligationCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DueToRelatedPartyMedicalPractices" xlink:label="FONR_DueToRelatedPartyMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DueToRelatedPartyMedicalPractices" xlink:to="FONR_DueToRelatedPartyMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DueToRelatedPartyMedicalPractices_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligation" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LongTermDebtAndCapitalLeaseObligation" xlink:to="FONR_LongTermDebtAndCapitalLeaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligation_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 11,463 and 11,643 shares of common stock at June 30, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Allowance for Doubtful Accounts, Premiums and Other Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other receivable allowances for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Related party receivable allowances for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees &#8211; related party medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpensesAbstract" xlink:label="us-gaap_OtherExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpensesAbstract" xlink:to="us-gaap_OtherExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpensesAbstract_lbl" xml:lang="en-US">Other Income and (Expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (expense) income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before provision for income taxes and noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income &#8211; Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="FONR_BuyoutOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterests_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfShares" xlink:label="FONR_CancellationOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfShares" xlink:to="FONR_CancellationOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfShares_lbl" xml:lang="en-US">Cancellation of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfSharesShares" xlink:label="FONR_CancellationOfSharesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfSharesShares" xlink:to="FONR_CancellationOfSharesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfSharesShares_lbl" xml:lang="en-US">Cancellation of shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:to="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_lbl" xml:lang="en-US">Stock issued to employees under stock bonus plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LossOnDispositionOfFixedAssets" xlink:label="FONR_LossOnDispositionOfFixedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LossOnDispositionOfFixedAssets" xlink:to="FONR_LossOnDispositionOfFixedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LossOnDispositionOfFixedAssets_lbl" xml:lang="en-US">Loss on disposition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="FONR_GainOnForgivenessOfPppLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnForgivenessOfPppLoan_lbl" xml:lang="en-US">Gain on forgiveness of PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountReceivable" xlink:label="FONR_IncreaseDecreaseInAccountReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountReceivable" xlink:to="FONR_IncreaseDecreaseInAccountReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInAccountReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountPayable" xlink:label="FONR_IncreaseDecreaseInAccountPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountPayable" xlink:to="FONR_IncreaseDecreaseInAccountPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInAccountPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInOperatingLiability" xlink:label="FONR_IncreaseDecreaseInOperatingLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInOperatingLiability" xlink:to="FONR_IncreaseDecreaseInOperatingLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInOperatingLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="FONR_IncreaseDecreaseInContractLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccruedLiability" xlink:label="FONR_IncreaseDecreaseInAccruedLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccruedLiability" xlink:to="FONR_IncreaseDecreaseInAccruedLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInAccruedLiability_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Proceeds of Short-term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="FONR_PurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="FONR_DisclosureCapitalStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureCapitalStockAbstract" xlink:to="FONR_DisclosureCapitalStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureCapitalStockAbstract_lbl" xml:lang="en-US">Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:to="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock_lbl" xml:lang="en-US">CAPITAL STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">CONTROLLING AND NONCONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_lbl" xml:lang="en-US">Long-term Debt Notes Payable And Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DebtAndCapitalLeaseDisclosuresTextBlock" xlink:label="FONR_DebtAndCapitalLeaseDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DebtAndCapitalLeaseDisclosuresTextBlock" xlink:to="FONR_DebtAndCapitalLeaseDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DebtAndCapitalLeaseDisclosuresTextBlock_lbl" xml:lang="en-US">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">ALLOWANCE FOR DOUBTFUL ACCOUNTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="us-gaap_InventoryWorkInProcessPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryWorkInProcessPolicy_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:to="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Acquired assets and assumed liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="FONR_CustomerAdvancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_lbl" xml:lang="en-US">Customer Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Estimated Useful Life in Years for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Patient Fee Revenue - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings Per Share (Continued)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Total Facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES - Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Components of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other Intangible Assets - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule Of Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">Class A and B Members' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Long-term Debt, Notes Payable and Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Maturities of Long-term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of components of the provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of components of company&#8217;s deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportProductSalesTableTextBlock" xlink:label="FONR_ExportProductSalesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportProductSalesTableTextBlock" xlink:to="FONR_ExportProductSalesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportProductSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of export product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportServiceRevenuesTableTextBlock" xlink:label="FONR_ExportServiceRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportServiceRevenuesTableTextBlock" xlink:to="FONR_ExportServiceRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportServiceRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of foreign service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US">Schedule of summary of allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Purchase of interests from Class A ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Direct ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="FONR_InvestorsOwnershipInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestorsOwnershipInterest_lbl" xml:lang="en-US">Investors ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Net Patient Fee Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Basic Numerator: Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="FONR_WeightedAverageSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageSharesOutstandingBasic" xlink:to="FONR_WeightedAverageSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageSharesOutstandingBasic_lbl" xml:lang="en-US">Basic Denominator: Weighted Average Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:to="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Income per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:to="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xml:lang="en-US">Maintenance and repair expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xml:lang="en-US">Management Agreements With Company Total Medical Practices</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xml:lang="en-US">Scanners With Management Agreements With Company Owned By Related Party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xml:lang="en-US">Scanners With Management With Company Located In New York State</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xml:lang="en-US">Contractual Fees For Services Rendered Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xml:lang="en-US">Contractual Fees For Services Rendered Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xml:lang="en-US">Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total non current receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at Beginning of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xml:lang="en-US">Internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="FONR_ManagedFacilitiesClosedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_lbl" xml:lang="en-US">Managed Facilities Closed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at End of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage Of Pcs Net Revenue Derived From No fault And Personal Injury Protection Claims</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage Of Consolidated Net Revenue From Management Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property plant and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="FONR_DepreciatedAssetsWriteoff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciatedAssetsWriteoff" xlink:to="FONR_DepreciatedAssetsWriteoff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciatedAssetsWriteoff_lbl" xml:lang="en-US">Depreciated assets write-off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present Value discount, Operating Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present Value discount, Financing Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_2_lbl" xml:lang="en-US">Operating Financing Leases - Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_3_lbl" xml:lang="en-US">Operating Financing Leases - Components Of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from financing leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xml:lang="en-US">Right-of-use and equipment assets obtained in exchange for lease obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Other intangible assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_2_lbl" xml:lang="en-US">Balance - Beginning of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AmountsCapitalized" xlink:label="FONR_AmountsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AmountsCapitalized_lbl" xml:lang="en-US">Amounts capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="FONR_SoftwareOrPatentsWrittenOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareOrPatentsWrittenOff_lbl" xml:lang="en-US">Software or patents written off</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_3_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableNature" xlink:label="us-gaap_DividendsPayableNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableNature" xlink:to="us-gaap_DividendsPayableNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableNature_lbl" xml:lang="en-US">Dividends Payable, Nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:to="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xml:lang="en-US">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common Stock, Voting Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SharesRegistered" xlink:label="FONR_SharesRegistered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesRegistered_lbl" xml:lang="en-US">Shares registered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Payments for Repurchase of Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="FONR_CancellationOfTreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryShares" xlink:to="FONR_CancellationOfTreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryShares_lbl" xml:lang="en-US">Cancellation of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="FONR_CancellationOfTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStock" xlink:to="FONR_CancellationOfTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryStock_lbl" xml:lang="en-US">Cancellation of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OpeningMembersEquity" xlink:label="FONR_OpeningMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OpeningMembersEquity_lbl" xml:lang="en-US">Opening Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ShareOfNetIncome" xlink:label="FONR_ShareOfNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShareOfNetIncome_lbl" xml:lang="en-US">Share of Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_Distributions" xlink:label="FONR_Distributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Distributions_lbl" xml:lang="en-US">Distributions</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EndingMembersEquity" xlink:label="FONR_EndingMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EndingMembersEquity_lbl" xml:lang="en-US">Ending Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Ownership interest</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentOwnershipPercentages" xlink:to="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xml:lang="en-US">Ownership interest of HDM after transaction (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="FONR_ProceedsFromContributionsFromCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProceedsFromContributionsFromCompany" xlink:to="FONR_ProceedsFromContributionsFromCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProceedsFromContributionsFromCompany_lbl" xml:lang="en-US">Contribution to HDM ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="FONR_PurchaseOfStandupMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfStandupMriCenters_lbl" xml:lang="en-US">Purchase Of Stand up Mr iCenters</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="FONR_PurchaseOfOtherMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfOtherMriCenters_lbl" xml:lang="en-US">Purchase Of Other Mri Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="FONR_ConsiderationToOutsideInvestors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationToOutsideInvestors_lbl" xml:lang="en-US">HDM purchase price includes consideration to outside investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalPurchasePrice" xlink:label="FONR_TotalPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchasePrice_lbl" xml:lang="en-US">HDM purchase from Health Diagnostics (HD) ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xml:lang="en-US">HDM entered agreement for consulting and non-competition agreement ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:to="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xml:lang="en-US">Purchase of interests from Class A (%)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="FONR_MonthlyPaymentPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MonthlyPaymentPeriod" xlink:to="FONR_MonthlyPaymentPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MonthlyPaymentPeriod_lbl" xml:lang="en-US">Monthly Payment Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MaturityDate" xlink:label="FONR_MaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaturityDate" xlink:to="FONR_MaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaturityDate_lbl" xml:lang="en-US">Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BookValueOfBuilding" xlink:label="FONR_BookValueOfBuilding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BookValueOfBuilding" xlink:to="FONR_BookValueOfBuilding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BookValueOfBuilding_lbl" xml:lang="en-US">Book Value Of Building</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of Long Term Debt, Notes Payable and Capital Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long Term Debt, Notes Payable and Capital Leases less Current Portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract_2_lbl" xml:lang="en-US">Long-term Debt Notes Payable And Capital Leases - Maturities Of Long-term Debt Over 5 Years -</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total long term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncomeTaxExpensesBenefit" xlink:label="FONR_IncomeTaxExpensesBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncomeTaxExpensesBenefit" xlink:to="FONR_IncomeTaxExpensesBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_IncomeTaxExpensesBenefit_lbl" xml:lang="en-US">Provision (Benefit) for Income Taxes - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes (benefit), net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Expiration of tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xml:lang="en-US">Return to provision adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_lbl" xml:lang="en-US">New York state audit settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in the valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Non-deductible accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Capitalized research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:to="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xml:lang="en-US">Right of use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">Other Operating Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xml:lang="en-US">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AdditionalTaxes" xlink:label="FONR_AdditionalTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalTaxes" xlink:to="FONR_AdditionalTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AdditionalTaxes_lbl" xml:lang="en-US">Additional Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LeaseAndRentalExpenses" xlink:label="FONR_LeaseAndRentalExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LeaseAndRentalExpenses" xlink:to="FONR_LeaseAndRentalExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LeaseAndRentalExpenses_lbl" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_lbl" xml:lang="en-US">Property Tax Abatement From Suffolk County IDA</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PropertyTaxAbatement" xlink:label="FONR_PropertyTaxAbatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyTaxAbatement_lbl" xml:lang="en-US">Property Tax Abatement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_lbl" xml:lang="en-US">Liability for individual claims</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_lbl" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SellingGeneralAndAdministrativeExpenses" xlink:to="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xml:lang="en-US">Related Party Transaction, Description of Transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Revenues - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Intersegment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total identifiable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignProductSales" xlink:label="FONR_ForeignProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignProductSales_lbl" xml:lang="en-US">Foreign Product Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="FONR_ForeignServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignServiceAndRepairFees_lbl" xml:lang="en-US">Foreign Service And Repair Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Export Sales Of Medical Equipment Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xml:lang="en-US">Additions (Included in provision for bad debts)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xml:lang="en-US">Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BroadcastersLicenseAgreementCommitmentsDescription" xlink:label="us-gaap_BroadcastersLicenseAgreementCommitmentsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BroadcastersLicenseAgreementCommitmentsDescription" xlink:to="us-gaap_BroadcastersLicenseAgreementCommitmentsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BroadcastersLicenseAgreementCommitmentsDescription_lbl" xml:lang="en-US">Broadcasters License Agreement Commitments, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">It represents the amount of accounts receivable service and repair fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredMember" xlink:to="FONR_ClassANonVotingPreferredMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredMember_doc" xml:lang="en-US">Class A non-voting Preferred [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassCCommonStockMember_doc" xml:lang="en-US">Class C Common Stock [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfSharesShares" xlink:to="FONR_CancellationOfSharesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CancellationOfSharesShares_doc" xml:lang="en-US">Cancellation of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ControllingInterestMember_doc" xml:lang="en-US">Controlling Interest [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:to="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_doc" xml:lang="en-US">Acquired Assets and Assumed Liabilities Policy Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_doc" xml:lang="en-US">Customer Advances Policy Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_doc" xml:lang="en-US">Estimated Usefu lLife In Years For Property And Equipment Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticEquipmentMember_doc" xml:lang="en-US">MRI Diagnostic Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_doc" xml:lang="en-US">Research Deveopment And Demonstration Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_doc" xml:lang="en-US">Total Imaging Centers with management agreements with Company.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_doc" xml:lang="en-US">Number of management agreements with PC's owned by a relarted party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_doc" xml:lang="en-US">Number of management agreements with PC's owned by two unrelated radiologists.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_doc" xml:lang="en-US">Minimum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticImagingFacilityMember_doc" xml:lang="en-US">Diagnostic Imaging Facility Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_doc" xml:lang="en-US">Maximum contractual fees for services rendered to the PC's.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_doc" xml:lang="en-US">Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageSharesOutstandingBasic" xlink:to="FONR_WeightedAverageSharesOutstandingBasic_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WeightedAverageSharesOutstandingBasic_doc" xml:lang="en-US">Weighted average shares outstanding basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_doc" xml:lang="en-US">Weighted average number of diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_doc" xml:lang="en-US">Total Facilities Owned Or Managed Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_doc" xml:lang="en-US">The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OperatingLeasePaymentsMember_doc" xml:lang="en-US">Operating Lease Payments [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_FinancingLeasePaymentsMember_doc" xml:lang="en-US">Financing Lease Payments [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_doc" xml:lang="en-US">Schedule Of Weighted Average Remaining Lease Term Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_FinanceLeaseCostsAbstract_doc" xml:lang="en-US">Finance Lease Costs Abstract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_doc" xml:lang="en-US">Supplemental Cash Flow Information Related To Leases Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_doc" xml:lang="en-US">Right of use Equipment Assets Obtained In Exchange For Lease Obligations Abstract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:to="FONR_CapitalStockAndOptionsDisclosureTextblock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CapitalStockAndOptionsDisclosureTextblock_doc" xml:lang="en-US">Capital Stock And Options Disclosure Text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_N2010StockBonusPlanMember_doc" xml:lang="en-US">N 2010 Stock Bonus Plan [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMEquityMember_doc" xml:lang="en-US">HDM Equity Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HDMMember_doc" xml:lang="en-US">HDM [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PurchaseOfStandupMriCenters_doc" xml:lang="en-US">Purchase of stand up mr icenters</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PurchaseOfOtherMriCenters_doc" xml:lang="en-US">Purchase Of Other Mri Centers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OpeningMembersEquity_doc" xml:lang="en-US">Opening Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ShareOfNetIncome_doc" xml:lang="en-US">Share Of Net Income for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_Distributions_doc" xml:lang="en-US">Distributions to each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EndingMembersEquity_doc" xml:lang="en-US">Ending Members Equity for each class of members equity as of June 30.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable1Member" xlink:to="FONR_NotePayable1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable1Member_doc" xml:lang="en-US">Long-term debt, notes payable and capital leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaturityDate" xlink:to="FONR_MaturityDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaturityDate_doc" xml:lang="en-US">Maturity Date description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportProductSalesTableTextBlock" xlink:to="FONR_ExportProductSalesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ExportProductSalesTableTextBlock_doc" xml:lang="en-US">Export Product Sales Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_doc" xml:lang="en-US">It represents the rate of Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignServiceAndRepairFees_doc" xml:lang="en-US">It represents the rate of Foreign Service And Repair Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportServiceRevenuesTableTextBlock" xlink:to="FONR_ExportServiceRevenuesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ExportServiceRevenuesTableTextBlock_doc" xml:lang="en-US">Export Service Revenues Table Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_doc" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMember" xlink:to="FONR_RelatedPartiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RelatedPartiesMember_doc" xml:lang="en-US">Related Parties [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMedicalPracticesMember" xlink:to="FONR_RelatedPartiesMedicalPracticesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RelatedPartiesMedicalPracticesMember_doc" xml:lang="en-US">Related Parties Medical Practices [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotePayable2Member" xlink:to="FONR_NotePayable2Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NotePayable2Member_doc" xml:lang="en-US">Note Payable 2 [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MonthlyPaymentPeriod" xlink:to="FONR_MonthlyPaymentPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MonthlyPaymentPeriod_doc" xml:lang="en-US">Monthly Payment Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DebtAndCapitalLeaseDisclosuresTextBlock" xlink:to="FONR_DebtAndCapitalLeaseDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DebtAndCapitalLeaseDisclosuresTextBlock_doc" xml:lang="en-US">Debt And Capital Lease Disclosures Text Block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalReceivable_doc" xml:lang="en-US">This represents the amount of medical receivable during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_doc" xml:lang="en-US">This represents the amount of management and other fees during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">This represents the amount of management and other fees receivable related medical practices net allowances during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetLongTerm_doc" xml:lang="en-US">This represents the amount of accounts receivable net long term during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:to="FONR_LongTermDebtAndCapitalLeaseObligationCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligationCurrent_doc" xml:lang="en-US">This represents the amount of long term debt and capital lease obligation current during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CustomerDeposits_doc" xml:lang="en-US">This represents the amount of customer deposits during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DueToRelatedPartyMedicalPractices" xlink:to="FONR_DueToRelatedPartyMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DueToRelatedPartyMedicalPractices_doc" xml:lang="en-US">This represents the amount of due to related party medical practices during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LongTermDebtAndCapitalLeaseObligation" xlink:to="FONR_LongTermDebtAndCapitalLeaseObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LongTermDebtAndCapitalLeaseObligation_doc" xml:lang="en-US">This represents the amount of long term debt and capital lease obligation during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_doc" xml:lang="en-US">This represents the amount of management and other receivable allowances for doubtful accounts during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_doc" xml:lang="en-US">This represents the amount of patient fee revenue net of contractual allowances and discounts during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_doc" xml:lang="en-US">This represents the amount of related party receivable allowances for doubtful accounts during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProductSalesNet_doc" xml:lang="en-US">This represents the amount of product sales net during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesNet_doc" xml:lang="en-US">This represents the amount of service and repair fees net during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xml:lang="en-US">This represents the amount of service and repair fees related parties net during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesNet_doc" xml:lang="en-US">This represents the value of management and other fees net during the year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xml:lang="en-US">This represents the value of management and other fees related medical practices net during the year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToProductSales_doc" xml:lang="en-US">This represents the value of costs related to product sales during the year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_doc" xml:lang="en-US">This represents the amount of costs related to service and repair fees during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xml:lang="en-US">This represents the amount of costs related to service and repair fees related parties during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_doc" xml:lang="en-US">This represents the amount of costs related to management and other fees during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">This represents the amount of costs related to management and other fees related medical practices during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:to="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StockIssuedToEmployeesUnderStockBonusPlansValue_doc" xml:lang="en-US">This represents the amount of stock issued to employees under stock bonus plans value during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfShares" xlink:to="FONR_CancellationOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CancellationOfShares_doc" xml:lang="en-US">This represents the amount of cancellation of shares during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BuyoutOfNoncontrollingInterests_doc" xml:lang="en-US">This represents the amount of buy out of noncontrolling interests during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProvisionForBadDebts_doc" xml:lang="en-US">This represents the amount of provision for bad debts during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LossOnDispositionOfFixedAssets" xlink:to="FONR_LossOnDispositionOfFixedAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LossOnDispositionOfFixedAssets_doc" xml:lang="en-US">This represents the amount of loss on disposition of fixed assets during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_GainOnForgivenessOfPppLoan_doc" xml:lang="en-US">This represents the amount of gain on forgiveness of ppp loan during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountReceivable" xlink:to="FONR_IncreaseDecreaseInAccountReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInAccountReceivable_doc" xml:lang="en-US">This represents the amount of increase decrease in account receivable during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountPayable" xlink:to="FONR_IncreaseDecreaseInAccountPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInAccountPayable_doc" xml:lang="en-US">This represents the amount of increase decrease in account payable during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_doc" xml:lang="en-US">This represents the amount of increase decrease in customer advance during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInOperatingLiability" xlink:to="FONR_IncreaseDecreaseInOperatingLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInOperatingLiability_doc" xml:lang="en-US">This represents the amount of increase decrease in operating liability during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_doc" xml:lang="en-US">This represents the amount of increase decrease in financing liabilities during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_doc" xml:lang="en-US">This represents the amount of increase decrease in contract liabilities during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccruedLiability" xlink:to="FONR_IncreaseDecreaseInAccruedLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncreaseDecreaseInAccruedLiability_doc" xml:lang="en-US">This represents the amount of increase decrease in accrued liability during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PurchaseOfNoncontrollingInterests_doc" xml:lang="en-US">This represents the amount of purchase of noncontrolling interests during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">This represents the rate of hmca ownership size of imperial management services percent during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_doc" xml:lang="en-US">This represents the rate of ownership interest of original investors of hdm during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_doc" xml:lang="en-US">This represents the amount of direct purchase of noncontrolling interests during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetPatientFeeRevenue_doc" xml:lang="en-US">This represents the amount of net patient fee revenue during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:to="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_doc" xml:lang="en-US">This represents the shares of incremental common shares attributable to conversion of common stock during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciatedAssetsWriteoff" xlink:to="FONR_DepreciatedAssetsWriteoff_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DepreciatedAssetsWriteoff_doc" xml:lang="en-US">This represents the amount of depreciated assets write off during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscount_doc" xml:lang="en-US">This represents the amount of present value discount during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscountFinancingLease_doc" xml:lang="en-US">This represents the amount of present value discount financing lease during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DepreciationOfLeasedEquipment_doc" xml:lang="en-US">This represents the amount of depreciation of leased equipment during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_FinanceLeaseCost_doc" xml:lang="en-US">This represents the amount of finance lease cost during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_doc" xml:lang="en-US">This represents the amount of operating cash flows from operating leases during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_doc" xml:lang="en-US">This represents the amount of financing cash flows from financing leases during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_doc" xml:lang="en-US">This represents the amount of right of use equipment assets obtained in exchange for lease obiligations operating leases during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AmountsCapitalized_doc" xml:lang="en-US">This represents the amount of amounts capitalized during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SoftwareOrPatentsWrittenOff_doc" xml:lang="en-US">This represents the amount of software or patents written off during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SharesRegistered_doc" xml:lang="en-US">This represents the shares of shares registered during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryShares" xlink:to="FONR_CancellationOfTreasuryShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CancellationOfTreasuryShares_doc" xml:lang="en-US">This represents the shares of cancellation of treasury shares during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ConsiderationToOutsideInvestors_doc" xml:lang="en-US">This represents the amount of consideration to outside investors during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStock" xlink:to="FONR_CancellationOfTreasuryStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CancellationOfTreasuryStock_doc" xml:lang="en-US">This represents the amount of cancellation of treasury stock during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TotalPurchasePrice_doc" xml:lang="en-US">This represents the amount of total purchase price during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_doc" xml:lang="en-US">This represents the amount of consideration for non competition and consulting agreements during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_doc" xml:lang="en-US">This represents the amount of buy out of noncontrolling interests value during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BookValueOfBuilding" xlink:to="FONR_BookValueOfBuilding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_BookValueOfBuilding_doc" xml:lang="en-US">This represents the amount of book value of building during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_doc" xml:lang="en-US">This represents the amount of deferred income tax expenses benefit during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncomeTaxExpensesBenefit" xlink:to="FONR_IncomeTaxExpensesBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncomeTaxExpensesBenefit_doc" xml:lang="en-US">This represents the amount of income tax expenses benefit during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement_doc" xml:lang="en-US">This represents the rate of effective income tax rate reconciliation nys audit settlement during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_InvestorsOwnershipInterest_doc" xml:lang="en-US">This represents the rate of investors ownership interest during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalTaxes" xlink:to="FONR_AdditionalTaxes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AdditionalTaxes_doc" xml:lang="en-US">This represents the amount of additional taxes during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LeaseAndRentalExpenses" xlink:to="FONR_LeaseAndRentalExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LeaseAndRentalExpenses_doc" xml:lang="en-US">This represents the amount of lease and rental expenses during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:to="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatementFromSuffolkCountyIda_doc" xml:lang="en-US">This represents the rate of property tax abatement from Suffolk county ida during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyTaxAbatement" xlink:to="FONR_PropertyTaxAbatement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PropertyTaxAbatement_doc" xml:lang="en-US">This represents the amount of property tax abatement during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:to="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_doc" xml:lang="en-US">This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SellingGeneralAndAdministrativeExpenses" xlink:to="FONR_SellingGeneralAndAdministrativeExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SellingGeneralAndAdministrativeExpenses_doc" xml:lang="en-US">This represents the amount of selling general and administrative expenses during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">This represents the amount of intersegment net revenues during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ForeignProductSales_doc" xml:lang="en-US">This represents the rate of foreign product sales during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_doc" xml:lang="en-US">This represents the amount of allowance for doubtful accounts additions during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_doc" xml:lang="en-US">This represents the amount of allowance for doubtful accounts deductions during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_doc" xml:lang="en-US">This represents the rate of export sales of medical equipment percentage during year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnForgivenessOfPppLoan_3_lbl" xml:lang="en-US">GainOnForgivenessOfPppLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountReceivable" xlink:to="FONR_IncreaseDecreaseInAccountReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInAccountReceivable_3_lbl" xml:lang="en-US">IncreaseDecreaseInAccountReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccountPayable" xlink:to="FONR_IncreaseDecreaseInAccountPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInAccountPayable_3_lbl" xml:lang="en-US">IncreaseDecreaseInAccountPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_3_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInAccruedLiability" xlink:to="FONR_IncreaseDecreaseInAccruedLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInAccruedLiability_3_lbl" xml:lang="en-US">IncreaseDecreaseInAccruedLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-Term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfNoncontrollingInterests_3_lbl" xml:lang="en-US">PurchaseOfNoncontrollingInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessPolicy_2_lbl" xml:lang="en-US">Inventory Work in Process, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_2_lbl" xml:lang="en-US">Financing Receivable, Noncurrent, Allowance for Credit Loss [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_3_lbl" xml:lang="en-US">BuyoutOfNoncontrollingInterestsValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Repayments of Principal in Next 12 Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_2_lbl" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_3_lbl" xml:lang="en-US">DeferredIncomeTaxExpensesBenefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncomeTaxExpensesBenefit" xlink:to="FONR_IncomeTaxExpensesBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncomeTaxExpensesBenefit_3_lbl" xml:lang="en-US">IncomeTaxExpensesBenefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_2_lbl" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>fonr-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230630.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment" xlink:href="fonr-20230630.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStock" xlink:href="fonr-20230630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactions" xlink:href="fonr-20230630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230630.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentTables" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230630.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesTables" xlink:href="fonr-20230630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccountsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:href="fonr-20230630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:href="fonr-20230630.xsd#EarningsPerShareContinuedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230630.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:href="fonr-20230630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="fonr-20230630.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:href="fonr-20230630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:href="fonr-20230630.xsd#OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230630.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:href="fonr-20230630.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:href="fonr-20230630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:href="fonr-20230630.xsd#Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:href="fonr-20230630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:href="fonr-20230630.xsd#IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="fonr-20230630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:href="fonr-20230630.xsd#SegmentAndRelatedInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:href="fonr-20230630.xsd#AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligationCurrent" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DueToRelatedPartyMedicalPractices" xlink:label="loc_FONRDueToRelatedPartyMedicalPractices" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRDueToRelatedPartyMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LongTermDebtAndCapitalLeaseObligation" xlink:label="loc_FONRLongTermDebtAndCapitalLeaseObligation" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRLongTermDebtAndCapitalLeaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpensesAbstract" xlink:label="loc_us-gaapOtherExpensesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassANonVotingPreferredMember" xlink:label="loc_FONRClassANonVotingPreferredMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassANonVotingPreferredMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfShares" xlink:label="loc_FONRCancellationOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfSharesShares" xlink:label="loc_FONRCancellationOfSharesShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfSharesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_StockIssuedToEmployeesUnderStockBonusPlansValue" xlink:label="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockIssuedToEmployeesUnderStockBonusPlansValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LossOnDispositionOfFixedAssets" xlink:label="loc_FONRLossOnDispositionOfFixedAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRLossOnDispositionOfFixedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountReceivable" xlink:label="loc_FONRIncreaseDecreaseInAccountReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInAccountReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccountPayable" xlink:label="loc_FONRIncreaseDecreaseInAccountPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInAccountPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInOperatingLiability" xlink:label="loc_FONRIncreaseDecreaseInOperatingLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInOperatingLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncreaseDecreaseInAccruedLiability" xlink:label="loc_FONRIncreaseDecreaseInAccruedLiability" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInAccruedLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000010 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="00000011 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000012 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="00000014 - Disclosure - CAPITAL STOCK">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CapitalStockAndOptionsDisclosureTextblock" xlink:label="loc_FONRCapitalStockAndOptionsDisclosureTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_FONRCapitalStockAndOptionsDisclosureTextblock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases" xlink:title="00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DebtAndCapitalLeaseDisclosuresTextBlock" xlink:label="loc_FONRDebtAndCapitalLeaseDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_FONRDebtAndCapitalLeaseDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000018 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000022 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts" xlink:title="00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_srtScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="loc_us-gaapInventoryWorkInProcessPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:label="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRAcquiredAssetsandAssumedLiabilitiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="loc_FONRCustomerAdvancesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRCustomerAdvancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000028 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000030 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables" xlink:title="00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportProductSalesTableTextBlock" xlink:label="loc_FONRExportProductSalesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportProductSalesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportServiceRevenuesTableTextBlock" xlink:label="loc_FONRExportServiceRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportServiceRevenuesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccountsTables" xlink:title="00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassBControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_FONRControllingInterestMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/EarningsPerShareContinuedDetails" xlink:title="00000041 - Disclosure - Earnings Per Share (Continued) (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="loc_FONRManagedFacilitiesAddedByInternalDevelopment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedByInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="loc_FONRManagedFacilitiesClosedDuringYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesClosedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000046 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DepreciatedAssetsWriteoff" xlink:label="loc_FONRDepreciatedAssetsWriteoff" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_FONRDepreciatedAssetsWriteoff" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000049 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails" xlink:title="00000050 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails" xlink:title="00000051 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails" xlink:title="00000052 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details" xlink:title="00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details" xlink:title="00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AmountsCapitalized" xlink:label="loc_FONRAmountsCapitalized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRAmountsCapitalized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="loc_FONRSoftwareOrPatentsWrittenOff" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRSoftwareOrPatentsWrittenOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="00000057 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details" xlink:title="00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable1Member" xlink:label="loc_FONRNotePayable1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_NotePayable2Member" xlink:label="loc_FONRNotePayable2Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_FONRNotePayable2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MonthlyPaymentPeriod" xlink:label="loc_FONRMonthlyPaymentPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMonthlyPaymentPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_MaturityDate" xlink:label="loc_FONRMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BookValueOfBuilding" xlink:label="loc_FONRBookValueOfBuilding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_FONRBookValueOfBuilding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details" xlink:title="00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:label="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IncomeTaxExpensesBenefit" xlink:label="loc_FONRIncomeTaxExpensesBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRIncomeTaxExpensesBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:label="loc_FONREffectiveIncomeTaxRateReconciliationNysAuditSettlement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONREffectiveIncomeTaxRateReconciliationNysAuditSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details" xlink:title="00000064 - Disclosure - INCOME TAXES - Components Of Company&apos;s Deferred Tax Assets And Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:label="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AdditionalTaxes" xlink:label="loc_FONRAdditionalTaxes" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRAdditionalTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_LeaseAndRentalExpenses" xlink:label="loc_FONRLeaseAndRentalExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRLeaseAndRentalExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PropertyTaxAbatementFromSuffolkCountyIda" xlink:label="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatementFromSuffolkCountyIda" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_PropertyTaxAbatement" xlink:label="loc_FONRPropertyTaxAbatement" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRPropertyTaxAbatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:label="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRStoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_SellingGeneralAndAdministrativeExpenses" xlink:label="loc_FONRSellingGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_FONRSellingGeneralAndAdministrativeExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ABillingCompanyMember" xlink:label="loc_FONRABillingCompanyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRABillingCompanyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManufacturingAndServicingOfMedicalEquipmentMember" xlink:label="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManufacturingAndServicingOfMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AE" xlink:label="loc_countryAE" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CH" xlink:label="loc_countryCH" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AE" xlink:label="loc_countryAE" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GR" xlink:label="loc_countryGR" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="loc_FONRExportSalesOfMedicalEquipmentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportSalesOfMedicalEquipmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails" xlink:title="00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srtValuationAndQualifyingAccountsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtValuationAndQualifyingAccountsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BroadcastersLicenseAgreementCommitmentsDescription" xlink:label="loc_us-gaapBroadcastersLicenseAgreementCommitmentsDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBroadcastersLicenseAgreementCommitmentsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201885456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Marcum llp<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202957856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 51,279,707<span></span>
</td>
<td class="nump">$ 48,722,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">32,799<span></span>
</td>
<td class="nump">32,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable &#8211; net of allowances for doubtful accounts of $198,593 and $204,597 at June 30, 2023 and 2022, respectively</a></td>
<td class="nump">3,861,512<span></span>
</td>
<td class="nump">4,335,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables &#8211; net</a></td>
<td class="nump">21,259,262<span></span>
</td>
<td class="nump">20,108,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">Management and other fees receivable &#8211; net of allowances for doubtful accounts of $12,608,567 and $16,627,917 at June 30, 2023 and 2022, respectively</a></td>
<td class="nump">35,888,253<span></span>
</td>
<td class="nump">33,419,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for doubtful accounts of $3,989,692 and $4,686,893 at June 30, 2023 and 2022, respectively</a></td>
<td class="nump">9,161,870<span></span>
</td>
<td class="nump">8,602,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,569,666<span></span>
</td>
<td class="nump">2,359,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,607,768<span></span>
</td>
<td class="nump">1,104,325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">125,660,837<span></span>
</td>
<td class="nump">118,686,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">710,085<span></span>
</td>
<td class="nump">1,871,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">10,041,960<span></span>
</td>
<td class="nump">12,842,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">22,146,373<span></span>
</td>
<td class="nump">22,281,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; operating leases</a></td>
<td class="nump">33,068,755<span></span>
</td>
<td class="nump">34,232,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; financing lease</a></td>
<td class="nump">729,229<span></span>
</td>
<td class="nump">928,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269,277<span></span>
</td>
<td class="nump">4,269,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">3,431,865<span></span>
</td>
<td class="nump">3,703,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">523,506<span></span>
</td>
<td class="nump">526,269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">200,581,887<span></span>
</td>
<td class="nump">199,341,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LongTermDebtAndCapitalLeaseObligationCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">43,767<span></span>
</td>
<td class="nump">40,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,579,240<span></span>
</td>
<td class="nump">1,551,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">5,443,724<span></span>
</td>
<td class="nump">6,417,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability &#8211; current portion</a></td>
<td class="nump">3,905,484<span></span>
</td>
<td class="nump">3,880,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liability &#8211; current portion</a></td>
<td class="nump">217,597<span></span>
</td>
<td class="nump">210,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,832,184<span></span>
</td>
<td class="nump">4,288,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">602,377<span></span>
</td>
<td class="nump">361,245<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">15,624,373<span></span>
</td>
<td class="nump">16,748,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">760,242<span></span>
</td>
<td class="nump">1,857,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">394,758<span></span>
</td>
<td class="nump">215,726<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DueToRelatedPartyMedicalPractices', window );">Due to related party medical practices</a></td>
<td class="nump">92,663<span></span>
</td>
<td class="nump">92,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">32,105,405<span></span>
</td>
<td class="nump">33,090,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">620,481<span></span>
</td>
<td class="nump">838,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LongTermDebtAndCapitalLeaseObligation', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">115,075<span></span>
</td>
<td class="nump">155,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">41,750<span></span>
</td>
<td class="nump">106,541<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">34,130,374<span></span>
</td>
<td class="nump">36,356,847<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">49,754,747<span></span>
</td>
<td class="nump">53,105,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">182,612,518<span></span>
</td>
<td class="nump">184,531,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(24,190,981)<span></span>
</td>
<td class="num">(33,566,757)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 11,463 and 11,643 shares of common stock at June 30, 2023 and 2022, respectively</a></td>
<td class="num">(515,820)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">157,906,433<span></span>
</td>
<td class="nump">150,290,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(7,079,293)<span></span>
</td>
<td class="num">(4,053,833)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">150,827,140<span></span>
</td>
<td class="nump">146,236,281<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">200,581,887<span></span>
</td>
<td class="nump">199,341,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of accounts receivable net long term during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the amount of accounts receivable service and repair fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of customer deposits during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DueToRelatedPartyMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of due to related party medical practices during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DueToRelatedPartyMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LongTermDebtAndCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of long term debt and capital lease obligation during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LongTermDebtAndCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LongTermDebtAndCapitalLeaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of long term debt and capital lease obligation current during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LongTermDebtAndCapitalLeaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other fees during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other fees receivable related medical practices net allowances during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of medical receivable during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201449072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Allowance for Doubtful Accounts, Premiums and Other Receivables</a></td>
<td class="nump">$ 198,593<span></span>
</td>
<td class="nump">$ 204,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts', window );">Management and other receivable allowances for doubtful accounts</a></td>
<td class="nump">12,608,567<span></span>
</td>
<td class="nump">16,627,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts', window );">Related party receivable allowances for doubtful accounts</a></td>
<td class="nump">$ 3,989,692<span></span>
</td>
<td class="nump">$ 4,686,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">11,463<span></span>
</td>
<td class="nump">11,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,462,524<span></span>
</td>
<td class="nump">6,565,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,450,882<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of management and other receivable allowances for doubtful accounts during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of related party receivable allowances for doubtful accounts during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202920608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 29,793,993<span></span>
</td>
<td class="nump">$ 29,582,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">731,607<span></span>
</td>
<td class="nump">517,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">7,419,104<span></span>
</td>
<td class="nump">7,590,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees &#8211; related parties &#8211; net</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">48,640,497<span></span>
</td>
<td class="nump">48,226,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees &#8211; related party medical practices &#8211; net</a></td>
<td class="nump">11,949,900<span></span>
</td>
<td class="nump">11,564,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">98,645,101<span></span>
</td>
<td class="nump">97,592,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">852,025<span></span>
</td>
<td class="nump">416,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">3,033,967<span></span>
</td>
<td class="nump">2,991,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees &#8211; related parties</a></td>
<td class="nump">44,983<span></span>
</td>
<td class="nump">43,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">16,183,166<span></span>
</td>
<td class="nump">13,307,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">26,975,563<span></span>
</td>
<td class="nump">27,251,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related party medical practices</a></td>
<td class="nump">5,807,454<span></span>
</td>
<td class="nump">6,567,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,567,749<span></span>
</td>
<td class="nump">1,494,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">29,390,932<span></span>
</td>
<td class="nump">23,512,581<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">83,855,839<span></span>
</td>
<td class="nump">75,584,963<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income from Operations</a></td>
<td class="nump">14,789,262<span></span>
</td>
<td class="nump">22,007,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(50,131)<span></span>
</td>
<td class="num">(346,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">1,222,176<span></span>
</td>
<td class="nump">247,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income</a></td>
<td class="num">(202,720)<span></span>
</td>
<td class="nump">861,087<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes and noncontrolling interests</a></td>
<td class="nump">15,758,587<span></span>
</td>
<td class="nump">22,768,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(3,632,071)<span></span>
</td>
<td class="num">(5,534,487)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">12,126,516<span></span>
</td>
<td class="nump">17,234,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Noncontrolling Interests</a></td>
<td class="num">(2,750,740)<span></span>
</td>
<td class="num">(4,793,482)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 9,375,776<span></span>
</td>
<td class="nump">$ 12,440,906<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to management and other fees during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to management and other fees related medical practices during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of costs related to product sales during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to service and repair fees during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of costs related to service and repair fees related parties during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of management and other fees net during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the value of management and other fees related medical practices net during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of patient fee revenue net of contractual allowances and discounts during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of product sales net during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of service and repair fees net during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of service and repair fees related parties net during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202884576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Class A non-voting Preferred [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Class C Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2021</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 185,100,976<span></span>
</td>
<td class="num">$ (46,007,663)<span></span>
</td>
<td class="num">$ (675,390)<span></span>
</td>
<td class="num">$ (3,048,524)<span></span>
</td>
<td class="nump">$ 135,370,125<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance, Shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,440,906<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,793,482<span></span>
</td>
<td class="nump">17,234,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterests', window );">Buyout of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(569,441)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">23,441<span></span>
</td>
<td class="num">(546,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue', window );">Stock issued to employees under stock bonus plans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,822,232)<span></span>
</td>
<td class="num">(5,822,232)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2022</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">184,531,535<span></span>
</td>
<td class="num">(33,566,757)<span></span>
</td>
<td class="num">(675,390)<span></span>
</td>
<td class="num">(4,053,833)<span></span>
</td>
<td class="nump">146,236,281<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,375,776<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,750,740<span></span>
</td>
<td class="nump">12,126,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,457)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,759,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfShares', window );">Cancellation of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,919,017)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,919,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfSharesShares', window );">Cancellation of shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,776,200)<span></span>
</td>
<td class="num">(5,776,200)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 182,612,518<span></span>
</td>
<td class="num">$ (24,190,981)<span></span>
</td>
<td class="num">$ (515,820)<span></span>
</td>
<td class="num">$ (7,079,293)<span></span>
</td>
<td class="nump">$ 150,827,140<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of buy out of noncontrolling interests during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of cancellation of shares during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfSharesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cancellation of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfSharesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockIssuedToEmployeesUnderStockBonusPlansValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of stock issued to employees under stock bonus plans value during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockIssuedToEmployeesUnderStockBonusPlansValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202889104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 12,126,516<span></span>
</td>
<td class="nump">$ 17,234,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,540,135<span></span>
</td>
<td class="nump">4,535,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="nump">5,513,476<span></span>
</td>
<td class="nump">1,343,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax - net</a></td>
<td class="nump">2,979,550<span></span>
</td>
<td class="nump">3,093,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">4,264,818<span></span>
</td>
<td class="nump">4,000,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LossOnDispositionOfFixedAssets', window );">Loss on disposition of fixed assets</a></td>
<td class="nump">213,244<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnForgivenessOfPppLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(700,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInAccountReceivable', window );">Accounts, medical and management fee receivables</a></td>
<td class="num">(8,055,843)<span></span>
</td>
<td class="num">(5,602,188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="num">(64,532)<span></span>
</td>
<td class="nump">43,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(209,845)<span></span>
</td>
<td class="num">(696,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(438,911)<span></span>
</td>
<td class="nump">90,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">2,763<span></span>
</td>
<td class="nump">129,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInAccountPayable', window );">Accounts payable</a></td>
<td class="nump">19,685<span></span>
</td>
<td class="num">(314,766)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(2,527,100)<span></span>
</td>
<td class="num">(3,765,215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="nump">241,132<span></span>
</td>
<td class="num">(369,856)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInOperatingLiability', window );">Operating lease liabilities</a></td>
<td class="num">(3,862,814)<span></span>
</td>
<td class="num">(3,437,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(210,353)<span></span>
</td>
<td class="num">(202,741)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInContractLiabilities', window );">Contract liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInAccruedLiability', window );">Other liabilities</a></td>
<td class="num">(64,791)<span></span>
</td>
<td class="num">(64,790)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">14,467,130<span></span>
</td>
<td class="nump">15,301,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(4,218,084)<span></span>
</td>
<td class="num">(4,545,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Proceeds of Short-term investment</a></td>
<td class="num">(473)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfNoncontrollingInterests', window );">Purchase of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(546,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(119,571)<span></span>
</td>
<td class="num">(87,882)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(4,338,128)<span></span>
</td>
<td class="num">(5,179,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(36,615)<span></span>
</td>
<td class="num">(37,239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Purchase of treasury stock</a></td>
<td class="num">(1,759,457)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(5,776,200)<span></span>
</td>
<td class="num">(5,822,232)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(7,572,272)<span></span>
</td>
<td class="num">(5,859,471)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">2,556,730<span></span>
</td>
<td class="nump">4,262,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</a></td>
<td class="nump">48,722,977<span></span>
</td>
<td class="nump">44,460,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - END OF YEAR</a></td>
<td class="nump">$ 51,279,707<span></span>
</td>
<td class="nump">$ 48,722,977<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnForgivenessOfPppLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of gain on forgiveness of ppp loan during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnForgivenessOfPppLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in account payable during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in account receivable during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInAccruedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in accrued liability during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInAccruedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in contract liabilities during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in customer advance during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in financing liabilities during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInOperatingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of increase decrease in operating liability during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInOperatingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LossOnDispositionOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of loss on disposition of fixed assets during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LossOnDispositionOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of provision for bad debts during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of purchase of noncontrolling interests during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202878640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zb24H4oNzOPg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
1 - <span id="xdx_829_zVI3HShgHmqg">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the &#8220;Company&#8221; or &#8220;FONAR&#8221;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#8220;MRI&#8221;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zyRfdB1dpfaj" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM">24.2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_90E_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zIF9tsz0Z6Ta" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM">45.8</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
in HDM, and the original investors in HDM retained a <span id="xdx_90D_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_ze5MYLfKl9yh" title="The ownership interest of the original investors of HDM">30.0</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$<span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ClassBControllingInterestsMember_zxfXvVcP7nT" title="Purchase of interests from Class A ($)">546,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">giving
the Company a direct ownership interest of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zCF8eX6iEAVd" title="Direct ownership interest percentage">70.8</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and the investors&#8217; a <span id="xdx_90D_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zXyzXHfsd8lk" title="Investors ownership interest percentage">29.2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and
recurrence of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and
the world economy in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing
global pandemic of COVID-19, the Company believes with the positive cash flows, low debt and cash on hand, it will be able to continue
operations going forward.&#160;</span></p>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658209366320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zkdxy9Houod2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_823_zghDXeiHcE16">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zKPD51EyDsj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_z2rB3dOQNvH5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--UseOfEstimates_zYNxcUhninLk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_z91PjCxPXmI5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--InventoryWorkInProcessPolicy_z0V0V8zLQo7a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_864_zG49sAr63Pv8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgEZUz7RXum6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zTnmhmOHipkj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost less accumulated depreciation. Property and equipment purchased in
connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is
being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold
improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other
disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the
resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to
operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_903_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20220701__20230630_zeLPNbmPBPS" title="Maintenance and repair expenses">2,801,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zNT9P9lUPqp6" title="Maintenance and repair expenses">2,783,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2023 and 2022 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; line-height: 115%"><span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated Useful Life in Years for Property and Equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg">13</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4">9</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f">10</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>





















<p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ztEJLUScpIq2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zdtqua1BNY4f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwejWLpF1pIi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_863_zuAp1j69iZhd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zWhzHSiGQFa5" title="Finite-Lived Intangible Asset, Useful Life">15
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight-line basis over the length of the agreement (<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zLXimc2TXHK3" title="Finite-Lived Intangible Asset, Useful Life">7
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1NqOvO07C2b" title="Finite-Lived Intangible Asset, Useful Life">20
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zbdMXyNzL1v2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_zRiwosQZ2OI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually at the end of
each fiscal year and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting
unit level by comparing the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed
to measure the amount of impairment loss, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_843_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zZNdzbsu7oca" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zrVI7zAtSWGk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805, &#8220;Business Combinations&#8221;, if the initial accounting for a business combination is incomplete by the end
of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the
acquisition date, the Company adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount
recognized for goodwill.&#160;</span></p>




















<p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjDCKZ9HVr8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_86B_z3irRoxrgEed" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span>Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2023, the Company has <span id="xdx_90A_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20230630_zu1GMVhlNeAg">22 </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which <span id="xdx_903_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20230630_z63iksoJVlj4">3 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">were
with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned
by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related medical
practices&#8221;) and <span id="xdx_90B_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20230630_zhF4TIENIJE4">19</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90B_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zdeKaV5lMUe8">84,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to
$<span id="xdx_90D_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zZq9uyt4UDWi">447,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad
debts for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of
Operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company currently recognizes revenue in accordance with the recognition accounting standard issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606
outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods
or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures
regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.&#160;</span></p>



























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2023 and 2022 are summarized in the following table.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue - Net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,124,646</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,248,708</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,063,846</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,060,920</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,670,019</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,907,335</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,935,482</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,365,275</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,793,993</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,582,238</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zvOUXNf3Jow5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--ResearchAndDevelopmentExpensePolicy_zCcM57Igdj39" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_866_zwXLEwU83yx2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&#160;&#160;</span></p>




















<p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zcrvaUItXfcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86B_zhkPe3HTjppk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_pp0p0_c20220701__20230630_zKZkoEVBqYll">570,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_902_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zs0vwBzoQKZ5">634,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_z6lN7U5pAQx6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zbMIL87Ze1o6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_848_ecustom--CustomerAdvancesPolicyTextBlock_zkYTUOYusfEg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_867_zNOLsjdj5iE" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z9PLWI0HYQEk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_zUzptieOT1t1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2023 and 2022, diluted EPS for common shareholders
includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_zmZ5QYUGnotk">127,504
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.&#160;</span></p>


















<p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_zP1e1w62Dcni">Earnings
Per Share (Continued)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,375,776</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,801,974</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,136</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.35</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,666,880</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.32</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,440,906</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,690,796</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">191,038</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.90</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.78</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,681,713</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.75</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>



















<p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i">49,203,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5">250,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210931888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zOvp50FpUZfj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
3 &#8211; <span id="xdx_824_zWN7Rf9LVOhi">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;&#160;</span></p>




















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years at June 30, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zYKHQPEvqGjc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
<tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt"></p>

 <span>Receivables - Non Current - Net</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 32%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td>
    <td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 2%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20230630_znrIcImoXpQh" style="width: 24%; font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">620,230</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ContractReceivableDueThreeToFourYears_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">140,012</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: top; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total non current receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">760,242</span></td>
    </tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third-party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s receivables from the related and non-related professional corporations (&#8220;PCs&#8221;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third-party
medical reimbursement organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90E_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20220701__20230630_zyTG4Ufu97ya">67</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zKye6CX3AiA4">66</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
respectively, of the PCs&#8217; 2023 and 2022 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#8217;s expectations.&#160;</span></p>





















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Net
revenues from management and other fees charged to the related party medical practices accounted for approximately <span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zIZK7t0BMva5">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_906_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_zQ3TiOR2fnK2">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%,
of the consolidated net revenues for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following table sets forth the number of our facilities for the years ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zNZKqR4isGYh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zqVKDBtZsVzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Facilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_ziCbS5DEjBg7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210701__20220630_z0H7dxI6RRT6" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagedFacilitiesClosedDuringYear_zBb50vwk3Bhb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0843">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>














<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//310-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210744496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zhcCVkyy2ISa" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
                                            4 &#8211; <span id="xdx_82F_zQ7nP1d1W6A3">INVENTORIES</span></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying consolidated balance sheets consist of:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zxmn31fB1U3h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_493_20230630_z5fnXPyLMjW7" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_498_20220630_z4LiPeIovZ21" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B2_zP8axrk5q5Ji" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzMGG_zx2JvSV1E76b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,346,300</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,125,805</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzMGG_zyWke2UcY5hc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">223,366</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">234,016</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzMGG_zlF8YCMD2fUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,569,666</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,359,821</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204528400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zKxnEGZ1QsGi" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
5 - <span id="xdx_82C_z1peDaeNis8i">PROPERTY AND EQUIPMENT</span></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2023 and 2022, is comprised of:&#160;&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zBjDgbuLNcne" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center; padding-left: 0.25in"><span id="xdx_8BE_zUkEImWg2N5f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property and Equipment</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zFE5I5Uydvgb" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">33,144,266</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z1hQgmHUEcle" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">31,304,258</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkxDNvzBNx93" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,199,941</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zTm3QR28b024" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,199,941</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zmdy1OLEJiDe" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zQX5ia2KuLw8" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0BCuCjUrr1" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,714,499</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsjOd8C50KZg" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,484,525</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvj5cLSAgUYk" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,650,041</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwgzcjF852Ia" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">14,087,581</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zKfnxmFnQee5" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zwHyepL5FNm8" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zbZ8fPWhLZA5" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61,717,416</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630_zXKbrO6DAOLl" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">58,084,974</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zk62conpjdag" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,571,043</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20220630_z6rlq9wXJsWi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,803,183</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zzlldLmaVQ3i" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,146,373</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220630_zv1Gk9Lf5794" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,281,791</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
and amortization of property and equipment for the years ended June 30, 2023 and 2022 was $<span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0">4,148,544 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0">4,113,640</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively. During fiscal year ended June 30 2022, the Company removed fully depreciated assets of $<span id="xdx_900_ecustom--DepreciatedAssetsWriteoff_pp0p0_c20220701__20230630_zCh3diTqmRed" title="Depreciated assets write-off">1,737,918 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">that
related to a location that was previously closed.&#160;</span></p>














<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210702864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_ztyYfbCTYehi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_827_zjIvlFRC88f">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of these practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zH9fVfdjztK" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
                                            of operating and financing lease payments</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Year
                                            Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease Payments</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,592,971</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,600,823</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,174,942</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,190,414</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,897</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDMy2mNDurQ4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,600,133</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,306,056</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0930">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscount_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBQW6Hr7QTbj" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Operating Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(10,454,450</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zbNyy5gYETsk" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Financing Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(57,848</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">36,010,889</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">838,078</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zrImfJStlpKj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B0_zKGhhdGBbs3h" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average Remaining Lease Term</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zk5uChC6bwS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.8</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zt5RrgC0pKdf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Discount Rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_z5xM5K3cLNnh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_zC0uyTsGS8w1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
components of lease expense were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LeaseCostTableTextBlock_zxy39OwJ5OYj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zyygSFR0RPUl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of Lease Expense</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_zGmMbeyWhzQ4" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210701__20220630_zucBadwZwugg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,887,390</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,668,199</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
                                    lease cost:</span></p></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zaUg4yKy4K5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,833</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,603</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCost_i01_pp0p0_zT0YjfaMdF4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">234,714</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">240,484</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
cash flow information related to leases as follows:&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9zePwdCb3Qh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8BA_zgxLD6WvH0z4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20220701__20230630_zzzkPQ3GoYz1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20210701__20220630_zm3L7Omts6Ge" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_405_ecustom--OperatingCashFlowsFromOperatingLeases_zX6I191tFDq8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,577,578</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,133,369</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zGoPDcDi7xIi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,344</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,344</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zGY8GpFt41ua" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,902,584</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,900,074</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658209304608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXINrkF1i5H6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
7 - <span id="xdx_826_z71ABYwLJHhh">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, at June 30, 2023 and 2022 are comprised of:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zUIORFkxq0A2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BB_zxXOUGIcS73d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets - Net</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,452,345</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,332,774</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507,192</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,387,621</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,075,327</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,683,736</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
estimated amortization of other intangible assets for the five years ending June 30, 2028 and thereafter is as follows:</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjZ0zCHUktAi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><p id="xdx_8BA_z8AOEZvCt3ih" style="margin-top: 0; margin-bottom: 0">Schedule Of Other Intangible Assets</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; width: 29%; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">376,600</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">176,600</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">371,645</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">171,645</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">369,022</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">169,022</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">366,427</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">166,427</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">362,172</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,172</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,585,999</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">671,832</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">914,167</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
                                            intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,517,698</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,914,167</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>





















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
weighted average amortization period for other intangible assets is <span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220701__20230630_z6lgHxazj58l">10.3
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years
and they have no expected residual value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Information
related to the above intangible assets for the years ended June 30, 2023 and 2022 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zb0iXarH8vzc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span id="xdx_8B1_zrayfMZnH9zf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Year Ended</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zIbCT4YdN9U5" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zYhsOIFManec" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zkRceRrU5th7" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">119,571</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">87,882</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20220701__20230630_zt3lWWpUAQ02" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1087">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1089">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AdjustmentForAmortization_c20220701__20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(391,591</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(421,596</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zAxEzLTjDDy9" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zM7BcuwscN26" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0">191,591
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0">184,096</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of non-competition agreements for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0">0
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0">37,500</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the years ended June 30, 2023 and 2022 amounted to $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0">200,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0">200,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210714960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureCapitalStockAbstract', window );"><strong>Capital Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalStockAndOptionsDisclosureTextblock', window );">CAPITAL STOCK</a></td>
<td class="text"><p id="xdx_800_ecustom--CapitalStockAndOptionsDisclosureTextblock_zspzh5bc7i7b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_821_z9NzzPP1xRU8">CAPITAL STOCK</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_902_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zozgmjrlfAbj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B Common Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zCEjy4Yviq4l" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</span> <span id="xdx_901_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjzK1n5DxQAd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
B common stock has 10 votes per share.</span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">There
were <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziWlZyNwmc08">146
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">of such
shares outstanding at June 30, 2023 and 2022.&#160;&#160;&#160;</span></p>




















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
C Common Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbKZqgOixFKh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class C common stock has 25 votes per share</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
as compared to 10 votes per share for the Class B common stock and <span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxPRe9as5iW4">one
vote per share for the common stock.</span></span> <span id="xdx_908_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzvFWlmhGrH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions. <span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlSZxxyUVxsc">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
A Non-Voting Preferred Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_90F_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zsS5rSJelvvc">one
share of Class A non-voting preferred stock for every five shares of common stock.</span></span> <span id="xdx_901_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zknp5hxWcc3a" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next
$20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company
in connection with the enforcement of five of the Company&#8217;s patents in its patent lawsuits, less the revised special dividend
payable on the common stock with respect to one of the Company&#8217;s patents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Stock
Bonus Plans</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve <span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">2,000,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the <span id="xdx_90C_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z44qqM8lbMj2" title="Shares registered">2,000,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares.
As of June 30, 2023, <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z128fjIzEL8">450,177
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2023 and 2022, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd">0
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
were issued.&#160;</span></p>




















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Treasury
Stock</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zLJAo4WJgEi1">9
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to be repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company utilizes the cost method of accounting to value the treasury stock when repurchasing stock. Under this method, the shares are
valued at the price paid and recorded to treasury stock. When the treasury stock is cancelled, the par value of the stock is reduced
and the additional paid in capital is reduced for the remaining value based upon the original stock sale. For the year ended June 30,
2023, the Company purchased <span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zbVKgbP4955b" title="Purchase of treasury shares">103,148
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
at a cost of $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_zaUzvszQYkn6" title="Purchase of treasury stock">1,759,457</span></span>
<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and cancelled <span id="xdx_907_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zDbQcALXM2Ak" title="Cancellation of treasury shares">103,328
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
valued at $<span id="xdx_901_ecustom--CancellationOfTreasuryStock_c20220701__20230630_zXX30Ms6m1I5" title="Cancellation of treasury stock">1,919,027</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalStockAndOptionsDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Stock And Options Disclosure Text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalStockAndOptionsDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureCapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureCapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658209344688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">CONTROLLING AND NONCONTROLLING INTERESTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zQO8lv4qtGig" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_828_zW1nhvcEn5Ah">CONTROLLING AND NONCONTROLLING INTERESTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
February 13, 2013, the Company entered into an agreement with outside investors to acquire a 50.5% controlling interest in a newly formed
limited liability company, Health Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM
there are two classes of members; Class A members and one Class B member. The Class A members have an ownership interest of <span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zITDnPqEL0ue" title="Ownership interest">49.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. The Class B member (HMCA) has an ownership of <span id="xdx_901_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zLQfxZl2D3l7">50.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $<span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zTpleUMySCWa" title="Contribution to HDM ($)">20,200,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to HDM
and the group of outside investors contributed $<span id="xdx_902_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_znd47uB9Rt6d">19,800,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for its
non-controlling membership interest.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
March 5, 2013, HDM purchased from Health Diagnostics, LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve
(<span id="xdx_90B_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zjFpaDEo1rb8">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
Stand-Up MRI Centers and two (<span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zxF20Bpatrel">2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_902_ecustom--ConsiderationToOutsideInvestors_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zZofmKyMrlW2" title="HDM purchase price includes consideration to outside investors">1.5
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million
to outside investors) aggregating $<span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z91ck1ngrdzi" title="HDM purchase from Health Diagnostics (HD) ($)">35.9
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $<span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zzr61Ti8GMz7" title="HDM entered agreement for consulting and non-competition agreement ($)">4.1
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business Combinations&#8221;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.</span></p>



















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;On
January 8, 2015, the Company purchased <span id="xdx_90A_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zBrMv2zTd845" title="Purchase of interests from Class A (%)">20</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the Class A members ownership interest at a cost of $<span id="xdx_90D_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMqOM4WFZj33" title="Purchase of interests from Class A ($)">4,971,094</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The Company has a <span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zJD348qEDs0c">60.4</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests
for $<span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z3YlRtCCgXIi" title="Purchase of interests from Class A ($)">546,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">giving
the Company a direct ownership interest of <span id="xdx_90E_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zYWPdVYP12qe">70.8</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and the investors&#8217; a <span id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20220630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zWqpEQIKAZzg" title="Ownership interest">29.2</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
ownership interest.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
amount of each class of HDM members&#8217; equity as of June 30, 2023 and 2022 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zrJSsZorVLE2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span id="xdx_8B2_zRSseaHm1Kld" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class A and B Members' Equity </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members' Equity</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,053,833</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,292,073</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,048,524</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,923,380</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share
    of Net Income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,750,740</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,513,540</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,793,482</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,228,693</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Buyout
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zoqoPWuts0ca" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--BuyoutOfNoncontrollingInterestsValue_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,441</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,776,200</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(14,023,800</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98D_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,822,232</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,860,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending
    Members' Equity</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,079,293</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">54,781,813</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,053,833</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,292,073</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210744496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DebtAndCapitalLeaseDisclosuresTextBlock', window );">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</a></td>
<td class="text"><p id="xdx_807_ecustom--DebtAndCapitalLeaseDisclosuresTextBlock_z0LoIwYoBhe8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
10 - <span id="xdx_82F_zbRoeFU5NrFi">LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt, notes payable and capital leases consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zEgujPxkPXbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zYWIKQ4Q2LZf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    Debt, Notes Payable and Capital Leases </span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRg68h9lrgK3">7</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90B_ecustom--MonthlyPaymentPeriod_dtM_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z6nYhUl9NSwg">240
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">monthly
    payments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">4,472
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_904_ecustom--MaturityDate_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member">October 2026</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_906_ecustom--BookValueOfBuilding_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zb0M1y52wIMk" title="Book Value Of Building">344,995
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2023.</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z49euvtnLP25" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zmO4ivBSS6Mh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">195,457</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
    revolving credit note was extended to November 15, 2023. The Company can borrow up to $<span id="xdx_90B_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zlyEtRYYdf8b">10,000,000
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zUq2b70gTFZ">8.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zPxMifvXD5si" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zOFyzWKlQKOi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LongTermDebtCurrent_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LongTermDebtCurrent_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">195,457</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">43,767</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">40,078</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">115,075</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,379</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_ze3NYm3Q0hF9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
maturities of debt over the next four years are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_znlr3sk58ur9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BF_zCEqiJZQudaj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities of Long-term Debt</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 2%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 9%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_c20230630_pp0p0" style="width: 43%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">43,767</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47,002</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,448</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,625</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: right"></td><td style="padding-bottom: 2.5pt; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif; color: Black">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230630_zJJN50r1PrW6" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total long term debt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>














<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DebtAndCapitalLeaseDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt And Capital Lease Disclosures Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DebtAndCapitalLeaseDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210779392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zLkDNGjO2QXj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;NOTE
11 - <span id="xdx_82C_zt7Zbe5Qf9ne">INCOME TAXES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740, &#8220;Accounting for Income Taxes&#8221; prescribes a recognition threshold and a measurement attribute for
the financial statement recognition and measurement of tax positions taken or expected to be taken in a corporate tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences
between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation
are referred to as unrecognized benefits. A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable
is reduced) for an unrecognized tax benefit because it represents an enterprise&#8217;s potential future obligation to the taxing authority
for a tax position that was not recognized as a result of applying the provisions of ASC 740. The Company believes there are no
uncertain tax positions in prior year&#8217;s tax filings and therefore it has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net. Penalties if incurred would be recognized as a component of &#8220;Selling, general
and administrative&#8221; expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has recorded a deferred tax asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_pp0p0_c20230630_zmrqxfrXaEfl">10,041,960 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
a deferred tax liability of $<span id="xdx_90C_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_pp0p0_c20230630_z2xG5R9k0Qhj">394,758 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
of June 30, 2023, primarily relating to its net Federal operating loss carryforwards of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_pp0p0_c20230630_zghzAHzWQ2Vk">9,110,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $<span id="xdx_906_eus-gaap--OperatingIncomeLoss_pp0p0_c20220701__20230630_zT1rO3MCQ1J3">11,130,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
city operating loss carryforwards allowance for doubtful accounts and tax credits of approximately $<span id="xdx_90A_eus-gaap--OtherOperatingIncome_pp0p0_c20220701__20230630_z4v22By4iEN7">1,235,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2023, no such changes in ownership have occurred.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15%&#160;corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#8217;s financial statements.&#160;&#160;</span></p>


















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to certain state net operating losses. A valuation allowance will be maintained until sufficient
positive evidence exists to support the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2023, by approximately $<span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20230630_zEW2pqvqsLH9">78,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
The valuation allowance decreased by approximately $<span id="xdx_905_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20220630_zizcqOtZTwT6">448,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">during
the year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
of the provision (benefit) for income taxes are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6y1hFTCOf9c" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_zysDaFNtEFVl" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of the provision for income taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20220701__20230630_z9bunqIZvHog" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210701__20220630_z2zyMGjQf8z1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zF1yzXEy8uz3" style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentFederalTaxExpenseBenefit_zsxb5kuS8NH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1300">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zZKXHI2RZ7f8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">652,522</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,594</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_z8HEcDRpBj1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">652,522</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,594</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqTyw3EjR307" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zvNDEJelDZX2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,770,980</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,935,921</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zRAwcBDX65A9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">208,569</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">157,972</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zFenrUvRYWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,979,549</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,093,893</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxExpensesBenefit_iT_pp0p0_mtITEBzXA8_z3mYrNiszNl2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,632,071</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,534,487</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">A
reconciliation of the federal statutory income tax rate to the Company&#8217;s effective tax rate as reported is as follows:&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLo3Ld9h7Id4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B6_zADvGj9GsS8b" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20220701__20230630_zRiACJwupoH7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20210701__20220630_zl40kX3RSMX7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z2XEbsfaH9Rk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zPahfCKGnEXe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.2</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zSXDrFLvbzs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling interest</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zWJ5JEKRwyP3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-indent: 10pt; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.8</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_z1B8EuDhvX1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left">)<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.7</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_401_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zN9Me9o5xBK4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">New
    York state audit settlement</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1348">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zDoc7tdj8dE1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(0.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zLs4Dx3JDR65" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(0.6</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zTQ4MMg0sHC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23.0</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24.3</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of June 30, 2023, the Company has net operating loss (&#8220;NOL&#8221;) carryforwards of approximately $9,110,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_pp0p0_c20230630_zAMoI9jdAnHb">2,981,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company was also under audit with New York State for income tax and was assessed additional taxes of $<span id="xdx_909_ecustom--AdditionalTaxes_pp0p0_c20220701__20230630_znYfcXKfGT3g" title="Additional Taxes">1,014,071
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">plus
interest and penalties. These amounts were paid during fiscal year ending June 30, 2022.&#160;&#160;&#160;</span></p>




















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Significant
components of the Company&#8217;s deferred tax assets and liabilities at June 30, 2023 and 2022 are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zk4dlaBdlo01" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BC_zsDy1qosNeo8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of company&#8217;s deferred tax assets and liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20230630_zNlrWkjeE10l" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20220630_zri6mvKsALf8" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company&#8217;s Deferred Tax Assets and Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zzjHJa2JLYX6" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,360,809</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,239,903</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_z9rn4rbW8iO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">707,400</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">707,400</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zhzhjUe3grx" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,768,844</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,820,010</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zG6dQHgCxejg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,981,214</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,346,509</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z2Qv9VuIR4Pl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">Capitalized research and development</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">369,675</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="padding-left: -10pt; text-indent: 0pt; vertical-align: middle; font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1389">&#8212;</span> </td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zkzC1StgmEzb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0">Right of use assets and lease liabilities</p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">112,938</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1392">&#8212;</span></td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zdeBPhyTmRHe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">105,310</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">98,945</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_z6zPnbSFXrD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1397">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">71,576</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z4QhO76n5m7a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,406,190</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,284,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zpcVtWGmQfx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(364,230</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(441,865</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_zxOQxyhXKJ4l" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,041,960</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,842,478</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z85ERFvIt3qi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt">Property and equipment and depreciation</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">(151,007</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1410">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMjpPTLPLpF8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(243,751</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(215,726</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_z5kmTeiwww35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(394,758</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(215,726</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zVGmIoVll3rf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,647,203</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,626,752</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204528400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zM3qi7ptRmqi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
12 - <span id="xdx_825_zEr90BR8vToi">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
in other current liabilities are the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zkBqSaGxKSv2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_z7Ev5TRSKybd" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of other current liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20230630_zMSbXzPsoTO3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_494_20220630_zaXLycoP2Lzg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,413,044</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,652,173</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">193,041</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">248,702</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48,353</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,207</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,707</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">120,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,971</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">79,167</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,534</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">59,516</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">573,574</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">854,962</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,443,724</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,417,227</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>














<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658211014512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zntCE5L5gqtc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
13 - <span id="xdx_82D_zWXnxBvOICL3">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leases</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Rent
expense for operating leases approximated $<span id="xdx_909_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zLQ2pV2k4kPk" title="Operating Leases, Rent Expense">5,887,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20210701__20220630_zkRKv5AGqn3i" title="Operating Leases, Rent Expense">5,668,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company received approval from the Suffolk County Industrial Development Agency on February 29, 2016 of a <span id="xdx_905_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_zZwwlKxQ7Brd" title="Property Tax Abatement From Suffolk County IDA">50</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
property tax abatement, valued at $<span id="xdx_90B_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zvABCvhoTFLf" title="Property Tax Abatement">440,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
over a 10 year period commencing January 2017.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Employee
Benefit Plans</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company has a non-contributory 401(k) Plan (the &#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $<span id="xdx_907_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zBF3MZhy5To8">36,523
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20210701__20220630_zeUoP5iWtYGj">0
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">employer
contributions to the Plan for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal counsel,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20220701__20230630_zOVsqVuRUbqe" title="Liability for individual claims">110,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2023
and 2022, the Company had approximately $<span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20230630_zZwyV47UBw4f">101,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_908_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20220630_ziUtQve0x3U5">79,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221;
in the consolidated balance sheets.&#160;</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210900816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_801_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGNTfroZi4zl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
14 - <span id="xdx_82E_zHfNFZoQEyB9">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022 the Company paid $<span id="xdx_90B_eus-gaap--InterestPaidNet_pp0p0_c20220701__20230630_zdwzZBvH1Vdj">50,132
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_909_eus-gaap--InterestPaidNet_pp0p0_c20210701__20220630_zqPfaa25zVq7">617,029
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for interest,
respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022 the Company paid $<span id="xdx_905_eus-gaap--IncomeTaxesPaid_pp0p0_c20220701__20230630_zwoBRzrbRP0a">1,439,507
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_906_eus-gaap--IncomeTaxesPaid_pp0p0_c20210701__20220630_zJ0Oyc6iTVF5">2,408,145
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for income
taxes, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
the years ended June 30, 2023 and 2022, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and
penalties in the amount of $<span id="xdx_902_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20220701__20230630_ztv4LP7ipUFh" title="Selling, General and Administrative Expenses">55,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_907_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20210701__20220630_zePjJScfVwX3" title="Selling, General and Administrative Expenses">119,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">,
respectively, which has been recorded under selling, general and administrative expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210968880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z45ey6Nlcw02" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
15 &#8211; <span id="xdx_82C_zZUHxSktMUtg">RELATED PARTY TRANSACTIONS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90B_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--ABillingCompanyMember_zDJXJOPyuz2b" style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was terminated on May 31, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_90D_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zduaEdq4gFV1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>














<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210990160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zanA7qWHO3Tl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
16 - <span id="xdx_821_z4FuE9q21gw8">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company provides segment data in accordance with the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise
and Related Information&#8221;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company&#8217;s reportable segments is shown in the following table:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summarized
Segment Financial Information&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zPXG9kSLthP7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BD_z7C7hc2iLLAb" style="display: none; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summarized segment financial information</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2023:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zpNMwgWqh7Yk" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,260,711</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zHxTupVuDJLj" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90,384,390</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220701__20230630_zAknCGKJZkla" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">98,645,101</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zOsO6rfotIJc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">985,833</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pdp0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zsNxiO6YETy5" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1513">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630_fKg_____zqbSeMrwjba" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">985,833</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zXR0iSaDwHle" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5,875,126</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zzdpLLifZtZ6" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,664,388</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630_zMTWT84bXrD2" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">14,789,262</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zojxEEEyBLJ9" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">263,720</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zuariS2sOssi" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,276,415</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630_zkZ9Uq6ZYsTj" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,540,135</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zfnR5AVfUzx8" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,892,807</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpgqVsDleOJl" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">170,153,612</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsNet_pp0p0_c20230630_zua5IeHhZe0l" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">201,046,419</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zhUVKAqmpuS6" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">119,571</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zlX9m0tmAvI7" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,218,084</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630_zqQ064GXbR3j" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,337,655</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2022:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zKMglThxge42" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,218,804</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrLkiYhx9D06" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,373,341</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20210701__20220630_zff7EAGeLXB8" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">97,592,145</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjMeTghUhDJd" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">965,417</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zGFoe4ufuqcc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1549">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zhfeDEwGjne9" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">965,417</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_znVhOlhMnb52" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4,604,305</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zCPs6OXoGRH" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26,611,487</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630_zEsuSmoDlGRi" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,007,182</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zbnqxGhQCkWe" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">263,559</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zYsxlOYyuZPk" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,271,677</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630_zaiNd5lWe1th" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,535,236</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zkqm6FASk111" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,182,037</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_z5MnKSAJphW5" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">169,159,945</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_iI_pp0p0_c20220630_zrAoywIBuDE1" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199,341,982</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zTFPZgfjNJK5" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">258,271</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyJqfV4JvZX2" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,374,903</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630_zyvDM4bzTfDi" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,633,174</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td id="xdx_F0F_zsV6KE79uDZ3" style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F13_z6TxoJTiISs8" style="width: 97%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation&#160;</span></td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

<p id="xdx_8A5_zsYVRsSlZHW5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Export
Product Sales</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to <span id="xdx_901_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_z0Jfn3udqT0g" title="Export Sales Of Medical Equipment Percentage">14.1</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_905_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_zcecMvPwN9O8" title="Export Sales Of Medical Equipment Percentage">48.9</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of product sales revenues to third parties for the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExportProductSalesTableTextBlock_z6ygtRfCAElb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B8_zs0G1fu2rRTi" style="display: none; font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of export product sales</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_za70KzLBfi0h" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">&#8212;</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zUeCyfTz5bmg" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">12.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zwnWaRixp2og" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">8.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zTHPj4mKQYC" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_z0MpxSKF60P" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">4.9</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zBG1YMht5atc" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1601">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zm8LSOFJqNJh" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">0.7</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--AE_zjMl2sPcl006" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1605">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zwvZKNJcZT64" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1607">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zn1o5GS82Are" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">36.3</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630_zP7xHOq0WGd9" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">14.1</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630_zpmnKRLlyyLi" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">48.9</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

<p id="xdx_8A8_z4r5uN0Ubweg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service and Repair Fees</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to <span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zUfwWckzmopi">6.4</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
and <span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zRkIWqrtPDol">4.4</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of consolidated net service and repair fees for the years ended June 30, 2023 and 2022 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Foreign
Service Repair Fees&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ExportServiceRevenuesTableTextBlock_zNTdDnFBKgw6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BA_zyn3KRxz8kA8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of foreign service and repair fees</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
                                            the Years</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ended
                                            June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zWUC5N2rrnsc" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="width: 12%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zy7sTtLtgDP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_zHUz06fBicM6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z78GlqwOwOw7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zZrDG1mOzLI9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zglZ5NQ90vac" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zlzbL7PYSnO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zqjVBH7xRhAj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zTtkp2daEkCl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zmEraVSvsot2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zxVyjjJPlBU3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zqY4i9Xq6jKk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_zYEf2OBkL3j4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zvIX1pLJR5Y7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.9</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zcznXqKAwZb3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zcKtHCqor8u2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.4</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zghWVedLFHNh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.4</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company does not have any material assets outside of the United States.&#160;&#160;</span></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658211033712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">ALLOWANCE FOR DOUBTFUL ACCOUNTS</a></td>
<td class="text"><p id="xdx_802_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zMEsVSSw2E4i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
17 &#8211; <span id="xdx_829_zOIphTVYkgNa">ALLOWANCE FOR DOUBTFUL ACCOUNTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2023 and 2022 respectively:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Summary
of Allowance For Doubtful Accounts&#160;&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zN2psGB4q6hf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8B1_zPUNyCV9PLBf" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summary of allowance for doubtful accounts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2022</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3c84wGytPAa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">204,597</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zWFykp0lXNj8" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,000</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7BvZoNcapV4" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61,004</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zJTLa3X6CNul" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,593</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zmYFaJiJZALj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,627,917</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zqKUaRQqYYq1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,007,382</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zXNQJ2KuLf5e" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,026,732</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zIRFpZFP48ai" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,608,567</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzh3AqMjv2sk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,686,893</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zPxmExHv0NVk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,451,094</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zJnui7QrFv33" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,148,295</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zO8tH05rN7l1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,989,692</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zeAHTCre7yWa" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zjYx5Y9qzGK9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1662">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zHSiDs9z0Dr4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1663">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEwr4pfZiX6c" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zme0piRnKc98" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,270</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z5gsunDsB1ac" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1666">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zamy9Xu4zwI" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">237,673</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zWt8BHrJqjHa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">204,597</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBq1gGJMhCw3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,786,878</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zMvpsGLiuAE9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">841,039</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zeyGJP1zUmFl" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1671">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNJyZMlxPOVj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,627,917</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zP5xUMx3gkm2" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,184,399</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zolmLfsiOFca" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">502,494</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzSvguOHpRUk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1675">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zqIEfuVrH8Gk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,686,893</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zcVaBiwFQY25" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zc79CWS3III1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1678">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEMrAKCt0vcb" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1679">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zkCgSPaWDJk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td id="xdx_F0B_zvbAfRny9CW4" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td id="xdx_F11_zPa1oeg5ikXa" style="padding-left: 11pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
    in provision for bad debts.</span></td></tr>
  </table>
<p id="xdx_8A6_zjDDdhSgWOpe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210970416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zKjxFtBaELZa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">NOTE
18 &#8211; <span id="xdx_824_zM6hgVunp0P2">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">On
July 31, 2023, <span id="xdx_909_eus-gaap--BroadcastersLicenseAgreementCommitmentsDescription_c20230729__20230731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyvLNlVUCQTc">the
Company entered into a software license agreement for a term of 3 years at a cost of $1,260,000. The effective date of the agreement
is October 1, 2023.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">During
August 2023 the Company amended their revolving credit agreement. The agreement was extended to November 15, 2023.&#160;The interest
rate on borrowings remains at <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230801__20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcY6vAQyqhQ4">8.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
along with certain financial covenants.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
of August 31, 2023, the Company repurchased <span id="xdx_90C_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znypzzQ2uwsg">27,844
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
at a cost of $<span id="xdx_905_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5nnRU49yCw9">469,372
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">which
was authorized under the stock repurchase plan adopted in September 2022.</span></p>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>


    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204282752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zKPD51EyDsj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_z2rB3dOQNvH5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--UseOfEstimates_zYNxcUhninLk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_z91PjCxPXmI5" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Use
of Estimates</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#8217;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessPolicy', window );">Inventories</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--InventoryWorkInProcessPolicy_z0V0V8zLQo7a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_864_zG49sAr63Pv8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgEZUz7RXum6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zTnmhmOHipkj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
and equipment procured in the normal course of business is stated at cost less accumulated depreciation. Property and equipment purchased in
connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is
being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold
improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other
disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the
resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to
operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_903_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20220701__20230630_zeLPNbmPBPS" title="Maintenance and repair expenses">2,801,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
$<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zNT9P9lUPqp6" title="Maintenance and repair expenses">2,783,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">for
the years ended June 30, 2023 and 2022 respectively. The estimated useful lives in years are generally as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; line-height: 115%"><span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated Useful Life in Years for Property and Equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg">13</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4">9</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f">10</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>





















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ztEJLUScpIq2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zdtqua1BNY4f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-Lived
Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwejWLpF1pIi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_863_zuAp1j69iZhd" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
Intangible Assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1)
Patents and Copyrights</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight-line basis over <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zWhzHSiGQFa5" title="Finite-Lived Intangible Asset, Useful Life">15
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2)
Non-Competition Agreements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
non-competition agreements are being amortized on the straight-line basis over the length of the agreement (<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zLXimc2TXHK3" title="Finite-Lived Intangible Asset, Useful Life">7
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3)
Customer Relationships</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization
is calculated on the straight line basis over <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1NqOvO07C2b" title="Finite-Lived Intangible Asset, Useful Life">20
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zbdMXyNzL1v2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86D_zRiwosQZ2OI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Goodwill</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually at the end of
each fiscal year and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting
unit level by comparing the reporting unit&#8217;s carrying amount, including goodwill to the fair value of the reporting unit. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed
to measure the amount of impairment loss, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock', window );">Acquired assets and assumed liabilities</a></td>
<td class="text"><p id="xdx_843_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zZNdzbsu7oca" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_868_zrVI7zAtSWGk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Acquired
assets and assumed liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Pursuant
to ASC No. 805, &#8220;Business Combinations&#8221;, if the initial accounting for a business combination is incomplete by the end
of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the
acquisition date, the Company adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount
recognized for goodwill.&#160;</span></p>




















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjDCKZ9HVr8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_86B_z3irRoxrgEed" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
Recognition</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on sales contracts for scanners, included in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Revenue
from product sales (upgrades and supplies) is recognized upon shipment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span>Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#8220;PCs&#8221;). As of June 30, 2023, the Company has <span id="xdx_90A_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20230630_zu1GMVhlNeAg">22 </span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">management
agreements of which <span id="xdx_903_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20230630_z63iksoJVlj4">3 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">were
with PC&#8217;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned
by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#8220;the Related medical
practices&#8221;) and <span id="xdx_90B_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20230630_zhF4TIENIJE4">19</span></span> <span style="font: normal 11pt Arial, Helvetica, Sans-Serif">are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $<span id="xdx_90B_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zdeKaV5lMUe8">84,000 </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">to
$<span id="xdx_90D_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zZq9uyt4UDWi">447,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad
debts for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of
Operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company currently recognizes revenue in accordance with the recognition accounting standard issued by the Financial Accounting Standards
Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606
outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods
or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures
regarding the Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.&#160;</span></p>



























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2023 and 2022 are summarized in the following table.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue - Net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,124,646</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,248,708</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,063,846</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,060,920</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,670,019</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,907,335</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,935,482</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,365,275</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,793,993</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,582,238</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zvOUXNf3Jow5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ResearchAndDevelopmentExpensePolicy_zCcM57Igdj39" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_866_zwXLEwU83yx2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and Development Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&#160;&#160;</span></p>




















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zcrvaUItXfcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86B_zhkPe3HTjppk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
Costs</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Advertising
costs are expensed as incurred. Advertising expense approximated $<span id="xdx_90E_eus-gaap--AdvertisingExpense_pp0p0_c20220701__20230630_zKZkoEVBqYll">570,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and $<span id="xdx_902_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zs0vwBzoQKZ5">634,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and for
the years ended June 30, 2023 and 2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_z6lN7U5pAQx6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zbMIL87Ze1o6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Income
Taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerAdvancesPolicyTextBlock', window );">Customer Advances</a></td>
<td class="text"><p id="xdx_848_ecustom--CustomerAdvancesPolicyTextBlock_zkYTUOYusfEg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_867_zNOLsjdj5iE" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
Advances</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z9PLWI0HYQEk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_862_zUzptieOT1t1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the
Two-Class Method&#8221;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2023 and 2022, diluted EPS for common shareholders
includes <span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_zmZ5QYUGnotk">127,504
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.&#160;</span></p>


















<p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_zP1e1w62Dcni">Earnings
Per Share (Continued)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,375,776</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,801,974</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,136</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.35</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,666,880</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.32</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,440,906</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,690,796</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">191,038</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.90</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.78</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,681,713</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.75</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>



















<p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i">49,203,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5">250,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and Cash Equivalents</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>



















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-Term Investments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments include certificates of deposit with original maturities of greater than 90 days.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Concentration
of Credit Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $<span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i">49,203,000
</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">in excess
of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5">250,000</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Related
Parties: Net revenues from related parties accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01">12</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6">13</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">See
Note 3 regarding the Company&#8217;s concentrations in the healthcare industry.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fair
Value of Financial Instruments</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#8220;Disclosures
about Fair Value of Financial Instruments&#8221;. Such information, which pertains to the Company&#8217;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">All
of the Company&#8217;s financial instruments are held for purposes other than trading.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Recent
Accounting Standards</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquired Assets and Assumed Liabilities Policy Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer Advances Policy Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208540768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock', window );">Estimated Useful Life in Years for Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.25in; line-height: 115%"><span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Estimated Useful Life in Years for Property and Equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg">13</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">2</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid">7</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">-<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4">9</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8211;<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f">10</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif">28</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Patient Fee Revenue - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patient Fee Revenue - Net</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,124,646</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,248,708</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,063,846</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,060,920</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Workers&#8217;
    Compensation/Personal Injury</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,670,019</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,907,335</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,935,482</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,365,275</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    Patient Fee Revenue</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,793,993</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">29,582,238</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share (Continued)</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_zP1e1w62Dcni">Earnings
Per Share (Continued)</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"></span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,375,776</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,801,974</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">146,136</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.35</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,539,376</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0728">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,666,880</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.32</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.38</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Numerator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    income available to common stockholders</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,440,906</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,690,796</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">191,038</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.90</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.78</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,554,209</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">127,504</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0762">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,681,713</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,513</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.75</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.50</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Usefu lLife In Years For Property And Equipment Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210910320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zYKHQPEvqGjc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
<tr style="vertical-align: bottom">
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt"></p>

 <span>Receivables - Non Current - Net</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 32%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td>
    <td style="width: 2%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 2%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20230630_znrIcImoXpQh" style="width: 24%; font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">620,230</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td>
    <td><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ContractReceivableDueThreeToFourYears_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">140,012</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td>
    <td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; vertical-align: top; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total non current receivables"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">760,242</span></td>
    </tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Total Facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zNZKqR4isGYh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zqVKDBtZsVzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total Facilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_ziCbS5DEjBg7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49C_20210701__20220630_z0H7dxI6RRT6" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at Beginning of Year)</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Facilities
    Added by:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Internal
    development</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0840">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--ManagedFacilitiesClosedDuringYear_zBb50vwk3Bhb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Managed
    Facilities Closed</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0843">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    Facilities Owned or Managed (at End of Year)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">27</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Facilities Owned Or Managed Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210974592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zxmn31fB1U3h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_493_20230630_z5fnXPyLMjW7" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td id="xdx_498_20220630_z4LiPeIovZ21" style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B2_zP8axrk5q5Ji" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzMGG_zx2JvSV1E76b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,346,300</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,125,805</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzMGG_zyWke2UcY5hc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">223,366</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">234,016</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzMGG_zlF8YCMD2fUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,569,666</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,359,821</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210906480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zBjDgbuLNcne" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center; padding-left: 0.25in"><span id="xdx_8BE_zUkEImWg2N5f" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property and Equipment</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Diagnostic
    equipment</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zFE5I5Uydvgb" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">33,144,266</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z1hQgmHUEcle" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">31,304,258</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Research,
    development and demonstration equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkxDNvzBNx93" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,199,941</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zTm3QR28b024" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,199,941</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Machinery
    and equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zmdy1OLEJiDe" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zQX5ia2KuLw8" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,069,055</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Furniture
    and fixtures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0BCuCjUrr1" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,714,499</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsjOd8C50KZg" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,484,525</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Leasehold
    improvements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvj5cLSAgUYk" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,650,041</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwgzcjF852Ia" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">14,087,581</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Building</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zKfnxmFnQee5" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zwHyepL5FNm8" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">939,614</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zbZ8fPWhLZA5" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61,717,416</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630_zXKbrO6DAOLl" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">58,084,974</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated depreciation and amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zk62conpjdag" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">39,571,043</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20220630_z6rlq9wXJsWi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,803,183</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zzlldLmaVQ3i" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,146,373</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220630_zv1Gk9Lf5794" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,281,791</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208584608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">OPERATING &amp; FINANCING LEASES - Lease Payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zH9fVfdjztK" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
                                            of operating and financing lease payments</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;Year
                                            Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    Lease Payments</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 27%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,592,971</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,600,823</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,174,942</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,190,414</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,897</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDMy2mNDurQ4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,600,133</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0928">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,306,056</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0930">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Present
    value discount</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscount_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBQW6Hr7QTbj" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Operating Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(10,454,450</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zbNyy5gYETsk" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Financing Lease"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(57,848</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    lease liability</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">36,010,889</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">838,078</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock', window );">Weighted Average Remaining Lease Term</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zrImfJStlpKj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8B0_zKGhhdGBbs3h" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted Average Remaining Lease Term</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases - years</span></td><td style="width: 10%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zk5uChC6bwS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">10.8</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease - years</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zt5RrgC0pKdf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Weighted
    Average Discount Rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_z5xM5K3cLNnh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
    lease</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90E_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_zC0uyTsGS8w1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">3.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LeaseCostTableTextBlock_zxy39OwJ5OYj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B9_zyygSFR0RPUl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    of Lease Expense</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_491_20220701__20230630_zGmMbeyWhzQ4" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20210701__20220630_zucBadwZwugg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    lease cost</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,887,390</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,668,199</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Finance
                                    lease cost:</span></p></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zaUg4yKy4K5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    of leased equipment</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,881</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Interest
    on lease liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">35,833</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,603</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--FinanceLeaseCost_i01_pp0p0_zT0YjfaMdF4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    finance lease cost</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">234,714</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">240,484</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9zePwdCb3Qh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span id="xdx_8BA_zgxLD6WvH0z4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Supplemental
    cash flow information related to leases </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20220701__20230630_zzzkPQ3GoYz1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_496_20210701__20220630_zm3L7Omts6Ge" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: center">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    Year Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Cash
    paid for amounts included in the measurement of lease liabilities:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_405_ecustom--OperatingCashFlowsFromOperatingLeases_zX6I191tFDq8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    cash flows from operating leases</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,577,578</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,133,369</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zGoPDcDi7xIi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Financing
    cash flows from financing leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,344</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">244,344</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Right-of-use
    and equipment assets obtained in exchange for lease obligations:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zGY8GpFt41ua" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Operating
    leases</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,902,584</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,900,074</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Weighted Average Remaining Lease Term Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supplemental Cash Flow Information Related To Leases Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210954384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other Intangible Assets - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zUIORFkxq0A2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td colspan="9" style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BB_zxXOUGIcS73d" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets - Net</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">As
    of June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,004,847</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,452,345</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,332,774</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-competition
    agreements</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,150,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,900,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,507,192</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,387,621</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,075,327</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,683,736</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjZ0zCHUktAi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><p id="xdx_8BA_z8AOEZvCt3ih" style="margin-top: 0; margin-bottom: 0">Schedule Of Other Intangible Assets</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Years Ending June 30,</span></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Patents
    and Copyrights</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Customer
    Relationships</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; width: 29%; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">376,600</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">176,600</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">371,645</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">171,645</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">369,022</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">169,022</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">366,427</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">166,427</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">362,172</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">162,172</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">200,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,585,999</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">671,832</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">914,167</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
                                            intangible assets - net</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,517,698</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,914,167</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zb0iXarH8vzc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span id="xdx_8B1_zrayfMZnH9zf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other Intangible Assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For the Year Ended</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; Beginning of Year</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zIbCT4YdN9U5" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zYhsOIFManec" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,037,599</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
    capitalized</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zkRceRrU5th7" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">119,571</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">87,882</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Software
    or patents written off</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20220701__20230630_zt3lWWpUAQ02" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1087">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1089">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amortization</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AdjustmentForAmortization_c20220701__20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(391,591</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(421,596</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; End of Year</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zAxEzLTjDDy9" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,431,865</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zM7BcuwscN26" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,703,885</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210974592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Class A and B Members' Equity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zrJSsZorVLE2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span id="xdx_8B2_zRSseaHm1Kld" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class A and B Members' Equity </span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            A Members</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Class
                                            B Member</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Opening
    Members' Equity</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,053,833</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,292,073</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98A_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,048,524</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">41,923,380</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Share
    of Net Income</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,750,740</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">18,513,540</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,793,482</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,228,693</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Buyout
    of noncontrolling interests</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zoqoPWuts0ca" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--BuyoutOfNoncontrollingInterestsValue_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23,441</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Distributions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,776,200</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(14,023,800</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98D_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,822,232</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_98E_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,860,000</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ending
    Members' Equity</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">7,079,293</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">54,781,813</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">($</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,053,833</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,292,073</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210020752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Long-term Debt, Notes Payable and Capital Leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zEgujPxkPXbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span id="xdx_8B7_zYWIKQ4Q2LZf" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Long-term
    Debt, Notes Payable and Capital Leases </span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Note
    payable requiring monthly payments of interest at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRg68h9lrgK3">7</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    until May 2009 followed by <span id="xdx_90B_ecustom--MonthlyPaymentPeriod_dtM_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z6nYhUl9NSwg">240
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">monthly
    payments of $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0">4,472
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">through
    <span id="xdx_904_ecustom--MaturityDate_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member">October 2026</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">.
    The loan is collateralized by a building with a net book value of $<span id="xdx_906_ecustom--BookValueOfBuilding_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zb0M1y52wIMk" title="Book Value Of Building">344,995
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">as
    of June 30, 2023.</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z49euvtnLP25" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zmO4ivBSS6Mh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">195,457</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">The
    revolving credit note was extended to November 15, 2023. The Company can borrow up to $<span id="xdx_90B_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zlyEtRYYdf8b">10,000,000
    </span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zUq2b70gTFZ">8.5</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#8217;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zPxMifvXD5si" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zOFyzWKlQKOi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--LongTermDebtCurrent_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LongTermDebtCurrent_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">195,457</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Less:
    Current portion</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">43,767</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">40,078</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">115,075</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">155,379</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Maturities of Long-term Debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_znlr3sk58ur9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8BF_zCEqiJZQudaj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">Maturities of Long-term Debt</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ending June 30,</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 2%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 9%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_c20230630_pp0p0" style="width: 43%; font-weight: normal; font-style: normal; text-align: right" title="2024"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">43,767</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">47,002</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">50,448</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2027"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">17,625</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: right"></td><td style="padding-bottom: 2.5pt; color: white; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif; color: Black">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230630_zJJN50r1PrW6" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total long term debt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">158,842</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208553072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of the provision for income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6y1hFTCOf9c" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_zysDaFNtEFVl" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of the provision for income taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49F_20220701__20230630_z9bunqIZvHog" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_49D_20210701__20220630_z2zyMGjQf8z1" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zF1yzXEy8uz3" style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Current:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_409_eus-gaap--CurrentFederalTaxExpenseBenefit_zsxb5kuS8NH6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1299">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1300">&#8212;</span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zZKXHI2RZ7f8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">652,522</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,594</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_z8HEcDRpBj1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">652,522</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,440,594</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqTyw3EjR307" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zvNDEJelDZX2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Federal
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,770,980</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,935,921</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zRAwcBDX65A9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    deferred taxes</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">208,569</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">157,972</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zFenrUvRYWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Subtotal</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,979,549</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,093,893</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--IncomeTaxExpensesBenefit_iT_pp0p0_mtITEBzXA8_z3mYrNiszNl2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Provision
    (Benefit) for Income Taxes - Net</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,632,071</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,534,487</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLo3Ld9h7Id4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B6_zADvGj9GsS8b" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_498_20220701__20230630_zRiACJwupoH7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_493_20210701__20220630_zl40kX3RSMX7" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Reconciliation
    Of Federal Statutory Income Tax Rate To Company&#8217;s Effective Tax Rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Years
    Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z2XEbsfaH9Rk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Taxes
    at federal statutory rate</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">21.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zPahfCKGnEXe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    and local income taxes (benefit), net of federal benefit</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5.1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.2</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zSXDrFLvbzs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Noncontrolling interest</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zWJ5JEKRwyP3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Expiration
    of tax credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-indent: 10pt; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.8</span></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_z1B8EuDhvX1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Return
    to provision adjustments</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left">)<span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.7</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_401_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zN9Me9o5xBK4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">New
    York state audit settlement</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1348">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zDoc7tdj8dE1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Change
    in the valuation allowance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(0.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(2.0</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zLs4Dx3JDR65" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(0.6</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)%</span></td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zTQ4MMg0sHC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Effective
    income tax rate</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">23.0</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">24.3</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of components of company&#8217;s deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zk4dlaBdlo01" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BC_zsDy1qosNeo8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of components of company&#8217;s deferred tax assets and liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20230630_zNlrWkjeE10l" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_497_20220630_zri6mvKsALf8" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Components
    Of Company&#8217;s Deferred Tax Assets and Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    tax assets:</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zzjHJa2JLYX6" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,360,809</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,239,903</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_z9rn4rbW8iO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Non-deductible
    accruals</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">707,400</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">707,400</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zhzhjUe3grx" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    operating carryforwards</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,768,844</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,820,010</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zG6dQHgCxejg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Tax
    credits</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,981,214</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,346,509</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z2Qv9VuIR4Pl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify">Capitalized research and development</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">369,675</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="padding-left: -10pt; text-indent: 0pt; vertical-align: middle; font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1389">&#8212;</span> </td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zkzC1StgmEzb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0">Right of use assets and lease liabilities</p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">112,938</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1392">&#8212;</span></td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zdeBPhyTmRHe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">105,310</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">98,945</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_z6zPnbSFXrD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Property
    and equipment and depreciation</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1397">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">71,576</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z4QhO76n5m7a" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deferred
    Tax Assets - gross</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,406,190</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">13,284,343</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zpcVtWGmQfx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Valuation
    allowance</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(364,230</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(441,865</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_zxOQxyhXKJ4l" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">10,041,960</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,842,478</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z85ERFvIt3qi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt">Property and equipment and depreciation</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">(151,007</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1410">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMjpPTLPLpF8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intangibles</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(243,751</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(215,726</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_z5kmTeiwww35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    deferred tax liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(394,758</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(215,726</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zVGmIoVll3rf" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    deferred tax asset</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">9,647,203</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,626,752</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204674288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zkBqSaGxKSv2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BB_z7Ev5TRSKybd" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of other current liabilities</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_499_20230630_zMSbXzPsoTO3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_494_20220630_zaXLycoP2Lzg" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,413,044</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,652,173</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">193,041</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">248,702</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">48,353</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">382,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">11,207</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,707</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">120,000</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">100,971</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">79,167</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,534</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">59,516</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">573,574</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">854,962</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">5,443,724</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">6,417,227</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210791760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zPXG9kSLthP7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BD_z7C7hc2iLLAb" style="display: none; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summarized segment financial information</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Manufacturing
    and Servicing of Medical</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    of Diagnostic Imaging</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2023:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Equipment</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Center</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zpNMwgWqh7Yk" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,260,711</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zHxTupVuDJLj" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">90,384,390</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220701__20230630_zAknCGKJZkla" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">98,645,101</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zOsO6rfotIJc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">985,833</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pdp0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zsNxiO6YETy5" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1513">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630_fKg_____zqbSeMrwjba" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">985,833</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zXR0iSaDwHle" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(5,875,126</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zzdpLLifZtZ6" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">20,664,388</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630_zMTWT84bXrD2" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">14,789,262</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zojxEEEyBLJ9" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">263,720</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zuariS2sOssi" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,276,415</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630_zkZ9Uq6ZYsTj" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,540,135</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zfnR5AVfUzx8" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,892,807</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpgqVsDleOJl" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">170,153,612</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--AssetsNet_pp0p0_c20230630_zua5IeHhZe0l" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">201,046,419</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zhUVKAqmpuS6" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">119,571</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zlX9m0tmAvI7" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,218,084</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630_zqQ064GXbR3j" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,337,655</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Fiscal
    2022:</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zKMglThxge42" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,218,804</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrLkiYhx9D06" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">89,373,341</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--Revenues_pp0p0_c20210701__20220630_zff7EAGeLXB8" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">97,592,145</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Intersegment
    net revenues *</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjMeTghUhDJd" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">965,417</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zGFoe4ufuqcc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1549">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zhfeDEwGjne9" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">965,417</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_znVhOlhMnb52" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(4,604,305</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zCPs6OXoGRH" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">26,611,487</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630_zEsuSmoDlGRi" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">22,007,182</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zbnqxGhQCkWe" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">263,559</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zYsxlOYyuZPk" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,271,677</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630_zaiNd5lWe1th" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,535,236</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Total
    identifiable assets</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zkqm6FASk111" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">30,182,037</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_z5MnKSAJphW5" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">169,159,945</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--AssetsNet_iI_pp0p0_c20220630_zrAoywIBuDE1" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">199,341,982</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zTFPZgfjNJK5" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">258,271</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyJqfV4JvZX2" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,374,903</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630_zyvDM4bzTfDi" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,633,174</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td id="xdx_F0F_zsV6KE79uDZ3" style="width: 3%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">*</span></td>
  <td id="xdx_F13_z6TxoJTiISs8" style="width: 97%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation&#160;</span></td></tr>
</table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportProductSalesTableTextBlock', window );">Schedule of export product sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExportProductSalesTableTextBlock_z6ygtRfCAElb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)">
  <tr style="vertical-align: bottom">
    <td id="xdx_8B8_zs0G1fu2rRTi" style="display: none; font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of export product sales</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
    the Years Ended June 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp0_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_za70KzLBfi0h" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">&#8212;</span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zUeCyfTz5bmg" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">12.0</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zwnWaRixp2og" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">8.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zTHPj4mKQYC" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_z0MpxSKF60P" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">4.9</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_904_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zBG1YMht5atc" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1601">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zm8LSOFJqNJh" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">0.7</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_900_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--AE_zjMl2sPcl006" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1605">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zwvZKNJcZT64" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"><span style="-sec-ix-hidden: xdx2ixbrl1607">&#8212;</span></span><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zn1o5GS82Are" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">36.3</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630_zP7xHOq0WGd9" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">14.1</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630_zpmnKRLlyyLi" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales">48.9</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportServiceRevenuesTableTextBlock', window );">Schedule of foreign service and repair fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ExportServiceRevenuesTableTextBlock_zNTdDnFBKgw6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8BA_zyn3KRxz8kA8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of foreign service and repair fees</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">For
                                            the Years</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Ended
                                            June 30,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2023</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Puerto
    Rico</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zWUC5N2rrnsc" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="width: 12%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zy7sTtLtgDP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.5</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Switzerland</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_zHUz06fBicM6" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z78GlqwOwOw7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Germany</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zZrDG1mOzLI9" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zglZ5NQ90vac" style="font: normal 11pt Arial, Helvetica, Sans-Serif">1.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">England</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zlzbL7PYSnO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zqjVBH7xRhAj" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">United
    Arab Emirates</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zTtkp2daEkCl" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Dominican
    Republic</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zmEraVSvsot2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.5</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Canada</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zxVyjjJPlBU3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.6</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#8212;&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Greece</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zqY4i9Xq6jKk" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_zYEf2OBkL3j4" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Australia</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zvIX1pLJR5Y7" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.9</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zcznXqKAwZb3" style="font: normal 11pt Arial, Helvetica, Sans-Serif">0.1</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zcKtHCqor8u2" style="font: normal 11pt Arial, Helvetica, Sans-Serif">6.4</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td>
    <td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zghWVedLFHNh" style="font: normal 11pt Arial, Helvetica, Sans-Serif">4.4</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">%</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Export Product Sales Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportServiceRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Export Service Revenues Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportServiceRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208591968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of summary of allowance for doubtful accounts</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zN2psGB4q6hf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td id="xdx_8B1_zPUNyCV9PLBf" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Schedule
    of summary of allowance for doubtful accounts</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2022</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions
    (1)</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance
    <br/> June 30, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3c84wGytPAa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Beginning Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">204,597</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zWFykp0lXNj8" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Additions (Included in provision for bad debts)"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">55,000</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7BvZoNcapV4" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Deductions"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">61,004</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zJTLa3X6CNul" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Ending Balance"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">198,593</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zmYFaJiJZALj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,627,917</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zqKUaRQqYYq1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,007,382</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zXNQJ2KuLf5e" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">8,026,732</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zIRFpZFP48ai" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">12,608,567</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzh3AqMjv2sk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,686,893</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zPxmExHv0NVk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">1,451,094</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zJnui7QrFv33" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">2,148,295</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zO8tH05rN7l1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">3,989,692</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zeAHTCre7yWa" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zjYx5Y9qzGK9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1662">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zHSiDs9z0Dr4" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1663">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEwr4pfZiX6c" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Balance</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Description</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2021</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Additions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Deductions</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zme0piRnKc98" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">442,270</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z5gsunDsB1ac" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1666">&#8212;</span>&#160;&#160;</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zamy9Xu4zwI" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">237,673</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 3%; font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zWt8BHrJqjHa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">204,597</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBq1gGJMhCw3" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">15,786,878</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zMvpsGLiuAE9" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">841,039</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zeyGJP1zUmFl" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1671">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNJyZMlxPOVj" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">16,627,917</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable - related medical practices</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zP5xUMx3gkm2" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,184,399</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zolmLfsiOFca" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">502,494</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzSvguOHpRUk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1675">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zqIEfuVrH8Gk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">4,686,893</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zcVaBiwFQY25" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zc79CWS3III1" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1678">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEMrAKCt0vcb" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1679">&#8212;</span>&#160;&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zkCgSPaWDJk" style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">777,354</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td id="xdx_F0B_zvbAfRny9CW4" style="width: 4px; padding-left: 11pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">(1)</span></td>
    <td id="xdx_F11_zPa1oeg5ikXa" style="padding-left: 11pt; text-align: justify"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
    in provision for bad debts.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204113904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm', window );">The ownership interest of the original investors of HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ClassBControllingInterestsMember', window );">Class B Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Purchase of interests from Class A ($)</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of direct purchase of noncontrolling interests during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of hmca ownership size of imperial management services percent during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of investors ownership interest during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of ownership interest of original investors of hdm during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfOriginalInvestorsOfHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ClassBControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ClassBControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198632656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">28 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210068064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 29,793,993<span></span>
</td>
<td class="nump">$ 29,582,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">4,124,646<span></span>
</td>
<td class="nump">4,248,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">1,063,846<span></span>
</td>
<td class="nump">1,060,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">18,670,019<span></span>
</td>
<td class="nump">17,907,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other Revenue Source [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 5,935,482<span></span>
</td>
<td class="nump">$ 6,365,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of net patient fee revenue during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198777376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Continued) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 9,375,776<span></span>
</td>
<td class="nump">$ 12,440,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,539,376<span></span>
</td>
<td class="nump">6,554,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 8,801,974<span></span>
</td>
<td class="nump">$ 11,690,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">6,539,376<span></span>
</td>
<td class="nump">6,554,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 1.35<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">6,539,376<span></span>
</td>
<td class="nump">6,554,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">6,666,880<span></span>
</td>
<td class="nump">6,681,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Basic Numerator: Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 146,136<span></span>
</td>
<td class="nump">$ 191,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Basic Denominator: Weighted Average Shares Outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the shares of incremental common shares attributable to conversion of common stock during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of diluted earnings per share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average shares outstanding basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198727312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfPropertyRepairsAndMaintenance', window );">Maintenance and repair expenses</a></td>
<td class="nump">$ 2,801,000<span></span>
</td>
<td class="nump">$ 2,783,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices', window );">Management Agreements With Company Total Medical Practices</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty', window );">Scanners With Management Agreements With Company Owned By Related Party</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState', window );">Scanners With Management With Company Located In New York State</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">$ 570,000<span></span>
</td>
<td class="nump">$ 634,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders', window );">Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">49,203,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC Insured Amount</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember', window );">Diagnostic Imaging Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMinimum', window );">Contractual Fees For Services Rendered Minimum</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMaximum', window );">Contractual Fees For Services Rendered Maximum</a></td>
<td class="nump">$ 447,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum contractual fees for services rendered to the PC's.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Imaging Centers with management agreements with Company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAgreementsWithCompanyTotalMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by a relarted party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of management agreements with PC's owned by two unrelated radiologists.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfPropertyRepairsAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfPropertyRepairsAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658211052848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2025</a></td>
<td class="nump">$ 620,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2026</a></td>
<td class="nump">140,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total non current receivables</a></td>
<td class="nump">$ 760,242<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208395968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear', window );">Total Facilities Owned or Managed (at Beginning of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedByInternalDevelopment', window );">Internal development</a></td>
<td class="nump">1<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesClosedDuringYear', window );">Managed Facilities Closed</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear', window );">Total Facilities Owned or Managed (at End of Year)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedByInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedByInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesClosedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesClosedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208552944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage Of Pcs Net Revenue Derived From No fault And Personal Injury Protection Claims</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage Of Consolidated Net Revenue From Management Fees</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204532768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,346,300<span></span>
</td>
<td class="nump">$ 2,125,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">223,366<span></span>
</td>
<td class="nump">234,016<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">$ 2,569,666<span></span>
</td>
<td class="nump">$ 2,359,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195006000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 61,717,416<span></span>
</td>
<td class="nump">$ 58,084,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="nump">39,571,043<span></span>
</td>
<td class="nump">35,803,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property plant and equipment, net</a></td>
<td class="nump">22,146,373<span></span>
</td>
<td class="nump">22,281,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">33,144,266<span></span>
</td>
<td class="nump">31,304,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">6,199,941<span></span>
</td>
<td class="nump">6,199,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">2,069,055<span></span>
</td>
<td class="nump">2,069,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">3,714,499<span></span>
</td>
<td class="nump">3,484,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">15,650,041<span></span>
</td>
<td class="nump">14,087,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 939,614<span></span>
</td>
<td class="nump">$ 939,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201461600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciatedAssetsWriteoff', window );">Depreciated assets write-off</a></td>
<td class="nump">$ 1,737,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">$ 4,148,544<span></span>
</td>
<td class="nump">$ 4,113,640<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciatedAssetsWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of depreciated assets write off during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciatedAssetsWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202111536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">$ 5,592,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">5,600,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">5,174,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">4,190,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, Year Five</a></td>
<td class="nump">3,600,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, to be Paid, after Year Five</a></td>
<td class="nump">22,306,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present Value discount, Operating Lease</a></td>
<td class="num">(10,454,450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">36,010,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, to be Paid, Year One</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, to be Paid, Year Two</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, to be Paid, Year Three</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, to be Paid, Year Four</a></td>
<td class="nump">162,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, to be Paid, Year Five</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, to be Paid, after Year Five</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present Value discount, Financing Lease</a></td>
<td class="num">(57,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, to be Paid</a></td>
<td class="nump">$ 838,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of present value discount during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of present value discount financing lease during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204610192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210048320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 5,887,390<span></span>
</td>
<td class="nump">$ 5,668,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">198,881<span></span>
</td>
<td class="nump">198,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">35,833<span></span>
</td>
<td class="nump">41,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 234,714<span></span>
</td>
<td class="nump">$ 240,484<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of depreciation of leased equipment during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of finance lease cost during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Costs Abstract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204393488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Related to leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 5,577,578<span></span>
</td>
<td class="nump">$ 5,133,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from financing leases</a></td>
<td class="nump">244,344<span></span>
</td>
<td class="nump">244,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use and equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases</a></td>
<td class="nump">$ 2,902,584<span></span>
</td>
<td class="nump">$ 7,900,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of financing cash flows from financing leases during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of operating cash flows from operating leases during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of right of use equipment assets obtained in exchange for lease obiligations operating leases during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right of use Equipment Assets Obtained In Exchange For Lease Obligations Abstract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201522496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 20,507,192<span></span>
</td>
<td class="nump">$ 20,387,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">17,075,327<span></span>
</td>
<td class="nump">16,683,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets - net</a></td>
<td class="nump">3,431,865<span></span>
</td>
<td class="nump">3,703,885<span></span>
</td>
<td class="nump">$ 4,037,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">7,004,847<span></span>
</td>
<td class="nump">7,004,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">5,452,345<span></span>
</td>
<td class="nump">5,332,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">4,150,000<span></span>
</td>
<td class="nump">4,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets - gross</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195207664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 376,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">371,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">369,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">366,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">362,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,585,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">3,431,865<span></span>
</td>
<td class="nump">$ 3,703,885<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">176,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">171,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">169,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">166,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">162,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">671,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">1,517,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">914,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">$ 1,914,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201439984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - Beginning of Year</a></td>
<td class="nump">$ 3,703,885<span></span>
</td>
<td class="nump">$ 4,037,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AmountsCapitalized', window );">Amounts capitalized</a></td>
<td class="nump">119,571<span></span>
</td>
<td class="nump">87,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareOrPatentsWrittenOff', window );">Software or patents written off</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="num">(391,591)<span></span>
</td>
<td class="num">(421,596)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 3,431,865<span></span>
</td>
<td class="nump">$ 3,703,885<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AmountsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of amounts capitalized during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AmountsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareOrPatentsWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of software or patents written off during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareOrPatentsWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204097552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 191,591<span></span>
</td>
<td class="nump">$ 184,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">37,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202007264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 10, 2010</div></th>
<th class="th"><div>Apr. 23, 2010</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,759,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryShares', window );">Cancellation of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStock', window );">Cancellation of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,919,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for Repurchase of Equity</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember', window );">N 2010 Stock Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SharesRegistered', window );">Shares registered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class
C common stock is convertible into shares of common stock on a three-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one
vote per share for the common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,450,882<span></span>
</td>
<td class="nump">6,554,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class
B common stock is convertible into shares of common stock on a one-for-one basis.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class
B common stock has 10 votes per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Class C common stock has 25 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends Payable, Nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one
share of Class A non-voting preferred stock for every five shares of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the shares of cancellation of treasury shares during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of cancellation of treasury stock during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesRegistered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the shares of shares registered during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesRegistered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195293040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details) - H D M Equity [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">$ 4,053,833<span></span>
</td>
<td class="nump">$ 3,048,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">2,750,740<span></span>
</td>
<td class="nump">4,793,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="nump">5,776,200<span></span>
</td>
<td class="nump">5,822,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">7,079,293<span></span>
</td>
<td class="nump">4,053,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">50,292,073<span></span>
</td>
<td class="nump">41,923,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">18,513,540<span></span>
</td>
<td class="nump">22,228,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(14,023,800)<span></span>
</td>
<td class="nump">13,860,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">$ 54,781,813<span></span>
</td>
<td class="nump">$ 50,292,073<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterestsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of buy out of noncontrolling interests value during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterestsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Distributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distributions to each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Distributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EndingMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ending Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EndingMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OpeningMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Opening Members Equity for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OpeningMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShareOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Of Net Income for each class of members equity as of June 30.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShareOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201522032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative) - Health Diagnostics Management, LLC (HDM) [Member]<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 13, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfStandupMriCenters', window );">Purchase Of Stand up Mr iCenters | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfOtherMriCenters', window );">Purchase Of Other Mri Centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationToOutsideInvestors', window );">HDM purchase price includes consideration to outside investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalPurchasePrice', window );">HDM purchase from Health Diagnostics (HD) ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements', window );">HDM entered agreement for consulting and non-competition agreement ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class B Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentOwnershipPercentages', window );">Ownership interest of HDM after transaction (%)</a></td>
<td class="nump">60.40%<span></span>
</td>
<td class="nump">50.50%<span></span>
</td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProceedsFromContributionsFromCompany', window );">Contribution to HDM ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentsOwnershipPercentage', window );">Purchase of interests from Class A (%)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Purchase of interests from Class A ($)</a></td>
<td class="nump">$ 4,971,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class A Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.50%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Proceeds from Contributions from Affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of consideration for non competition and consulting agreements during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationForNoncompetitionAndConsultingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationToOutsideInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of consideration to outside investors during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationToOutsideInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of direct purchase of noncontrolling interests during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentOwnershipPercentages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentOwnershipPercentages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentsOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentsOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProceedsFromContributionsFromCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProceedsFromContributionsFromCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfOtherMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Of Other Mri Centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfOtherMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfStandupMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of stand up mr icenters</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfStandupMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of total purchase price during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_ClassAControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_ClassAControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658204360880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 158,842<span></span>
</td>
<td class="nump">$ 195,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">43,767<span></span>
</td>
<td class="nump">40,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long Term Debt, Notes Payable and Capital Leases less Current Portion</a></td>
<td class="nump">$ 115,075<span></span>
</td>
<td class="nump">155,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member', window );">Note Payable 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MonthlyPaymentPeriod', window );">Monthly Payment Period</a></td>
<td class="text">240 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt Instrument, Periodic Payment</a></td>
<td class="nump">$ 4,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MaturityDate', window );">Maturity Date</a></td>
<td class="text">October 2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BookValueOfBuilding', window );">Book Value Of Building</a></td>
<td class="nump">$ 344,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="nump">$ 158,842<span></span>
</td>
<td class="nump">195,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member', window );">Note Payable 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long Term Debt, Notes Payable and Capital Leases</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from Lines of Credit</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BookValueOfBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of book value of building during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BookValueOfBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity Date description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MonthlyPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly Payment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MonthlyPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=FONR_NotePayable2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201568848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract', window );"><strong>Long-term Debt Notes Payable And Capital Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 43,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">47,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">50,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">17,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long term debt</a></td>
<td class="nump">$ 158,842<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195193104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Components Of Provision For Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">652,522<span></span>
</td>
<td class="nump">2,440,594<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">652,522<span></span>
</td>
<td class="nump">2,440,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred taxes</a></td>
<td class="nump">2,770,980<span></span>
</td>
<td class="nump">2,935,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred taxes</a></td>
<td class="nump">208,569<span></span>
</td>
<td class="nump">157,972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredIncomeTaxExpensesBenefit', window );">Subtotal</a></td>
<td class="nump">2,979,549<span></span>
</td>
<td class="nump">3,093,893<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncomeTaxExpensesBenefit', window );">Provision (Benefit) for Income Taxes - Net</a></td>
<td class="nump">$ 3,632,071<span></span>
</td>
<td class="nump">$ 5,534,487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredIncomeTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of deferred income tax expenses benefit during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredIncomeTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncomeTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of income tax expenses benefit during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncomeTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195192240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Taxes at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (benefit), net of federal benefit</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interest</a></td>
<td class="num">(4.60%)<span></span>
</td>
<td class="num">(5.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Expiration of tax credits</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Return to provision adjustments</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement', window );">New York state audit settlement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in the valuation allowance</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">24.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of effective income tax rate reconciliation nys audit settlement during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202200832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 3,360,809<span></span>
</td>
<td class="nump">$ 4,239,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Non-deductible accruals</a></td>
<td class="nump">707,400<span></span>
</td>
<td class="nump">707,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating carryforwards</a></td>
<td class="nump">2,768,844<span></span>
</td>
<td class="nump">4,820,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">2,981,214<span></span>
</td>
<td class="nump">3,346,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">369,675<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities', window );">Right of use assets and lease liabilities</a></td>
<td class="nump">112,938<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">105,310<span></span>
</td>
<td class="nump">98,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment and depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">71,576<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets - gross</a></td>
<td class="nump">10,406,190<span></span>
</td>
<td class="nump">13,284,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(364,230)<span></span>
</td>
<td class="num">(441,865)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">10,041,960<span></span>
</td>
<td class="nump">12,842,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment and depreciation</a></td>
<td class="num">(151,007)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(243,751)<span></span>
</td>
<td class="num">(215,726)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(394,758)<span></span>
</td>
<td class="num">(215,726)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 9,647,203<span></span>
</td>
<td class="nump">$ 12,626,752<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202833728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred Tax Assets, Net of Valuation Allowance</a></td>
<td class="nump">$ 10,041,960<span></span>
</td>
<td class="nump">$ 12,842,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus</a></td>
<td class="nump">394,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">9,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">11,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other Operating Income</a></td>
<td class="nump">1,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital', window );">Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="nump">$ 448,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred Tax Assets, Tax Credit Carryforwards, Research</a></td>
<td class="nump">2,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AdditionalTaxes', window );">Additional Taxes</a></td>
<td class="nump">$ 1,014,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AdditionalTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of additional taxes during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AdditionalTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480135/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202076784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 4,413,044<span></span>
</td>
<td class="nump">$ 4,652,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">193,041<span></span>
</td>
<td class="nump">248,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">State income taxes payable</a></td>
<td class="nump">48,353<span></span>
</td>
<td class="nump">382,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">11,207<span></span>
</td>
<td class="nump">20,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">100,971<span></span>
</td>
<td class="nump">79,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">3,534<span></span>
</td>
<td class="nump">59,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">573,574<span></span>
</td>
<td class="nump">854,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 5,443,724<span></span>
</td>
<td class="nump">$ 6,417,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195148256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2016</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LeaseAndRentalExpenses', window );">Operating Leases, Rent Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,887,000<span></span>
</td>
<td class="nump">$ 5,668,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda', window );">Property Tax Abatement From Suffolk County IDA</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyTaxAbatement', window );">Property Tax Abatement</a></td>
<td class="nump">$ 440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,523<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims', window );">Liability for individual claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth', window );">Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000<span></span>
</td>
<td class="nump">$ 79,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LeaseAndRentalExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of lease and rental expenses during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LeaseAndRentalExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of property tax abatement during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyTaxAbatementFromSuffolkCountyIda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of property tax abatement from Suffolk county ida during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyTaxAbatementFromSuffolkCountyIda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658202880944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest Paid, Excluding Capitalized Interest, Operating Activities</a></td>
<td class="nump">$ 50,132<span></span>
</td>
<td class="nump">$ 617,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">1,439,507<span></span>
</td>
<td class="nump">2,408,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SellingGeneralAndAdministrativeExpenses', window );">Selling, General and Administrative Expenses</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 119,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of selling general and administrative expenses during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658208546768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember', window );">A Billing Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#8217; Compensation claims of the Company&#8217;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was terminated on May 31, 2023.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember', window );">Bensonhurst M R I Limited Partnership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related Party Transaction, Description of Transaction</a></td>
<td class="text">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481440/840-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479741/842-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_ABillingCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_ABillingCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198962432">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 98,645,101<span></span>
</td>
<td class="nump">$ 97,592,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">985,833<span></span>
</td>
<td class="nump">965,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,789,262<span></span>
</td>
<td class="nump">22,007,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,540,135<span></span>
</td>
<td class="nump">4,535,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">201,046,419<span></span>
</td>
<td class="nump">199,341,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,337,655<span></span>
</td>
<td class="nump">4,633,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember', window );">Manufacturing And Servicing Of Medical Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,260,711<span></span>
</td>
<td class="nump">8,218,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">985,833<span></span>
</td>
<td class="nump">965,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,875,126)<span></span>
</td>
<td class="num">(4,604,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">263,720<span></span>
</td>
<td class="nump">263,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,892,807<span></span>
</td>
<td class="nump">30,182,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">119,571<span></span>
</td>
<td class="nump">258,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues - Net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">90,384,390<span></span>
</td>
<td class="nump">89,373,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,664,388<span></span>
</td>
<td class="nump">26,611,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,276,415<span></span>
</td>
<td class="nump">4,271,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total identifiable assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">170,153,612<span></span>
</td>
<td class="nump">169,159,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,218,084<span></span>
</td>
<td class="nump">$ 4,374,903<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation&#160;</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of intersegment net revenues during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManufacturingAndServicingOfMedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658195182880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">14.10%<span></span>
</td>
<td class="nump">48.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AE', window );">UNITED ARAB EMIRATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign Product Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of foreign product sales during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198748224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AE', window );">UNITED ARAB EMIRATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GR', window );">GREECE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign Service And Repair Fees</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the rate of Foreign Service And Repair Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658210954512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportSalesOfMedicalEquipmentPercentage', window );">Export Sales Of Medical Equipment Percentage</a></td>
<td class="nump">14.10%<span></span>
</td>
<td class="nump">48.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage', window );">Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportSalesOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the rate of export sales of medical equipment percentage during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportSalesOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents the rate of Foreign Revenues Of Service And Repair Of Medical Equipment Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658201960864">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 204,597<span></span>
</td>
<td class="nump">$ 442,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">55,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61,004<span></span>
</td>
<td class="nump">237,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">198,593<span></span>
</td>
<td class="nump">204,597<span></span>
</td>
<td class="nump">$ 204,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember', window );">Management And Other Fees Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,627,917<span></span>
</td>
<td class="nump">15,786,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,007,382<span></span>
</td>
<td class="nump">841,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,026,732<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,608,567<span></span>
</td>
<td class="nump">16,627,917<span></span>
</td>
<td class="nump">16,627,917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember', window );">Management And Other Fees Receivable Related Medical Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,686,893<span></span>
</td>
<td class="nump">4,184,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,451,094<span></span>
</td>
<td class="nump">502,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,148,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,989,692<span></span>
</td>
<td class="nump">4,686,893<span></span>
</td>
<td class="nump">4,686,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">777,354<span></span>
</td>
<td class="nump">777,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 777,354<span></span>
</td>
<td class="nump">$ 777,354<span></span>
</td>
<td class="nump">$ 777,354<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
    in provision for bad debts.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of allowance for doubtful accounts additions during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of allowance for doubtful accounts deductions during year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139658198735024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BroadcastersLicenseAgreementCommitmentsDescription', window );">Broadcasters License Agreement Commitments, Description</a></td>
<td class="text">the
Company entered into a software license agreement for a term of 3 years at a cost of $1,260,000. The effective date of the agreement
is October 1, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 469,372<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BroadcastersLicenseAgreementCommitmentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the commitments for license agreements that have been executed but were not reported because they do not meet the conditions for recording a liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483279/920-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BroadcastersLicenseAgreementCommitmentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>fonar_10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20230630"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20230630.xsd" xlink:type="simple"/>
    <context id="From2022-07-01to2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-08_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-08</instant>
        </period>
    </context>
    <context id="AsOf2023-09-08_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-08</instant>
        </period>
    </context>
    <context id="AsOf2023-09-08_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-08</instant>
        </period>
    </context>
    <context id="AsOf2023-09-08_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-08</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember1131540968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassANonVotingPreferredMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassANonVotingPreferredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember1131541015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-04-23</instant>
        </period>
    </context>
    <context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-08-10</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-09-26</endDate>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2013-03-05_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-05</instant>
        </period>
    </context>
    <context id="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-08</instant>
        </period>
    </context>
    <context id="From2015-01-072015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-07</startDate>
            <endDate>2015-01-08</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NotePayable1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_NotePayable2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">FONR:NotePayable2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2016-02-282016-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2016-02-28</startDate>
            <endDate>2016-02-29</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ABillingCompanyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:ABillingCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_BensonhurstMRILimitedPartnershipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManufacturingAndServicingOfMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-292023-07-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-29</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="From2023-08-012023-08-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>FONR:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-01to2023-06-30">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-01to2023-06-30">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2022-07-01to2023-06-30">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-07-01to2023-06-30">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0330"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0332"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:StockIssuedToEmployeesUnderStockBonusPlansValue
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0338"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_custom_ClassANonVotingPreferredMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:LossOnDispositionOfFixedAssets
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0728"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0762"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0840"
      unitRef="Integer"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl0843"
      unitRef="Integer"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl0928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl0930"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl1087"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1089"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      id="xdx2ixbrl1199"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      id="xdx2ixbrl1205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2023-06-30_custom_NotePayable2Member"
      id="xdx2ixbrl1245"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_custom_NotePayable2Member"
      id="xdx2ixbrl1247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl1299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      id="xdx2ixbrl1300"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement
      contextRef="From2022-07-01to2023-06-30"
      id="xdx2ixbrl1348"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1389"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="AsOf2023-06-30"
      id="xdx2ixbrl1397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl1410"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1513"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1549"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_DE"
      id="xdx2ixbrl1601"
      unitRef="Pure"
      xsi:nil="true"/>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_AE"
      id="xdx2ixbrl1605"
      unitRef="Pure"
      xsi:nil="true"/>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_PR"
      id="xdx2ixbrl1607"
      unitRef="Pure"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1662"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1663"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember"
      id="xdx2ixbrl1666"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      id="xdx2ixbrl1671"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2020-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1675"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1678"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1679"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-07-01to2023-06-30">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2022-07-01to2023-06-30">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2023-06-30">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-07-01to2023-06-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2022-07-01to2023-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-07-01to2023-06-30">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-07-01to2023-06-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-01to2023-06-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-01to2023-06-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-01to2023-06-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-01to2023-06-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-01to2023-06-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-01to2023-06-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-01to2023-06-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-01to2023-06-30">694-2929</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-07-01to2023-06-30">Common     Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-01to2023-06-30">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-01to2023-06-30">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2022-07-01to2023-06-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2022-07-01to2023-06-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2022-07-01to2023-06-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-07-01to2023-06-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-07-01to2023-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-07-01to2023-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-01to2023-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-07-01to2023-06-30">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2022-12-31" decimals="-5" unitRef="USD">106200000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-09-08_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">6450882</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-09-08_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-09-08_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-09-08_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2022-07-01to2023-06-30">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:AuditorName contextRef="From2022-07-01to2023-06-30">Marcum llp</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2022-07-01to2023-06-30">688</dei:AuditorFirmId>
    <dei:AuditorLocation contextRef="From2022-07-01to2023-06-30">New York, New York</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">51279707</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">48722977</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">32799</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">32326</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3861512</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4335956</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:MedicalReceivable contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">21259262</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20108989</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">12608567</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16627917</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherFees contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">35888253</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33419219</FONR:ManagementAndOtherFees>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3989692</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4686893</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">9161870</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8602561</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2569666</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2359821</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">1607768</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1104325</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">125660837</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">118686174</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">710085</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1871890</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">10041960</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12842478</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">22146373</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">22281791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">33068755</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">34232109</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">729229</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">928109</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3431865</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">523506</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">526269</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">200581887</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:Assets>
    <FONR:LongTermDebtAndCapitalLeaseObligationCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">43767</FONR:LongTermDebtAndCapitalLeaseObligationCurrent>
    <FONR:LongTermDebtAndCapitalLeaseObligationCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">40078</FONR:LongTermDebtAndCapitalLeaseObligationCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">1579240</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1551269</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">5443724</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6417227</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3905484</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3880129</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">217597</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">210140</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3832184</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4288766</us-gaap:DeferredRevenueCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">602377</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">361245</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">15624373</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16748854</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">760242</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1857257</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">394758</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:DueToRelatedPartyMedicalPractices contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">92663</FONR:DueToRelatedPartyMedicalPractices>
    <FONR:DueToRelatedPartyMedicalPractices contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">92663</FONR:DueToRelatedPartyMedicalPractices>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">32105405</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">33090990</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">620481</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">838291</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <FONR:LongTermDebtAndCapitalLeaseObligation contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">115075</FONR:LongTermDebtAndCapitalLeaseObligation>
    <FONR:LongTermDebtAndCapitalLeaseObligation contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">155379</FONR:LongTermDebtAndCapitalLeaseObligation>
    <us-gaap:OtherLiabilities contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">41750</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">106541</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">34130374</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">36356847</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">49754747</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">53105701</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6462524</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6565853</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6450882</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">647</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">657</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">182612518</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">184531535</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">-24190981</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-33566757</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2023-06-30" decimals="INF" unitRef="Shares">11463</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">11643</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">515820</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">675390</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">157906433</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">150290114</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">-7079293</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-4053833</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">150827140</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">146236281</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">200581887</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">29793993</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">29582238</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">731607</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">517939</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">7419104</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">7590865</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">48640497</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">48226787</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">11949900</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">11564316</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">98645101</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">97592145</us-gaap:Revenues>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">852025</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">416814</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">3033967</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2991069</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">44983</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">43344</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">16183166</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">13307819</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">26975563</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">27251268</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5807454</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">6567887</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1567749</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">1494181</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">29390932</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">23512581</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">83855839</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">75584963</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">14789262</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">22007182</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">50131</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">346552</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1222176</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">247158</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-202720</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">861087</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">15758587</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">22768875</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">3632071</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5534487</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2750740</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4793482</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">9375776</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">12440906</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember1131540968"
      decimals="INF"
      unitRef="Shares">6554210</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember1131540968"
      decimals="0"
      unitRef="USD">657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <FONR:CancellationOfSharesShares
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-103328</FONR:CancellationOfSharesShares>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-10</FONR:CancellationOfShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassANonVotingPreferredMember"
      decimals="0"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1131541015"
      decimals="INF"
      unitRef="Shares">6450882</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember1131541015"
      decimals="0"
      unitRef="USD">647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">185100976</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-46007663</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">12440906</us-gaap:ProfitLoss>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-569441</FONR:BuyoutOfNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">184531535</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-33566757</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9375776</us-gaap:ProfitLoss>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-1919017</FONR:CancellationOfShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">182612518</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-24190981</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-3048524</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">135370125</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">4793482</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">23441</FONR:BuyoutOfNoncontrollingInterests>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-546000</FONR:BuyoutOfNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">5822232</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5822232</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      unitRef="USD">-675390</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-4053833</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">146236281</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">2750740</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      unitRef="USD">1919027</FONR:CancellationOfShares>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">5776200</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5776200</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      unitRef="USD">-515820</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      unitRef="USD">-7079293</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">150827140</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">12126516</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">17234388</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">4540135</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4535236</us-gaap:OtherDepreciationAndAmortization>
    <FONR:ProvisionForBadDebts
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5513476</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">1343533</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2979550</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">3093893</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">4264818</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4000131</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:LossOnDispositionOfFixedAssets
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">213244</FONR:LossOnDispositionOfFixedAssets>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">700764</FONR:GainOnForgivenessOfPppLoan>
    <FONR:IncreaseDecreaseInAccountReceivable
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">8055843</FONR:IncreaseDecreaseInAccountReceivable>
    <FONR:IncreaseDecreaseInAccountReceivable
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5602188</FONR:IncreaseDecreaseInAccountReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">64532</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-43334</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">209845</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">696402</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">438911</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-90638</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-2763</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-129411</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <FONR:IncreaseDecreaseInAccountPayable
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">19685</FONR:IncreaseDecreaseInAccountPayable>
    <FONR:IncreaseDecreaseInAccountPayable
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-314766</FONR:IncreaseDecreaseInAccountPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-2527100</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-3765215</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">241132</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-369856</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInOperatingLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-3862814</FONR:IncreaseDecreaseInOperatingLiability>
    <FONR:IncreaseDecreaseInOperatingLiability
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-3437743</FONR:IncreaseDecreaseInOperatingLiability>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">210353</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">202741</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-14739</FONR:IncreaseDecreaseInContractLiabilities>
    <FONR:IncreaseDecreaseInAccruedLiability
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-64791</FONR:IncreaseDecreaseInAccruedLiability>
    <FONR:IncreaseDecreaseInAccruedLiability
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-64790</FONR:IncreaseDecreaseInAccruedLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">14467130</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">15301360</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">4218084</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4545292</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">473</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">149</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">546000</FONR:PurchaseOfNoncontrollingInterests>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">119571</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">87882</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-4338128</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-5179323</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">36615</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">37239</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1759457</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5776200</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5822232</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-7572272</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-5859471</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2556730</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4262566</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">48722977</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">44460411</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">51279707</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">48722977</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80D_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zb24H4oNzOPg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
1 - &lt;span id="xdx_829_zVI3HShgHmqg"&gt;DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FONAR
Corporation (the &#x201c;Company&#x201d; or &#x201c;FONAR&#x201d;) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR
is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance
Imaging (&#x201c;MRI&#x201d;) for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale
of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FONAR,
through its wholly-owned subsidiary Health Management Corporation of America (&#x201c;HMCA&#x201d;) provides comprehensive management services
to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space,
facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting,
billing and collection and the development and implementation of practice growth and marketing strategies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zyRfdB1dpfaj" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"&gt;24.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_90E_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zIF9tsz0Z6Ta" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"&gt;45.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
in HDM, and the original investors in HDM retained a &lt;span id="xdx_90D_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_ze5MYLfKl9yh" title="The ownership interest of the original investors of HDM"&gt;30.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest in the newly expanded HDM. During the year ended June 30, 2022, the Company purchased noncontrolling interests for
$&lt;span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ClassBControllingInterestsMember_zxfXvVcP7nT" title="Purchase of interests from Class A ($)"&gt;546,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;giving
the Company a direct ownership interest of &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--ControllingInterestMember_zCF8eX6iEAVd" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and the investors&#x2019; a &lt;span id="xdx_90D_ecustom--InvestorsOwnershipInterest_iI_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zXyzXHfsd8lk" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely effected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company was
able to enact certain decisions to allow the Company to navigate the global pandemic and from further losses, additional decreases in
scan volume and avoid any significant disruption of the business. The Company must now take into account the severity, duration and
recurrence of new strains of the COVID-19 virus which adds a new dimension to the challenges and uncertainty facing our business and
the world economy in general. Although we are unable to predict if there will be additional consequences on our operations from the continuing
global pandemic of COVID-19, the Company believes with the positive cash flows, low debt and cash on hand, it will be able to continue
operations going forward.&#160;&lt;/span&gt;&lt;/p&gt;

















</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestOfOriginalInvestorsOfHdm
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestOfOriginalInvestorsOfHdm>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember"
      decimals="0"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zkdxy9Houod2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
2 - &lt;span id="xdx_823_zghDXeiHcE16"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zKPD51EyDsj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86D_z2rB3dOQNvH5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zYNxcUhninLk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_862_z91PjCxPXmI5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Use
of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--InventoryWorkInProcessPolicy_z0V0V8zLQo7a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_864_zG49sAr63Pv8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgEZUz7RXum6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zTnmhmOHipkj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment procured in the normal course of business is stated at cost less accumulated depreciation. Property and equipment purchased in
connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is
being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold
improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other
disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the
resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to
operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $&lt;span id="xdx_903_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20220701__20230630_zeLPNbmPBPS" title="Maintenance and repair expenses"&gt;2,801,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
$&lt;span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zNT9P9lUPqp6" title="Maintenance and repair expenses"&gt;2,783,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for
the years ended June 30, 2023 and 2022 respectively. The estimated useful lives in years are generally as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.25in; line-height: 115%"&gt;&lt;span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ztEJLUScpIq2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_868_zdtqua1BNY4f" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwejWLpF1pIi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_863_zuAp1j69iZhd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1)
Patents and Copyrights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight-line basis over &lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zWhzHSiGQFa5" title="Finite-Lived Intangible Asset, Useful Life"&gt;15
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2)
Non-Competition Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
non-competition agreements are being amortized on the straight-line basis over the length of the agreement (&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zLXimc2TXHK3" title="Finite-Lived Intangible Asset, Useful Life"&gt;7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3)
Customer Relationships&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight line basis over &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1NqOvO07C2b" title="Finite-Lived Intangible Asset, Useful Life"&gt;20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zbdMXyNzL1v2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86D_zRiwosQZ2OI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually at the end of
each fiscal year and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting
unit level by comparing the reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed
to measure the amount of impairment loss, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zZNdzbsu7oca" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_868_zrVI7zAtSWGk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquired
assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Pursuant
to ASC No. 805, &#x201c;Business Combinations&#x201d;, if the initial accounting for a business combination is incomplete by the end
of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the
acquisition date, the Company adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount
recognized for goodwill.&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjDCKZ9HVr8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span id="xdx_86B_z3irRoxrgEed" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on sales contracts for scanners, included in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
from product sales (upgrades and supplies) is recognized upon shipment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2023, the Company has &lt;span id="xdx_90A_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20230630_zu1GMVhlNeAg"&gt;22 &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;management
agreements of which &lt;span id="xdx_903_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20230630_z63iksoJVlj4"&gt;3 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;were
with PC&#x2019;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned
by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#x201c;the Related medical
practices&#x201d;) and &lt;span id="xdx_90B_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20230630_zhF4TIENIJE4"&gt;19&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $&lt;span id="xdx_90B_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zdeKaV5lMUe8"&gt;84,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to
$&lt;span id="xdx_90D_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zZq9uyt4UDWi"&gt;447,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad
debts for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of
Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company currently recognizes revenue in accordance with the recognition accounting standard issued by the Financial Accounting Standards
Board (&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606
outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods
or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures
regarding the Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2023 and 2022 are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,124,646&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,248,708&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,063,846&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,060,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,670,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,907,335&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,935,482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,365,275&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,793,993&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,582,238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zvOUXNf3Jow5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ResearchAndDevelopmentExpensePolicy_zCcM57Igdj39" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_866_zwXLEwU83yx2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&#160;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zcrvaUItXfcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86B_zhkPe3HTjppk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
costs are expensed as incurred. Advertising expense approximated $&lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_pp0p0_c20220701__20230630_zKZkoEVBqYll"&gt;570,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zs0vwBzoQKZ5"&gt;634,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and for
the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_z6lN7U5pAQx6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zbMIL87Ze1o6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Income
Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--CustomerAdvancesPolicyTextBlock_zkYTUOYusfEg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_867_zNOLsjdj5iE" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z9PLWI0HYQEk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_862_zUzptieOT1t1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the
Two-Class Method&#x201d;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2023 and 2022, diluted EPS for common shareholders
includes &lt;span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_zmZ5QYUGnotk"&gt;127,504
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B1_zP1e1w62Dcni"&gt;Earnings
Per Share (Continued)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,375,776&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,801,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;146,136&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,666,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,440,906&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,690,796&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;191,038&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,681,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments include certificates of deposit with original maturities of greater than 90 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $&lt;span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i"&gt;49,203,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;in excess
of federally insured limits of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Related
Parties: Net revenues from related parties accounted for approximately &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;See
Note 3 regarding the Company&#x2019;s concentrations in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#x201c;Disclosures
about Fair Value of Financial Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;All
of the Company&#x2019;s financial instruments are held for purposes other than trading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zKPD51EyDsj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86D_z2rB3dOQNvH5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships.
The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant
intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84E_eus-gaap--UseOfEstimates_zYNxcUhninLk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_862_z91PjCxPXmI5" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Use
of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable
allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies,
revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue
to impact the Company&#x2019;s operations and the determination of contractual and other allowance estimates. Actual results could differ
from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:InventoryWorkInProcessPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84D_eus-gaap--InventoryWorkInProcessPolicy_z0V0V8zLQo7a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_864_zG49sAr63Pv8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the
first-in, first-out method, or market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryWorkInProcessPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zgEZUz7RXum6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zTnmhmOHipkj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment procured in the normal course of business is stated at cost less accumulated depreciation. Property and equipment purchased in
connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is
being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold
improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other
disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the
resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to
operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $&lt;span id="xdx_903_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20220701__20230630_zeLPNbmPBPS" title="Maintenance and repair expenses"&gt;2,801,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
$&lt;span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_pp0p0_c20210701__20220630_zNT9P9lUPqp6" title="Maintenance and repair expenses"&gt;2,783,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for
the years ended June 30, 2023 and 2022 respectively. The estimated useful lives in years are generally as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.25in; line-height: 115%"&gt;&lt;span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2801000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2783000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zKufoyPKYtok" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.25in; line-height: 115%"&gt;&lt;span id="xdx_8B1_zqpux3lqNz31" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zyDCLPOW6ezk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zAqCbTcQBQrg"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zGJCUX28tzj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zz1OS37tQuLc"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z11cr4LomaDg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z40cWSvwrcid"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zkjqdaM6rZlg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;-&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzdnZFyEQgW4"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zJzfhjJ7WNR8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2013;&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z5cb90EvYy1f"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 78%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -10pt; padding-left: 10pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 20%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20230630__srt--RangeAxis__srt--WeightedAverageMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zhDJ67Nmo4D" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="AsOf2023-06-30_srt_WeightedAverageMember_us-gaap_BuildingMember">P28Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84A_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ztEJLUScpIq2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_868_zdtqua1BNY4f" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-Lived
Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill,
when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is
calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis,
management considers such factors as current results, trends, and future prospects, in addition to other economic factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zwejWLpF1pIi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_863_zuAp1j69iZhd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1)
Patents and Copyrights&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight-line basis over &lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zWhzHSiGQFa5" title="Finite-Lived Intangible Asset, Useful Life"&gt;15
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2)
Non-Competition Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
non-competition agreements are being amortized on the straight-line basis over the length of the agreement (&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zLXimc2TXHK3" title="Finite-Lived Intangible Asset, Useful Life"&gt;7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3)
Customer Relationships&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
is calculated on the straight line basis over &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1NqOvO07C2b" title="Finite-Lived Intangible Asset, Useful Life"&gt;20
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2023-06-30_us-gaap_IntellectualPropertyMember">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zbdMXyNzL1v2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86D_zRiwosQZ2OI8" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Generally
accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually at the end of
each fiscal year and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting
unit level by comparing the reporting unit&#x2019;s carrying amount, including goodwill to the fair value of the reporting unit. If the
carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed
to measure the amount of impairment loss, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_843_ecustom--AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock_zZNdzbsu7oca" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_868_zrVI7zAtSWGk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Acquired
assets and assumed liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Pursuant
to ASC No. 805, &#x201c;Business Combinations&#x201d;, if the initial accounting for a business combination is incomplete by the end
of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the
acquisition date, the Company adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount
recognized for goodwill.&#160;&lt;/span&gt;&lt;/p&gt;




















</FONR:AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zjDCKZ9HVr8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span id="xdx_86B_z3irRoxrgEed" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on sales contracts for scanners, included in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is
recognized under the percentage-of-completion method in accordance with FASB ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Revenue
from product sales (upgrades and supplies) is recognized upon shipment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;Revenue
under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily
under various long-term agreements with various medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2023, the Company has &lt;span id="xdx_90A_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20230630_zu1GMVhlNeAg"&gt;22 &lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;management
agreements of which &lt;span id="xdx_903_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20230630_z63iksoJVlj4"&gt;3 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;were
with PC&#x2019;s owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned
by Raymond V. Damadian, M.D., Chairman of the Board of FONAR until his unexpected death in August 2022)(&#x201c;the Related medical
practices&#x201d;) and &lt;span id="xdx_90B_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20230630_zhF4TIENIJE4"&gt;19&lt;/span&gt;&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by two unrelated
radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility
ranging from approximately $&lt;span id="xdx_90B_ecustom--ContractualFeesForServicesRenderedMinimum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zdeKaV5lMUe8"&gt;84,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to
$&lt;span id="xdx_90D_ecustom--ContractualFeesForServicesRenderedMaximum_iI_pp0p0_c20230630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zZq9uyt4UDWi"&gt;447,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a provision for bad
debts for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of
Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company currently recognizes revenue in accordance with the recognition accounting standard issued by the Financial Accounting Standards
Board (&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606
outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods
or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures
regarding the Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&#160;&lt;/span&gt;&lt;/p&gt;



























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenues, net of contractual allowances and discounts less the provision for bad debts for the years ended
June 30, 2023 and 2022 are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,124,646&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,248,708&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,063,846&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,060,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,670,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,907,335&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,935,482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,365,275&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,793,993&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,582,238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zvOUXNf3Jow5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <FONR:ManagementAgreementsWithCompanyTotalMedicalPractices contextRef="AsOf2023-06-30" decimals="INF" unitRef="Pure">22</FONR:ManagementAgreementsWithCompanyTotalMedicalPractices>
    <FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty contextRef="AsOf2023-06-30" decimals="INF" unitRef="Pure">3</FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty>
    <FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState contextRef="AsOf2023-06-30" decimals="INF" unitRef="Pure">19</FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState>
    <FONR:ContractualFeesForServicesRenderedMinimum
      contextRef="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">84000</FONR:ContractualFeesForServicesRenderedMinimum>
    <FONR:ContractualFeesForServicesRenderedMaximum
      contextRef="AsOf2023-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      unitRef="USD">447000</FONR:ContractualFeesForServicesRenderedMaximum>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--DisaggregationOfRevenueTableTextBlock_zK9mVmlR5nbi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8B8_zembrX5jDn9l" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patient Fee Revenue - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z9Dp13bKnOOh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,124,646&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,248,708&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,063,846&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,060,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Workers&#x2019;
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,670,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,907,335&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_c20220701__20230630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,935,482&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_c20210701__20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,365,275&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,793,993&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetPatientFeeRevenue_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Net Patient Fee Revenue"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;29,582,238&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4124646</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      unitRef="USD">4248708</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">1063846</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      unitRef="USD">1060920</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">18670019</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      unitRef="USD">17907335</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-012023-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">5935482</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      unitRef="USD">6365275</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">29793993</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">29582238</FONR:NetPatientFeeRevenue>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_846_eus-gaap--ResearchAndDevelopmentExpensePolicy_zCcM57Igdj39" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_866_zwXLEwU83yx2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research
and development costs are charged to expense as incurred. The costs of equipment that are acquired or constructed for research and development
activities, and have alternative future uses (either in research and development, marketing or production), are classified as property
and equipment and depreciated over their estimated useful lives.&#160;&#160;&lt;/span&gt;&lt;/p&gt;




















</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zcrvaUItXfcl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86B_zhkPe3HTjppk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Advertising
costs are expensed as incurred. Advertising expense approximated $&lt;span id="xdx_90E_eus-gaap--AdvertisingExpense_pp0p0_c20220701__20230630_zKZkoEVBqYll"&gt;570,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--AdvertisingExpense_pp0p0_c20210701__20220630_zs0vwBzoQKZ5"&gt;634,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and for
the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">570000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">634000</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_z6lN7U5pAQx6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zbMIL87Ze1o6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Income
Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets
and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <FONR:CustomerAdvancesPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_848_ecustom--CustomerAdvancesPolicyTextBlock_zkYTUOYusfEg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_867_zNOLsjdj5iE" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:CustomerAdvancesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_z9PLWI0HYQEk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_862_zUzptieOT1t1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the
Two-Class Method&#x201d;, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted
method in calculating diluted earnings per share for the years ended June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the years ended June 30, 2023 and 2022, diluted EPS for common shareholders
includes &lt;span id="xdx_906_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20210701__20220630_zmZ5QYUGnotk"&gt;127,504
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B1_zP1e1w62Dcni"&gt;Earnings
Per Share (Continued)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,375,776&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,801,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;146,136&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,666,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,440,906&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,690,796&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;191,038&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,681,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;



















&lt;p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments include certificates of deposit with original maturities of greater than 90 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $&lt;span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i"&gt;49,203,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;in excess
of federally insured limits of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Related
Parties: Net revenues from related parties accounted for approximately &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;See
Note 3 regarding the Company&#x2019;s concentrations in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#x201c;Disclosures
about Fair Value of Financial Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;All
of the Company&#x2019;s financial instruments are held for purposes other than trading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zo6gR0OEiKVh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B1_zP1e1w62Dcni"&gt;Earnings
Per Share (Continued)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,375,776&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,801,974&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;146,136&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,539,376&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZeYAjp7vBi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,666,880&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--EarningsPerShareDiluted_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.38&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center; font-weight: normal; font-style: normal; vertical-align: top"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 46%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,440,906&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,690,796&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Basic Numerator: Net Income Available to Common Stockholders"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;191,038&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Denominator: Weighted Average Shares Outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Basic Income Per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,554,209&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="font-weight: normal; font-style: normal; text-align: right" title="Weighted average shares outstanding"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdjqVS7lJwpi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;127,504&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0762"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,681,713&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,513&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_c20210701__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">9375776</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="0"
      unitRef="USD">8801974</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">146136</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">6539376</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="Shares">6539376</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="USDPShares">1.43</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="USDPShares">1.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.38</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="Shares">6539376</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="Shares">6666880</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953"
      decimals="INF"
      unitRef="USDPShares">1.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">12440906</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="0"
      unitRef="USD">11690796</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      unitRef="USD">191038</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Shares">6554209</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="Shares">6554209</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">1.90</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="USDPShares">1.78</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="Shares">6554209</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="Shares">6681713</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonStockMember1131542984"
      decimals="INF"
      unitRef="USDPShares">1.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zZUTpDq92iXc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span id="xdx_867_z9eH8RUZwsH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents includes cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90 days
or less, and money market funds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_844_eus-gaap--InvestmentPolicyTextBlock_zhX8dl60p66c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_861_z0y85ONhJLJg" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments include certificates of deposit with original maturities of greater than 90 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zFfbOEL2t673" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86A_zZoD5QlA3cP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash:
The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout
the year. At June 30, 2023, the Company had cash on deposit of approximately $&lt;span id="xdx_903_eus-gaap--Cash_iI_pp0p0_c20230630_zjB3oXy1lV3i"&gt;49,203,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;in excess
of federally insured limits of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20230630_zM3gbcNcPWj5"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Related
Parties: Net revenues from related parties accounted for approximately &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zhFEoax0WF01"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated net revenues for the years ended June 30, 2023 and 2022. Net management fee receivables from the related party medical
practices accounted for approximately &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zO4AhVmanDH6"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the consolidated accounts receivable for the years as of June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;See
Note 3 regarding the Company&#x2019;s concentrations in the healthcare industry.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">49203000</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012022-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zMUrKKoL3dN9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_865_z2Cl7lkIx1ll" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
financial statements include various estimated fair value information at June 30, 2023 and 2022, as required by ASC topic 820, &#x201c;Disclosures
about Fair Value of Financial Instruments&#x201d;. Such information, which pertains to the Company&#x2019;s financial instruments, is based
on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
standard establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring and revaluing fair value. These
tiers include, Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted
prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little
or no market data exists, therefore requiring an entity to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable
to estimate that value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Short-term investments: The carrying amount approximates fair value because of the short-term maturity of those instruments. Such amounts include
Certificates of Deposits with original maturities greater than 90 days. These securities are classified as Level 1.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Receivable
and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties
approximates the carrying value of the amounts due to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt and notes payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the
interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market
rates available to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;All
of the Company&#x2019;s financial instruments are held for purposes other than trading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLJqRgTK5NOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_86F_z6V0GsHmlIlf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not believe that any
of those standards will have a significant impact on our consolidated financial statements at the time they become effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_80A_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zOvp50FpUZfj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;NOTE
3 &#x2013; &lt;span id="xdx_824_zWN7Rf9LVOhi"&gt;ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&#160;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following two years at June 30, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zYKHQPEvqGjc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt"&gt;&lt;/p&gt;

 &lt;span&gt;Receivables - Non Current - Net&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 32%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 2%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20230630_znrIcImoXpQh" style="width: 24%; font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;620,230&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ContractReceivableDueThreeToFourYears_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;140,012&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; vertical-align: top; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total non current receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;760,242&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Medical
receivables are due under fee-for-service contracts from third-party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s receivables from the related and non-related professional corporations (&#x201c;PCs&#x201d;) substantially consist of fees
outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third-party
medical reimbursement organizations, principally insurance companies and health management organizations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third-party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90E_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20220701__20230630_zyTG4Ufu97ya"&gt;67&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_90F_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_dp_c20210701__20220630_zKye6CX3AiA4"&gt;66&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
respectively, of the PCs&#x2019; 2023 and 2022 net revenues were derived from no-fault and personal injury protection claims. The Company
considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes
all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated
financial statements and have historically been within management&#x2019;s expectations.&#160;&lt;/span&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;Net
revenues from management and other fees charged to the related party medical practices accounted for approximately &lt;span id="xdx_905_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zIZK7t0BMva5"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_906_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20210701__20220630_zQ3TiOR2fnK2"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%,
of the consolidated net revenues for the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related party medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company,
which have arisen under each individual management agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following table sets forth the number of our facilities for the years ended June 30, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zNZKqR4isGYh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span id="xdx_8B7_zqVKDBtZsVzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total Facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20220701__20230630_ziCbS5DEjBg7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210701__20220630_z0H7dxI6RRT6" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at Beginning of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Facilities
    Added by:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Internal
    development&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0840"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ManagedFacilitiesClosedDuringYear_zBb50vwk3Bhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Managed
    Facilities Closed&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0843"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at End of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;














</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zYKHQPEvqGjc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt"&gt;&lt;/p&gt;

 &lt;span&gt;Receivables - Non Current - Net&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; width: 32%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 2%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20230630_znrIcImoXpQh" style="width: 24%; font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;620,230&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ContractReceivableDueThreeToFourYears_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;140,012&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: middle; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; vertical-align: top; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total non current receivables"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;760,242&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">620230</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">140012</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">760242</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.67</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.66</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zNZKqR4isGYh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span id="xdx_8B7_zqVKDBtZsVzl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total Facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20220701__20230630_ziCbS5DEjBg7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20210701__20220630_z0H7dxI6RRT6" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at Beginning of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Facilities
    Added by:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ManagedFacilitiesAddedByInternalDevelopment_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Internal
    development&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0840"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ManagedFacilitiesClosedDuringYear_zBb50vwk3Bhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Managed
    Facilities Closed&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0843"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    Facilities Owned or Managed (at End of Year)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Integer">-1</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_804_eus-gaap--InventoryDisclosureTextBlock_zhcCVkyy2ISa" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
                                            4 &#x2013; &lt;span id="xdx_82F_zQ7nP1d1W6A3"&gt;INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories
included in the accompanying consolidated balance sheets consist of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zxmn31fB1U3h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20230630_z5fnXPyLMjW7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20220630_z4LiPeIovZ21" style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8B2_zP8axrk5q5Ji" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzMGG_zx2JvSV1E76b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,346,300&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,125,805&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzMGG_zyWke2UcY5hc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;223,366&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;234,016&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzMGG_zlF8YCMD2fUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,569,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,359,821&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zxmn31fB1U3h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20230630_z5fnXPyLMjW7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20220630_z4LiPeIovZ21" style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8B2_zP8axrk5q5Ji" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OtherInventorySupplies_iI_pp0p0_maIFGAWzMGG_zx2JvSV1E76b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 56%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,346,300&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,125,805&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIFGAWzMGG_zyWke2UcY5hc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;223,366&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;234,016&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pp0p0_mtIFGAWzMGG_zlF8YCMD2fUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,569,666&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,359,821&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2346300</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2125805</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">223366</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">234016</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2569666</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2359821</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zKxnEGZ1QsGi" style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;NOTE
5 - &lt;span id="xdx_82C_z1peDaeNis8i"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2023 and 2022, is comprised of:&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zBjDgbuLNcne" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="font-weight: normal; font-style: normal; text-align: center; padding-left: 0.25in"&gt;&lt;span id="xdx_8BE_zUkEImWg2N5f" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zFE5I5Uydvgb" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;33,144,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z1hQgmHUEcle" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;31,304,258&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkxDNvzBNx93" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,199,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zTm3QR28b024" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,199,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zmdy1OLEJiDe" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zQX5ia2KuLw8" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0BCuCjUrr1" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,714,499&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsjOd8C50KZg" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,484,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvj5cLSAgUYk" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,650,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwgzcjF852Ia" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;14,087,581&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zKfnxmFnQee5" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zwHyepL5FNm8" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zbZ8fPWhLZA5" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61,717,416&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630_zXKbrO6DAOLl" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;58,084,974&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zk62conpjdag" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,571,043&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20220630_z6rlq9wXJsWi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,803,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zzlldLmaVQ3i" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,146,373&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220630_zv1Gk9Lf5794" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,281,791&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
and amortization of property and equipment for the years ended June 30, 2023 and 2022 was $&lt;span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220701__20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"&gt;4,148,544 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
$&lt;span id="xdx_90A_eus-gaap--DepreciationAndAmortization_c20210701__20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_pp0p0"&gt;4,113,640&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively. During fiscal year ended June 30 2022, the Company removed fully depreciated assets of $&lt;span id="xdx_900_ecustom--DepreciatedAssetsWriteoff_pp0p0_c20220701__20230630_zCh3diTqmRed" title="Depreciated assets write-off"&gt;1,737,918 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;that
related to a location that was previously closed.&#160;&lt;/span&gt;&lt;/p&gt;














</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_zBjDgbuLNcne" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="font-weight: normal; font-style: normal; text-align: center; padding-left: 0.25in"&gt;&lt;span id="xdx_8BE_zUkEImWg2N5f" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Diagnostic
    equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zFE5I5Uydvgb" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;33,144,266&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z1hQgmHUEcle" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;31,304,258&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Research,
    development and demonstration equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zkxDNvzBNx93" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,199,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zTm3QR28b024" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,199,941&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zmdy1OLEJiDe" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zQX5ia2KuLw8" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,069,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0BCuCjUrr1" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,714,499&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zsjOd8C50KZg" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,484,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvj5cLSAgUYk" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,650,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwgzcjF852Ia" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;14,087,581&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zKfnxmFnQee5" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20220630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zwHyepL5FNm8" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;939,614&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20230630_zbZ8fPWhLZA5" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61,717,416&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220630_zXKbrO6DAOLl" style="font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;58,084,974&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20230630_zk62conpjdag" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;39,571,043&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20220630_z6rlq9wXJsWi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,803,183&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20230630_zzlldLmaVQ3i" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,146,373&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220630_zv1Gk9Lf5794" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Property plant and equipment, net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,281,791&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">33144266</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      unitRef="USD">31304258</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3714499</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">3484525</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">15650041</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">14087581</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-06-30_us-gaap_BuildingMember"
      decimals="0"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">61717416</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">58084974</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">39571043</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">35803183</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">22146373</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">22281791</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-07-012023-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">4148544</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2021-07-012022-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      unitRef="USD">4113640</us-gaap:DepreciationAndAmortization>
    <FONR:DepreciatedAssetsWriteoff
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1737918</FONR:DepreciatedAssetsWriteoff>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_ztyYfbCTYehi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
6 &#x2013; &lt;span id="xdx_827_zjIvlFRC88f"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of these practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company. A reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as
of June 30, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zH9fVfdjztK" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
                                            of operating and financing lease payments&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;Year
                                            Ending June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,592,971&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,600,823&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,174,942&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,190,414&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,897&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDMy2mNDurQ4" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,600,133&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,306,056&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0930"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PresentValueDiscount_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBQW6Hr7QTbj" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Operating Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(10,454,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zbNyy5gYETsk" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Financing Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(57,848&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;36,010,889&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;838,078&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zrImfJStlpKj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8B0_zKGhhdGBbs3h" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zk5uChC6bwS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zt5RrgC0pKdf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_z5xM5K3cLNnh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_zC0uyTsGS8w1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
components of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LeaseCostTableTextBlock_zxy39OwJ5OYj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zyygSFR0RPUl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    of Lease Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20220701__20230630_zGmMbeyWhzQ4" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20210701__20220630_zucBadwZwugg" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,887,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,668,199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
                                    lease cost:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zaUg4yKy4K5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCost_i01_pp0p0_zT0YjfaMdF4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;234,714&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;240,484&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
cash flow information related to leases as follows:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9zePwdCb3Qh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8BA_zgxLD6WvH0z4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
    cash flow information related to leases &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20220701__20230630_zzzkPQ3GoYz1" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210701__20220630_zm3L7Omts6Ge" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OperatingCashFlowsFromOperatingLeases_zX6I191tFDq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,577,578&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,133,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zGoPDcDi7xIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right-of-use
    and equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zGY8GpFt41ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,902,584&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,900,074&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

















</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zH9fVfdjztK" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
                                            of operating and financing lease payments&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;Year
                                            Ending June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 27%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,592,971&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="width: 26%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,600,823&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,174,942&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,190,414&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,897&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zDMy2mNDurQ4" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,600,133&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,306,056&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0930"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Present
    value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PresentValueDiscount_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zBQW6Hr7QTbj" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Operating Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(10,454,450&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PresentValueDiscountFinancingLease_iI_pp0p0_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zbNyy5gYETsk" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Present Value discount, Financing Lease"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(57,848&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;36,010,889&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDue_c20230630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;838,078&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5592971</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5600823</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">5174942</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">4190414</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">162897</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">3600133</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">22306056</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">-10454450</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">-57848</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">36010889</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      unitRef="USD">838078</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_zrImfJStlpKj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8B0_zKGhhdGBbs3h" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases - years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zk5uChC6bwS4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10.8&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease - years&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230630_zt5RrgC0pKdf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_z5xM5K3cLNnh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
    lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20230630_zC0uyTsGS8w1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-06-30">P10Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-06-30">P3Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2023-06-30" decimals="INF" unitRef="Pure">0.050</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2023-06-30" decimals="INF" unitRef="Pure">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--LeaseCostTableTextBlock_zxy39OwJ5OYj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B9_zyygSFR0RPUl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    of Lease Expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_491_20220701__20230630_zGmMbeyWhzQ4" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20210701__20220630_zucBadwZwugg" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,887,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,668,199&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--FinanceLeaseCostsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Finance
                                    lease cost:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zaUg4yKy4K5b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,881&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Interest
    on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;35,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--FinanceLeaseCost_i01_pp0p0_zT0YjfaMdF4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;234,714&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;240,484&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5887390</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5668199</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">35833</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">41603</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">234714</FONR:FinanceLeaseCost>
    <FONR:FinanceLeaseCost
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">240484</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z9zePwdCb3Qh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span id="xdx_8BA_zgxLD6WvH0z4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Supplemental
    cash flow information related to leases &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20220701__20230630_zzzkPQ3GoYz1" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_496_20210701__20220630_zm3L7Omts6Ge" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    Year Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
    paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OperatingCashFlowsFromOperatingLeases_zX6I191tFDq8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,577,578&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,133,369&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--FinancingCashFlowsFromFinancingLeases_zGoPDcDi7xIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Financing
    cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;244,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Right-of-use
    and equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zGY8GpFt41ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Operating
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,902,584&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,900,074&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5577578</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5133369</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2902584</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">7900074</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zXINrkF1i5H6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
7 - &lt;span id="xdx_826_z71ABYwLJHhh"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets, net of accumulated amortization, at June 30, 2023 and 2022 are comprised of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zUIORFkxq0A2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8BB_zxXOUGIcS73d" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other Intangible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,452,345&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,332,774&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-competition
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,387,621&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,075,327&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,683,736&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
estimated amortization of other intangible assets for the five years ending June 30, 2028 and thereafter is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjZ0zCHUktAi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p id="xdx_8BA_z8AOEZvCt3ih" style="margin-top: 0; margin-bottom: 0"&gt;Schedule Of Other Intangible Assets&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For the Years Ending June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and Copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 29%; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;376,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;176,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;371,645&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;171,645&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;369,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;169,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;366,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;166,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;362,172&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,172&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,585,999&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;671,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;914,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
                                            intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,517,698&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,914,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
weighted average amortization period for other intangible assets is &lt;span id="xdx_90C_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220701__20230630_z6lgHxazj58l"&gt;10.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;years
and they have no expected residual value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Information
related to the above intangible assets for the years ended June 30, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zb0iXarH8vzc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span id="xdx_8B1_zrayfMZnH9zf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For the Year Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zIbCT4YdN9U5" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zYhsOIFManec" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
    capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zkRceRrU5th7" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;119,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;87,882&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Software
    or patents written off&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20220701__20230630_zt3lWWpUAQ02" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1089"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdjustmentForAmortization_c20220701__20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(391,591&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(421,596&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; End of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zAxEzLTjDDy9" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zM7BcuwscN26" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the years ended June 30, 2023 and 2022 amounted to $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"&gt;191,591
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"&gt;184,096&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of non-competition agreements for the years ended June 30, 2023 and 2022 amounted to $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0"&gt;37,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the years ended June 30, 2023 and 2022 amounted to $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"&gt;200,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zUIORFkxq0A2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td colspan="9" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8BB_zxXOUGIcS73d" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other Intangible Assets - Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
    of June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pp0p0" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,004,847&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,452,345&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,332,774&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-competition
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,150,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,900,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,507,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - gross"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,387,621&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,075,327&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,683,736&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherIntangibleAssetsNet_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherIntangibleAssetsNet_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5452345</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">5332774</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">20507192</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20387621</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">17075327</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">16683736</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3431865</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zjZ0zCHUktAi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 100%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p id="xdx_8BA_z8AOEZvCt3ih" style="margin-top: 0; margin-bottom: 0"&gt;Schedule Of Other Intangible Assets&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For the Years Ending June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and Copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; width: 29%; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;376,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;176,600&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="width: 16%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;371,645&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;171,645&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;369,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;169,022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;366,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;166,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;362,172&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;162,172&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2028"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,585,999&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;671,832&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;914,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
                                            intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,517,698&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Other intangible assets - net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,914,167&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">376600</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">176600</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">371645</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">171645</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">369022</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">169022</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">366427</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">166427</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">362172</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">162172</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">1585999</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">671832</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">914167</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3431865</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">1517698</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">1914167</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2022-07-01to2023-06-30">P10Y3M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zb0iXarH8vzc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span id="xdx_8B1_zrayfMZnH9zf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For the Year Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20220701__20230630_zIbCT4YdN9U5" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20210701__20220630_zYhsOIFManec" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Balance - Beginning of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,037,599&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
    capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20220701__20230630_zkRceRrU5th7" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;119,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AmountsCapitalized_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Amounts capitalized"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;87,882&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Software
    or patents written off&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20220701__20230630_zt3lWWpUAQ02" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SoftwareOrPatentsWrittenOff_c20210701__20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Software or patents written off"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1089"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AdjustmentForAmortization_c20220701__20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(391,591&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_c20210701__20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(421,596&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &#x2013; End of Year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20220701__20230630_zAxEzLTjDDy9" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,431,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20210701__20220630_zM7BcuwscN26" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Balance - End of Year"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,703,885&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">4037599</us-gaap:OtherIntangibleAssetsNet>
    <FONR:AmountsCapitalized
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">119571</FONR:AmountsCapitalized>
    <FONR:AmountsCapitalized
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">87882</FONR:AmountsCapitalized>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">-391591</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">-421596</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3431865</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3703885</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">191591</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">184096</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      unitRef="USD">37500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <FONR:CapitalStockAndOptionsDisclosureTextblock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_800_ecustom--CapitalStockAndOptionsDisclosureTextblock_zspzh5bc7i7b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
8 - &lt;span id="xdx_821_z9NzzPP1xRU8"&gt;CAPITAL STOCK&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Common
Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_902_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zozgmjrlfAbj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_90F_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zCEjy4Yviq4l" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B common stock is convertible into shares of common stock on a one-for-one basis.&lt;/span&gt; &lt;span id="xdx_901_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjzK1n5DxQAd" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
B common stock has 10 votes per share.&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;There
were &lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_ziWlZyNwmc08"&gt;146
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;of such
shares outstanding at June 30, 2023 and 2022.&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
C Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbKZqgOixFKh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class C common stock has 25 votes per share&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
as compared to 10 votes per share for the Class B common stock and &lt;span id="xdx_900_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxPRe9as5iW4"&gt;one
vote per share for the common stock.&lt;/span&gt;&lt;/span&gt; &lt;span id="xdx_908_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zzvFWlmhGrH7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.&lt;/span&gt; &lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Although
having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to
dividends and distributions. &lt;span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlSZxxyUVxsc"&gt;Class
C common stock is convertible into shares of common stock on a three-for-one basis.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
A Non-Voting Preferred Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with
special dividend rights and the declaration of a stock dividend on the Company&#x2019;s common stock consisting of &lt;span id="xdx_90F_eus-gaap--CommonStockVotingRights_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zsS5rSJelvvc"&gt;one
share of Class A non-voting preferred stock for every five shares of common stock.&lt;/span&gt;&lt;/span&gt; &lt;span id="xdx_901_eus-gaap--DividendsPayableNature_c20220701__20230630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zknp5hxWcc3a" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next
$20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company
in connection with the enforcement of five of the Company&#x2019;s patents in its patent lawsuits, less the revised special dividend
payable on the common stock with respect to one of the Company&#x2019;s patents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks
equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Stock
Bonus Plans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve &lt;span id="xdx_903_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
of common stock. On August 10, 2010, the Company filed Form S-8 to register the &lt;span id="xdx_90C_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z44qqM8lbMj2" title="Shares registered"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares.
As of June 30, 2023, &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z128fjIzEL8"&gt;450,177
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2023 and 2022, &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20210701__20220630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_pdd"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
were issued.&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Treasury
Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_90A_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20220925__20220926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zLJAo4WJgEi1"&gt;9
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million
to be repurchased under the plan which will be purchased on the publicly traded open market at prevailing prices.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company utilizes the cost method of accounting to value the treasury stock when repurchasing stock. Under this method, the shares are
valued at the price paid and recorded to treasury stock. When the treasury stock is cancelled, the par value of the stock is reduced
and the additional paid in capital is reduced for the remaining value based upon the original stock sale. For the year ended June 30,
2023, the Company purchased &lt;span id="xdx_90E_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20230630_zbVKgbP4955b" title="Purchase of treasury shares"&gt;103,148
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
at a cost of $&lt;span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20220701__20230630_zaUzvszQYkn6" title="Purchase of treasury stock"&gt;1,759,457&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and cancelled &lt;span id="xdx_907_ecustom--CancellationOfTreasuryShares_c20220701__20230630_zDbQcALXM2Ak" title="Cancellation of treasury shares"&gt;103,328
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
valued at $&lt;span id="xdx_901_ecustom--CancellationOfTreasuryStock_c20220701__20230630_zXX30Ms6m1I5" title="Cancellation of treasury stock"&gt;1,919,027&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</FONR:CapitalStockAndOptionsDisclosureTextblock>
    <us-gaap:DividendsPayableNature contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953">Cash
dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend
payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common
stock.</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember">Class
B common stock is convertible into shares of common stock on a one-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2022-07-012023-06-30_us-gaap_CommonClassBMember">Class
B common stock has 10 votes per share.</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember">The
Class C common stock has 25 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockVotingRights contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953">one
vote per share for the common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2022-07-012023-06-30_us-gaap_CommonClassCMember">The
Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare contextRef="From2022-07-012023-06-30_us-gaap_CommonStockMember1131542953">Class
C common stock is convertible into shares of common stock on a three-for-one basis.</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2022-07-012023-06-30_us-gaap_PreferredClassAMember">one
share of Class A non-voting preferred stock for every five shares of common stock.</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableNature contextRef="From2022-07-012023-06-30_us-gaap_PreferredClassAMember">The
stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such
stock dividend approximates 313,000 shares.</us-gaap:DividendsPayableNature>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <FONR:SharesRegistered
      contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">2000000</FONR:SharesRegistered>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">450177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2021-07-012022-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2022-09-252022-09-26_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      unitRef="USD">9000000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">103148</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1759457</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryShares
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Shares">103328</FONR:CancellationOfTreasuryShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1919027</FONR:CancellationOfTreasuryStock>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_801_eus-gaap--MinorityInterestDisclosureTextBlock_zQO8lv4qtGig" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
9 &#x2013; &lt;span id="xdx_828_zW1nhvcEn5Ah"&gt;CONTROLLING AND NONCONTROLLING INTERESTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
February 13, 2013, the Company entered into an agreement with outside investors to acquire a 50.5% controlling interest in a newly formed
limited liability company, Health Diagnostics Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM
there are two classes of members; Class A members and one Class B member. The Class A members have an ownership interest of &lt;span id="xdx_90B_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zITDnPqEL0ue" title="Ownership interest"&gt;49.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of HDM. The Class B member (HMCA) has an ownership of &lt;span id="xdx_901_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zLQfxZl2D3l7"&gt;50.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of
ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be allocated
among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be
allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions
of the operating agreement. The Company contributed $&lt;span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zTpleUMySCWa" title="Contribution to HDM ($)"&gt;20,200,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;to HDM
and the group of outside investors contributed $&lt;span id="xdx_902_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_znd47uB9Rt6d"&gt;19,800,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for its
non-controlling membership interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
March 5, 2013, HDM purchased from Health Diagnostics, LLC (&#x201c;HD&#x201d;) and certain of its subsidiaries, a business managing twelve
(&lt;span id="xdx_90B_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zjFpaDEo1rb8"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)
Stand-Up MRI Centers and two (&lt;span id="xdx_909_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zxF20Bpatrel"&gt;2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)
other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $&lt;span id="xdx_902_ecustom--ConsiderationToOutsideInvestors_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zZofmKyMrlW2" title="HDM purchase price includes consideration to outside investors"&gt;1.5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million
to outside investors) aggregating $&lt;span id="xdx_90A_ecustom--TotalPurchasePrice_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z91ck1ngrdzi" title="HDM purchase from Health Diagnostics (HD) ($)"&gt;35.9
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million.
Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $&lt;span id="xdx_902_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn3n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zzr61Ti8GMz7" title="HDM entered agreement for consulting and non-competition agreement ($)"&gt;4.1
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;million.
The acquisition was accounted for using the purchase method in accordance with ASC 805, &#x201c;Business Combinations&#x201d;. The Company
recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair
value of the identified net assets acquired.&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;On
January 8, 2015, the Company purchased &lt;span id="xdx_90A_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zBrMv2zTd845" title="Purchase of interests from Class A (%)"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of the Class A members ownership interest at a cost of $&lt;span id="xdx_90D_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zMqOM4WFZj33" title="Purchase of interests from Class A ($)"&gt;4,971,094&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The Company has a &lt;span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zJD348qEDs0c"&gt;60.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest in HDM after this transaction. During the year ended June 30, 2022, the Company purchased noncontrolling interests
for $&lt;span id="xdx_90A_ecustom--DirectPurchaseOfNoncontrollingInterests_c20210701__20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z3YlRtCCgXIi" title="Purchase of interests from Class A ($)"&gt;546,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;giving
the Company a direct ownership interest of &lt;span id="xdx_90E_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20220630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zYWPdVYP12qe"&gt;70.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and the investors&#x2019; a &lt;span id="xdx_900_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20220630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zWqpEQIKAZzg" title="Ownership interest"&gt;29.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
ownership interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
amount of each class of HDM members&#x2019; equity as of June 30, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zrJSsZorVLE2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span id="xdx_8B2_zRSseaHm1Kld" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class A and B Members' Equity &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Opening
    Members' Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,053,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,292,073&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,048,524&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,923,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Share
    of Net Income&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,750,740&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,513,540&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,793,482&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,228,693&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Buyout
    of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zoqoPWuts0ca" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BuyoutOfNoncontrollingInterestsValue_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,441&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,776,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(14,023,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,822,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,860,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ending
    Members' Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,079,293&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;54,781,813&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,053,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,292,073&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      unitRef="Pure">0.495</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="INF"
      unitRef="Pure">0.505</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:ProceedsFromContributionsFromCompany
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="0"
      unitRef="USD">20200000</FONR:ProceedsFromContributionsFromCompany>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="0"
      unitRef="USD">19800000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <FONR:PurchaseOfStandupMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="Integer">12</FONR:PurchaseOfStandupMriCenters>
    <FONR:PurchaseOfOtherMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      unitRef="Integer">2</FONR:PurchaseOfOtherMriCenters>
    <FONR:ConsiderationToOutsideInvestors
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">1500000</FONR:ConsiderationToOutsideInvestors>
    <FONR:TotalPurchasePrice
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">35900000</FONR:TotalPurchasePrice>
    <FONR:ConsiderationForNoncompetitionAndConsultingAgreements
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-3"
      unitRef="USD">4100000</FONR:ConsiderationForNoncompetitionAndConsultingAgreements>
    <FONR:EquityMethodInvestmentsOwnershipPercentage
      contextRef="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.20</FONR:EquityMethodInvestmentsOwnershipPercentage>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2015-01-072015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember"
      decimals="0"
      unitRef="USD">4971094</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2015-01-08_custom_ClassBControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.604</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember"
      decimals="0"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2022-06-30_custom_ClassBControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      unitRef="Pure">0.708</FONR:EquityMethodInvestmentOwnershipPercentages>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2022-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      unitRef="Pure">0.292</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zrJSsZorVLE2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span id="xdx_8B2_zRSseaHm1Kld" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class A and B Members' Equity &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            A Members&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Class
                                            B Member&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Opening
    Members' Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,053,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpeningMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,292,073&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,048,524&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Opening Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;41,923,380&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Share
    of Net Income&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,750,740&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareOfNetIncome_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;18,513,540&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,793,482&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareOfNetIncome_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Share of Net Income"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,228,693&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Buyout
    of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zoqoPWuts0ca" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BuyoutOfNoncontrollingInterestsValue_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23,441&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterestsValue_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Buyout of noncontrolling interests"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,776,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--Distributions_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(14,023,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,822,232&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--Distributions_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Distributions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,860,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in; line-height: 115%; text-indent: -0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ending
    Members' Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;7,079,293&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EndingMembersEquity_c20230630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;54,781,813&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;($&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,053,833&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EndingMembersEquity_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Ending Members Equity"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,292,073&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">4053833</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">50292073</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">3048524</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">41923380</FONR:OpeningMembersEquity>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">2750740</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">18513540</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">4793482</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">22228693</FONR:ShareOfNetIncome>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">23441</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:Distributions
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">5776200</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">-14023800</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">5822232</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">13860000</FONR:Distributions>
    <FONR:EndingMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">7079293</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">54781813</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">4053833</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      unitRef="USD">50292073</FONR:EndingMembersEquity>
    <FONR:DebtAndCapitalLeaseDisclosuresTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_807_ecustom--DebtAndCapitalLeaseDisclosuresTextBlock_z0LoIwYoBhe8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
10 - &lt;span id="xdx_82F_zbRoeFU5NrFi"&gt;LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
debt, notes payable and capital leases consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zEgujPxkPXbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span id="xdx_8B7_zYWIKQ4Q2LZf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
    Debt, Notes Payable and Capital Leases &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Note
    payable requiring monthly payments of interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRg68h9lrgK3"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    until May 2009 followed by &lt;span id="xdx_90B_ecustom--MonthlyPaymentPeriod_dtM_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z6nYhUl9NSwg"&gt;240
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;monthly
    payments of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;4,472
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;through
    &lt;span id="xdx_904_ecustom--MaturityDate_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member"&gt;October 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
    The loan is collateralized by a building with a net book value of $&lt;span id="xdx_906_ecustom--BookValueOfBuilding_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zb0M1y52wIMk" title="Book Value Of Building"&gt;344,995
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as
    of June 30, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z49euvtnLP25" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zmO4ivBSS6Mh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;195,457&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
    revolving credit note was extended to November 15, 2023. The Company can borrow up to $&lt;span id="xdx_90B_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zlyEtRYYdf8b"&gt;10,000,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zUq2b70gTFZ"&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zPxMifvXD5si" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zOFyzWKlQKOi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebtCurrent_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtCurrent_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;195,457&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;43,767&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;40,078&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;115,075&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;155,379&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_ze3NYm3Q0hF9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
maturities of debt over the next four years are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_znlr3sk58ur9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8BF_zCEqiJZQudaj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Maturities of Long-term Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_c20230630_pp0p0" style="width: 43%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;43,767&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47,002&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,448&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; color: white; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230630_zJJN50r1PrW6" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total long term debt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;














</FONR:DebtAndCapitalLeaseDisclosuresTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zEgujPxkPXbh" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span id="xdx_8B7_zYWIKQ4Q2LZf" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Long-term
    Debt, Notes Payable and Capital Leases &lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Note
    payable requiring monthly payments of interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zRg68h9lrgK3"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    until May 2009 followed by &lt;span id="xdx_90B_ecustom--MonthlyPaymentPeriod_dtM_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z6nYhUl9NSwg"&gt;240
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;monthly
    payments of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPayment_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_pp0p0"&gt;4,472
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;through
    &lt;span id="xdx_904_ecustom--MaturityDate_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member"&gt;October 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
    The loan is collateralized by a building with a net book value of $&lt;span id="xdx_906_ecustom--BookValueOfBuilding_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zb0M1y52wIMk" title="Book Value Of Building"&gt;344,995
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as
    of June 30, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_z49euvtnLP25" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable1Member_zmO4ivBSS6Mh" style="width: 12%; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;195,457&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
    revolving credit note was extended to November 15, 2023. The Company can borrow up to $&lt;span id="xdx_90B_eus-gaap--ProceedsFromLinesOfCredit_pp0p0_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zlyEtRYYdf8b"&gt;10,000,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
    prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220701__20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zUq2b70gTFZ"&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
    per annum and is payable monthly. The loan is collateralized by substantially all of the Company&#x2019;s assets. The loan also contains
    certain financial covenants that must be met on a periodic basis. The Company still has the ability to draw down on the line.&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20230630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zPxMifvXD5si" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermDebtCurrent_iI_pp0p0_c20220630__us-gaap--LongtermDebtTypeAxis__custom--NotePayable2Member_zOFyzWKlQKOi" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt Current"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LongTermDebtCurrent_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtCurrent_c20220630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;195,457&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;43,767&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_c20220630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="Current portion of Long Term Debt, Notes Payable and Capital Leases"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;40,078&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20230630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;115,075&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LongTermDebtAndCapitalLeaseObligations_c20220630_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Long Term Debt, Notes Payable and Capital Leases less Current Portion"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;155,379&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-07-012023-06-30_custom_NotePayable1Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <FONR:MonthlyPaymentPeriod contextRef="From2022-07-012023-06-30_custom_NotePayable1Member">P240M</FONR:MonthlyPaymentPeriod>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2022-07-012023-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">4472</us-gaap:DebtInstrumentPeriodicPayment>
    <FONR:MaturityDate contextRef="From2022-07-012023-06-30_custom_NotePayable1Member">October 2026</FONR:MaturityDate>
    <FONR:BookValueOfBuilding
      contextRef="AsOf2023-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">344995</FONR:BookValueOfBuilding>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2023-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">158842</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2022-06-30_custom_NotePayable1Member"
      decimals="0"
      unitRef="USD">195457</us-gaap:LongTermDebtCurrent>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2022-07-012023-06-30_custom_NotePayable2Member"
      decimals="0"
      unitRef="USD">10000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-07-012023-06-30_custom_NotePayable2Member"
      decimals="INF"
      unitRef="Pure">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">158842</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">195457</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">43767</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">40078</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">115075</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">155379</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_znlr3sk58ur9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8BF_zCEqiJZQudaj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Maturities of Long-term Debt&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ending June 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths_c20230630_pp0p0" style="width: 43%; font-weight: normal; font-style: normal; text-align: right" title="2024"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;43,767&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2025"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;47,002&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_c20230630_pp0p0" style="font-weight: normal; font-style: normal; text-align: right" title="2026"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;50,448&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_c20230630_pp0p0" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right" title="2027"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;17,625&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; color: white; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; color: white; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif; color: Black"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermDebt_iI_c20230630_zJJN50r1PrW6" style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right" title="Total long term debt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;158,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">43767</us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">47002</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">50448</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">17625</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebt contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">158842</us-gaap:LongTermDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_806_eus-gaap--IncomeTaxDisclosureTextBlock_zLkDNGjO2QXj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;NOTE
11 - &lt;span id="xdx_82C_zt7Zbe5Qf9ne"&gt;INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 740, &#x201c;Accounting for Income Taxes&#x201d; prescribes a recognition threshold and a measurement attribute for
the financial statement recognition and measurement of tax positions taken or expected to be taken in a corporate tax return. For those
benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences
between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation
are referred to as unrecognized benefits. A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable
is reduced) for an unrecognized tax benefit because it represents an enterprise&#x2019;s potential future obligation to the taxing authority
for a tax position that was not recognized as a result of applying the provisions of ASC 740. The Company believes there are no
uncertain tax positions in prior year&#x2019;s tax filings and therefore it has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net. Penalties if incurred would be recognized as a component of &#x201c;Selling, general
and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has recorded a deferred tax asset of $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_pp0p0_c20230630_zmrqxfrXaEfl"&gt;10,041,960 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
a deferred tax liability of $&lt;span id="xdx_90C_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_pp0p0_c20230630_z2xG5R9k0Qhj"&gt;394,758 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;as
of June 30, 2023, primarily relating to its net Federal operating loss carryforwards of approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_pp0p0_c20230630_zghzAHzWQ2Vk"&gt;9,110,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;available
to offset future taxable income through 2031. In addition the Company has state operating loss carryforwards of approximately $&lt;span id="xdx_906_eus-gaap--OperatingIncomeLoss_pp0p0_c20220701__20230630_zT1rO3MCQ1J3"&gt;11,130,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and
city operating loss carryforwards allowance for doubtful accounts and tax credits of approximately $&lt;span id="xdx_90A_eus-gaap--OtherOperatingIncome_pp0p0_c20220701__20230630_z4v22By4iEN7"&gt;1,235,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The net operating losses begin to expire in 2025 for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of June 30, 2023, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Inflation Reduction Act (&#x201c;IRA&#x201d;) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on share
repurchases that occur after December 31, 2022 and introduces a 15%&#160;corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#x2019;s financial statements.&#160;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which temporary
differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable income,
the regulatory environment of the industry, and tax planning strategies in making this assessment. At present, the Company believes that
it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to certain state net operating losses. A valuation allowance will be maintained until sufficient
positive evidence exists to support the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
valuation allowance for deferred tax assets decreased during the year ended June 30, 2023, by approximately $&lt;span id="xdx_901_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20230630_zEW2pqvqsLH9"&gt;78,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
The valuation allowance decreased by approximately $&lt;span id="xdx_905_eus-gaap--DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_pp0p0_c20220630_zizcqOtZTwT6"&gt;448,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;during
the year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
of the provision (benefit) for income taxes are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6y1hFTCOf9c" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_zysDaFNtEFVl" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of components of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20220701__20230630_z9bunqIZvHog" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210701__20220630_z2zyMGjQf8z1" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zF1yzXEy8uz3" style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentFederalTaxExpenseBenefit_zsxb5kuS8NH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1299"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1300"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zZKXHI2RZ7f8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;652,522&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_z8HEcDRpBj1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;652,522&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,594&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqTyw3EjR307" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zvNDEJelDZX2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,770,980&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,935,921&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zRAwcBDX65A9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;208,569&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;157,972&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zFenrUvRYWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,979,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,093,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxExpensesBenefit_iT_pp0p0_mtITEBzXA8_z3mYrNiszNl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Provision
    (Benefit) for Income Taxes - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,632,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,534,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;A
reconciliation of the federal statutory income tax rate to the Company&#x2019;s effective tax rate as reported is as follows:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLo3Ld9h7Id4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td id="xdx_8B6_zADvGj9GsS8b" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20220701__20230630_zRiACJwupoH7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20210701__20220630_zl40kX3RSMX7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    Of Federal Statutory Income Tax Rate To Company&#x2019;s Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z2XEbsfaH9Rk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Taxes
    at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zPahfCKGnEXe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    and local income taxes (benefit), net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zSXDrFLvbzs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zWJ5JEKRwyP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Expiration
    of tax credits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-indent: 10pt; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_z1B8EuDhvX1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Return
    to provision adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zN9Me9o5xBK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;New
    York state audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1348"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zDoc7tdj8dE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Change
    in the valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zLs4Dx3JDR65" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zTQ4MMg0sHC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Effective
    income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
of June 30, 2023, the Company has net operating loss (&#x201c;NOL&#x201d;) carryforwards of approximately $9,110,000 that will be available
to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant
to Section 1502 of the Internal Revenue Code.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has, for federal income tax purposes, research and development tax credits and investments tax credits carryforwards aggregating
$&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_pp0p0_c20230630_zAMoI9jdAnHb"&gt;2,981,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;.
However, the realization of these credits may be limited as a result of expiring prior to their utilization. These credits can only be
applied after all net operating losses have been used, which expire through 2031.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company was also under audit with New York State for income tax and was assessed additional taxes of $&lt;span id="xdx_909_ecustom--AdditionalTaxes_pp0p0_c20220701__20230630_znYfcXKfGT3g" title="Additional Taxes"&gt;1,014,071
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;plus
interest and penalties. These amounts were paid during fiscal year ending June 30, 2022.&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Significant
components of the Company&#x2019;s deferred tax assets and liabilities at June 30, 2023 and 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zk4dlaBdlo01" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BC_zsDy1qosNeo8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of components of company&#x2019;s deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20230630_zNlrWkjeE10l" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20220630_zri6mvKsALf8" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of Company&#x2019;s Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zzjHJa2JLYX6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,360,809&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,239,903&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_z9rn4rbW8iO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-deductible
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;707,400&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;707,400&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zhzhjUe3grx" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    operating carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,768,844&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,820,010&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zG6dQHgCxejg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tax
    credits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,981,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,346,509&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z2Qv9VuIR4Pl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;Capitalized research and development&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;369,675&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-left: -10pt; text-indent: 0pt; vertical-align: middle; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1389"&gt;&#x2014;&lt;/span&gt; &lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zkzC1StgmEzb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;Right of use assets and lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;112,938&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1392"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zdeBPhyTmRHe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;105,310&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;98,945&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_z6zPnbSFXrD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1397"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;71,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z4QhO76n5m7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    Tax Assets - gross&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,406,190&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,284,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zpcVtWGmQfx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(364,230&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(441,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_zxOQxyhXKJ4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,041,960&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,842,478&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z85ERFvIt3qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;Property and equipment and depreciation&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;(151,007&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1410"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMjpPTLPLpF8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(243,751&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(215,726&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_z5kmTeiwww35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(394,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(215,726&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zVGmIoVll3rf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,647,203&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,626,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">10041960</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">394758</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">9110000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">11130000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherOperatingIncome
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1235000</us-gaap:OtherOperatingIncome>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">78000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">448000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z6y1hFTCOf9c" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_zysDaFNtEFVl" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of components of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49F_20220701__20230630_z9bunqIZvHog" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49D_20210701__20220630_z2zyMGjQf8z1" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zF1yzXEy8uz3" style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CurrentFederalTaxExpenseBenefit_zsxb5kuS8NH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1299"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1300"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzwci_zZKXHI2RZ7f8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;652,522&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,594&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzwci_maITEBzXA8_z8HEcDRpBj1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;652,522&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,440,594&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zqTyw3EjR307" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zvNDEJelDZX2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Federal
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,770,980&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,935,921&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zRAwcBDX65A9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;208,569&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;157,972&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zFenrUvRYWEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,979,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,093,893&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--IncomeTaxExpensesBenefit_iT_pp0p0_mtITEBzXA8_z3mYrNiszNl2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Provision
    (Benefit) for Income Taxes - Net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,632,071&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,534,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">652522</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2440594</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">652522</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2440594</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2770980</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2935921</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">208569</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">157972</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">2979549</FONR:DeferredIncomeTaxExpensesBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">3093893</FONR:DeferredIncomeTaxExpensesBenefit>
    <FONR:IncomeTaxExpensesBenefit
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">3632071</FONR:IncomeTaxExpensesBenefit>
    <FONR:IncomeTaxExpensesBenefit
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5534487</FONR:IncomeTaxExpensesBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLo3Ld9h7Id4" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td id="xdx_8B6_zADvGj9GsS8b" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_498_20220701__20230630_zRiACJwupoH7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_493_20210701__20220630_zl40kX3RSMX7" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Reconciliation
    Of Federal Statutory Income Tax Rate To Company&#x2019;s Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Years
    Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_z2XEbsfaH9Rk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Taxes
    at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;21.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zPahfCKGnEXe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    and local income taxes (benefit), net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_iN_dpi_zSXDrFLvbzs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zWJ5JEKRwyP3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Expiration
    of tax credits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-indent: 10pt; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_dp_z1B8EuDhvX1h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Return
    to provision adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--EffectiveIncomeTaxRateReconciliationNysAuditSettlement_dp_zN9Me9o5xBK4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;New
    York state audit settlement&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1348"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_zDoc7tdj8dE1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Change
    in the valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_zLs4Dx3JDR65" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zTQ4MMg0sHC3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Effective
    income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;23.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;24.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.051</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.042</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.055</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">-0.023</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.045</FONR:EffectiveIncomeTaxRateReconciliationNysAuditSettlement>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">-0.020</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.230</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.243</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2981000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <FONR:AdditionalTaxes
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1014071</FONR:AdditionalTaxes>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zk4dlaBdlo01" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BC_zsDy1qosNeo8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of components of company&#x2019;s deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20230630_zNlrWkjeE10l" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_497_20220630_zri6mvKsALf8" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Components
    Of Company&#x2019;s Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zzjHJa2JLYX6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,360,809&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,239,903&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_z9rn4rbW8iO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Non-deductible
    accruals&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;707,400&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;707,400&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_zhzhjUe3grx" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    operating carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,768,844&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,820,010&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_zG6dQHgCxejg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Tax
    credits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,981,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,346,509&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z2Qv9VuIR4Pl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;Capitalized research and development&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;369,675&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-left: -10pt; text-indent: 0pt; vertical-align: middle; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1389"&gt;&#x2014;&lt;/span&gt; &lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zkzC1StgmEzb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;Right of use assets and lease liabilities&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;112,938&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1392"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zdeBPhyTmRHe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;105,310&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;98,945&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_i01I_pp0p0_maDTAGzM4n_z6zPnbSFXrD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Property
    and equipment and depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1397"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;71,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_z4QhO76n5m7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deferred
    Tax Assets - gross&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,406,190&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;13,284,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zpcVtWGmQfx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(364,230&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(441,865&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_zxOQxyhXKJ4l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;10,041,960&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,842,478&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzImD_z85ERFvIt3qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;Property and equipment and depreciation&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;(151,007&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1410"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMjpPTLPLpF8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(243,751&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(215,726&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_z5kmTeiwww35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(394,758&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(215,726&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zVGmIoVll3rf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    deferred tax asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;9,647,203&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,626,752&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3360809</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4239903</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">707400</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">707400</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2768844</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4820010</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">2981214</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3346509</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">369675</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">112938</FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">105310</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">98945</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">71576</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">10406190</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13284343</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">364230</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">441865</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">10041960</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12842478</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">151007</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">243751</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">394758</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">215726</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">9647203</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">12626752</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_803_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zM3qi7ptRmqi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
12 - &lt;span id="xdx_825_zEr90BR8vToi"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
in other current liabilities are the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zkBqSaGxKSv2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_z7Ev5TRSKybd" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20230630_zMSbXzPsoTO3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20220630_zaXLycoP2Lzg" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,413,044&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,652,173&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;193,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;248,702&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48,353&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,207&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,707&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;120,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;79,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,534&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;59,516&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;573,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;854,962&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,443,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,417,227&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;














</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zkBqSaGxKSv2" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_z7Ev5TRSKybd" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_499_20230630_zMSbXzPsoTO3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_494_20220630_zaXLycoP2Lzg" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedSalariesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,413,044&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,652,173&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;193,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;248,702&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TaxesPayableCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;48,353&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;382,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;11,207&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,707&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;120,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--SelfInsuranceReserve_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;100,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;79,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,534&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;59,516&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;573,574&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;854,962&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_iIC_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
    current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;5,443,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6,417,227&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">4413044</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4652173</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">193041</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">248702</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">48353</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">382000</us-gaap:TaxesPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">11207</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">20707</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">100000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">120000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">100971</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">79167</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">3534</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">59516</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">573574</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">854962</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">5443724</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">6417227</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zntCE5L5gqtc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
13 - &lt;span id="xdx_82D_zWXnxBvOICL3"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through
March 2030. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain
maintenance costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Rent
expense for operating leases approximated $&lt;span id="xdx_909_ecustom--LeaseAndRentalExpenses_pp0p0_c20220701__20230630_zLQ2pV2k4kPk" title="Operating Leases, Rent Expense"&gt;5,887,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_903_ecustom--LeaseAndRentalExpenses_pp0p0_c20210701__20220630_zkRKv5AGqn3i" title="Operating Leases, Rent Expense"&gt;5,668,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
for the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company received approval from the Suffolk County Industrial Development Agency on February 29, 2016 of a &lt;span id="xdx_905_ecustom--PropertyTaxAbatementFromSuffolkCountyIda_dp_c20160228__20160229_zZwwlKxQ7Brd" title="Property Tax Abatement From Suffolk County IDA"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
property tax abatement, valued at $&lt;span id="xdx_90B_ecustom--PropertyTaxAbatement_pp0p0_c20160228__20160229_zvABCvhoTFLf" title="Property Tax Abatement"&gt;440,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
over a 10 year period commencing January 2017.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Employee
Benefit Plans&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company has a non-contributory 401(k) Plan (the &#x201c;401(k) Plan&#x201d;). The 401(k) Plan covers all non-union employees who are at
least 21 years of age with no minimum service requirements. There were $&lt;span id="xdx_907_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20220701__20230630_zBF3MZhy5To8"&gt;36,523
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_90B_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_c20210701__20220630_zeUoP5iWtYGj"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;employer
contributions to the Plan for the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
stockholders of the Company approved the 2000 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019;
meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%.
This plan has not been put into effect as of June 30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company is subject to other legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims besides the claim above. In the opinion of management, and with consultation with legal counsel,
the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial
position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third-party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_902_ecustom--StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims_pp0p0_c20220701__20230630_zOVsqVuRUbqe" title="Liability for individual claims"&gt;110,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;per person
and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical
and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2023
and 2022, the Company had approximately $&lt;span id="xdx_903_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20230630_zZwyV47UBw4f"&gt;101,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_908_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth_pp0p0_c20220630_ziUtQve0x3U5"&gt;79,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively, in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d;
in the consolidated balance sheets.&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the years covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <FONR:LeaseAndRentalExpenses
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">5887000</FONR:LeaseAndRentalExpenses>
    <FONR:LeaseAndRentalExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">5668000</FONR:LeaseAndRentalExpenses>
    <FONR:PropertyTaxAbatementFromSuffolkCountyIda
      contextRef="From2016-02-282016-02-29"
      decimals="INF"
      unitRef="Pure">0.50</FONR:PropertyTaxAbatementFromSuffolkCountyIda>
    <FONR:PropertyTaxAbatement
      contextRef="From2016-02-282016-02-29"
      decimals="0"
      unitRef="USD">440000</FONR:PropertyTaxAbatement>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">36523</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">110000</FONR:StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">101000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">79000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_801_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zGNTfroZi4zl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
14 - &lt;span id="xdx_82E_zHfNFZoQEyB9"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2023 and 2022 the Company paid $&lt;span id="xdx_90B_eus-gaap--InterestPaidNet_pp0p0_c20220701__20230630_zdwzZBvH1Vdj"&gt;50,132
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_909_eus-gaap--InterestPaidNet_pp0p0_c20210701__20220630_zqPfaa25zVq7"&gt;617,029
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for interest,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2023 and 2022 the Company paid $&lt;span id="xdx_905_eus-gaap--IncomeTaxesPaid_pp0p0_c20220701__20230630_zwoBRzrbRP0a"&gt;1,439,507
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_906_eus-gaap--IncomeTaxesPaid_pp0p0_c20210701__20220630_zJ0Oyc6iTVF5"&gt;2,408,145
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;for income
taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
the years ended June 30, 2023 and 2022, the Company resolved certain sales tax liabilities and was able to reverse accrued interest and
penalties in the amount of $&lt;span id="xdx_902_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20220701__20230630_ztv4LP7ipUFh" title="Selling, General and Administrative Expenses"&gt;55,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;and $&lt;span id="xdx_907_ecustom--SellingGeneralAndAdministrativeExpenses_pp0p0_c20210701__20220630_zePjJScfVwX3" title="Selling, General and Administrative Expenses"&gt;119,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;,
respectively, which has been recorded under selling, general and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">50132</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">617029</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">1439507</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">2408145</us-gaap:IncomeTaxesPaid>
    <FONR:SellingGeneralAndAdministrativeExpenses
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">55000</FONR:SellingGeneralAndAdministrativeExpenses>
    <FONR:SellingGeneralAndAdministrativeExpenses
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">119000</FONR:SellingGeneralAndAdministrativeExpenses>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z45ey6Nlcw02" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
15 &#x2013; &lt;span id="xdx_82C_zZUHxSktMUtg"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_90B_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--ABillingCompanyMember_zDJXJOPyuz2b" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#x2019; Compensation claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was terminated on May 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span id="xdx_90D_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20220701__20230630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zduaEdq4gFV1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;














</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2022-07-012023-06-30_custom_ABillingCompanyMember">The
CEO and President of the Company is a minority owner of a billing company, which performs billing and collection services with respect
to No-Fault and Workers&#x2019; Compensation claims of the Company&#x2019;s clients. The monthly fee charged to the Company was $85,000.
The Company terminated this agreement on January 1, 2021. On June 1, 2017, the Company also entered into a one year renewable agreement
to provide IT services to the billing company for a monthly fee of $23,884. The agreement was terminated on May 31, 2023.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2022-07-012023-06-30_custom_BensonhurstMRILimitedPartnershipMember">Bensonhurst
MRI Limited Partnership, in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for
the service and maintenance of its Upright MRI Scanner for a price of $110,000 per annum.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zanA7qWHO3Tl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
16 - &lt;span id="xdx_821_z4FuE9q21gw8"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company provides segment data in accordance with the provisions of ASC 280, &#x201c;Disclosures about Segments of an Enterprise
and Related Information&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment
sales are market-based. The Company evaluates performance based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
financial information concerning the Company&#x2019;s reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summarized
Segment Financial Information&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zPXG9kSLthP7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BD_z7C7hc2iLLAb" style="display: none; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Manufacturing
    and Servicing of Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Center&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zpNMwgWqh7Yk" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,260,711&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zHxTupVuDJLj" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90,384,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220701__20230630_zAknCGKJZkla" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;98,645,101&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zOsO6rfotIJc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;985,833&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntersegmentNetRevenues_pdp0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zsNxiO6YETy5" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630_fKg_____zqbSeMrwjba" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;985,833&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zXR0iSaDwHle" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5,875,126&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zzdpLLifZtZ6" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,664,388&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630_zMTWT84bXrD2" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;14,789,262&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zojxEEEyBLJ9" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;263,720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zuariS2sOssi" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,276,415&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630_zkZ9Uq6ZYsTj" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,540,135&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zfnR5AVfUzx8" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,892,807&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpgqVsDleOJl" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;170,153,612&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsNet_pp0p0_c20230630_zua5IeHhZe0l" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;201,046,419&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zhUVKAqmpuS6" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;119,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zlX9m0tmAvI7" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,218,084&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630_zqQ064GXbR3j" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,337,655&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zKMglThxge42" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,218,804&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrLkiYhx9D06" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,373,341&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_c20210701__20220630_zff7EAGeLXB8" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;97,592,145&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjMeTghUhDJd" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;965,417&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zGFoe4ufuqcc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1549"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zhfeDEwGjne9" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;965,417&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_znVhOlhMnb52" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4,604,305&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zCPs6OXoGRH" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;26,611,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630_zEsuSmoDlGRi" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,007,182&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zbnqxGhQCkWe" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;263,559&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zYsxlOYyuZPk" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,271,677&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630_zaiNd5lWe1th" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,535,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zkqm6FASk111" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,182,037&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_z5MnKSAJphW5" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;169,159,945&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_iI_pp0p0_c20220630_zrAoywIBuDE1" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199,341,982&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zTFPZgfjNJK5" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;258,271&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyJqfV4JvZX2" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,374,903&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630_zyvDM4bzTfDi" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,633,174&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top; text-align: left"&gt;
  &lt;td id="xdx_F0F_zsV6KE79uDZ3" style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F13_z6TxoJTiISs8" style="width: 97%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
  eliminated in consolidation&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A5_zsYVRsSlZHW5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Export
Product Sales&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting
to &lt;span id="xdx_901_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20220701__20230630_z0Jfn3udqT0g" title="Export Sales Of Medical Equipment Percentage"&gt;14.1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_905_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20210701__20220630_zcecMvPwN9O8" title="Export Sales Of Medical Equipment Percentage"&gt;48.9&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of product sales revenues to third parties for the years ended June 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExportProductSalesTableTextBlock_z6ygtRfCAElb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zs0G1fu2rRTi" style="display: none; font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of export product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp0_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_za70KzLBfi0h" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&#x2014;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zUeCyfTz5bmg" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zwnWaRixp2og" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zTHPj4mKQYC" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_z0MpxSKF60P" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zBG1YMht5atc" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1601"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;United
    Arab Emirates&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zm8LSOFJqNJh" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--AE_zjMl2sPcl006" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1605"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zwvZKNJcZT64" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1607"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zn1o5GS82Are" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;36.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630_zP7xHOq0WGd9" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630_zpmnKRLlyyLi" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;48.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z4r5uN0Ubweg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Foreign
Service and Repair Fees&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair
of medical equipment amounting to &lt;span id="xdx_900_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20220701__20230630_zUfwWckzmopi"&gt;6.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
and &lt;span id="xdx_901_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20210701__20220630_zRkIWqrtPDol"&gt;4.4&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
of consolidated net service and repair fees for the years ended June 30, 2023 and 2022 respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Foreign
Service Repair Fees&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ExportServiceRevenuesTableTextBlock_zNTdDnFBKgw6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BA_zyn3KRxz8kA8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of foreign service and repair fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Years&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zWUC5N2rrnsc" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zy7sTtLtgDP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_zHUz06fBicM6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z78GlqwOwOw7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zZrDG1mOzLI9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zglZ5NQ90vac" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;England&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zlzbL7PYSnO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zqjVBH7xRhAj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;United
    Arab Emirates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zTtkp2daEkCl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zmEraVSvsot2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zxVyjjJPlBU3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Greece&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zqY4i9Xq6jKk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_zYEf2OBkL3j4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Australia&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zvIX1pLJR5Y7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zcznXqKAwZb3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zcKtHCqor8u2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zghWVedLFHNh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company does not have any material assets outside of the United States.&#160;&#160;&lt;/span&gt;&lt;/p&gt;















</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zPXG9kSLthP7" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BD_z7C7hc2iLLAb" style="display: none; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Manufacturing
    and Servicing of Medical&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2023:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Center&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zpNMwgWqh7Yk" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,260,711&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zHxTupVuDJLj" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;90,384,390&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pp0p0_c20220701__20230630_zAknCGKJZkla" style="width: 11%; font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;98,645,101&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zOsO6rfotIJc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;985,833&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntersegmentNetRevenues_pdp0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zsNxiO6YETy5" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1513"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pp0p0_c20220701__20230630_fKg_____zqbSeMrwjba" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;985,833&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zXR0iSaDwHle" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(5,875,126&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zzdpLLifZtZ6" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;20,664,388&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20220701__20230630_zMTWT84bXrD2" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;14,789,262&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zojxEEEyBLJ9" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;263,720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zuariS2sOssi" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,276,415&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20220701__20230630_zkZ9Uq6ZYsTj" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,540,135&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zfnR5AVfUzx8" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,892,807&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsNet_pp0p0_c20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zpgqVsDleOJl" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;170,153,612&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsNet_pp0p0_c20230630_zua5IeHhZe0l" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;201,046,419&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zhUVKAqmpuS6" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;119,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zlX9m0tmAvI7" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,218,084&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20220701__20230630_zqQ064GXbR3j" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,337,655&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Fiscal
    2022:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zKMglThxge42" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,218,804&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zrLkiYhx9D06" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;89,373,341&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pp0p0_c20210701__20220630_zff7EAGeLXB8" style="font-weight: normal; font-style: normal; text-align: right" title="Total Revenues - Net"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;97,592,145&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Intersegment
    net revenues *&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_fKg_____zjMeTghUhDJd" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;965,417&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pdp0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_fKg_____zGFoe4ufuqcc" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1549"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntersegmentNetRevenues_pp0p0_c20210701__20220630_fKg_____zhfeDEwGjne9" style="font-weight: normal; font-style: normal; text-align: right" title="Intersegment net revenues"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;965,417&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_znVhOlhMnb52" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(4,604,305&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zCPs6OXoGRH" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;26,611,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_pp0p0_c20210701__20220630_zEsuSmoDlGRi" style="font-weight: normal; font-style: normal; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;22,007,182&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zbnqxGhQCkWe" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;263,559&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zYsxlOYyuZPk" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,271,677&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pp0p0_c20210701__20220630_zaiNd5lWe1th" style="font-weight: normal; font-style: normal; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,535,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Total
    identifiable assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zkqm6FASk111" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;30,182,037&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsNet_iI_pp0p0_c20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_z5MnKSAJphW5" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;169,159,945&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsNet_iI_pp0p0_c20220630_zrAoywIBuDE1" style="font-weight: normal; font-style: normal; text-align: right" title="Total identifiable assets"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;199,341,982&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 20pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManufacturingAndServicingOfMedicalEquipmentMember_zTFPZgfjNJK5" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;258,271&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zyJqfV4JvZX2" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,374,903&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PaymentsToAcquireProductiveAssets_pp0p0_c20210701__20220630_zyvDM4bzTfDi" style="font-weight: normal; font-style: normal; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,633,174&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: top; text-align: left"&gt;
  &lt;td id="xdx_F0F_zsV6KE79uDZ3" style="width: 3%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;
  &lt;td id="xdx_F13_z6TxoJTiISs8" style="width: 97%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Amounts
  eliminated in consolidation&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-indent: 20pt; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">8260711</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">90384390</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">98645101</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001511"
      unitRef="USD">985833</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      id="Fact001515"
      unitRef="USD">985833</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-5875126</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">20664388</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">14789262</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">263720</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4276415</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">4540135</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">30892807</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">170153612</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2023-06-30" decimals="0" unitRef="USD">201046419</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012023-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">119571</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-012023-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4218084</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2022-07-01to2023-06-30"
      decimals="0"
      unitRef="USD">4337655</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">8218804</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">89373341</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">97592145</us-gaap:Revenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      id="Fact001547"
      unitRef="USD">965417</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      id="Fact001551"
      unitRef="USD">965417</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">-4604305</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">26611487</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">22007182</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">263559</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4271677</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4535236</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AssetsNet
      contextRef="AsOf2022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">30182037</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="AsOf2022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">169159945</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">199341982</us-gaap:AssetsNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-012022-06-30_custom_ManufacturingAndServicingOfMedicalEquipmentMember"
      decimals="0"
      unitRef="USD">258271</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-012022-06-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="0"
      unitRef="USD">4374903</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2021-07-012022-06-30"
      decimals="0"
      unitRef="USD">4633174</us-gaap:PaymentsToAcquireProductiveAssets>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.141</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.489</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportProductSalesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExportProductSalesTableTextBlock_z6ygtRfCAElb" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td id="xdx_8B8_zs0G1fu2rRTi" style="display: none; font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of export product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
    the Years Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp0_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_za70KzLBfi0h" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&#x2014;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DO_zUeCyfTz5bmg" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zwnWaRixp2og" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CA_zTHPj4mKQYC" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_z0MpxSKF60P" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zBG1YMht5atc" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1601"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;United
    Arab Emirates&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zm8LSOFJqNJh" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignProductSales_c20210701__20220630__srt--StatementGeographicalAxis__country--AE_zjMl2sPcl006" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1605"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zwvZKNJcZT64" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1607"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignProductSales_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zn1o5GS82Are" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;36.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20220701__20230630_zP7xHOq0WGd9" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20210701__20220630_zpmnKRLlyyLi" style="font: normal 11pt Arial, Helvetica, Sans-Serif" title="Foreign Product Sales"&gt;48.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ExportProductSalesTableTextBlock>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0.120</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.085</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.049</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-012023-06-30_country_AE"
      decimals="INF"
      unitRef="Pure">0.007</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.363</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.141</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.489</FONR:ForeignProductSales>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.064</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.044</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ExportServiceRevenuesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ExportServiceRevenuesTableTextBlock_zNTdDnFBKgw6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BA_zyn3KRxz8kA8" style="display: none; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of foreign service and repair fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Years&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Puerto
    Rico&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--PR_zWUC5N2rrnsc" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--PR_zy7sTtLtgDP3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CH_zHUz06fBicM6" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--CH_z78GlqwOwOw7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Germany&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DE_zZrDG1mOzLI9" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--DE_zglZ5NQ90vac" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;England&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GB_zlzbL7PYSnO1" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GB_zqjVBH7xRhAj" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;United
    Arab Emirates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_908_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AE_zTtkp2daEkCl" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Dominican
    Republic&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--DO_zmEraVSvsot2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Canada&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--CA_zxVyjjJPlBU3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Greece&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--GR_zqY4i9Xq6jKk" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--GR_zYEf2OBkL3j4" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Australia&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630__srt--StatementGeographicalAxis__country--AU_zvIX1pLJR5Y7" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630__srt--StatementGeographicalAxis__country--AU_zcznXqKAwZb3" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20220701__20230630_zcKtHCqor8u2" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20210701__20220630_zghWVedLFHNh" style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:ExportServiceRevenuesTableTextBlock>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_PR"
      decimals="INF"
      unitRef="Pure">0.015</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_CH"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.016</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_DE"
      decimals="INF"
      unitRef="Pure">0.016</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_GB"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_AE"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_DO"
      decimals="INF"
      unitRef="Pure">0.005</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_CA"
      decimals="INF"
      unitRef="Pure">0.006</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_GR"
      decimals="INF"
      unitRef="Pure">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-012023-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.009</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30_country_AU"
      decimals="INF"
      unitRef="Pure">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2022-07-01to2023-06-30"
      decimals="INF"
      unitRef="Pure">0.064</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2021-07-012022-06-30"
      decimals="INF"
      unitRef="Pure">0.044</FONR:ForeignServiceAndRepairFees>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_802_esrt--ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_zMEsVSSw2E4i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
17 &#x2013; &lt;span id="xdx_829_zOIphTVYkgNa"&gt;ALLOWANCE FOR DOUBTFUL ACCOUNTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
following represents a summary of allowance for doubtful accounts for the years ended June 30, 2023 and 2022 respectively:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Summary
of Allowance For Doubtful Accounts&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zN2psGB4q6hf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8B1_zPUNyCV9PLBf" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of summary of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions
    (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3c84wGytPAa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;204,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zWFykp0lXNj8" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7BvZoNcapV4" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61,004&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zJTLa3X6CNul" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,593&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zmYFaJiJZALj" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,627,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zqKUaRQqYYq1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,007,382&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zXNQJ2KuLf5e" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,026,732&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zIRFpZFP48ai" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,608,567&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzh3AqMjv2sk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,686,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zPxmExHv0NVk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,451,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zJnui7QrFv33" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,148,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zO8tH05rN7l1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,989,692&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zeAHTCre7yWa" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zjYx5Y9qzGK9" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zHSiDs9z0Dr4" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEwr4pfZiX6c" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zme0piRnKc98" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,270&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z5gsunDsB1ac" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1666"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zamy9Xu4zwI" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;237,673&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zWt8BHrJqjHa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;204,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBq1gGJMhCw3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,786,878&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zMvpsGLiuAE9" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;841,039&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zeyGJP1zUmFl" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1671"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNJyZMlxPOVj" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,627,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zP5xUMx3gkm2" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,184,399&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zolmLfsiOFca" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;502,494&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzSvguOHpRUk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zqIEfuVrH8Gk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,686,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zcVaBiwFQY25" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zc79CWS3III1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEMrAKCt0vcb" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1679"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zkCgSPaWDJk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zvbAfRny9CW4" style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zPa1oeg5ikXa" style="padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
    in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zjDDdhSgWOpe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2022-07-01to2023-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zN2psGB4q6hf" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8B1_zPUNyCV9PLBf" style="display: none; font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Schedule
    of summary of allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions
    (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance
    &lt;br/&gt; June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3c84wGytPAa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Beginning Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;204,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zWFykp0lXNj8" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Additions (Included in provision for bad debts)"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;55,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z7BvZoNcapV4" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Deductions"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;61,004&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zJTLa3X6CNul" style="width: 10%; font-weight: normal; font-style: normal; text-align: right" title="Ending Balance"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;198,593&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zmYFaJiJZALj" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,627,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zqKUaRQqYYq1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,007,382&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zXNQJ2KuLf5e" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;8,026,732&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zIRFpZFP48ai" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;12,608,567&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzh3AqMjv2sk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,686,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zPxmExHv0NVk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;1,451,094&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zJnui7QrFv33" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;2,148,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zO8tH05rN7l1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;3,989,692&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zeAHTCre7yWa" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zjYx5Y9qzGK9" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zHSiDs9z0Dr4" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1663"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20220701__20230630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEwr4pfZiX6c" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in; width: 40%"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zme0piRnKc98" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;442,270&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z5gsunDsB1ac" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1666"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zamy9Xu4zwI" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;237,673&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zWt8BHrJqjHa" style="width: 10%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;204,597&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBq1gGJMhCw3" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;15,786,878&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zMvpsGLiuAE9" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;841,039&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zeyGJP1zUmFl" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1671"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNJyZMlxPOVj" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;16,627,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable - related medical practices&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zP5xUMx3gkm2" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,184,399&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_zolmLfsiOFca" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;502,494&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20200701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzSvguOHpRUk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zqIEfuVrH8Gk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;4,686,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Notes
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zcVaBiwFQY25" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zc79CWS3III1" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zEMrAKCt0vcb" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1679"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20210701__20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zkCgSPaWDJk" style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;777,354&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td id="xdx_F0B_zvbAfRny9CW4" style="width: 4px; padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zPa1oeg5ikXa" style="padding-left: 11pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;Included
    in provision for bad debts.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001648"
      unitRef="USD">55000</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">61004</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">16627917</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001654"
      unitRef="USD">4007382</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">8026732</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">12608567</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4686893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001658"
      unitRef="USD">1451094</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2022-07-012023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">2148295</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">3989692</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">442270</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2021-07-012022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">237673</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">204597</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">15786878</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001670"
      unitRef="USD">841039</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      unitRef="USD">16627917</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4184399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2021-07-012022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001674"
      unitRef="USD">502494</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      unitRef="USD">4686893</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2021-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-07-01to2023-06-30">&lt;p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zKjxFtBaELZa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;NOTE
18 &#x2013; &lt;span id="xdx_824_zM6hgVunp0P2"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;The
Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;On
July 31, 2023, &lt;span id="xdx_909_eus-gaap--BroadcastersLicenseAgreementCommitmentsDescription_c20230729__20230731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zyvLNlVUCQTc"&gt;the
Company entered into a software license agreement for a term of 3 years at a cost of $1,260,000. The effective date of the agreement
is October 1, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;During
August 2023 the Company amended their revolving credit agreement. The agreement was extended to November 15, 2023.&#160;The interest
rate on borrowings remains at &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230801__20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcY6vAQyqhQ4"&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;%
along with certain financial covenants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;As
of August 31, 2023, the Company repurchased &lt;span id="xdx_90C_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znypzzQ2uwsg"&gt;27,844
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;shares
at a cost of $&lt;span id="xdx_905_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5nnRU49yCw9"&gt;469,372
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 11pt Arial, Helvetica, Sans-Serif"&gt;which
was authorized under the stock repurchase plan adopted in September 2022.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;


    &lt;div style="margin-top: 6pt; margin-bottom: 6pt"&gt;&lt;/div&gt;


&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BroadcastersLicenseAgreementCommitmentsDescription contextRef="From2023-07-292023-07-31_us-gaap_SubsequentEventMember">the
Company entered into a software license agreement for a term of 3 years at a cost of $1,260,000. The effective date of the agreement
is October 1, 2023.</us-gaap:BroadcastersLicenseAgreementCommitmentsDescription>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-08-012023-08-31_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.085</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="AsOf2023-08-31_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="Shares">27844000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2023-08-31_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="USD">469372000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001511"
          xlink:label="Fact001511"
          xlink:type="locator"/>
        <link:footnote id="Footnote001576" xlink:label="Footnote001576" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Amounts
  eliminated in consolidation&#160;</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001511"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1513"
          xlink:label="xdx2ixbrl1513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1513"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001515"
          xlink:label="Fact001515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001515"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001547"
          xlink:label="Fact001547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001547"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1549"
          xlink:label="xdx2ixbrl1549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1549"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001551"
          xlink:label="Fact001551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001551"
          xlink:to="Footnote001576"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001648"
          xlink:label="Fact001648"
          xlink:type="locator"/>
        <link:footnote id="Footnote001681" xlink:label="Footnote001681" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: normal 11pt Arial, Helvetica, Sans-Serif">Included
    in provision for bad debts.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001648"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001654"
          xlink:label="Fact001654"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001654"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001658"
          xlink:label="Fact001658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001658"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1662"
          xlink:label="xdx2ixbrl1662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1662"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1666"
          xlink:label="xdx2ixbrl1666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1666"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001670"
          xlink:label="Fact001670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001670"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001674"
          xlink:label="Fact001674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001674"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1678"
          xlink:label="xdx2ixbrl1678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1678"
          xlink:to="Footnote001681"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MBO-[\?8SKW:HW,! Q%GY+WE;+SMT>R189;E(JF*U!4F4KO]G[Y40.P7NL*'
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MWSF3S;K#K*9C'JSJJCPFC"+!-.5MJS[CMT"]_)64^])#?<\!7+]OC?JN97(
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M+.;1V,84HP<PL<D#U"R,2J-8--V#.@L[K;)PV?$0G^7\64CS*2G,F8FTSX*
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M!VXJF68[.W"^SA+HME<!E$_PK6@T[TWY\Z319!3\]Z-<W<GR?]8LO-Y/IM%
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MWN:$LU7]-M<=XYQE]>&2Q@M:5 ;B^CUC_.6D>D%L^]KD^']02P,$%     @
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M0]^IXS=(-BPM\?>.7F'#M'Q?O-G/47$D4;X:/MP]_'I@4+PSK]V_Q&?#\C<
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ML)5#['PIM:;D@-F4C:EICIR' F>K- O[&&$JIF![5:1.)L21Q4/NFY3TH_:
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M28?B) F65;;(J)@ %O11&?= '6F\Y1YD'DYT8B=FZS PL'.1 C/<T9F]X\]
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M_(V9!7&<OA,_<L><GHH?ATE</[#+%=OA+J,NIC0,(A+'CZFHE&]9U(F-HNF
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M+%GA=F?2".#]6@A]8(R!\?_"_&]02P,$%     @ 9GL\5^I"Y.'#!P  ^Q$
M !D   !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULG5AK<]NV$OW.7X%1;S/)
M#"/Q)8GR:\9VG-:=-O'8[LW<CQ )2IA0!$. EMU?W[, 2<G/WND'VR >NV=W
MSRX6/MJJYKM>"V'8_::L]/%H;4Q],)GH;"TV7(]5+2JL%*K9<(//9C71=2-X
M;@]MRDD4!+/)ALMJ=')DYZZ:DR/5FE)6XJIANMUL>/-P)DJU/1Z%HW[B6J[6
MAB8F)T<U7XD;8?ZLKQI\308IN=R(2DM5L484QZ/3\. LH?UVPW^EV.J],2-+
MEDI]IX_+_'@4$"!1BLR0!(X_=^)<E"4) HP?G<S1H)(.[H][Z9^M[;!ER;4X
M5^4WF9OU\2@=L5P4O"W-M=K^*CI[IB0O4Z6VO]G6[8T6(Y:UVJA-=Q@(-K)R
M?_E]YX>] VGPRH&H.Q!9W$Z11?F)&WYRU*@M:V@WI-' FFI/ YRL*"@WIL&J
MQ#ES\O7JXOKT]O+++^P=W]2'[//EE],OY_3]^\7IS<7-T<1 "^V=9)W$,R<Q
M>D5B&+$_5&76FEU4N<@?"Y@ WH QZC&>16]*_*VMQBP.?!8%4?R&O'BP.;;R
M9J_97(N&&UFMV&=9\2JCT>\"H=4O6>MDQ2_+HIPYT#7/Q/$(2:%%<R=&)^]^
M"F?!X1M(DP%I\I;T?Q6=-R6^C/?+U]L+;\;>_91&87C(_DDKNZR\W]KR ?$(
M%SXS:\'.U:;FU0/CN:J-R-GIS9^T.OL81'[G6_;^5M4R8VD2?1BSV[743!M>
MY;S)D=T_6@DXK!1:"_PUBO&ZA@K.\I:7]-$HGJU]EI5<:UD\(&A>Z01SS80$
MBH85-IZ"J8:I(<C=+LK=G+4U2@$AKAN)R-<E-A=LNQ;V/,Y5RMAU>XH!I"@*
M84N'1=-IR%G=-MD:6[SE0[>?D(_9-\'6_$XP6W>PC];@$U0@F&$:CG)FR]$&
M&E6^,Y3V#?Z 14!%4X-VEG,C&-9I&I5+-<)G6X%R498$VGM!#(33=T;!(6=
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M$97"@#T(WB#HET2BG$+5B$IL<=:EKF:56"D(ZRGKU,)1)6+M>]L^,R#.4-;
MV03.B9\Y\>0P.E;PK/,EY6^'_?91D.[0?%!JPFD@MJ$4TD[OG:ARU;@8N?9
M--I''T)&PF!41;.&(CKJ(FS4\PA3LDM-Q@"DJE W5 $Z"F:OAF>T)L?LJW )
M^:IT8//V&/.8@;G,=X'NSHE[T[5YO;M="=@_5PA18EZU)>@O;/JCI"X!7=R+
M)I,H[HX!2 )7)GCI+56#&]?&DZJG3;0H.+P\N[:C$(G6TJV *.52VSSM2A'D
M6WH]<<6.T^!B5BI-MT*?*UVYE2BKR MC=<(;=UR6  K*JGV+D+76$16Q@?=9
MN]-'$2Z&_N2)]K;J\4)OQC7HC/;:%L9G&;N?5UQ[4(*&2@P-%5G"J;25).'
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MX_ETY*[>_L.HVC[OE\J@&[##M>"Y:&@#U@NE3/]!"H;_]YS\#5!+ P04
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M-.PP[=_D_<&JM7M[GBN+=W'W=24XNA<1X/E"86FM#R2@_3GEXG]02P,$%
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M%+JA]D)\HX7)YFS'<15M7!$/G'_ )>,!]E#$'$Q*DM^ @U#EAL#1R?.5SNA
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M:6@.NB4UJT)E 71?2VE.&YO@_%<V_0=02P,$%     @ 9GL\5\9OX"W?!P
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M(EJI:@H(9;TSAA(_$+^_R%;DWDE^]Y_U':5",]O@""A:8RRS&3A-70$5%9H
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M8M#R5_0Y^(X.X/G,@5_;"U*P_7'F[#]02P,$%     @ 9GL\5\7QO!T5 P
M"0<  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULI57);MLP$+W[*P9J
MT)-J+;:SU3;@N Z2(HN1I3D4/=#2V")"D2I)Q<G?=RC):@(X+M!<) XU\]X;
M+D_#M=*/)D.T\)P+:49>9FUQ' 0FR3!GIJL*E/1EJ73.+(5Z%9A"(TNKHEP$
M<1CN!SGCTAL/J[FY'@]5:067.-=@RCQG^N4$A5J/O,C;3-SP56;=1# >%FR%
MMVCOB[FF*&A14IZC-%Q)T+@<>9/H^*3O\JN$'QS7YM487"<+I1Y=<)Z.O- )
M0H&)=0B,7D\X12$<$,GXW6!Z+:4K?#W>H)]6O5,O"V9PJL0#3VTV\@X]2'')
M2F%OU/H,FWX&#B]1PE1/6->Y_9X'26FLRIMB4I!S6;_9<[,.KPH.PW<*XJ8@
MKG371)7*;\RR\5"K-6B736AN4+5:59,X+MVFW%I-7SG5V?'M_7Q^,;N<7=U-
M+F ZN3V#TXOK!SB_.KV^N9S<G5]?#0-+/"X[2!K,DQHS?@<SBN%229L9F,D4
MT[<  0EL5<8;E2?Q3L3OI>Q"+_0A#N/>#KQ>VW6OPMM_K^NR* 32V;),P)29
M#$[I=,*LGC/P<[(P5M.)^;6M^QJ[MQW;W:)C4[ $1QY=$X/Z";WQYT_1?OAU
MA_)^J[R_"_T_]VLGYG;%5]=WLT[4AR_P;TKX5FHN5QV;(;P@TP;0;3S0MF&[
M;<!DZ@8QN+2IR@LF7Z!@/(4]&(1^U(L[+F4/]J,#/XR/.F0YP*5%TF3]#CT+
MK.ZP>.E^G#'R^[TC?Q >-*2QWP\/_:@_:&@3E6/'LF<T/GR VG_#34!*/%%R
M@MJ28X)A @T0#0C.%EQPRREVQ6M&[X5 L(K*GE ;) M+=$G5FT5QB1VR9R:J
M,L)S9"Q7I;2@EFY=!WX8ADV+473D(GB[ECZL,YYDD!'A M%9;:*TZZBDOLB_
MR3&I7Q]6*%'3?7%@+"4OXNZ..!# 9U)AT'1AVQ$/7ME3CGI5F;"!Q,FLG:J=
M;7U^4MO;W_3Z)W')](I+ P*75!IV#P8>Z-IXZ\"JHC*[A;)DG=4PHW\5:I=
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M\2*)JTX2ER!T7A&L9$=TVLOIW"F%WBO+*T-NA"5:/(IF+;KLBB=XW$  WQ&
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M23QT0;7CM%T8N6U&V%(:'(B-N,%_(%Q9!3Q?24R]6U@'_7^:R=]02P,$%
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M?B"O<MAVMBBR>9;$12VRHE:5H>HWCGR#+A4Z)G>DY3*^5W*F5"%5GH%ETZ+
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M.1J?1Z?#$\%L",J_VMOF4Y^B2JQPYK3#P)Y.S=!V>DB07UBN!)F>_(13>X:
MN",1$55AJ4KZ47QH5E@0*ZMG!'^_U]R>R,MH<GX:G9\CB+^@4<#+\Q/X/#HY
MBT:3,_%:X61/P:1_-68IK%EV',%9=#I!HF?!IPG@[-.1V9-E;JW: L9%!R<3
M^F]R"O\-!Y,+837Q'^##KMXE.'N*W&D;/Q<D\' U4T_::U9GT=G9671Q,73K
M6);[]CD9VPV&IS[^9YWZ:!R=G$ F-L1C'XVBL\LA9$;TY1*2-)3[#\C[%++
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MN45&WQ5D);?H<X99[H74P-O7.$E7+%C'BUIT#4G1<&Q$6/D-9+<T]7:-0U8
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M--P#W4VWW<:JE9\H'Y3%^=232_Q#P+5CP/NY4G:S<0:V?S&&?P)02P,$%
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M)4<]7OI:R0JOM#+/E*QK)@QAHB2K;QUO\:X9\N]BJXW"R_+?I=H'Y.@RLGU
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M@68^!<'16S78^S[05:H-0<<3CG&"/Q;:O!CAXX=!V$UN-!"M*7:M%SC"M41
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M=V]R:W-H965T<R]S:&5E=#,U+GAM;'U546_C-@Q^]Z\@O&'8 *^V93M.NB1
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M2<6J43L G3=*V=/&!3C_!<W_!5!+ P04    " !F>SQ7I1_KM@\%  #N"P
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MKN!!SK43@/V%4G8[<0:&)_[T?U!+ P04    " !F>SQ7:@<UYH,#   /"
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M]+TL\@=$WE \S6KP)ZYT19]]1OK1A<),T.,KSM6A818HGG&][U!+ P04
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M0NTWR7K_0/KW#]<P*7*\1S ^]?-Q;1+U5H+T;R6^PJ+*BN?D90[KRLMNG$#
MXKO1!S,2-C-9JHK7^NIN=?CSH(\\.O<?\?V\.,*IRQ0G2B]4;*)4HIBMH:0#
M+FDA41S2%!>*[_0YQXHKQ1/]=<LH+.UY /R^YEP=+O(!JJ.RV7]02P,$%
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MNM"*WS)R80=/"#NJ0ML5L:QN8XQ3";N0TR15;HZ)U*^R$$Y\XH=Q6.4.6):
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MM76_3:U:C$.7J2>P%EUH-5]Y:T"]5N ]=:(OM'8K-@P/'$*S%:K;^LZ%8>C
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MU/U'QN3+23XBK4?BD_\ 4$L#!!0    ( &9[/%>\4'"(V (  +4(   9
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MHAB<"JT>A,H1!)VHR!9 M4T"<0=#?S]+#98.ZF!" FC.4[0[!Z#V@\"1I;9
MJ3) @8N(VRBV!DNU\7'@=0[L*;3KWZBU._[/@ML.^AL5]P1 =>&[OHW:&_<O
MRW+A7PWZ&7+423-H5&:#*2*!!R$\E$N[KHW:V_;1U;G J9X;7,</4( :F6^P
MW-\C.5N[<FW0=[;;D"^C5("8+I0K//<5$L^O0?E LG5VDY@RJ>XEV>-*71TI
MUP9J?L&8?!WHRTEY&>W_!%!+ P04    " !F>SQ7&:UA@V4%   -'@  &0
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M<VAE971S+W-H965T-C$N>&ULA95K;]HP%(;_RE$V39W4-B'D@KH0*5S6=:*
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MEW0.1#Y)*2NPD%,V-?F< 4XTJ,A-Q[("L\ 9,>*.7ANRN$,7(L\(#!GBBZ+
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M\!U?E<QR6_9AF.-YEA]Y5=R.K*"2%33+6HP%%?49#TY3=AC6J"RLE(6-]3Z
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MT[G/-;;=H.P&7,^D-/N!/:!IY&?_ E!+ P04    " !F>SQ7<GHY%%,$  !
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MTJ%UCZXWYF[YGLHE+Q6XX@)2O8L8!,O]=6W_HL6FOO',A8;[4_VX@BLNDR8
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M<&V@OI>,R>>.?H!T#\[L/U!+ P04    " !F>SQ7LI871;P#  "-#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6RM5VV/XC80_BNC]%3M2AQY 0)L
M 8E-V![5\:)EK_U0]8-)#''7B5/;@=U_7SMA4SA"=%1\@=B>YYF9Q_9D,M@S
M_BHBC"6\Q3010R.2,GTP31%$.$:BR5*<J)4-XS&2:LBWID@Y1F$.BJGI6)9K
MQH@DQFB0SRWY:, R24F"EQQ$%L>(OS]BRO9#PS8^)I[)-I)ZPAP-4K3%*RR_
MI4NN1F;)$I(8)X*P!#C>#(VQ_>#WM7UN\#O!>W'T##J3-6.O>C -AX:E \(4
M!U(S(/6WPQZF5!.I,/XY<!JE2PT\?OY@?\IS5[FLD< >HW^04$9#HV= B#<H
MH_*9[;_@0SX=S1<P*O)?V!]L+0."3$@6'\ J@I@DQ3]Z.^AP!+#;%P#. >!\
M#W O %H'0.M'/;0/@':N3)%*KH./)!H-.-L#U]:*33_D8N9HE3Y)]+:O)%>K
M1.'DR%O,9M.7V63^LH+QW =O,7^9SG^=S+WI9 5W/I:(4 %SQ#G2.W0/G^';
MRH>[3_<#4ZH -(T9')QYA3/G@C/;@1E+9"1@DH0X/"4P5>1E^,Y'^(].+>,3
M7C?!Z3? L6RW*J!Z^&]9TH26I>%.JP+N_SC<J<FF56Y&*^=S+VT&BV,BU:62
M E 2@J?$(LD6)P'! GPB LI$QC'\.5X+R=6=^:LBZ,?"2:O:B:XC#R)% 1X:
MJE (S'?8&/W\D^U:OU0)>$LR_T9D)^*V2W';=>RC18KU$4ZV\!6K0B$:\*R$
MALF;JJ "5^E8RW>MC@59-R?3M7@WZO1Z7<NR!N;N6*(*.]?M'=N=9-\IL^_4
M9K_DZDW!Y3N\H#<8KY'$^IC!$V<QK++-AM%7==RR1%E,_7&5&@6_;1]%9C4[
MI]%[M4%<>UIN1':BEUOJY?X/O:IT<<\VK-VVSO;5JW5WK3(W(CM1IELJTZU5
M9A*GE+UC#"O)@E=8[!/,14126%*4P-UDM5C>-\!#(LKK%R?K3+_A!4@&>K%*
MPUJ/U]ZT@JQSM"$MMZ/+^\D].[>Z<,-ZI2Z]6EV^$K0FE*@CHYHQ($E(=B3,
M$(6 (A*+JK1K":]-NW>6D&V?GT/_1CY/).J7$O6OD,C+=2E>=,7C./Q;=3SQ
M45ENZ+?> =2 <1"04*]JS!>,J(RJ9*T-XEI9^V?7V[;L<UG/S;K]\Z)M'C5J
M,>;;O.$5$.C"6S0]Y6S94X_S5O*[>4_UVD5K_!]-T:C/$-\2==LHWBA*J]E5
M)X(7S6\QD"S-V\$UDZJYS!\C];V N390ZQO&Y,= .RB_0$;_ E!+ P04
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M/Z:\H\N!TX6_%U?:T2WK/U-ZUJ!A UK?:.V. PY0/Y0F_P!02P,$%     @
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MV["O'\ZY**>UN[UB6B7+3I%EIS;+\7SJS_R1.Q-OQN)Y./%'JA1K,6[=E(;
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MGYSL#['AEOWQ#TW9K:=4;AA7)(4U4GJM*Y0FRPY8+K3(;1-9"8TMR4ZW^-,
M:0+P?"V$/BQ,@OHW%/T&4$L#!!0    ( &9[/%=!=4HBD@4  '(A   9
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MZ4<:^_*\ !]^^3B6".U:UH#D%MV8'[N!SG0#(G 71V23 CORL,< L/D 2.4
M2)24DAGTRLP<<1'_W$470)$_ 20CA=&A1?]TQ*IG<'JM&J6\SDJ.IYR[SJ^7
MZPF[V-\[RP"#KW<X7.+D;];EXJ)EL]=ENG5</!G1Z2G%R1Z/IK_^#'7Y=Q93
M(L%L06 U%M62135'USM8_ 3N8X+IWVWL1"EP(@]<^Q$=)'ZTKC%\2P' #<%A
MRF19%<FR2#!;$%B-9:UD6>/>JU=X[4=11N65$V0S#XNZ(X210V1JN)\B6=4L
M8RSM3TEIAZDJ0H9<#[.Y'1I8KEZ6J_.'IN?YF6C2J?0F<H,=G;Z 'X%M$N_]
M7(^I':!BZ%']6Y*4-;E>\1OX"IDWWS%).Z%&TV2YP<R""\UF!K!NJ $XG0P;
M)<,&EX %]G:Y+TE9/!@M'G0HRVJ#AW844@S=4!HW$K<C \LTRS)-;IE4^3H&
MC=DJ EJF9C6*6+3#6&/+-KN&8*T*JZS"XE9QYT34H5(O2L",SJL/9(,3<(UQ
M;^GBPK]U4A4)9@L"J]$*Y<KIR>\J7D5S@H@6BF:+0JM3?6*JX?]7L *C-AIU
M'1D6;(H8*U(S3-TTS,:0Y/=K:-VHJAO]:"GK:.&,EA59IPRILFPH)FI2V0XT
M52@K5I-(;C>&$EFY=<BWZWS%*I)K1<B(BE&KV@%FF:G>0X"ZZ:AL-^3ZS1[*
M5@#4A@C295/36X.)$<D<=G:?R'I!E<.%?(O;2^2><. 0.H+NL.>[3@ >D^RQ
MBDN#>/+';_G-T[)(-%L46IWURFA#_7T54)"I+:@6B6:+0JM373ENR+?<_12P
M;:I5G<I:RY"R J&I*E9KVOX1_AM6!ASR';@(_>.W<$[_&,Y>U:!L-9<QC$!-
M1FHSSN9W8RB1U1H \A<!'?IGM1<H4#61I36K%6K?AZ !#AVHLNZ(ZU=[Z%\!
M<$J)8IF6;C4M 2.0.>;L'H'U:BIWC/CN.)]\^Z[F^%AOG6.%HMFBT.H\5FX;
MH7>5,R3(\Q94BT2S1:'5J:[\..+[\5YRAMJVW# ,16O.P3WC;'Z?AM9<F6[$
M-]T"Q*RCA3-BQL_JOVI9B *RAP!U7XEJM8#XJP6^&O*3WT*7("!["% W797-
M1_SGW3W44F\]NF2/U'YQ=G=<O93,1M>/5!83=1I \#H<?SH_'"]83$HG[XE#
MG*SS%_0IR%7D^!*L/%I^!'"5O_IN')_#RP5D')\AXW)!JV.=,>F9_'L"J6KZ
M^#7"G9/0V34% 5[1;L@7!KU]DN,+_N,.B;?Y&^QE3$@<YIL;['@XR0+H^55,
M]:_8R1HH/[.8_@=02P,$%     @ 9GL\5ULC2N^# P  G D  !D   !X;"]W
M;W)K<VAE971S+W-H965T-S4N>&ULK59M;]LV$/[>7W'0@J$%/$N6_))EM@&_
M%<O09)[==!^&?J"ELT5$%%62LIO^^AXE174Z15B*^8/,E[OG[KD[\C@^276O
M8T0#GT62ZHD3&Y-=N:X.8Q1,=V6&*>WLI1+,T%0=7)TI9%&A)!+7][RA*QA/
MG>FX6%NKZ5CF)N$IKA7H7 BF'N:8R-/$Z3F/"QM^B(U=<*?CC!UPB^8N6RN:
MN35*Q 6FFLL4%.XGSJQWM1A9^4+@ \>3/AN#9;*3\MY.KJ.)XUF',,'06 1&
M?T=<8))8('+C4X7IU":MXOGX$?UMP9VX[)C&A4S^YI&))\ZE Q'N69Z8C3S]
MCA6?@<4+9:*++YPJ6<^!,-=&BDJ9/! \+?_9YRH._T7!KQ3\[Q3(<+-"4"D$
M!='2LX+6DADV'2MY F6E"<T.BM@4VL2&IS:+6Z-HEY.>F6[OYMO57W>KV_>P
M^D#?+;Q>HF$\T7#+E&(VR&_@%]CF.XV?<DP-K([V^\\-BAVJC[1WMUW"ZXLW
MH&.F4 -/X7TL<\W22'?@XLE\[!IRVIIVP\K!1>F@_XR#/;B1J8DUK-((HZ?Z
M+I&M&?N/C.=^*^ ?>=*%H-<!W_.#)G_:U6?YX3GU)^X$=0*" F_X7 +^%=AW
M) '7!H7^V.#>O(0+FN'LH;_2&0MQXM"IUJB.Z$Q__JDW]'YKXOH_@3UAWJ^9
M]]O0IW,E610R;5!I>,=#NAH09@>%*&P<%E((;NR0JFB).E0\LR>_*2;MADR,
MKP@M8^D#$!PJC*@HC00&6N[-B:H6DLH^J^W3#4D")"U [B& !V3D)S.T&$IM
M[.)%K^,/O8[G>5TJ<03<[[&XEB!B!JT$F?X&^8IK^#,TDHX-5 74;4I**YL?
M3,J@3LJ@-59+W!FX3K51N76Y0V,;,.*[L926N>+I =:HN(R:,M&*_M+J+,%Z
M7H%F^]%QZG6]RX%W_NN-W6,#X6%->-A*>&MD> \;S'(5QM0/8*WD03'1@=O<
M7G VB]OR8IOE)I:*?Z'RH>+9X9E68RQ:#;\T%B78X"P4_NBRWV\F/ZK)CWZ0
M_ ;M$\#F^HSUF>!,R#PU3:Q;+;Z4=0DV.F/='_X:C/SO:+MG#5"@.A3O DWG
ME'PL>V&]6C\]9D7'=;^)E^^6&Z8./-60X)Y4O>Z(0J[*MT Y,3(KVNE.&FK.
MQ3"FYQ,J*T#[>RG-X\0:J!]DTZ]02P,$%     @ 9GL\5RICKNQ) P  3!0
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M[!'[BZV_//YE=:>.8S?Y"@K4G8&.W63Z"DQV7^Q[?J_)R)TR-HXR6P>9)AK
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MVIB1[#/OY>AYU,:L9)]G.T<.T:C;:C/?QJQD$UOI-&8JK[Z&F)B5[%=9&YW
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M7/E[P/.YWX\40MO0;&-#NK%]WL4.'8OIV%$LSY?XH$>WW;8U-:Y^Z/.1,OI
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M4$L! A0#%     @ 9GL\5P=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !F>SQ7ZVJP-N\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" !F>SQ7F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( &9[/%? ?%I\H @  '=%   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" !F>SQ7AD!JKPH*  !R-   &               @('D$   >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 9GL\5[ DKD+2!   UA@  !@
M             ("!)!L  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( &9[/%?XR/:L/@8  %89   8              " @2P@  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !F>SQ7@RH^(DT&  !"
M*0  &               @(&@)@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ 9GL\5_L1K"/V!P  =R$  !@              ("!(RT
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( &9[/%=&D @J
M8P<  /P0   8              " @4\U  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " !F>SQ7L63VHQ$8  #"0@  &
M@('H/   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 9GL\
M5V:956X$"0  GA4  !@              ("!+U4  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( &9[/%>$"G[:JP(  *\%   9
M      " @6E>  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ 9GL\5[00T5#2 P  .P@  !D              ("!2V$  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !F>SQ7ZD+DX<,'  #[$0
M&0              @(%490  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( &9[/%?)N2H8  4  #8,   9              " @4YM  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 9GL\5P16@W!O
M!P  %Q,  !D              ("!A7(  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " !F>SQ79V.:5GX'  !:$0  &0
M@($K>@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( &9[
M/%<[Y.S[CP0  +H)   9              " @>"!  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ 9GL\5\4;XGKT#   M"   !D
M         ("!IH8  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " !F>SQ7O^KB"CL#  #6!@  &0              @('1DP  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &9[/%?&;^ MWP<  *@1
M   9              " @4.7  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ 9GL\5\7QO!T5 P  "0<  !D              ("!69\
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !F>SQ7S7=1
M+9L#  #J!P  &0              @(&EH@  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( &9[/%?QV?M>+P<  %T1   9
M  " @7>F  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M9GL\5V,GFG#) P  WP@  !D              ("!W:T  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " !F>SQ7)S6Z#84#  !?!P  &0
M            @('=L0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( &9[/%?*VQM(T!D   E=   9              " @9FU  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 9GL\5_VKNLS4!
M;@P  !D              ("!H,\  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " !F>SQ7]Z%Q$><"  #]!@  &0              @(&K
MU   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( &9[/%<0
M)C";>@(  $P%   9              " @<G7  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ 9GL\5RALN)0A P  >08  !D
M     ("!>MH  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &9[/%?:*#J-GP4  -,-   9              "
M@>;N  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 9GL\
M5YIJFHTG P  C@8  !D              ("!O/0  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " !F>SQ7I1_KM@\%  #N"P  &0
M        @($:^   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( &9[/%=J!S7F@P,   \(   9              " @6#]  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 9GL\5\U?!66P P  T@T
M !D              ("!&@$! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " !F>SQ7#*=KN"8$  #Z&@  &0              @($!!0$
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( &9[/%>AUYN)
MT0,  +H0   9              " @5X) 0!X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ 9GL\5RF$P\24!   -A,  !D
M ("!9@T! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !F
M>SQ7>"&(T]\%   ''P  &0              @($Q$@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( &9[/%<2V5.Q3 (  "@%   9
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M970T-RYX;6Q02P$"% ,4    " !F>SQ7O%!PB-@"  "U"   &0
M    @($3* $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M &9[/%<3:FQXA@,  '4.   9              " @2(K 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ 9GL\5SH+L\=M @  ?@8  !D
M             ("!WRX! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " !F>SQ7<D%J _X"  "X"   &0              @(&#,0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( &9[/%=IWN=C] (
M %8(   9              " @;@T 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ 9GL\5_IAM?D=!   PA8  !D              ("!
MXS<! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !F>SQ7
MM4/4P$\$  !=&   &0              @($W/ $ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( &9[/%=B%[&='P,  +@(   9
M      " @;U  0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ 9GL\5YV]!-1T P  3 X  !D              ("!$T0! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !F>SQ7VU.(]B8(  #?.@
M&0              @(&^1P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( &9[/%?B(5!LM ,  )@.   9              " @1M0 0!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 9GL\5QFM88-E
M!0  #1X  !D              ("!!E0! 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " !F>SQ7O82@V%<$  !T$P  &0
M@(&B60$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( &9[
M/%>#X4W-D0(  !X&   9              " @3!> 0!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ 9GL\5P!<]^,H P  H@H  !D
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M=#8V+GAM;%!+ 0(4 Q0    ( &9[/%>REA=%O ,  (T,   9
M  " @5YT 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
M9GL\5X1P/C/V @  3 <  !D              ("!47@! 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " !F>SQ7GSG>'\\#   T"0  &0
M            @(%^>P$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( &9[/%=CM;UE)@4  &T4   9              " @81_ 0!X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 9GL\5V)6U>+4 P
MW1,  !D              ("!X80! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6Q02P$"% ,4    " !F>SQ76UWQ#; $  !$'P  &0              @('L
MB $ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( &9[/%<B
MF2;AH (  )(&   9              " @=.- 0!X;"]W;W)K<VAE971S+W-H
M965T-S,N>&UL4$L! A0#%     @ 9GL\5T%U2B*2!0  <B$  !D
M     ("!JI ! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &9[/%=G_%)"3 (  &@L   :
M          "  :.D 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( &9[/%>&IF-(# (  &$K   3              "  2>G 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !3 %, O!8  &2I 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>196</ContextCount>
  <ElementCount>410</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccounts</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterests</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccountsTables</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AllowanceForDoubtfulAccounts</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Earnings Per Share (Continued) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/EarningsPerShareContinuedDetails</Role>
      <ShortName>Earnings Per Share (Continued) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Weighted Average Remaining Lease Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Related to leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - CAPITAL STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>CAPITAL STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CapitalStock</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details</Role>
      <ShortName>LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Components Of Provision For Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details</Role>
      <ShortName>INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/RelatedPartyTransactions</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="fonar_10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>75</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="fonar_10-k.htm">fonar_10-k.htm</File>
    <File>fonr-20230630.xsd</File>
    <File>fonr-20230630_cal.xml</File>
    <File>fonr-20230630_def.xml</File>
    <File>fonr-20230630_lab.xml</File>
    <File>fonr-20230630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_graph.jpg</File>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="609">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>94
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fonar_10-k.htm": {
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20230630",
   "dts": {
    "inline": {
     "local": [
      "fonar_10-k.htm"
     ]
    },
    "schema": {
     "local": [
      "fonr-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "fonr-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20230630_pre.xml"
     ]
    }
   },
   "keyStandard": 296,
   "keyCustom": 114,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 39,
   "memberCustom": 28,
   "hidden": {
    "total": 83,
    "http://fonar.com/20230630": 35,
    "http://fasb.org/us-gaap/2023": 44,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 196,
   "entityCount": 1,
   "segmentCount": 70,
   "elementCount": 611,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 609,
    "http://xbrl.sec.gov/dei/2023": 38,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://fonar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfIncome",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2021-06-30_custom_ClassANonVotingPreferredMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30_custom_ClassANonVotingPreferredMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "longName": "00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fonar.com/role/Inventories",
     "longName": "00000010 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fonar.com/role/PropertyAndEquipment",
     "longName": "00000011 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "longName": "00000012 - Disclosure - OPERATING & FINANCING LEASES",
     "shortName": "OPERATING & FINANCING LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "longName": "00000013 - Disclosure - OTHER INTANGIBLE ASSETS",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fonar.com/role/CapitalStock",
     "longName": "00000014 - Disclosure - CAPITAL STOCK",
     "shortName": "CAPITAL STOCK",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:CapitalStockAndOptionsDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests",
     "longName": "00000015 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases",
     "longName": "00000016 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fonar.com/role/IncomeTaxes",
     "longName": "00000017 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "longName": "00000018 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "longName": "00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "longName": "00000020 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fonar.com/role/RelatedPartyTransactions",
     "longName": "00000021 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "longName": "00000022 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccounts",
     "longName": "00000023 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fonar.com/role/SubsequentEvents",
     "longName": "00000024 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "longName": "00000027 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://fonar.com/role/InventoriesTables",
     "longName": "00000028 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://fonar.com/role/PropertyAndEquipmentTables",
     "longName": "00000029 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "longName": "00000030 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "longName": "00000031 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables",
     "longName": "00000032 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables",
     "longName": "00000033 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fonar.com/role/IncomeTaxesTables",
     "longName": "00000034 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "longName": "00000035 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "longName": "00000036 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccountsTables",
     "longName": "00000037 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
     "longName": "00000038 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ControllingInterestMember",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-06-30_custom_ControllingInterestMember",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
     "longName": "00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Useful Life in Years - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1",
     "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://fonar.com/role/EarningsPerShareContinuedDetails",
     "longName": "00000041 - Disclosure - Earnings Per Share (Continued) (Details)",
     "shortName": "Earnings Per Share (Continued) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "longName": "00000043 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "longName": "00000044 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "longName": "00000045 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "longName": "00000046 - Disclosure - INVENTORIES - Inventories (Details)",
     "shortName": "INVENTORIES - Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
     "longName": "00000047 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "shortName": "PROPERTY AND EQUIPMENT - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "00000048 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:DepreciatedAssetsWriteoff",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:DepreciatedAssetsWriteoff",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "longName": "00000049 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails",
     "longName": "00000050 - Disclosure - OPERATING & FINANCING LEASES - Weighted Average Remaining Lease Term (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Weighted Average Remaining Lease Term (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails",
     "longName": "00000051 - Disclosure - OPERATING & FINANCING LEASES - Components of lease expense (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Components of lease expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails",
     "longName": "00000052 - Disclosure - OPERATING & FINANCING LEASES - Related to leases (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Related to leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "longName": "00000053 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
     "longName": "00000054 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Schedule of Other Intangible Assets - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details",
     "longName": "00000055 - Disclosure - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30",
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:AmountsCapitalized",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "longName": "00000056 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://fonar.com/role/CapitalStockDetailsNarrative",
     "longName": "00000057 - Disclosure - CAPITAL STOCK (Details Narrative)",
     "shortName": "CAPITAL STOCK (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "FONR:CapitalStockAndOptionsDisclosureTextblock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
     "longName": "00000058 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
     "longName": "00000059 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details",
     "longName": "00000060 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Long-Term Debt, Notes Payable And Capital Leases - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details",
     "longName": "00000061 - Disclosure - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "shortName": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "FONR:DebtAndCapitalLeaseDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails",
     "longName": "00000062 - Disclosure - INCOME TAXES - Components Of Provision For Income Taxes (Details)",
     "shortName": "INCOME TAXES - Components Of Provision For Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails",
     "longName": "00000063 - Disclosure - INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "shortName": "INCOME TAXES - Reconciliation of Federal Statutory Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
     "longName": "00000064 - Disclosure - INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "shortName": "INCOME TAXES - Components Of Company's Deferred Tax Assets And Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000065 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "longName": "00000066 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:LeaseAndRentalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:LeaseAndRentalExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "longName": "00000068 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_ABillingCompanyMember",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-012023-06-30_custom_ABillingCompanyMember",
      "name": "us-gaap:RelatedPartyTransactionDescriptionOfTransaction",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
     "longName": "00000070 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:IntersegmentNetRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
     "longName": "00000071 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign Product Sales - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details",
     "longName": "00000072 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative",
     "longName": "00000073 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-07-01to2023-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails",
     "longName": "00000074 - Disclosure - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)",
     "shortName": "ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2022-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000075 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2023-07-292023-07-31_us-gaap_SubsequentEventMember",
      "name": "us-gaap:BroadcastersLicenseAgreementCommitmentsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-292023-07-31_us-gaap_SubsequentEventMember",
      "name": "us-gaap:BroadcastersLicenseAgreementCommitmentsDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fonar_10-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners With Management Agreements With Company Owned By Related Party",
        "documentation": "Number of management agreements with PC's owned by a relarted party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r133"
     ]
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ContractualFeesForServicesRenderedMinimum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ContractualFeesForServicesRenderedMinimum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual Fees For Services Rendered Minimum",
        "documentation": "Minimum contractual fees for services rendered to the PC's."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization on right-of-use assets",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "FONR_ManagedFacilitiesClosedDuringYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagedFacilitiesClosedDuringYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Managed Facilities Closed",
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r619"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at Beginning of Year)",
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share (Continued)",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "TotalFacilitiesOwnedOrManagedAtEndOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at End of Year)",
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "FONR_ContractualFeesForServicesRenderedMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ContractualFeesForServicesRenderedMaximum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual Fees For Services Rendered Maximum",
        "documentation": "Maximum contractual fees for services rendered to the PC's."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ScannersWithManagementWithCompanyLocatedInNewYorkState",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners With Management With Company Located In New York State",
        "documentation": "Number of management agreements with PC's owned by two unrelated radiologists."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DepreciationOfLeasedEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment",
        "documentation": "This represents the amount of depreciation of leased equipment during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Property and equipment and depreciation",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ClassANonVotingPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]",
        "documentation": "Class A Non Voting Preferred Stock [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292"
     ]
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r664"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r443",
      "r506",
      "r507",
      "r632",
      "r754"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127"
     ]
    },
    "FONR_MedicareMedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "MedicareMedicaidMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Medicaid [Member]",
        "documentation": "Medicare Medicaid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r470",
      "r471",
      "r472",
      "r473",
      "r561",
      "r562"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for Income Taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r179",
      "r242",
      "r243",
      "r271",
      "r365",
      "r379",
      "r462"
     ]
    },
    "FONR_ClassANonVotingPreferredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ClassANonVotingPreferredMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A non-voting Preferred [Member]",
        "documentation": "Class A non-voting Preferred [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r226"
     ]
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total long term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r155",
      "r332",
      "r342",
      "r602",
      "r603",
      "r746"
     ]
    },
    "FONR_ClassCCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ClassCCommonStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]",
        "documentation": "Class C Common Stock [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135"
     ]
    },
    "FONR_ControllingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ControllingInterestMember",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Controlling Interest [Member]",
        "documentation": "Controlling Interest [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r386",
      "r614",
      "r615"
     ]
    },
    "FONR_ClassBControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ClassBControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DiagnosticImagingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DiagnosticImagingFacilityMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Imaging Facility [Member]",
        "documentation": "Diagnostic Imaging Facility Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Policyholders' Surplus",
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r614",
      "r615"
     ]
    },
    "FONR_RelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "RelatedPartiesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Member]",
        "documentation": "Related Parties [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CommercialInsuranceManagedCareMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Insurance Managed Care [Member]",
        "documentation": "Commercial Insurance Managed Care Member"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ResearchDeveopmentAndDemonstrationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ResearchDeveopmentAndDemonstrationEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Deveopment And Demonstration Equipment [Member]",
        "documentation": "Research Deveopment And Demonstration Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartiesMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "RelatedPartiesMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties Medical Practices [Member]",
        "documentation": "Related Parties Medical Practices [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r609",
      "r693",
      "r749",
      "r752"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "FONR_DiagnosticEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DiagnosticEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Equipment [Member]",
        "documentation": "MRI Diagnostic Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r55"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r302",
      "r600"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "Long-Term Debt and Capital Lease Obligations, Repayments of Principal in Next 12 Months",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r448",
      "r620"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury shares",
        "label": "Purchase of treasury stock",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r105",
      "r106",
      "r145",
      "r486",
      "r554",
      "r573",
      "r631"
     ]
    },
    "FONR_PresentValueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PresentValueDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount, Operating Lease",
        "documentation": "This represents the amount of present value discount during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "label": "Financing Receivable, Noncurrent, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r685"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r61"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r292"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r305",
      "r306",
      "r307",
      "r437",
      "r438"
     ]
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r101",
      "r102",
      "r103",
      "r104",
      "r227",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r389",
      "r392",
      "r393",
      "r403",
      "r690",
      "r735",
      "r736"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r98"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r60"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-MaturitiesOfLong-termDebtOver5Years-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance, Shares",
        "periodEndLabel": "Ending Balance, Shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct ownership interest percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use and equipment assets obtained in exchange for lease obligations:",
        "documentation": "Right of use Equipment Assets Obtained In Exchange For Lease Obligations Abstract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (expense) income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r191",
      "r286",
      "r287",
      "r499",
      "r500",
      "r501",
      "r560",
      "r564",
      "r567",
      "r569",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r608",
      "r624",
      "r693",
      "r749"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from financing leases",
        "documentation": "This represents the amount of financing cash flows from financing leases during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated depreciation and amortization",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r198",
      "r454"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PresentValueDiscountFinancingLease",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present Value discount, Financing Lease",
        "documentation": "This represents the amount of present value discount financing lease during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets - net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r59"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries, commissions and payroll taxes",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r592"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r201",
      "r444",
      "r632"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of treasury shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r105",
      "r106",
      "r145",
      "r478",
      "r554",
      "r573"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Numerator: Net Income Available to Common Stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r244",
      "r247",
      "r248",
      "r249",
      "r250",
      "r254",
      "r257"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventorySupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInventorySupplies",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased parts, components and supplies",
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r412",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r673"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "FONR_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "FinanceLeaseCost",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost",
        "documentation": "This represents the amount of finance lease cost during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r66",
      "r67",
      "r90",
      "r91",
      "r93",
      "r97",
      "r143",
      "r144",
      "r229",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r412",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r673"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r286",
      "r287",
      "r499",
      "r500",
      "r501",
      "r560",
      "r564",
      "r567",
      "r569",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r591",
      "r608",
      "r624",
      "r693",
      "r749"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets - gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r438"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r727",
      "r728",
      "r729"
     ]
    },
    "us-gaap_OtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income",
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_OtherOwnershipInterestsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOwnershipInterestsNameDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the ownership interest, which details special or unusual rights. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44",
      "r88",
      "r89",
      "r288"
     ]
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total non current receivables",
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details",
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r91",
      "r337"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted Income per Common Share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r245",
      "r255",
      "r256",
      "r257",
      "r258",
      "r401",
      "r402",
      "r440",
      "r460",
      "r596"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in capital in excess of par value",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r620",
      "r755"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentOperatingActivitiesDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r511"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r449",
      "r620"
     ]
    },
    "us-gaap_OtherOwnershipInterestsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOwnershipInterestsByNameAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Ownership Interests Name [Axis]",
        "documentation": "Information by ownership interests about other units or shares or classes of ownership in a partnership. Excludes limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r486",
      "r676",
      "r677",
      "r678",
      "r730",
      "r757"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/EarningsPerShareContinuedDetails",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r259",
      "r436",
      "r470",
      "r498",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r534",
      "r535",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r625"
     ]
    },
    "FONR_GainOnForgivenessOfPppLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "GainOnForgivenessOfPppLoan",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on forgiveness of PPP loan",
        "documentation": "This represents the amount of gain on forgiveness of ppp loan during year.",
        "label": "GainOnForgivenessOfPppLoan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING &amp; FINANCING LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r202",
      "r227",
      "r266",
      "r275",
      "r280",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r388",
      "r392",
      "r403",
      "r445",
      "r524",
      "r620",
      "r632",
      "r690",
      "r691",
      "r735"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r106",
      "r511",
      "r530",
      "r757",
      "r758"
     ]
    },
    "FONR_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits",
        "documentation": "This represents the amount of customer deposits during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment and depreciation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_BookValueOfBuilding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "BookValueOfBuilding",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Book Value Of Building",
        "documentation": "This represents the amount of book value of building during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r26",
      "r192",
      "r213",
      "r214",
      "r215",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241",
      "r243",
      "r259",
      "r294",
      "r295",
      "r349",
      "r356",
      "r357",
      "r358",
      "r376",
      "r377",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r425",
      "r464",
      "r465",
      "r466",
      "r486",
      "r554"
     ]
    },
    "FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "RelatedPartyReceivableAllowancesForDoubtfulAccounts",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party receivable allowances for doubtful accounts",
        "documentation": "This represents the amount of related party receivable allowances for doubtful accounts during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241",
      "r243",
      "r294",
      "r295",
      "r356",
      "r357",
      "r358",
      "r376",
      "r377",
      "r394",
      "r396",
      "r397",
      "r399",
      "r400",
      "r464",
      "r466",
      "r486",
      "r757"
     ]
    },
    "FONR_DueToRelatedPartyMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DueToRelatedPartyMedicalPractices",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party medical practices",
        "documentation": "This represents the amount of due to related party medical practices during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A and B Members' Equity",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total identifiable assets",
        "documentation": "Amount of net assets (liabilities)."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Activities [Axis]",
        "documentation": "Information by continuing and discontinuing operations."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DeferredIncomeTaxExpensesBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DeferredIncomeTaxExpensesBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_IncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "documentation": "This represents the amount of deferred income tax expenses benefit during year.",
        "label": "DeferredIncomeTaxExpensesBenefit"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_LongTermDebtAndCapitalLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "LongTermDebtAndCapitalLeaseObligation",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt and capital leases, less current portion",
        "documentation": "This represents the amount of long term debt and capital lease obligation during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncomeTaxExpensesBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncomeTaxExpensesBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Provision (Benefit) for Income Taxes - Net",
        "documentation": "This represents the amount of income tax expenses benefit during year.",
        "label": "IncomeTaxExpensesBenefit"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherReceivableAllowancesForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other receivable allowances for doubtful accounts",
        "documentation": "This represents the amount of management and other receivable allowances for doubtful accounts during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue, net of contractual allowances and discounts",
        "documentation": "This represents the amount of patient fee revenue net of contractual allowances and discounts during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r511"
     ]
    },
    "FONR_DepreciatedAssetsWriteoff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DepreciatedAssetsWriteoff",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciated assets write-off",
        "documentation": "This represents the amount of depreciated assets write off during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r511",
      "r530",
      "r757",
      "r758"
     ]
    },
    "FONR_ProductSalesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ProductSalesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net",
        "documentation": "This represents the amount of product sales net during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_EffectiveIncomeTaxRateReconciliationNysAuditSettlement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "EffectiveIncomeTaxRateReconciliationNysAuditSettlement",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New York state audit settlement",
        "documentation": "This represents the rate of effective income tax rate reconciliation nys audit settlement during year."
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r589",
      "r737",
      "r739",
      "r742"
     ]
    },
    "FONR_ServiceAndRepairFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ServiceAndRepairFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net",
        "documentation": "This represents the amount of service and repair fees net during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DeferredTaxAssetsInRightUseAssetsAndLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r619"
     ]
    },
    "FONR_AdditionalTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AdditionalTaxes",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Taxes",
        "documentation": "This represents the amount of additional taxes during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r164",
      "r216",
      "r269",
      "r411",
      "r539",
      "r630",
      "r756"
     ]
    },
    "FONR_LeaseAndRentalExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "LeaseAndRentalExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Rent Expense",
        "documentation": "This represents the amount of lease and rental expenses during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r192",
      "r213",
      "r214",
      "r215",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241",
      "r243",
      "r259",
      "r294",
      "r295",
      "r349",
      "r356",
      "r357",
      "r358",
      "r376",
      "r377",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r425",
      "r464",
      "r465",
      "r466",
      "r486",
      "r554"
     ]
    },
    "FONR_ManagedFacilitiesAddedByInternalDevelopment": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagedFacilitiesAddedByInternalDevelopment",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal development",
        "documentation": "The Company's receivables from the related and non-related professional corporations (PS's) substantially consist of fees outstanding under management agreements. Set forth in the table are the number of facilities for the fiscal year-end."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 related parties \u2013 net",
        "documentation": "This represents the amount of service and repair fees related parties net during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net",
        "documentation": "This represents the value of management and other fees net during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r172"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "FONR_PropertyTaxAbatementFromSuffolkCountyIda": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PropertyTaxAbatementFromSuffolkCountyIda",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Tax Abatement From Suffolk County IDA",
        "documentation": "This represents the rate of property tax abatement from Suffolk county ida during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r289",
      "r296",
      "r297",
      "r298",
      "r747"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r343"
     ]
    },
    "FONR_PropertyTaxAbatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PropertyTaxAbatement",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Tax Abatement",
        "documentation": "This represents the amount of property tax abatement during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 related party medical practices \u2013 net",
        "documentation": "This represents the value of management and other fees related medical practices net during the year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CostsRelatedToProductSales",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales",
        "documentation": "This represents the value of costs related to product sales during the year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Pcs Net Revenue Derived From No fault And Personal Injury Protection Claims",
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "StoplossUmbrellaPolicyWith3RdParyinsurerToLimitMaximumPotentialLiabilityForIndividualClaims",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for individual claims",
        "documentation": "This represents the amount of stop loss umbrella policy with 3 rd paryinsurer to limit maximum potential liability for individual claims during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related party medical practices",
        "documentation": "This represents the amount of costs related to management and other fees related medical practices during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SellingGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "SellingGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expenses",
        "documentation": "This represents the amount of selling general and administrative expenses during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CostsRelatedToServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees",
        "documentation": "This represents the amount of costs related to service and repair fees during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IntersegmentNetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IntersegmentNetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intersegment net revenues",
        "documentation": "This represents the amount of intersegment net revenues during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r170",
      "r171",
      "r174",
      "r175"
     ]
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees \u2013 related parties",
        "documentation": "This represents the amount of costs related to service and repair fees related parties during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CostsRelatedToManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees",
        "documentation": "This represents the amount of costs related to management and other fees during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_BuyoutOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "BuyoutOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buyout of noncontrolling interests",
        "documentation": "This represents the amount of buy out of noncontrolling interests during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ForeignProductSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ForeignProductSales",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Product Sales",
        "documentation": "This represents the rate of foreign product sales during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r646",
      "r647"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r257"
     ]
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Consolidated Net Revenue From Management Fees",
        "documentation": "Percentage of consolidated net revenue from management fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntellectualPropertyMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual Property [Member]",
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r270"
     ]
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "FONR_CancellationOfShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CancellationOfShares",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares",
        "documentation": "This represents the amount of cancellation of shares during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r620"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2024",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "FONR_ForeignServiceAndRepairFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ForeignServiceAndRepairFees",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Service And Repair Fees",
        "documentation": "It represents the rate of Foreign Service And Repair Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "FONR_AllowanceForDoubtfulAccountsDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AllowanceForDoubtfulAccountsDeductions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions",
        "documentation": "This represents the amount of allowance for doubtful accounts deductions during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Upon Conversion Of Class C Common Included In Diluted Eps For Common Shareholders",
        "documentation": "Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For applicable years ended June 30, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ExportSalesOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ExportSalesOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Export Sales Of Medical Equipment Percentage",
        "documentation": "This represents the rate of export sales of medical equipment percentage during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "FONR_CancellationOfSharesShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CancellationOfSharesShares",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares, shares",
        "documentation": "Cancellation of shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income \u2013 Attributable to FONAR",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r133",
      "r163",
      "r194",
      "r210",
      "r211",
      "r215",
      "r227",
      "r234",
      "r236",
      "r237",
      "r238",
      "r239",
      "r242",
      "r243",
      "r253",
      "r266",
      "r274",
      "r279",
      "r282",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r402",
      "r403",
      "r459",
      "r532",
      "r552",
      "r553",
      "r598",
      "r630",
      "r690"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r13"
     ]
    },
    "FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Revenues Of Service And Repair Of Medical Equipment Percentage",
        "documentation": "It represents the rate of Foreign Revenues Of Service And Repair Of Medical Equipment Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "FONR_AllowanceForDoubtfulAccountsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AllowanceForDoubtfulAccountsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions (Included in provision for bad debts)",
        "documentation": "This represents the amount of allowance for doubtful accounts additions during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_LossOnDispositionOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "LossOnDispositionOfFixedAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on disposition of fixed assets",
        "documentation": "This represents the amount of loss on disposition of fixed assets during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_StockIssuedToEmployeesUnderStockBonusPlansValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "StockIssuedToEmployeesUnderStockBonusPlansValue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued to employees under stock bonus plans",
        "documentation": "This represents the amount of stock issued to employees under stock bonus plans value during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ProvisionForBadDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ProvisionForBadDebts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debts",
        "documentation": "This represents the amount of provision for bad debts during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AmountsCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AmountsCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts capitalized",
        "documentation": "This represents the amount of amounts capitalized during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases",
        "documentation": "This represents the amount of right of use equipment assets obtained in exchange for lease obiligations operating leases during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r721"
     ]
    },
    "FONR_SoftwareOrPatentsWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "SoftwareOrPatentsWrittenOff",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software or patents written off",
        "documentation": "This represents the amount of software or patents written off during year."
       }
      }
     },
     "auth_ref": []
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r227",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r389",
      "r392",
      "r393",
      "r403",
      "r510",
      "r597",
      "r632",
      "r690",
      "r735",
      "r736"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "country_DO": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "DO",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DOMINICAN REPUBLIC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables",
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "FONR_IncreaseDecreaseInOperatingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInOperatingLiability",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities",
        "documentation": "This represents the amount of increase decrease in operating liability during year."
       }
      }
     },
     "auth_ref": []
    },
    "country_AE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "AE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED ARAB EMIRATES"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInAccountReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts, medical and management fee receivables",
        "documentation": "This represents the amount of increase decrease in account receivable during year.",
        "label": "IncreaseDecreaseInAccountReceivable"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "FONR_IncreaseDecreaseInAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "documentation": "This represents the amount of increase decrease in account payable during year.",
        "label": "IncreaseDecreaseInAccountPayable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances",
        "documentation": "This represents the amount of increase decrease in customer advance during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financing lease liabilities",
        "documentation": "This represents the amount of increase decrease in financing liabilities during year.",
        "label": "IncreaseDecreaseInFinancingLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInContractLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "documentation": "This represents the amount of increase decrease in contract liabilities during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_IncreaseDecreaseInAccruedLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncreaseDecreaseInAccruedLiability",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "documentation": "This represents the amount of increase decrease in accrued liability during year.",
        "label": "IncreaseDecreaseInAccruedLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r156",
      "r227",
      "r293",
      "r316",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r403",
      "r451",
      "r513"
     ]
    },
    "FONR_PurchaseOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PurchaseOfNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of noncontrolling interests",
        "documentation": "This represents the amount of purchase of noncontrolling interests during year.",
        "label": "PurchaseOfNoncontrollingInterests"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Assets",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases",
        "verboseLabel": "Operating Financing Leases - Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Financing Leases - Components Of Lease Expense"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DisclosureCapitalStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DisclosureCapitalStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r157",
      "r452",
      "r620",
      "r674",
      "r684",
      "r731"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "FONR_AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AcquiredAssetsandAssumedLiabilitiesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired assets and assumed liabilities",
        "documentation": "Acquired Assets and Assumed Liabilities Policy Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital",
        "documentation": "Amount of valuation allowance for tax benefit to be credited to shareholders' equity if tax benefit subsequently becomes realizable. Includes, but is not limited to, adjustment to opening balance of retained earnings for change in accounting principle or correction of error, gain (loss) in comprehensive income (loss) but excluded from net income (loss), deductible expenditure for income tax purposes reported as reduction of shareholders' equity, and deductible temporary difference existing at date of quasi-reorganization."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "FONR_CapitalStockAndOptionsDisclosureTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CapitalStockAndOptionsDisclosureTextblock",
     "presentation": [
      "http://fonar.com/role/CapitalStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAPITAL STOCK",
        "documentation": "Capital Stock And Options Disclosure Text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44",
      "r88",
      "r89",
      "r288",
      "r577",
      "r656"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r682",
      "r734"
     ]
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "FONR_DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DisclosureLongtermDebtNotesPayableAndCapitalLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt Notes Payable And Capital Leases",
        "verboseLabel": "Long-term Debt Notes Payable And Capital Leases - Maturities Of Long-term Debt Over 5 Years -"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DebtAndCapitalLeaseDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DebtAndCapitalLeaseDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES",
        "documentation": "Debt And Capital Lease Disclosures Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "GB",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "FONR_CustomerAdvancesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CustomerAdvancesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Advances",
        "documentation": "Customer Advances Policy Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTROLLING AND NONCONTROLLING INTERESTS",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information related to leases",
        "documentation": "Supplemental Cash Flow Information Related To Leases Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Useful Life in Years for Property and Equipment",
        "documentation": "Estimated Usefu lLife In Years For Property And Equipment Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities",
        "documentation": "Total Facilities Owned Or Managed Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue on service contracts",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Lease Term",
        "documentation": "Schedule Of Weighted Average Remaining Lease Term Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ExportProductSalesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ExportProductSalesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of export product sales",
        "documentation": "Export Product Sales Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ExportServiceRevenuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ExportServiceRevenuesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of foreign service and repair fees",
        "documentation": "Export Service Revenues Table Text Block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM",
        "documentation": "This represents the rate of hmca ownership size of imperial management services percent during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM",
        "documentation": "This represents the rate of ownership interest after reorganization for health management corporation of America of newly expanded hdm percent during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r644",
      "r646",
      "r647"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OwnershipInterestOfOriginalInvestorsOfHdm": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OwnershipInterestOfOriginalInvestorsOfHdm",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of the original investors of HDM",
        "documentation": "This represents the rate of ownership interest of original investors of hdm during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r644",
      "r646",
      "r647"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A ($)",
        "documentation": "This represents the amount of direct purchase of noncontrolling interests during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "FONR_InvestorsOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "InvestorsOwnershipInterest",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors ownership interest percentage",
        "documentation": "This represents the rate of investors ownership interest during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r81",
      "r84",
      "r122"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r644",
      "r646",
      "r647"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "FONR_NetPatientFeeRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "NetPatientFeeRevenue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Patient Fee Revenue",
        "documentation": "This represents the amount of net patient fee revenue during year."
       }
      }
     },
     "auth_ref": []
    },
    "country_GR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "GR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GREECE"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r619"
     ]
    },
    "FONR_WeightedAverageSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "WeightedAverageSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Denominator: Weighted Average Shares Outstanding",
        "documentation": "Weighted average shares outstanding basic"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "IncrementalCommonSharesAttributableToConversionOfCommonStock",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares included upon conversion of Class C Common to calculate a diluted EPS",
        "documentation": "This represents the shares of incremental common shares attributable to conversion of common stock during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for Diluted Earnings Per Share",
        "documentation": "Weighted average number of diluted earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases",
        "documentation": "This represents the amount of operating cash flows from operating leases during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r619"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r57",
      "r61"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "us-gaap_BroadcastersLicenseAgreementCommitmentsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BroadcastersLicenseAgreementCommitmentsDescription",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Broadcasters License Agreement Commitments, Description",
        "documentation": "A description of the commitments for license agreements that have been executed but were not reported because they do not meet the conditions for recording a liability."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r301",
      "r439",
      "r600",
      "r620",
      "r686",
      "r687"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r362",
      "r367",
      "r368",
      "r373",
      "r378",
      "r383",
      "r384",
      "r385",
      "r480"
     ]
    },
    "FONR_LongTermDebtAndCapitalLeaseObligationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "LongTermDebtAndCapitalLeaseObligationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt",
        "documentation": "This represents the amount of long term debt and capital lease obligation current during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r196",
      "r227",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r389",
      "r392",
      "r393",
      "r403",
      "r620",
      "r690",
      "r735",
      "r736"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r481",
      "r482",
      "r483",
      "r536",
      "r537",
      "r538",
      "r557",
      "r558"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AccountsReceivableNetLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term",
        "documentation": "This represents the amount of accounts receivable net long term during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r434",
      "r435",
      "r463",
      "r502",
      "r503",
      "r559",
      "r563",
      "r565",
      "r566",
      "r568",
      "r588",
      "r589",
      "r599",
      "r606",
      "r616",
      "r621",
      "r624",
      "r688",
      "r692",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenues \u2013 Net",
        "label": "Total Revenues - Net",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r227",
      "r267",
      "r268",
      "r273",
      "r277",
      "r278",
      "r284",
      "r286",
      "r288",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r403",
      "r441",
      "r690"
     ]
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related party medical practices \u2013 net of allowances for doubtful accounts of $3,989,692 and $4,686,893 at June 30, 2023 and 2022, respectively",
        "documentation": "This represents the amount of management and other fees receivable related medical practices net allowances during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Notes Payable and Capital Leases less Current Portion",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r446"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r274",
      "r279",
      "r282",
      "r598"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient Fee Revenue - Net",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of Long Term Debt, Notes Payable and Capital Leases",
        "documentation": "Amount of long-term debt and lease obligation, classified as current."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "WorkersCompensationPersonalInjuryMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers Compensation Personal Injury [Member]",
        "documentation": "Workers Compensation Personal Injury"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r363",
      "r364",
      "r368",
      "r369",
      "r372",
      "r374",
      "r474"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and capital lease obligations",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r352",
      "r435",
      "r463",
      "r502",
      "r503",
      "r559",
      "r563",
      "r565",
      "r566",
      "r568",
      "r588",
      "r589",
      "r599",
      "r606",
      "r616",
      "r621",
      "r692",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ]
    },
    "FONR_OtherRevenueSourceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OtherRevenueSourceMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Revenue Source [Member]",
        "documentation": "Other Revenue Source"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/ConsolidatedStatementsOfIncome",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income",
        "label": "Net income",
        "verboseLabel": "Net Income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r210",
      "r211",
      "r221",
      "r227",
      "r234",
      "r242",
      "r243",
      "r266",
      "r274",
      "r279",
      "r282",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r387",
      "r390",
      "r391",
      "r402",
      "r403",
      "r441",
      "r457",
      "r485",
      "r532",
      "r552",
      "r553",
      "r598",
      "r617",
      "r618",
      "r631",
      "r666",
      "r690"
     ]
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInReceivables",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Notes receivable",
        "label": "Increase (Decrease) in Receivables",
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r434",
      "r435",
      "r463",
      "r502",
      "r503",
      "r559",
      "r563",
      "r565",
      "r566",
      "r568",
      "r588",
      "r589",
      "r599",
      "r606",
      "r616",
      "r621",
      "r624",
      "r688",
      "r692",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r349",
      "r676",
      "r677",
      "r678",
      "r757"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623",
      "r626",
      "r627",
      "r628",
      "r629",
      "r753",
      "r757"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r352",
      "r435",
      "r463",
      "r502",
      "r503",
      "r559",
      "r563",
      "r565",
      "r566",
      "r568",
      "r588",
      "r589",
      "r599",
      "r606",
      "r616",
      "r621",
      "r692",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ]
    },
    "FONR_OperatingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OperatingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]",
        "documentation": "Operating Lease Payments [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r205",
      "r206",
      "r207",
      "r227",
      "r245",
      "r246",
      "r255",
      "r257",
      "r260",
      "r261",
      "r293",
      "r316",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r403",
      "r475",
      "r476",
      "r477",
      "r478",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r511",
      "r533",
      "r554",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r654",
      "r672",
      "r679"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "FONR_FinancingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "FinancingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]",
        "documentation": "Financing Lease Payments [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity",
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r85",
      "r192",
      "r193",
      "r214",
      "r231",
      "r232",
      "r233",
      "r235",
      "r241",
      "r294",
      "r295",
      "r349",
      "r356",
      "r357",
      "r358",
      "r376",
      "r377",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r404",
      "r405",
      "r409",
      "r425",
      "r465",
      "r466",
      "r484",
      "r513",
      "r530",
      "r555",
      "r556",
      "r575",
      "r631",
      "r674",
      "r684",
      "r731",
      "r757"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r65"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44",
      "r88",
      "r89",
      "r288",
      "r577"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r433"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r646",
      "r647",
      "r649"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from Operations",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r675",
      "r724"
     ]
    },
    "FONR_N2010StockBonusPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "N2010StockBonusPlanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2010 Stock Bonus Plan [Member]",
        "documentation": "N 2010 Stock Bonus Plan [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "FinanceLeaseCostsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:",
        "documentation": "Finance Lease Costs Abstract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost \u2013 11,463 and 11,643 shares of common stock at June 30, 2023 and 2022, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r69",
      "r70"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r609",
      "r693",
      "r749",
      "r752"
     ]
    },
    "FONR_HDMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "HDMMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Diagnostics Management, LLC (HDM) [Member]",
        "documentation": "HDM [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromContributionsFromAffiliates",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Contributions from Affiliates",
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "FONR_ClassAControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ClassAControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseDisabilityAccidentAndHealth",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Claims and Claims Adjustment Expense, Disability, Accident and Health",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to disability, accident and health insurance insured events that have occurred on or before a particular date (ordinarily, the balance sheet date) and the amount needed to provide for the estimated ultimate cost required to investigate and settle claims relating to insured events that have occurred on or before a particular date (ordinarily, the balance sheet date), whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r750",
      "r751"
     ]
    },
    "FONR_HDMEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "HDMEquityMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "H D M Equity [Member]",
        "documentation": "HDM Equity Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income \u2013 Noncontrolling Interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r152",
      "r210",
      "r211",
      "r242",
      "r243",
      "r458",
      "r666"
     ]
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Proceeds of Short-term investment",
        "label": "Payments for (Proceeds from) Short-Term Investments",
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r667",
      "r668",
      "r671"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_PR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "PR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NotePayable1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "NotePayable1Member",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 1 [Member]",
        "documentation": "Long-term debt, notes payable and capital leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_CommonClassCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassCMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class C [Member]",
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "FONR_NotePayable2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "NotePayable2Member",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Payable 2 [Member]",
        "documentation": "Note Payable 2 [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r145",
      "r450",
      "r467",
      "r468",
      "r479",
      "r512",
      "r620"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ABillingCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ABillingCompanyMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A Billing Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r209",
      "r227",
      "r293",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r388",
      "r392",
      "r403",
      "r620",
      "r690",
      "r691",
      "r735"
     ]
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractReceivableDueTwoToThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCostOfOperatingRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to patient fee revenue",
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction, Description of Transaction",
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r204",
      "r422",
      "r423",
      "r424",
      "r428"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State deferred taxes",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r723",
      "r724"
     ]
    },
    "FONR_ManagementAndOtherFeesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherFeesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest and penalty",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractReceivableDueThreeToFourYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "FONR_BensonhurstMRILimitedPartnershipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "BensonhurstMRILimitedPartnershipMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bensonhurst M R I Limited Partnership [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManufacturingAndServicingOfMedicalEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManufacturingAndServicingOfMedicalEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing And Servicing Of Medical Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Of Diagnostic Imaging Centers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable Related Medical Practices [Member]",
        "documentation": "Management And Other Fees Receivable Related Medical Practices [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "AccountsReceivableServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net of allowances for doubtful accounts of $198,593 and $204,597 at June 30, 2023 and 2022, respectively",
        "documentation": "It represents the amount of accounts receivable service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicalReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "MedicalReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivables \u2013 net",
        "documentation": "This represents the amount of medical receivable during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r288"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r619"
     ]
    },
    "FONR_ManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowances for doubtful accounts of $12,608,567 and $16,627,917 at June 30, 2023 and 2022, respectively",
        "documentation": "This represents the amount of management and other fees during year."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAgreementsWithCompanyTotalMedicalPractices": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ManagementAgreementsWithCompanyTotalMedicalPractices",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Agreements With Company Total Medical Practices",
        "documentation": "Total Imaging Centers with management agreements with Company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r131"
     ]
    },
    "us-gaap_DividendsPayableNature": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableNature",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Payable, Nature",
        "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r620"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r306"
     ]
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal deferred taxes",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r723",
      "r724"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets - gross",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF YEAR",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r131",
      "r225"
     ]
    },
    "us-gaap_CostOfPropertyRepairsAndMaintenance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfPropertyRepairsAndMaintenance",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maintenance and repair expenses",
        "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Notes Payable and Capital Leases",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury stock",
        "label": "Payments for Repurchase of Convertible Preferred Stock",
        "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax - net",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r149",
      "r178",
      "r380",
      "r381",
      "r675"
     ]
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes and noncontrolling interests",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r117",
      "r161",
      "r266",
      "r274",
      "r279",
      "r282",
      "r441",
      "r456",
      "r598"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized research and development",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Costs and Expenses",
        "label": "Costs and Expenses [Default Label]",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44",
      "r88",
      "r89",
      "r288",
      "r577"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r44",
      "r88",
      "r89",
      "r288",
      "r469",
      "r577"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r64"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details",
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r673"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r223",
      "r224"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-deductible accruals",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r722"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credits",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r722"
     ]
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r62"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r62",
      "r124"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "totalLabel": "Inventories",
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r722"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP",
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MonthlyPaymentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "MonthlyPaymentPeriod",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly Payment Period",
        "documentation": "Monthly Payment Period"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MaturityDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "MaturityDate",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity Date",
        "documentation": "Maturity Date description"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r116"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r310",
      "r311",
      "r578",
      "r689"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "AU",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summarized segment financial information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r55"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r432"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Voting Rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "FONR_SharesRegistered": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "SharesRegistered",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares registered",
        "documentation": "This represents the shares of shares registered during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return to provision adjustments",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r725"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r87"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r432"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration of tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r725"
     ]
    },
    "FONR_CancellationOfTreasuryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CancellationOfTreasuryShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury shares",
        "documentation": "This represents the shares of cancellation of treasury shares during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r432"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623",
      "r624",
      "r626",
      "r627",
      "r628",
      "r629",
      "r676",
      "r677",
      "r730",
      "r753",
      "r757"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r205",
      "r206",
      "r207",
      "r227",
      "r245",
      "r246",
      "r255",
      "r257",
      "r260",
      "r261",
      "r293",
      "r316",
      "r318",
      "r319",
      "r320",
      "r323",
      "r324",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r403",
      "r475",
      "r476",
      "r477",
      "r478",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r498",
      "r511",
      "r533",
      "r554",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r654",
      "r672",
      "r679"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r197",
      "r455"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of company\u2019s deferred tax assets and liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local income taxes (benefit), net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r725"
     ]
    },
    "FONR_CancellationOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "CancellationOfTreasuryStock",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury stock",
        "documentation": "This represents the amount of cancellation of treasury stock during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of the provision for income taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r361",
      "r745"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self-funded health insurance reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of federal statutory income tax rate to company\u2019s effective tax rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r109",
      "r110",
      "r136",
      "r513",
      "r530",
      "r555",
      "r556",
      "r620",
      "r632",
      "r674",
      "r684",
      "r731",
      "r757"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OpeningMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "OpeningMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Opening Members Equity",
        "documentation": "Opening Members Equity for each class of members equity as of June 30."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment \u2013 net",
        "verboseLabel": "Property plant and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r442",
      "r455",
      "r620"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Assets - Net",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts-AllowanceForDoubtfulAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r432"
     ]
    },
    "FONR_ShareOfNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ShareOfNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of Net Income",
        "documentation": "Share Of Net Income for each class of members equity as of June 30."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expenses",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r36"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income from operations",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r121",
      "r133",
      "r236",
      "r237",
      "r238",
      "r239",
      "r253",
      "r257"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_BuyoutOfNoncontrollingInterestsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "BuyoutOfNoncontrollingInterestsValue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Buyout of noncontrolling interests",
        "documentation": "This represents the amount of buy out of noncontrolling interests value during year.",
        "label": "BuyoutOfNoncontrollingInterestsValue"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_Distributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "Distributions",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions",
        "documentation": "Distributions to each class of members equity as of June 30."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r309",
      "r538"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r173",
      "r176",
      "r453"
     ]
    },
    "FONR_EndingMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "EndingMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ending Members Equity",
        "documentation": "Ending Members Equity for each class of members equity as of June 30."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Income Per Common Share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r160",
      "r162",
      "r218",
      "r234",
      "r236",
      "r237",
      "r238",
      "r239",
      "r245",
      "r255",
      "r256",
      "r402",
      "r440",
      "r748"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r173",
      "r176",
      "r177"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r538"
     ]
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "presentation": [
      "http://fonar.com/role/EarningsPerShareContinuedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding",
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r432"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r447",
      "r497",
      "r519",
      "r620",
      "r632",
      "r658"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r112",
      "r113",
      "r114"
     ]
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CA",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "FONR_EquityMethodInvestmentOwnershipPercentages": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "EquityMethodInvestmentOwnershipPercentages",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest of HDM after transaction (%)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 operating leases",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "FONR_ProceedsFromContributionsFromCompany": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ProceedsFromContributionsFromCompany",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution to HDM ($)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "FONR_PurchaseOfStandupMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PurchaseOfStandupMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Of Stand up Mr iCenters",
        "documentation": "Purchase of stand up mr icenters"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "FONR_PurchaseOfOtherMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "PurchaseOfOtherMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Of Other Mri Centers",
        "documentation": "Purchase Of Other Mri Centers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r675",
      "r724"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "CH",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of patents",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 financing lease",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "FONR_ConsiderationToOutsideInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ConsiderationToOutsideInvestors",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase price includes consideration to outside investors",
        "documentation": "This represents the amount of consideration to outside investors during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccounts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ALLOWANCE FOR DOUBTFUL ACCOUNTS",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r230"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_IncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r375",
      "r381",
      "r675"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r417",
      "r619"
     ]
    },
    "FONR_TotalPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "TotalPurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase from Health Diagnostics (HD) ($)",
        "documentation": "This represents the amount of total purchase price during year."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "FONR_EquityMethodInvestmentsOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "EquityMethodInvestmentsOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A (%)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredClassAMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Class A [Member]",
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConsiderationForNoncompetitionAndConsultingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20230630",
     "localname": "ConsiderationForNoncompetitionAndConsultingAgreements",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM entered agreement for consulting and non-competition agreement ($)",
        "documentation": "This represents the amount of consideration for non competition and consulting agreements during year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r655"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r60"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r60",
      "r437"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r757"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PatentsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_InventoryWorkInProcessPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory Work in Process, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average)."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_OtherExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and (Expenses):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note, Impact of Conversion of Contingently Convertible Securities on Diluted Earnings Per Share",
        "documentation": "Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Repurchase of Equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r478"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING &amp; FINANCING LEASES - Lease Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r594"
     ]
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AllowanceForDoubtfulAccountsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of summary of allowance for doubtful accounts",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r685"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfIntangleAssets-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets - net",
        "periodStartLabel": "Balance - Beginning of Year",
        "periodEndLabel": "Balance - End of Year",
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in the valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r725"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfCompanysDeferredTaxAssetsAndLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r590",
      "r595"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes at federal statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r366",
      "r382"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfStockholdersEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/EarningsPerShareContinuedDetails",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r259",
      "r436",
      "r470",
      "r498",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r534",
      "r535",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r554",
      "r625"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Noncontrolling interest",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r720",
      "r725"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Long-termDebtNotesPayableAndCapitalLeases-Long-termDebtNotesPayableAndCapitalLeases-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Notes Payable and Capital Leases",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "documentation": "Information by major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT AND RELATED INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r272",
      "r276",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r288"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480135/944-740-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "44",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-44"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "920",
   "SubTopic": "440",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483279/920-440-50-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.13)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.19)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//230/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-9"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-7"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//310-10/tableOfContent"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>95
<FILENAME>0000355019-23-000044-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-23-000044-xbrl.zip
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M5<>N>2E\Z=F\ZNF?4ZRY?PS(</*]_%TQ/5X</IIFC<KWZX[I"]C0=^+QO$A
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M[Q_M8M^ HTG#B+F?_%$_^4OY;!(0^7](D-T(1_3POI0Y7$ '@Q,A@S),P#_
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M,9/KJ-=SZ&_3[QO8@C-G&B]B&KDE\9J6Q-$;LB1J9H0:/]#IN8>CY&K4WRG
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M:'HN,E!NR8"<G'>+0\33*&4Q2R_PO7KW+I^"1TT;!#(UN,#A]8T6F+D.\S8
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MP?R%%WJ*,3G4L&*0_!X/Q>WEH;@%A>+V\E!<'HK+0W'+('"'%5>5D4I9J[$
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M"^>7^+*6Y5&@ MUNII\T=[C5,S;#5./?5.YWNN$'1F@HMP/T=+I2:B,#)@_
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M]IWQP_A<!]./R8RU/>+.Z5Q>_*ECWN?,:5Z99X.%(#F;FM^9IY-.-S>('O5
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M1A/3J,5U\CRG2UW^E]A/K$)LFQNZ^ @5-95-AK[S"T*T4?W(NT*$X\%+&U:
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ME#+O(E*J678+:/T4-1%X\V(6M!M(;MN/#O]([)..GA.$#>E2XJ%M9C25@-O
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MM0LKE;\LS?$(IQ!K]-*_.JX;>I??=5EP613U+7U%2!GI]YP$8+(#9]=;HXS
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M\+:S_A-3<7(N+ZKC#U%\3GLFE%[TP)G47/VXO;T.81P(7$!,W@5[S\I *54
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M1[I5G.68YN_!1T?#CR_E)F%+ERQKPY'UK.+QJ$9PB8UE&-GC%)$[LL!#1]J
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M9;@)\V2-%QWMTY6+(^3)-9V#65V@JU%J7.>K]P&VPU:6@$!P*[64LR?^?JH
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MZK0LDCNN[J4XZ4NDE%P>[TMJD#IJ$FXO1NJ.!#W;'6Y]S/P,"VP[O/-0[*Q
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M5IF>F>4I69^($00UJ?CZ7!O6ZHIK:H4@@:? $22 1HHI3R'?%LJ16ESA,D"
MF5\A0)EA_>P(*>3<!2P+X*OBD6767!6;I0+3R^=!P!W[3H8O9(QO%5 ;>+:_
MC@+N"14MW0=IKD[TNFTH.?V=8) !8E;^E8[Y"G\O.63=Z0%?*1<QVK4YFU"0
MX):5]A9)AW]>*7\<7=YI4G(?=W;!']GX91K?!+?@?#>-W,,J8"/%*I4@HMXT
M3&3"8<W:<9Y6KN6&M*+E#B3]?8GT"5/,N5DRA"<=#!@5TOB >X&TL409XBK\
MTIVSI3=+WC'(,$AFJZ2S<1X#A(:%--(KJ5]1,XN2==0KNPD=V2OZ36;T2$J.
M8\N#.:\%<[8[$ZBF#;)-9S8&1SG-+S+Q89DH%@(U7N.5UG?B N8 ^EUQZ%/!
MR5<  -]!;%,O#2&V\?9B%;NHCK[(N"V=8@2B? 8F8CI14'PU&!KQPFX67L5$
M]HQQ<C?+D\P:XZG*YWGB<S=]?R?>=Q9"\I,XJW-GAR4)P,9%E;@FCXQW(QFW
M68&$>54EH%/2Q$[B0:_B<8L0&<3&H(!FNPW\9>XX-,=@M\)'(\F!N>1;W.27
MGX$KW*.\JP2K9 ,=5%VZ6D+=C>'%UW%+@=N1UX)#VWR.!C#UV$P4SD9',*2B
M'1 -<?\5KP5S%4*USJJ!9F5N2#?#7#76: \"WF[#X4_S3,0X\9X2@[3X%%_7
M@8E>S$HH1V38!QCY1BAJ2Z8*;>IQQ\E4EMA;5:\ >,9>2_*W*M3>#:@D4!GG
M8!(\#ZEKV5&>2<DQ15=D"M&D^:3#]6+;9$"S6FNR0N%S#$JS9I129G21+K&F
MJR"Z"\<OBQES&FEO>M_+@FL+-,W!C$YC:.%A]!KU!A>E4&ES98Z!O[O!\-YB
MI(GL7R<!39<G#+_A1(A=ZURG8V]FFMK-GVTX<<:XBD%0X'-%@<?.:QM%L!=9
M?*T8\?:ZTA!KTY0.+K?S0-37=<Z+-;4#9EP1YRR$!N@+T\'>#B<C\/VZ%>PV
M,L1X@]<MY<* QMM!1%!/"M7.XM=^T=+ ]4UOS&F+\%H:N(86=T::'YXJNHQC
M8=9#SY*B#A]Z7^38A+6AK,#XJP)Y@WW&UL-P4H]9$)D2UW&J@P^TPL^UJ+%2
M\/N$T Q]-$\4QB, #5DLN?"D3RY\J^3"DSZYT"<7OM-&F&58W(? /N-(BX3W
M43)39,7EC<5_U72"3TO*^N37U\X,1-2\T<F@%[!P46D)("PCYGX4&DK6^.U8
MBE"TI!JZ:3:IT@,K*<C!+-K1Z@Z[U=LD5@"3EO*H!&'_PUPM-EQ4 VEO1C&/
MP+G*K=UZ2,?(CB<D=D3?[N-F'.4)V"[)3!,'-H%U$X\X@,4OA;[J&O>;& /9
MC;PYW/ J1<<.::5TQ": 1HRG"$MC890&/=@V'I%O2W*P8RT\-+.9+EC#Q1K0
MORRR2DZ(-'^[/G1O:%J03#I8NOU/(Z8-'VF,Z+U7><]3?77XM[>D]\[^L;H"
M-;B_=WQXMO<J.CDX/7I[LM^G6._=BX^KJX$2KH&+!Q5=[^-,P\E!"?B.QY?>
M?A:4@L9U!XC)SD: C][Z1%\/^A![R'CR/O[F<JV*#YAVH,4%181CIAYQ^>YA
MA"&CCX[(!>?M4D/+]]["!3/X2#N*H#ON^(_? N#4SM$/?#I;GLP96I?1MUM>
MJ@%\?MO79ZJ'=WXSUP!H.6AQV^S>:W%R721)H[\ #WH60 /U4O\@4C]3F\Q7
M'W^RQ&][':6Q=PC]G0-V"'PTG96C*UA9W%7=S>:F4NW[6"6\4XD8&Q.L')7U
M/H/[X-*B!N BTA+P3(FT>!1NYLI$"4(H/YV/D.H%";4Q3Z;FA$"O6I1E<8UH
M6,@(#)L=EN\YK4705;CU%$(R<++'.;*2,T4WM$+%Z)UV3C]K2-P8[3:071X(
MREJX@.?[&$V]NN_W GG?O:2HB0>)=-#3%;*S/!EN_61=7HU^94%%;C0 _+BS
M%9"M=5EDK<]O[X:24;=AXY9B 9=HK_?:*\SU44AE6:S8CCNZP9M;M=$NQPNK
MW3N^_N/&^D: <]T6!K7U64=<,;:ZRYWCMI+"DQ\W=M8; M(TX-NS^-A@VT_"
MFZ]N5A-N#J,7=^,B&M.@\J/'=UF7O>@^1&V*O^JJ8F;L#UE*6SS&)L=MM+(>
M.?(A=\-AOR/]:28%0Y^6Q6493]B0(<]DAD+4F9+PCJT+M[NJS#$E<.301TPU
MI97D5VK,X-NE]8^>WT2^!$RS@@NW +G7L>PC'H&D/@E77-Y(:Y"D=9$NU[:_
M\1P,KWAR+I!+WEH';K]Z=V1Y9?$H,=LKZ)G,&JLAL5DP2=RU8LU"38$@TFGK
M7&ASI >./K>]T7R$ZR_<W&[^H863]X9F\0_2]])9]_06&#U7[(?:T$K@3/**
M%D#;*WTY8F"6VLIC':Y2EI@F+(E\"Y.";'4522R8F'S:)R:_56+R:9^8[!.3
MWVEBLK_>V]<[*W' KXKJC<,^AV0RO0(*:\2)1\1J[88>T73(/+8+3*[O9-SH
MU_:H#]RQD.1<-.0JT/E.E8:1C"R[4BK>Z;99*R[6Z*)8HXM_8+@ Z7M?>!7]
M>Q9SU99_F&O59Z(<+3_E"D$8 ^0 &%ILD:])Y54P/91&^_FYOMLTI]ED&9QE
M#8#X2QLM\@V\BH\BKS/V20AA\7%L]:60J"42?J3J^>[EH"IM,W"BFCC=W /F
MZAV%GHREGV4>T3=?T2WNB4/=85/66G.XYO+RLD3>6@I5V6[F+B* MP7UU\/H
MF,Q= $Z@UD^ZQJPDVX7S A9X"&_#/BH8]CF"99+(:63%VOUW24+3V[DB^(I\
M7BM-@[?/['N#9C4^OF5=;))'5T0-COS4->F)VBH.\/8.:B<>E44E0!_G15R.
MD4.IIFF=A%8S=WGY@K?:& 7@ L;G1:DJ1#JG*@,.\;QO*$KG>09L!!IR=(#P
M4D1:R\D$.GS.)MZ,2R*P:*CPI1.H[67\[.+:J.84Y,040*04<V3KOTN2*6O*
M$"."E%"&)CC#ND8%WWEB/5E*]=&FI\-+-OI[^O-_WQ%Z 59?74E(.HH)>8O2
MG@AA$4=$Z\I9>!#%%EF)HTK*69BX AV$>*"[19/\?5H6>I8;E(1!N0CW&%0S
MM$X-HNH*!1]R_'0*XO^@2:]VW5YZ%G)<$-*%H'B07-39;&T4['9[BU0&0@?D
M#<.%]6&KAZ--8H.!3V[0P-=(WT"WZ8TO[*K!E3.P F[^,IEB%[3;/(:E_X([
M9>RSQEQ>'[0".B4ZWW$GR")2C$WZC:8Q$1TDZK]FS!^K"Q/,6;0C73.' 9JV
M:J<@I9[[(XTPNB2W]6=Q:T)Z5112N^[[+%!-AK",5+XWGO,5Y/F/([K[$LM7
M"%F[M!9(9>][H"E-+1NSY#QTE,LW1\>6QHY:66R:B#/DNT8(TMK]MG^QNYU*
MO2G.4PNH[9T$<F^<K>6R/FT$+"4&V6X0@_1;\V6POP:*H*1&E?7N5U'38<?N
M\07123L4D_%[D8H14QDS3 -G4TY?X/0\"K._I+Q#C&#_PT;XPWH337AC][%>
M'#IC$QQ@C4H^Q\ +R$LG][U.0I""H!06_KN9:6I#6^SX-)F2HX$[33WD[=ZH
MN>_P$'G(?IDWMC2CV\#L8 P-SI)*&4B9N!H1B.<P.LJ#K=I\$H[Q*WQ ".!S
M-F&ED;,2?8_<WFPJ:&P>7JTN!,C6GF&(KRSK. U:7J?2Y3^F+8XD6KD:UY"M
M*5E,<9I)$;J$AIYW5$!<-QZYNK*QOC78V'Y&AGML5V58^M++X7T3B?">K*[L
MS2YIO"Y ICRYE@Q=RMG"(GO/50KB3#EV*C$XA79*0RF^#(H,T4DJ=4@J=QML
MJ3BHXCHDNEI=06D>-^9J".$-B:R<DYV0#+%)X5" YFL:I^.&.P"3GG7=]D]1
M#% 6B=L8(+/O'@!^,_V[=AT.TVE&JW4^3Q/WD738LSX=]JW28<_Z=%B?#NO3
M8=_C5.7+Z?C//_R-4TJ<9P*+559P_)T^(:]Q>';P>G7EZ=XP^MO;O5>'9[0]
M?S_@[:&?WYS9+YX?GNZ_.CI]>W)P&NW]>O3V+'J]=_+7@[/HY/#TKTNQ(DNT
M>0VG:5PDXM,JXL5- ,C-+JO8@'R1P2TJ.?\X8"@&FI,Z'2/^W63&K-\79&D"
M^P&7#1(5BALR3KBE#SV<BL:7?H"-6"K645W.%%!A+\LLL<)C:1)"\T@&.XA2
MJB)/;IR5:G\(N"PYT]1;F?==-)MEW%$15)P-7#M/6"*OGD"KI@D[4Y<TGD %
MT<:^S5/\Z[1F61G#CBD?((WS?>[0%\[J-*'3+,P]ZP;$T8"C>N&,8EY?!1\K
MD*='1%M[NW+&.%R#R<]=7/WJ][.ZYUF)+?"LEZP%32QW@/WY=?;5B\,W>V_V
M#_=>K:Z<DBUU\/K@S=D?!97B2\7QS?.#_[.Z<G84[1^].3UZ=?B<UN]YY%8T
M\@L:M>?N'?O0D6\[^O/OMT_W\'F9WOJ&@>-^AX/_ WN0=_CUXI3^8(XF_-Y[
MW#\:S@WL7&:9JWG#YUD\>A=A9+Z''L#I.][[[6 83HD]^T77I15 V.5XR1>=
MVCBZ*I.+/__POTX2A.B/+O;$+"69>)&6].R3 _)2SZ*C%Q$$\/B _NL-^3D'
MOQV>GAV<D  >O_WUU>%^M+>_?_26/*0WOY%(GKS^WW^*_W+G#LRO<"!.7_I:
MV^M?O-0/)H+W/? W>#LO-;_&&8HI3Z^2A/1;0S']NO>*%--!=/KRX  Z?F%Y
M^%(9V/K&J[17!YT<&+'!>/??*AM_%,D7ME1GXK2$/[B+67/N'[T^^ 9'X,DW
M7B[KQ_P'$M(RYD%8,VW3^Y)G!(=+AXN^:#PN5-$1^U.ZE&_G3^FI;R@^X#[B
M.\_IZ=G1_E]?'KUZ?G!R:NW'!W][>WCVCV]P=I]]YV=WT-]GR_]V_J0 UN1%
M5ES?>4#V]TY?1B]>'?W^#>RYG6]MT_<'X@]U(!"CKG[XRYNCLX/3Z%.B+M_@
M2&QVKY;6"WRT6&2W+Q;Y5L4BN\M4+++^L,4BWV=P]S-*6!X@;OA5)WH>1/%O
MBP?JA!8/"ZZN2%SP_&%?QJ6,O6 ^_+.4SN,49:,*7\1V0$<=+/WPW_?^)#E<
MU13M%R6)C6\F/37TE32IOM[6TW3L[>]^Y'T][6B:YIJ69@:-CA3VUYK*5WQQ
M1P8W&W,]!-?1CD92J<-ENF%>_UQ"Q:LK%8+%?! ^+C/1(PP*7WQS_1>M >*?
M-GYY'#"*SEO? ^T=%NK*QD0JMR=<%2+X7X/H#NPQAVE\00Z2%",D,2CL!/"G
MOBZTY<)0B[BYN!N S J.;6IYP9UTCXS-A$'!2\>G6E@;M*Z!+QGVKV$+PHA+
M*'(I1!QE#;J^@?KXBK%FX[1$.WK*?*( 2-".(/2<@#.M/8;!G-N[NVZ!._?"
MO[2#1>>*[* ?!#V/W% "=,U[6&<FQ.&*$>R@,/2ZJ\R*M &O*URD:#BDOR=3
M+?%A3M!FG0_-8F]"3QS%PP<_6@^BO%D__,HX'UA:55H/H)874$3W> =S<W2G
MM,>E\?6$9%!\^@,9_G]#,#&AEFNQ1Z6,(I!\P.F!R-I!:W'\TD"=TW <"#BC
MK#2!L;"ZPH3/T71VGJ6C4$@OR. "9VU:H=,@(.H[EH_:V?,F6G3$7 CD&*CI
M\:@APH^C1__/_]K:_N5X?^_H5_Z7M'/%PGM'RDYUSCDS*CK.2'ZP:@2KV7+4
MOH)J78Z5NE:G^'9X.G1$B[X04ZBD7-.%ZW*(RIER56$BCJ773OZI'P#?/?@@
M3$Z8Q"2M*KLY>&WP;G<>T.4TL02, YW2BK_& E1UK+_"?:"-&X38MH:R,-$9
M]WS[O^JV2TO?M39;83&U@UPV2IX%TK=S[ER13G?>N;ARA&GGQ:S!M8$>PUN.
MXT69*+>D7CC81_O(P TR%N@1N@Q1AEO2UV@J32IR[1D/Q1=6"?K92VDSOJ:)
M)/DE."P9$49>;,#8+7@QNXZXHR?G;AP!%0&S2(-+#BX1'3.&?T##NY7]ZOHH
MQF$X%5VO.)=^-FNN5\OC$Y_'%"3<&&_=G[.2F41I$-5&TM+;5DC2<T\V!7>5
MSJD[FX#@U'SDC5G(Z)\P%X2'CK5@7@A$@3[YO_#D'86'36%Z5(::)#?,\4K'
M(5$DG#*MWE6W"KECH^TX(A\Y (/P@+:(=H3U3BZNL2AK2 K/94BV]>@J_+1[
MH>1#3".!7E%(>FITMIW#5AAXVG'2S'%IE.D@6Y@9]^W8]U*8<>;>BRQ^]V)R
MK>IJ*JRDS4#)R&WT3F-M9BR@ :Q0!'3]"9MHDQB-?S?!/<Y,E]<);%NT]36?
M 6DGR\^LX3@T;+NVA2&1M&W;<P#IVRC'!</"..5X[JRMP"[W9^2.X.SV^N<%
M9]?[X.R7!F>WUY<I./O'[>3[^E.[[TG=&H?]W/!J]&B_$,2V\>-[=;T^,;2]
M=D'72';S\T>&Y8\"D$YF,N<O/N0JW]Y3] 63WX=W,L)=M\<6Y6N Y9755WR;
M^[>(-N[TM:.1OK+:T!-Y8\::F>7<1D>^'%V6Q34;Q?;WF"P1=FX%.BHQ&! +
MYCB+_-;8E7HJH(0.G@7CJ.7"-J>B?JN,;X@XB8,S^3EZM/%8HW)"N.O[]D+K
MAI^N+R1&G0[<[>K0Z(\V'Z-)L: %IVG #F!/.N68$SFR698(L35 L?XE]CI3
M1R*2FB4?:-G'EVI_".ZAO9::*[?LA&N5C#-P8K,7<A-=QS="!-QR%;K-T#I^
MES!71$P6:9$E#L4,*T!C,S9B,"$UK&Z9$4O#($"8K1+RHNAI;C:53>>6$1C9
M-;0/Y_>GT(9*IC>7_;Q7IV3# EP-_<''9)R,-)#]L[A[8%[^X2^OE>=KSZ9\
MXMB]Z)\54$4YO+NQ\0O]?"&XI2@_6%W9NE.ZG&JYWQC;QOQ%>=?KF>Z+0M47
M/4\JVL,IR^@#W.5W*"=;;B<AGDP-P8(2;\$HO'2000 B?"#\9[@'B8_3L0NM
MSL78^3MA]$NHQI4<'4]17&'/X,[JI0&0QTC_!^:S(!(@NMMH7-&33$JAN$90
MI5(<'/%HD(8H!;1UDI0C7BP\X1*>#"-3TG<];SNSVO-1E5>:3?6EC"U*$%-8
M&P'7GVGD6WD3/R5#2.$C%W.P5!(J,D,_!WE) \,%T[WG:%! 6=9]@,--KBMK
M 9U_^=457?U4<*E'[%DS_&R5XIF*E*@))% ZC-D/I,^X0&,83K0@X46IV(/&
M",^-XWZ%YS:$K@]>*D];S]OLF'<!5'-9U&GP',:N(1=W&!SWRJTLS9!4II#L
M-J7%_WI4V#X)>C;#)-(H)+DJBG LW9=)04L^KLT6S.@R)>Q\@)/R1Z QU7M'
M##9IQ=38,Y>#4@4G()T@7IO6@JG$42-F[*57EA5[Y([.55K51<GG$&>D3.%!
M/0Y?WQW/VA[5U.O!J:6#Z@,.7>>/;W?-H'WB 90)GX'-F%]+I%U?QRP)!0)B
M;&>[A27\X&YJCG].6,]5P]65P\82!4/:UN,/I,C(SN1%T(U$F$?@7NGW\R_0
M.L(^O.' GR7LI'&EU95@^:])/0-J_4*&DA5#XC&I;<DPO8%'G^./.>A<AS8[
M #$<X V 7"21_8'<1AJ/*FF[Z 436H(""D#DD+FJO0P. F1M_WBD&V! ,'@H
MWR,X8QWO:<)H%N+\,E\KIQ0L)SS*]@V'6*-I@H?J TBD-&*:P72FR]V]N\IR
M+?E!([%V**Q=%PFP3N?%^2&LD4^]JU^2-<[GI_/._IV6;F\\1ES794'E$P]T
M@P?!U3 J&6B).]9V=47/2/=-;W%%UO<%KA3:JY\[6F(_.4*V>$ML&+M9GP_5
M?2Q$AJK6^6#3^G!S)\U_N"T697]>:__]'IU@3D=):H/CL<WDQL#BK+KZXP2'
M3?GB$%C6WWLFX+D\A2&D:5["W"Z1S4\)KK,(\>$4&5*D?4%X U:RPK(+V2YC
M@NBM[>[J83177=NHK.TEZ$LE2&4A /: .YV,KO(B*RYOK#3#20%2Y730QZ$)
MX&Z&\U18R:H;&G0BUV95%:"'IF= Q>,&[3?UH3?5G_V.ZWN2U%?%6'97D_VB
MZH-[=J"Z6^@HJZN6E7*CC)&*TC.38B4N*V)TX[EGAJ:H>5T?$X-;[[>/[?-'
M@XZ?!..XO=%7YG^KY,]&G_SIDS]]\N>39OH -7ZWMR:$3^FOZ7NRO6!)B7_(
M%=OL";?<+P1GR%?&_<NFLWE=#-N."%IYF?C06D#LX3'T[KK2^9O,'L]PB6.\
MG&8[>E/MJ\E &']E<A?RD+C>K+Y2!AF4%;;#: %V)8=/4%%6?*IU3A_+^?=:
MEA<$O/[$=6[S0;M>(+Z:0)"9?)7 *=-4RHRDX\:B;HG/7FC\6 LKTV*\EL#S
MZ@A[];OWU3PO+:XNBVD)]S>L_DSS,3VJO!EX>C0)R5I('5S?:%3S:?99M5C,
M\XZPW&?[7?>2&7R8&HD%D\$^%_8B23Z2$\9T-3.\NM)(#4=W9H:'#YD:OBWM
MZE\,0;5;LZ^9*\>X %EK,:L=XYBK"7%1 34-[&?PV4B<GZ-"KF^L0F,#]T<=
M[[MVJ$;F5#(W+H4Y)(_OQ@4#.1@9S@,3H\GZ#@C-F]+HD;'IA!DG9IWMX$*S
M/E!WMYTGHYB.DVK8<,$JZ0-A;[I&U(LS#4K>QL_M.DV6Q0HI,R1K-_^$KA$J
M/L0MK8X\\.UIK$9V'!,+>-Z"-6F5:=A4[\B/A6M<-F;3J.BUO$1%CCM^G1M+
MS!W) .ZP(9FY^8]D.C\KZ;>Z<DO6+_I&23^4- =9O^@;)OWH,FEF_:)OEO23
M-(//^D7?+NF'\&:?]?O,K-\MRBM<4^-DCD36Z,A6M>M7\\5^P3."C(#[D"F.
MVVXM?0AWU\(RQ?*2]73-J/ C9RXWE+F]1.!:!_4SYBM;?H,\H,NDO)>NTD\Q
M<CY]K#]5?R(I*4>SR3RFWMI[4F@QQJPF<9:1^SZM?O@+6>_W")S<90YW/O:V
ML"&0+#Z,/_QS]]F3?Y+V2M?66+"+$F'??X[0G;S^='WCG_]$T_#ZDZWU?_[G
M^.+@V=;1U<&[<J?+W?CTF:<??B;;Y<V,>X;9P:8C>@)LH1>DZ_'HM?6G:^L;
M=8&'KZT_6=LB!R>GB?WY!YKJS\%,85U][BXTIO%][,H7/-DP!_A(CJTYOAUM
MB&7I2-\C=+^QN[L^D"ZU,5?WQN]@;G&L0@^\YHC+2V'2/8O/SP<T:IY>9FE<
M%H/H]>@W,C4&T?%P?^B,37S,69LR7&Y<(>6$*VX;#*>;Z^L;O@8-]+PEBAC*
M.D\$&00#1O\JY(;1+7_UZA@CT7<W'TI#^%.RUSPE@'PY''>?D^3UV\M_;Y33
M9T=77W!.?D$IVC2+_W_VKK4W;:5;?X^4_^!3O97VEDSKNTV[]Y8(EX8V 0HD
M;?H%&1C "=B.;9+ KS\S8QM,8L A-MADSM9[FA P,VN>=9UUF:%(/-)5<;&-
MN_0/_TF*DB0/+$C'/"/=A>$F:(<3K_^[I_[\/?G^IZ?%MV7_*S_\5P./U(UA
MW=&4_]-+&KA,V;6HS_\%AT%RBMM!(8Y;'/SP?8WDBE)3QY%KU4-=JW+D6C5>
MO._EEO7@*SW\L+QXVK@ME,5JQWQO[<'>DJ<GSSOGIW][A58KB94F@O)H8MS7
MZSQ3Z; LVYE?UJ^O[0?G_F=%AD)^.H%+G>&W?%DV^:)RU(81"*^WDJ(JA4@M
M4N'CU-[=$"?0H4<:UA?JUTAS0,A\$6S2/P(D<'V"^W6/Z W+UT+43<PM8%^]
MJ-B7D'+J^$@5\NS"P/SPIJ4FH6)V.DJ"KQ109XDOIH-=&8*OU[>PWF7(TZ'P
MN L=/56Z,*#9N)7W"I] [85>_O>#O #BLX%>9\\'>AT.J*@OH;MTGJ%CFP!&
MP+$5''P&P!&86D/(FPAYU[3(ARRW4&R,V %3.S=453.7*]@V<.RBVY2BT+5Q
M5EQ'._NPF47#K&MKV/V+8P2:XQ6:$\6_4V1H>_MSU^-N^0LQB_9E:7B1K)2M
M*B6D(D B0-HV"V8INLL!T8U&&!7T/OH'#?MZ4,?HMKVB:M8URLPH+;K$=#2&
MK79,DS&9SD0M%.>BPG;FS+#=F@L5^>9.VT'8KPNE>($:4?JXHR*,0]KCIMIH
M88M.YF!)H#5'[RU<B;[NY#G7CWH=D);_VTPNEMMU;7'PLG>36$$V"TJP<J\(
M/0;Y$ID_/JS<01;L^B!X[^@6Z_[[07MRONC32=]P^J"GH?.GO!]L]R8,\@W
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M+>0%FE4BEV*GZ(37#CM8:-86&(\U??@-Z,!2QY#0A?Y$TS54).IH#V"CBC6
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M]?X9E4FZ]\]RCF$13>/LYVO#O4(!$)+OQ#(\S7.IOY?^F[![EO3.:SEB3[S
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M=*-X5J!E*?6-?*-<%TK;XY=%UV4-.%'K]*MP;EUIQB-?U_-'X%P%0I;^]6#
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M93L@53?RC[\^;M<%[J%S3G2VV>/H&9IC%9I1(E?=I@ (Z]*I"-\0OMG/S:-
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ML+^H-"_14M;F@Q+4OR/4)Q AYF7H1!Q%?I0<GIX,";RXIB\:.E:5D+X-"PR
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M+1;7[7@CH+Q-=3;M*1Y0\<RG#>7)L8 JA,2>Y?"2SS]1I:F%K"?TYQGT]2F
M__1]J@/*"Q=SJW:;WY2V3ZWKNX@(=7KRO^<X/5OBM(0%^]:QS B?'.OB$RV$
MD7AF!SD[AD;568BPL'VP/@U^/USW&K+>7F#57QNVRY8;0QX^?AY5H/[ZW]\;
MH1EQD]&*>1<R;\MFHF<01)M,#2W$^, YQ"$7Y((OX?1*+1_,-72/_1(X(U0]
MC9@=@6$A$3Q- K7/4MKY&+(M!^*G-P+]Z1@>3?B37KX* +HOC:S&BQ4%_):T
M<N&ZOP!6:>UNS<5ZM^6?1-[XIER3/6E1F4E<B_K:<Z$X<)M@^>MF7;E4#\]5
MR$NXQ*P<?\_FO\\'=E\9WRUP45UJO5V@@27.^BUM!,+^M!^73]SQ>$D]-X0&
MR0<Y+WH88>%E^_$$S88+>:2Z +_+T%$$W W$(3U*PDGQ+A4>V>G)<&QT4? 0
MF2L3>$;PQ(KUZVHIQ^8IJ%.IGCI%=H@SM;I0C.M^)!W^8"%KV9GYAL\5A"%\
M(^9>-\2)P:%C9P1^@QLA=/\"X-D:$Q0*Q3&8TQ/T36K_ 8("Q8, [L"!KE&F
M%O5H6'>0+WJ IL8:E A]*!/H0!H4@@F^<K 7]P8VCJ4.-$?MHI#K#'_G,J2S
MB"^YJ/6UY*-J0SF'\IH< T(9<@[E;1(SGXTC4O!/ZG@,,1K4KZ@_MOJ !C&Y
M$:SG-$5?C\V:P=2"?[>HL6';."[KW9; -_>]EB3(&SD]03<[U(,QGDY<>JL/
MA@;_/_PNU.U,&\"SA.S2UVQK:@8C>(M(W,K.)A NF+$<]0Z)<+0)-R*,/V1#
MJEF8JOVIY]#"[SP]@4IT:EGXS%T'%L=V-3<NA_?O ^5!LZ;>6:(]H>LR]/:^
M-D%Q>?<V"(<?1^C*1A]Z  FB:(#3QE;"B>XJT.<@!L8^:C#@W NA\2>J -U?
M?-7P" F% GFZ?X*FA>+B4*;@M<(_/6KC,10M0:*CS#HO^\I&=W;HVP/AQ\5U
M%1+9FC[%AM4&AEDUXKM@K$'*0KIHS@C_Q31L^,T/\'FJ/:(&$$80 PA,?=!U
MO.E>\ ]P(2/X"TUISG+1WJZ\E:!;L^4ZAP:^T#"L1]7JAR<#(HT&<+<;$$QH
MX'B^,_]Q6Q\XA>NJ7;E[<U)"$G+JGZY%?0[F$&#UYN]FX^Z*G;GV_<IL_RQ5
M^M_9Q':W=4V;$C$YDHAYJ$1,[ATF8D9G'JDSOX6R;%*RB]<-,96BX86LB[Z[
M<F?.V[W^!2LTFI=RS+L[0/IG])USG?G@_DJZL;[-?O12N?/=,D-?18%1Z5$7
M;P=LX??;,_$.DDSZJMT^#=NJ/NA>WXL'SSN,P+*?5_(^_TL@#;2UM**CYWZ>
M!>)BT1[0F=_UGV;Y<V-J]+E#$]Y-^.1"$CZA#3@<E7X#[;Q79J4/_[6N+B\+
MS1N4[-FJ?JM5*]5BH=:F"L5B_:K61EV2&I GB]6,Y7?&#Z/BHC('VN'X]&=K
MP"/PP0+N#1^#YGBC)++E6<F^35;E+M8FE3ISSCKC^_6?M8?SYXH^.M4;BWQ#
MG-.WLLM,!$2R%KO96ABVR%E#WJ?G\F/O'9L6P2ML&F?&3-1;/"H&ZYOPQ#T_
M?\U4+<>+ OIY/YY'BE++%FW?W52VX&<MX*]JD6VS4O:VLJG 5I:YHSA]:0 _
M=3_5;.S*HSC .!@:\9(C>OX%B+]U',:V(!W=N*@-'6WHCG<!T"GHK4\@"1UW
M6;T@>+,<>4Q>EUZAB[<RW,%$=:M[@F*O'!![JV_LS&]J3[VKD:[I%PG''9:2
M#II">;9Q6WQJ_)Y4=Y=T5[:;MKS83(8!DLJE8O%F6@!*F94,Q2@2#[T)7:0@
M.89#;\OLUV!*O!="'&/I $QG*8Y6(MDH# KEC 7LX+T&2F)$L53@ \"-TMKV
M=&*Z@L49J0ZEXD"VE^8/12U.1)PLI+"7B(@^.M;<6+4O7ON:W1L;]M1R4]MQ
MU ^N& JV-1_RUKZ=0'BA+^J,W8#QQ+"=E0CS<G\6&./PMN&E-J+P!EP,BH6C
M6@*;1G%E51^B\;G>QFA<$S&!'U*?O&VY3^FC5]PW40_J>.K%G //FMI@,!W#
M#3ZX*L2TD'+Q%%,@97I!&&1VT^BLW,(!N$8#[F(EL1E]GVW[UU*(;$-7N@?K
M%FAJA%.J>JZ>ZD,T6RB/%@'*WX(VZ4XMVP6"GPMMNY':97@6$DJ#)/9./U!H
MPLI?@W<0@;QKJ+"P!O+PCN\)X0.F\/S0FPQ\=;"@TO)LH/9SWP5!.AT[*"=^
M.D80@NBS3D\\Q6G8P8]D0@H<2J.A.U[=,:S9+\.ZJ^H-RX ';+N&^C/]%JP'
MW/2QSIRY9JZ5^<5/0U;WI>V$SOR;D+<+EL0W'I2=M9V_+XWHN;B7&B"M:\YK
M;DK.,@$,V=DVC;/EW2P(OPS$JPY1H>0!4/*@?R'L<IJ>,UW@N2F/2(YAZ0]_
M=&41E!]0CF !8SOT0NZX56L.4KP#S;)1Z0*Z9D4_&5.'FN!,&!K5R+DWN42$
M;!(A#4]A-<8H0J3WR[[.VAPE"(YTBOJ(SGQ8_G,UEYN_IQ-I7Z*ET)FW]<EH
M4C_7S+OG@8K7A S</;H)1HL=9AA:J5SJ*ID7]A,RJWJX*,=/7G6?".T'RTW+
M7%S%:W9 BB#!08WQ#7VO-YU,79NN#Z#!#JU-UZ9JA%IL <&&TAQZJ%[-3;%R
M+74]Z-6O?BF*3_CV"S1M5<W"MB.@ Y9\%S\9VWR4:D+;3+-1DL":M6A0YKJI
M1HNEHR=#";<TG(.^P]0R#92@,;7];%Z<#S$<.3G4Z= 3D93Q '#E+%S@<KU!
M@_83=8$R/4;&N']Z HU$"W["L\TMX"4_02_!<G!%DO\XRAXA!\+R7:'%$P<H
MK]OS,2:JA@N"41DBM+NA8/]$74'%@7+;H0_C&K^6:TJ>GD GPTU)6#A8]M)V
M=[T)VUFQV]>=]_./XYW [S,>_)K=E0B49_,B>QU9K&C%0S>QQ,^-\1XP&+N)
M0,M::6S@HKJS0!9/^<D$.OK0 &LG%/K!!<[>TDV(%?>!$'K6$->@!?,G/E%-
MB*!'=>PNK L<1+C%@4 AKSDJ+@_[1%V&/AWE>[LK< SX5D0HB#[C"1\^Q.6+
M/.W5:##*J/<QVG27"^5]X*N\R0QNMJ2?JLWCO,DYN&C4NI/&6:.UR'/<LLBM
MK=>V+VB? \<4A@U-FZ9B3&K$F48O3JFX\RD]3ZB?U]KY1GY\U;@WI4,?4P)#
MK#A:5OC$#PF7//A%%'9(%<7RGA1)"A-IE@?(?EYR:J@L1I+%?1QB]4!," D3
MY&K;7S*AX>,U1MPD%.9%"LKZN^[X[]APMK4?8.U?X3.[@,JNJM^@\ZH8E@_]
MH&W<1G&IH'4=+4%J8=@J@>SU-WYY9_YC.C!FC1\WCH$"W-,)I.8,?\\7JK2,
M[^6HZ/>M\,WN8BBT&@1>O![X\E\E5+TVMO_>U0/P>C>K4\>(DOFE,!\7G[3<
M#I;HHQ^BC0G8,N35A=6RT>N6MM(OW),SMC._-Z=/_/B^-N>?Y_U%YZH% L*I
MCLR-%=ORI0-#^K(?5U_V P_ 2$)UE!8%&NZJP'L&\=+X$Z*$8I:: 1<T.3?8
M^N,#!7!--%;4K5S"OU]"!VTRG7AE2IWM7W$V0TFLJ_5PRR-;O&W1P*%4O&C4
M?TE@_OQ2]=6=F<.T^&I'<[2ESNJ.O(JWM2M<,39S-NA]Z4\M9(%%CJ M:?[A
M/_%%*"\&.S/W' I,0E!0GQ*%0N&^V&WW?I[]M(:O/M.5I>WW3%E^W:%F1$?L
M."8IC;,UFGYS.G=5SWM#]<'$T/WF5T1Q)"LMXE <_GF6X$&ZYP@_40J>X@LI
M\NU[\>HWISCSW:/\,>B35R\\7IFT5B3%JF?R*=8S.R!GSM9;O.S\G%[T8M$_
M!\: _#[54KJ=ETNU-X*:T)JYBUJYX'G?:JB80C6T>/?BV(+O].4&R_8LX<*8
MJ*7GQ2K[43E^KX8-BXQ7LG![T2Y<"K5+-$ (3.]7Z^'1ZFG]MRF2O9_L.]49
MZUR9 RJ*RM32-=2!=*DH!O"$X0OV^]83I33KB<6IP7=6O./RI<+=[7U?O92L
M/^/#JHGU:\RB#W*69BVQ"0[SOOZG,BO_'/X2XE$2^SK7_/O4$>GV*P(96FA1
MP2RM]ZTN^#2KB\6I50/GY0N([_/!Z/:[_*O6W#T5/@Y]L6&1&5 8N(2%_;HO
M;S,6M;$1%F*OFV?*#S<S]O7G&ZHW]G:^+/,^-<<Z[\++3)&5CSN.5O54Q_.;
M%!:G/:U>P[!O;U)P-M7&Z(D;]8G?9VG7+26M6KSU<<RN"URC9A(R0W_AU8%^
M :)-'8(WRA7_!'U1,BI]E^3:Q!!*>U(PX=OQ!='J\F(.62EK94\H0%(&X.?C
MCI]OQIV?F[5TSZ@=YWC2<>Y0'>=XTG%N0Z>J0F?^[<?/X6_'_E'4M%1VG'.;
M4;ZA[QS?F;./CW=_SLH/TI_DNNJ]:DVESKS &N</W<;WRD,WC?W0$NR%UZU/
M'T11-Q\&0AIW7DNX%Y[4F5>O?_PN@-_?1FH_C12(LQ>>W)G?3EM:[V?QX:J9
MRMZ';Q M0F?^73!'#:7:+DU2R<9OV!S3F8_O!M]_SIA6\WO<.(U'-]06'?9>
M4='Q%V1K^,I5N?3W3G3)HVZ>/WH7RF6^6ARDDBZI:/E8G: ".3S$PRKAPE=U
M7!]<&/KP @WJ*^"ZU2KN3.9.9O":V;A_<&ON-Q?O%X*]0.+_ML[<*7^_N&KU
MS.K]VYM)1JSS5SKSOG,_5=FSVHWP'%VO"*?#C>?PSD]/W"V^PZJZY#MF+>9'
MP=<,/!46ES*BOD>H-GGD-D9"P0)O, )JA(2.9NS.JERV;7)QN:;ODC_=P<,L
M_(3;F\@9P?4/#:./>B'1IR>/(Z![S?>]=DIP28O)GJ;AH($A:!K9@EGH90G_
MLO44?.]41PVQ4/$XJB>?HKNX0!-]M\#3;:R%ATDMGH=K_"$9>E[->G>&.ZFH
MECL %Y)1,]UB]@V/7S;P[ZF6A7MFX<X#?B7^HC@>D0]WDX(TPQW(<)L -,1:
M5\<S6T,=J@)-Q'"_ESZ>ISKMC= $!#R;!@W=P',7'+_>G:8<^&O?Z^CBK0\>
M#2YQQ>>U,G?;/0QOQD;/?R[IU[)).WSS4%O0^^'">)W0#Z9/1'](9_X(;G]=
MF!76K";LYRYE.?0\IP63O97RVI_1<PLJ^A'5W>81RQU21*(GL53V[].3ANHL
M>CX5#7.&@S^$TC$OM> V6\&JZ?1$0T./%AK#[8GUK-,+5%+P7;@SR_.+"R4@
M#RH:ZB2)S9YG\F#CS46$S]MGLTO4JQ>/*GQV*X&&BN&I[E-U[,?R_1N*7Z/Y
M>4O[]K.BBHLV%.ZWN-89]9RKZ6#E\VNN)_Q+B/6KB7PA$86,D%U>U +&.E<1
M-XG(L@Y-Y5(Y*.-JAIY#ABO\,[9@"D,+/,NT2?,6,D1M["- !LGU N16%^0.
M;S^U1?[ACH) 'T(+V3.'%P^D_MHT6?0PPA'/7T2;!TN8^<+QXK<VZ7'MW^<_
M^#T)Q_6KB5DXOLA#CU\V_DV$8\Q+Y:%P+.+2-\AG3>1D(M<9-=S/Q/(S1.E7
M&(#4-@/P\#+.Q\P*9!;%5;7[^D.=D8M<=T]";L-R8I9RW(N$.&("IB:,XO\I
MM(UV(5H49?49G7FW?_E[5IM?L ]["XB7.O.F]FC8/_]P]>KNB<3^3C*,IE0N
M]9O?P>_T9#'6(7S^0^C88F_6P_/IOEX\EU(7T>U@C-D!N$NJ/G7#[6Z7;8 Z
M]@].3X"*0KL:ZIR(&PWB4 Y4-X :6#C[QX&?P8%R':!Y! \@,-$8]4-5*<?2
MAD. 0]9HO '\+DNS41O9Y243LKV72[/QDI8=O]W9$WAZ+>K;".WU!S!>C86O
MO UW=US,*E@$O=T >_!Z8/&5WGS?95?>96P\^$RXY(';^/790\/?3H&G'@!]
M&_?^7>GX&]BJ'T5'O=+]&P5(4O=\$ U0$W3*1N%PE%L%3/0A[T#1=10:Y0%4
MW(G/67>+@'K2TFB2,,0#40!KNS46>IA[O-M-2/@"&H@"^A?_S]ZW-K6M-.M^
MIXK_H)WS9M=:52++]TOR[E5E?"$.8!-L(.2+2Y;&6"!+CB0#UJ\_W3.2+%^1
M;<F60>^I?58 23/3T]W3W=/=SP2GY$V0-*??Q/K?ZEB_&Y+5-49Y3=P9Q$*A
M8^FW];Q5,EMW9YMWW')6.P7O(K 5>V%>#ICW(CG5JY%NC"A>&*B!4JO,-;0O
M7"&1Y3E4?ZG$MU.G 3J<!ET;G,6@?TM^XVUL<0Z-TYEFX3VJN=WVZ>+D;50_
M%!<'3B&3H!:VCPN**#6M!-D]+AY5#%N=]>2>?$H315@ #^.8B-WN*'**$0.,
M8^LUUGB=?4K5*'@14ZS@V[!FNFZ+;CPU)_W7$45H&M-<D)#N["H9BUMD@P&I
M.Z!&-NZ.-3E[9K^'"X9YL2M@]CEWVO0C%'?>^0B2T5'VBX'-UTA[SL1IS_M*
M>\[$:<^KTYY_:E>-/^,_-?/W(BR\?[#!VWK:<G^)>N A"3DY/?@A-D=_(IEB
M&58R,1@#N<=*^O'QJ=_Z$\6%AYU+G.U8%]6[=+'4:$I:% D09"HQ+/92KFN#
M'Z?C'V3[Q,O]"6R^8Q53B>:@8#U=)(H'O)!:QWI]T:Z4^NEI\>?>%[*7;. ,
MD.#7\TWYXM>?9[S&BOQ>AA^3O&:8D-<32,C53JBW]/3-=SO68Z5\_KOX_58O
M*(&1>^)?GG:LM*Q?:Z_Z0Y5LGK-EK^/XR+.2PP!MCZ3;Z)(3G!I#P&BB ];)
M0 & &U4$Q^:GH*YMEQ+\)FDDFNQ%VY5<"PE["OV(IRFN'I=II$KVM3P\@X<F
MF*,G6N_$]CC1#[.!JC!M%,;3)8I 0Y-<:Z76*?6#<XF<ZP/;J^4\O,/9;2 H
MR#L('05[.4$G@$&,7;$U.K_$QQAY[/6RC%W'JQP(Z@BS5+'##HWU.?2S%X-Y
MKHA(ZZ$RA=>E'JA$*,GAWP\ZNMI#84S)].7X:#(+.V,9B*BP2RC.1/C>:90F
MLZ\3BG!KR*_< (;J'_1M3R2G.B4Y;)<Y@^C/LD@\NRM/11(6IJ#,@*VY2=C.
M1^R !T()L[B\$^N(MS2L+:5!I"GMQOTU&C[H@D2F44O_GMG@$2+4X;4P"FZ\
M/T%7++-)NMO$=.IT'<)"N6.E&'1SIK"H)PEC#&_/_9 MR/@1E=W(V-%-MRY%
M!UVKRW@[QV;Q##]I(X,5H2#JGO?K]$1RGA@06L_BZ'PX&_["+]M'U%79.5G^
M_L*5Z!$Y!0PV'<7L"\9<VD9I<O5PZ:YHDI5U!W.Q7V\CQ-\EF\Z5 _^-61R3
M# YKE#R[O.TK#5*:0"_,P+C1&Y--AOJT(NG")Y1;O5'S0+A=P;G[Z=^4VX5V
M'KQM&_:;\ >8!I/-A1UB,>T%#<:<C6C99@!2Y U*-5]4(IV.K]DI<"7HYGAF
M2W)I^<G0?MPJCYF56[+=H"%M3GKYW@2P12\$VZ)2<;LJ3S#J<74HP6UYH)G]
M,5<1!H(D"RK/E?MX,RHXL)_<J2;H<-1>@0$F2[2,J]R728^KOL)>TCOM9@_L
M-\)NO]LZNY?0N;_H):R.IS,.=GP$HUV#_897M;=?/ ->?JE\63(L_D #>AQ>
MO2@<UEN!Z+\.&7*H1 18%IBZI=$#L!4-]_S]EZTV\"/V[CD*YOAHZ B:HU'H
MI!<T*%K-IAX^N=!$'**N-LC+O:8_T62#&?;LUS+M>K51_U'=A#W?&BPDMDP6
MY_ARFBVY[5 Y%[ E;ZL-S%4&NPY.#KI<QX&B;A*R!*R>P^5SWKUV?SGYGK/)
M_(3?S1<-%FH;E.!; 0]JBO8@&Z9=:>@]#7O$QIV=/_SLI @XFS@;VIVJO9[\
MBNR&_@4P/GT?;%5.<M%U.*#X [U$%$1:IHES4-EOT,1Z UO6PYGER41K,$Y-
MTUOV+*_M2=HM"I$9)^BELVF(;1C>8/N["H"HSJ9=LV?M9!Q*Y%RXS2J7-Z2P
MDK-]3W85,\]C%2V<U?:0IX5,Z'BGB%(\M[N5M7:7-2@,<W=__RF.QF;FIG(G
M;[N[;+*1V-U,)K]P>P/<W2_'1R7%UA\,[/I$)0^:*=.+9N?V7%7A]-0-01_/
ME5<PGXKFE]$[?%IH+?3 BIZ.KJ!%KTOP].3&GBJLK@#*32)=VX[WX..J>/V,
MZ+DX$YR@HW2I?^#!Y&:5QG8P"M/3'!ALVV4O>R-8+2>"1?/BFA/X[8/PH@[(
MX9MJ!6"7DBOCB6>'F\@B>@LB@$Z3 "?0Y\EI@;-5E=#BD@UC-''N:C)B36/^
M2VGR;,M^UC@^8E::<PQCA''*L!(U2>[)DQ,<HX\" JD/X23,)7+NFW98<N+G
MM>E4V4J\4Y[,4W5BF<='VLC$N!&*@0$35&@BS5 G?6!8-% 'FD04*@@.G7 9
MSN<%-V604DKKPGXY\5>)]&25S5^8A)\H,>%GIWX#OH")+$ /KZU@HN[M$=UC
M+KAOP/?(J]C'#I9T7DZB(QV7ISK#@'\;2#Q&#'?AH-XT)Y?50*D4*%:VY((.
MTY#Q SSJY-[8[.(:_XOH.L2K#]F)Y0##8DQ6 'E^'$D/3".1P5#1QI/-E @Z
M]6ZZ4L_Y[N)<'M^9/-DXDV=?F3S9.)-G=9,J#%?UY><R&817D[!N/L[M0R(]
MKCTG?J6CV2#J"^NJN-&-=[EC/5\\_GC\GOB>ZD:R@U]8Z49YV-AK]<(LOPP'
MK[,8*)%8>=CY1M6.=7I?UNZ?1X-<E421 D$F'!4[5N.V5AY<-Q\;Y6AV1]VN
M>6'V]/E^=-_\7KZ;+:PZ^-5E.U9F?#7.WER=Y>^W3TUZ-]T+TQWKSZGX6V]<
MW+3,:-)EBUT'_22<_:J\I&X-JS*+GQN-U2W*#()=U="- R=OXRRTYO>?8O%[
MIG)V^^XTU2G(<NU\T/C]F"N<1[,3J8_513)TT1SIZ)E2E@2'V2GFM+,[T$56
MB0G&OREC' E#4VREX*826KU. ^3.G?%0&.-%,1ZZ]BNT<F5@X.!.<I'G]MLI
ML]%P%DO\?>IW8TFHG7OD"=M/O'KFR3MC?N&NG16Q0!]&7- =GU3LV-4Y,/#4
M6!@!7C703 P J+<L3$$C",L^,:&S^S&66"/8$Z.E20IF5]$6CYA*(PGC^<L0
MW5OBST(@#A%HE\(!#(Z-%3&B2&,4LOJLP5Y@D6M?UJ63(=ZALGWC_F(7WSKA
M.?8O67+[)TI8E4JX/A$4'$/!>B(63!H,B$Z#4;)JC'1*!I92)Y/ISI8*JT'J
ML:N:OJZ-'ECTR_[HY'TG"F.P@!4MDS(G07/,:A#M2R!Z!>60UMXYB=)8(D-"
M 6580@4^B*$1SU/=\63)="!GU7]C&; =&\9 *J7K7S8A:"GMVI3XFTU@EN;V
M_9:=0@?SQGLG;S;&_!O.LH^/W'6_$%<Z;$EPDK,F4C@>RJP[*<OM&[MI>QCY
M=JK)/!PWTB?1+=@-_<$.0TU8UQ[R^(AF SI?\^2P#&&C[7 4_$JG]=XS%V_N
M$JBP3#J"$G("7SUQ$M7HNU^XR^D4&MDN  ?U)9,7 WAD1CKL"#MC&4VDB]/<
ML)Z=H@BZ8:CA #!IB<X1GE&$%[9<G3R,%$<1,5YTZ\@YFTNIH'FD!#C$,PG&
M=*RQJ'NCZ$8M=>+PF3L$_NH%A#4.TX<8IG?CKIZCS8F5@MK"0P\T\%06%M9X
MHE"S77*XU14:,G_;PTTN>_#OM)T)%IZB$IG*EG+=5'; C :8M&5-HKH]#0>G
M9Q>&[ Z#,PYBDDO#X@'71%1D0WAXT FS#IH]VT!IXW9ZZR+\Q<K=<H6B%QW2
MUQ@=Z[PXN!THUUFUBXX"Y;4Q_=Q7KN+>5ZSGE)YP5[88U0CA%J6OGW!_58@I
MR(K!)?_>U(*WH>"$D:GY"?P7$"/-?E-G(%CXZB=_0'@AP:.Z6W=:Z%ADT-5_
M91\K:G&VE&6-BOH%E#_A&L3<#I0P< BPCX+<&IE91814,2/%C+0<$7!?:GBO
MQ'6039U;TV30I7Q34@+G(O[Z_SY-6@/89Z<S_JDBB$\X"XXF#VT('!G,U9VF
MLYFCV7M/#>8J3:6P[>7-0&UC)@J,B=('P$1HE,?D#9.\J<WD<!&XM/[0_2N5
MR/"I=(%/9;-_+Y#5:23HQ)=45E:_T;ZP)WV; -BO919&VGG0=@>RN<];+KSL
MAOC8%.M.G.\?.S0E<65PX%<#\ZX!EAV^Z10!L.#_S)++3;TNE">IU^#/V(X.
M^#FVF^-)L4XE\HEDI[,@V?H[C=/BMC3U!T&U>P[;7VAI(UTDQG0&]F27W?VU
M=Q>_XJ1A%RO#9+I[KC:;?;>M+TQRD2/\:9;:J4"PNS<-RRQ/&5]$Y$\KPA_S
M>>)^:!= LCB?3&7X7":W/%W\$#"Q8]6PN6I(OJ$:4"DD7:60VHU2H/KHXVF#
MI*L-4OO1!JE,@<\G"H>M#;8RHN[ZLDFBY>4X-ZO_.+>J<1AIG9-AHNHR/E1=
MD/:/LW'.OFVDW Y:H2TU;Q:39GL5EN1AU_B"?X,F6KP:2[(_2<[MV&B))7FI
M:1*F)"?X8FI%)6MD)3G289PMEWNGZ4]$-^RT#S8UBH&G&E2,_KF"O]+.VG7U
M<:2/8Q6WF8I+[=A8L??5NY7.3K*-_'@Z;ZGUXI-6 2C! I_+)_C$JFXED=6"
ML;#[%O;$CNV96-C]&SB[$_8\7TSD^70Z>X#"'KF@2Q@7CQ0__K#N0\.\ WV'
M5A#=X:D'-M*$H9 [*IIRJ5FTC'C;J\8L7TQG^4QAOM'C$FE<(&118_)8;^PY
MU!ND017KC2TLK/#T1HY/Y[)\*N_;HHJZW@@[LA2LQ97ZDMT>BX28;)8+Y"9H
ME1K$?#=5JG1L3M)&785$,E$@NX$I%H#V"X N45& "VN=ME5QJ2*?+Z;Y8G&^
MT;)/'4<I'"DM%XMRN**<W\ ZBD5YI2T3B"!G"RD\G-^/(+OFBMTA;R%NE@?!
MJI3J6,_-FU^-7OJ']I(]C 8E.P,#,XB@B_V2*E40!5VCF"-5UK>687O-P('E
MIN# WGR[8Y7%RVR^_B ]ID/N9S1!"<MUK)=?%]67FT)Z_#K;=M#_ICC+8QA.
MGA5R9<TP8_#IP%LO><DM><@M(KEI\3WK=2$QS&;*9MA)5E9I6U_)Z<!B=Y;'
MAJ_L Q0>B_81L8'%.;N!+,7JLH&5=7M\;F9X!($VY6<*.,[3/_8%[-&BF$3'
M3J[P[]X(P;JX$?9Z_HO(M VTK"[](H_D?"*TX03#ZK)QN?YF?6Q%13 ,U@58
MH!U1AN".C1E=)HMB'QWJ< [0;B(.]I,\U;S:(+V1PBDP2\/N,KLM;G0N[C:[
MKVZSN;C;[&J\T]-7\?9U=*K^&ATZ;'2A8V5KC3/R.U_0+X(^.2/=QS79L93[
M\EGR_O4Z+T<2,+L1?A_79/I2DLU,2ZH&W:(XBGU<:\WQGX28&<C"]AB]2U:[
MUI02'>M[/Y.I-!]3+S^CV:AR"]62[EC=BTKB_O?WPGDIDHMK[*/W*G@-;;/0
M$FNOUL@,NGORSC8]?)^Q)%&C"6$CJ!^T&CXZZ?$7WWBS8XGZLW!3-W_UQ.W!
MHWWZBJ<=J_]T1=+?VX_#X=/&OJ)G:=C%+'8/ Y_J%(4G'J'M!DK3?J#GX8FC
M.,$)D^9APJJ+^=0.9JPH9K;.?S]IU=O3/_>*LBP.N$!T[ _O+J:?Q9S/!1A.
MJ#/L[6?_V6:3T!"8(VW*+VEGP\.6D7A^.;6TG^>_LP&1-H08:RZ]&/LL<,+V
ML/O*3*M";G&G0AYC#PCY"'Z_,CZ,CH0KHA,[.-7JJJ@-2%MX77V<E3V\O.R5
MCI53&OF;[+#T\S6WJW.L!$;=9?VBD/]-DMKLJ/XW@:T)?!OAE<1'6,!3K1"&
M;052++S"@640&[5.D84N O;)=@=J3V->UK'7;I$LR;1!,\9\NL1\(<1N0.I"
MCADNJ)PHZ/H8CS^G>S#MCPO#P@=E&AYEX[.HHG<"(W9JJ@*-C.(KK#DP G#!
M\*+I]#UE:LAM$SX]P<GIS#ZCT?ZMNG$@[5%WK888**2-=09G&6UENUH5%3S0
MEZM?[%A/]^V;YOW(Z%6#!L99JI#R':O1O# >I<>L7-U8'SDK.SYRUG; [!/)
MJ98% Z]<;.HR= !=>]"Q;[+;-]P%%$ \03"#L"4X19UG'?P=#$RPP2<(?\X7
M&0ZU,4(5(0_HA<TB.#U-!./]H-MJAV^D5 5=!>5L7!&]U0?2KU80"8^M\L:;
M':MX=7%73WR__UF==8)#TQ"ICG5C#>',:;:39G)C%>$L[?@(%L?1U1TP$T5R
MJJ=@,XC'1\2F-,4),)#0+AII]:KEPIC*!D56&)D,Q4&2GV6*,8%MVV5J7W+"
MLR K]"J0MOP?#"A.*3!B7U.H7K'!5%G&"6H6L!WP0@@<M"Z>!F"_T D8K!'\
MY .<-C(I- *.. <I\H6KSV.\(B@JPU=-Y1(G2?"E[$5="7@Y* \9FF\+CEO=
MMM$<W(OVBW92QMM:[I*8?4VR:<![043Q#I9!$TR>'M"G&8ZIH(@4Q "&0-M,
MY!:0&0<4AD-%MK\DT^[WZ/&B-6E_#2PQ[\<D6:%;L.!S"WK>+W$D#UD?1W*J
M%;8KQT<@,<[):0,4:":<M6C%TYVC2 6(1H%_(Z_8J<D@=MX"&M(V@JR@.,\_
M(]:*RZ*R.B-9TYZ$+4\(((.9" RTQ2M+MG"M%J::;S[B77;$=3/\WLE MM0?
M'S% &AAX-H;D;<Y!54"S1S6]<3/4U+)+D6:/RE>Y3#]>9U^3ZJI-]>H0D=;9
M'UN>@1='GP:_LS_O;\Y4S7Q:G> 7_(0"C5W5&S5/S(K-\M._R52>SR8RX8:M
M&!L='U'$F6G&98JPS+'%+T9 7B,K)1]GI>PK*R4?9Z6L3F>P<H)V-BJ54^U%
M@+P'E992ZEC-X8]N]VZ<3^>"#FY&.BVEW+'.'X339.[[6?=9C.+*PTY+J72L
M7+5_WQZ(M?9U)%.2@DQ+27>LVV2S?R7IMS^>^UNO-A"1/3[:0G1K'2OYRRB_
M7'2%[,7V.)V'F.(!VNM'K_!0[J7[Y=KVE0 [4<,!AY!:8I]((X4T>[,A(>KD
M8RH_,TWGP*\\H:6B-[2TX1<[EI9[N$XTJ_+Y[=[%:Q;]"0[MJR1)ON12%5&5
M%\:8%J("3SN@&YB5 =J3(6-O;$OQN*M3B)6+'Q6V*&:DF)%B1HH>=3XN(X4.
MI!8).NX)CRDYN36,+B 3!L39W!W'-#"8M( 6'<3MX(%RT"$@>K4U4U!B^H9&
M7W8#P2;?PJNRF-;AT1IO?>P&W_;5SP*:;Z,3]]G'G 9J!%/3OT;6F%S +8=C
M:,1T^=!TB30$@AM]RVR-9.FVI_.9+;4:22N[#I)6=%M>10 7;$7WJ[0G( [;
MQ\HH+C3#*#E[U];L- _/QMF!<1]M[JB-S4W.%PZ;9;%1N)*7/;QGJIM,LCZ5
M-R9S>,VTG!N,M<F[NQJ[(I_.9_E\?A/HR^@WWHHURSXT2S)PS3+I2=QRRH6H
M6=[LT2^P)L3N,YYO+VP_'&NF<#23IQ6Z_?W.W%8DD^ED-I,J9M/;ZZX"7T@D
M^6)^/B,PUEVQ[MI,=Z4BH;M8!FZLO**@O+Q[$0"Z32;')]/OT]K:)_C-UG7.
MJC:0U6@'PJ)W51C?JAYDA.P=4"=FI)B18D9ZO['I+9=[9U?ALDDYI;CS)8(Q
MWL*N(:E.)V61SB:5V/:P,K_F9'.HJ[,XTBQ),PZ1UX#CG ]S]I=9^K/!>;Y]
MZ! -OF@7<!AY<55FCL^F,8KLVZ>)OB,3*X(=*()\$(I@Z\!PK$BV522A1'UC
M51.KFN!4375?JF8ZCAOKFM!TS09!VL4J)EU(\=GD.P*1"R4HNT_7SN[LY$DV
MPBY!WMXLL8+=X8598:Z]+-[&H-C:Q:9 R>80+ZM C+#.ENX?%3>?KIU]N85E
MK,Z=%KY]P,IPNH.O;WJ%ZL[=M"I7;J.=+YEWI %C#1"N!L@$K &"]^EB#>)#
M@^S CYO6,>F-X<AC'?/1=,QI!'3,&\Y<K&2V43);.W!>W9+X\B[1@T.ZI]M1
MA@U+P8JOLN.K[ A,*F:DF)%B1HH9*9J'=IP+&PM'-&85$5+%C!0S4LQ(,2-%
M\[B.<V%CR8HE*U;1VZ8IU3Q![IE4F4ETU9LO<Z5K-1P]]&LT-S=IN?98M]?.
MKH/8:Q'T4/,=H\79L=S[D_O"WN5^Z=56+/@13CZ,$#^_NRQ#?UT?(]]I,WJ<
M$G73><'^1.HV^%!8+I2&KKLM2ZJKHD[/3T'QX!T:)=/4Y>[(=)J->( 3)W9@
M*":Y]9O<EQZ'^>=3V3VA[2H!&X92XM[$+:0=&6W05<()7I3+<+OQAEQ<L,UN
M1<3>7P9P&:NJ6%6]T:MJ;>Z_TDF/Z#J1@E572ST)SP2G\N,,SCM'5$X5!QNX
MVNL1T:0:;$J?N5/G;.&-O-;ROGQB$/%$?CWIRQ(8K%\YV,N4_-K5E40^5<!-
M+Z22*6?7&0L<M,'RGD/K%.> S<AS:XY'P HL\P--'(X02QV:#Q&]G-+#8;L(
MYZN_=3YGEI8=._CK#J;Z# IEZ/%\JK?F5%;%\00<E>4B1QYP$ONBPN,WR!\1
M;R#'YW(YOE!(O)]4]ECM[,8MV+/:6>H$Q'HG<+T3=S[X,'<2-MN\Q]X'$6*;
MV+F(3_D(G/(KBF&SGKC?[!D2*HJ&YR1WSNSZ1 V]LZK7)92-5@E]ZOT<U['6
MV!TJ3]A:8ZD#$*N-N"@^6./^'WIO!/\^/OKOT!E@(.@/LGIB:D.PT;]Q]H_.
M:A)!*XGAS/#L<V]^QYD8S C_7TBS8O=J(E$4>U<I*@G^#,^)SL_KSMP64/"6
M%&%HP-8[_YH@QR02GS]MC(F[KZ31Z%]:;P(E/P^*O(8PS^X92-66RYO#ET]M
MYKC'^/(AL-4A8'+'^/+ATC?&E]\AK4/'E]^-SGO72/+1K-^+2163ZK#SKV((
M^G#C4-$&6]T>*#KI!JM2,01]^%BI23=@E0H*@#Z9XC.9!%],O$],U%BQ[$.Q
MY -7+#$"_6$IIK<OX J9 )17DL\5$WR^&"NO6'D%I;P2D5!>,01]=+17P!#T
MQ22?\'\7>% :*VZ[&6ZL8YOX1F321J(8GXHDJ6)&BADI9J28D:)Y7$>\-G@W
M;3>C[&9%B-&F'*S*)G"P<Y'F&,W5#^T"#2,O[9*8!2V0*+Z?[,98#>Q #62#
M4 ,Q 'V$U$B 0=]8U<2J)CA54]Z7JHD!Z'>D:^(R[ ]3AAT#T$?JNBR_)33L
MVXY=C.RZ"MDU&&=NNJZU&/>\B>7?I_SG I;_&'Y^S_HC-"]N6L?DWU$U;*QC
MPM4QF0CHF!A^/D0E$W"E??8=V2\Q_'Q\C1U?8\?Y$#$C19!4,2/%C!3GP<;"
M$0M'K&6CL64Q(\6,%#-2Q'SL]Y\'&TM6+%FQBMXV+7H+&.HPK]'<S*2/C$)]
M -F.T>+L6.[]R7UU[W(?P\]O(_@Q_/Q>PUWSZPNCW66,1Q^5@R+&HS](ECM4
MD.=R@'CT0=OHEO3XY[:55WZ\#&- ^O !Z7?O <2 ]+&N6D-7)0(&I _5MX@!
MZ>V75P#2YU(Q(/U!!=MC0/I#.5ABS,@#9;L(9["'"T@?9H0_!H9>&QAZ'_<!
MN4*2S[^GXN18[7P(M1,#TN].[\2=$#Y,)X08D#ZB9U3L7!PHVT7XE%]1'GOJ
M$UHZ3 \B1I:.1%%]]OT<U['6"%=KI'>H-6) ^D#41EPF_[9QOQ"0G@WPYI=W
M@PAOTYP"N,BBPS[VCXO8(L78PM3@WVFGR1,Q1&$(<S+U$8C)-,^5!:-?4B7\
M3_7/2'X6%!!2XTI39''<AH^?*GA-]B_0QU$'A4S)HPY\O=^Q?M^TAY4_Q93\
M2UP?P7X)I=T)Y?(=JTB^%ZYO?K\8W_.?-MT#7,3QD:!*'/Z+\ZQG=E^BR2U;
MSVI:^AY'ABGWQMNFP[E$%9&H9$)4)_'$8'\!==B'QWCVDZR"9ZT^&3S\ZYD8
MYL!^@Q/1#^_!,"9FE_9 ?PTU0S:Y%]F$;X"2EE68&&B[D2Z;,GNFF. D86P<
M'VDZZ!0#/HKS 2U)QDB")V)R/7#@C2\[HZ@S  @T>:54^/>__W-RPM5DHDA?
MN2OA 8ZI%A"+J"(HQVR!.SEQK E)?G:FQ48[,;7A5RZ'H]F_<)1OCG(:NQX7
MB:+8RIE"#>'/L%K1^7FC_?W&V<>MJ"F*,#1@KLZ_)JA0B00BQBX/I<#T%^K]
M.62C=/KSA/<78A^E,Y^G/^4 ?R-%.2^)'>)^X]KC(4R[I M=6?S&-4 ]L@UH
M:$CT;,'[UC_.:_BG97-(?UYH.7@GCF>0<_[\]Q_8T06;V]6)\'32)7!XPXR&
ME"7\;?APFC^^,HWCC#^<'M&[.DHENC(/8\XQZN0L2*6+'<OX>7YUWC/$G\^/
M6^OV,#20O>ZNSOWSKT? _:\QV['R-\KW?.H^-31[ :\Q$&3Z6K-1NCX^*C>O
MKYK7I7:]V>!*C0K7NCEMU2OUTG6]VMITY6=FM?^@F"]GIAS%E3>:[6KK^*C=
MY,K-1JMY4:^4VM4*5ZLW2HURO73!M=KPB\MJH[T9!0H=ZV=ME,N-:XV[/]DH
M4N#'3:-Z?)1.\!S:?/1D0T-PH]56.M;+\#*9:JC/U5P_,$LM*"O'_T*J'>M7
MRS+.JC>->H FYUX6TKR0LYE+7?B=>XJD?D41/#Y*<33]+ EFR\WE9>GZGFO6
MN%;]K%&OU<NE1ILKE<O-FT:[WCCCKD!.RZ"3N+] :.$W-]7*WQM1)]VQ;JS'
M'V==\;=PUHTD=7SL??A>7MVUH5=[=M/=$Y>\T['ZOPJ2DDL,<[GM16LES2<N
M7K)C)<:%;+/1_W'QXV%C%Z_5UW3SI$WT 3=97_#NW4X8*;I3950VD<K3WAME
M^HU<N <PAN&#G D^HN//[<Y=.\C(CJ:B?<$:;U[+QE-9)Y)LXK]FI-Y[*;3B
MK8Y5ZW6;U8N4F<NG=R7WI8[U6ZMD?RJEM'@U.^H:40COLHZ/,"^<KHO#A1TP
M&T5RJACR^0HV>9]@A!X^A%$6637A_T )F':\9V%(B*J 9T&7M9'!]4 /J"*,
M!)H#YF6.: M9GGOIRR*\]BH2(G$](A%=4)0Q/C3"S'Y%'N @9E_71@]];60>
M'YDPE3$1]"]<R>1^C%3".?8RSYF>:?8%R0U&.5H)>$48#G7M50:-1&"<_TSS
M:#&1GHF'=N0ZP^&FER)I>A5B/9ZFM5_CI'*;EM^Z!\!O3 ?]2T:SYY7[;8&E
M,T4^E4CSB<1\6!]UD\UC[#_;<(*LTFW">E@@X]*M@K_-$;4R0]1:!4Q&]EII
MH(U4<R&5+],/7;$A7MT]9OU0>>ZCX9(]E4TLI'F %#_D,S&24[TF6.PH'1]=
M"3H:(U^Y!C$YG3P3=02F20].9_B)/L,-V2.<((K(3*B=-'U&>\SR>775X7M%
M=/R%\$"2'6GXQAWKW-NGXU.BBGV,<,]<M;: /XUKM@98CGW;NO)3&"6=O;"E
MJ:)$GWO:^9X!5N#)I?"HZ<ZC!ON$DV1J$]<FK5.KVJ]5->$U<5=+)-\4XA44
M6_/>=#%-W%O5-];*5M19M*!UKE]MS7&2\JB.*U!/6. 9IMKX3!4T'H5 ,UKS
M1AE:G6)U3>><@]3@B(HEPU-GJ1M[^D)E9""HL UH^H/F)_ =D< YWU4<J<%O
M>24'K 0PR42LBAK2)8IKBE(^%J4)YU%*7CET=$2KF2GU;V%C*M]SARY:BQ88
MD*BMR&0.3=1L1C<\<C(C<0(UE)9(W$&<I0=T[+<(.3YJ:";0&G;D0=#QWM3K
M*]!H9_Z;@;LX85MZ18U/]8F@F'U1T G\1H(IZ>-#WJ/PPQ4U0=9O!65$FKV:
MX_>!:0Z/#B89)2L"%[[>!P?A1C\_UR[24J.XJQ!&MF.ERDI>>:J_)A5EXQ &
M+O#XB"X1]8"[2,ZSR@/FL$A.M=T'+3 )0QA.%N,DENG$*@@,-Z"*O ?[!+_&
M;9)5=ASAX2J82U0WCXI=QR (>L3=,5=JE3$E N2JD(*'4=&D$M\JLB$J&KJJ
MX$P+76UD<L@1W&J&H"\GOWWA6B.Q[YV/$T49$IW%94QMH7:;CL'87^4YV>"Z
M@H%ND:;:AAQ= "..@0DUFF[VF3:$I;OYGW39D@:6G:J9W'"D#^$Y'%PG0U@:
M/H&?$QX>4.N"^D43U$/2Z6D>LDJ-Y%0IP]->=W#B(5.#'2(;?33$,:!&R D8
M7[IW0_KPLZ"+_;'+42 0&+>WB$&W2E:'(^")$7 +LL. ",#$>)@B)X!S 5_!
MGR:?_,+!+ R8!P[E2AK/78 !"8O@P9 #KD23"0RBKD%T9BS9XQC(Z/"7/R.-
M.A8Z=2-@8+3DGHF=[V5\LS^7FOJ<_0T-YFU?-;#/H$>R^#N,O?&8)S)]2P(I
M$$WP3L!V@Y/?_<F=Z#>Z<#9Z>FKTD3J_'!B0D56135,A-(5-U9RL-3 =!8Z
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M[,:"]?8KF%;%LK=DE:N!$29+ LU=.CZ:+4MT*L08P;RY5S)^1AJ)K,80]D+
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M%R)P#R-!%U1XUKW2XK%7IS'"3G#P! .DHFW=1%TS#.<%@O=OBC)SJ6'8S],
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MB]^X!L@OVX"&AD3/9;UO_>.\AG]:-H?TYX5J9C8W:\*NL*,+-K>K$^'II$M
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MCE<A^LP2'Q)!]SY?IM7@V56.5^$=*G)X-FS'*\4G\W$P_%W+72I(N0O9\?J
M4AR>XQ7+]KN7[<T+04.0[;4<KX\LZ;'CM;MKKL-J"NYSTM'SUMIN)[\#[78=
M^1Y !\G/021<E9"KWG0!)PSXGCO;OT&=D)$M^&PARQ>+Q??2X3Z6^:C6MBV3
M^3#=SUB#[,E3S>63?"'MVU.-M<K'UBJ;7S:&I57\.[ZQCHF$CUQ,9OAD[MT
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MTGM*Z_?KZ_CF]M40=Z;W=GHC4-[N1F"!X+RA=6-K+UB3NL0U-/6$'9#<E4Y
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MPIMU@_N+_=7L"XPK[46SI_^.F2SHGM*X@<='IYHZ,K@K!?YR$-,.E\*R"I(
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M@N8=]0*76"[#E<O402)"1R[K%S/SX4;Z<U/_0G*9^81R&?81^Y$7Q$2TBO,
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M#XY5D:P!&@GU.=7 D.GH%HN(>B/V#*PTG*&6Q0%:%*@=+8UNC=P"$F)0FAK
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MJ?3TR$4O1@KO\(I,TWWQ(:Z9.RZQ]5?GOUD4PLZ,<G0FP]"Y[(8;&Y%5-[$
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MS:-F83 RZ8F2Z&#_(_Q&N_L@PF4W,'B^N[TWPFI?TR5KWL'+^29NXXR@UH%
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M1=]-H!NJ9>5UA1K;P"44/R="K'N.2?<$$&DL2T'(MEF#:X<_>>@@WTA*>[#
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M9:Q=-K'](9 7.#:VKC'_'Q'_!V99$W0BF:93_@]4(K3#WI8UM<FR5N2&JO2
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MK^"*[Y,LG4W[SJQ'6+YV0PM;#KZ)BX"#[VK-O,@_=<RW^I^WV?#QYCH9E?K
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M0?-&8MR<H( C[D#?-;B3?Q<B^BC#_=9PG\68 ?8V*?P_^)\,V5M#=@'!4:6
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M6OC"VG)YG]9*9'Q<#:92J5 LP6*O+RWID> E<UX1<B=+<W\[2=QF'F>GYYD
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M/,0^G6:S3:9X-@QJ#HF";2)BZV0+\ XA)&9U11[*%J&A&5J??3'(4_QV"W@
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M3!.9%^3,(\.:"EJG3)UVWSHCR<@6<*HL1 %*DM84SGM:-<O(FPSGB+F,UT6
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M<//<Q(]VN9G_&?;CD3JJ7AX.-C ID!Q&\R%<,(G?<WTM W.B<W"3,]^31.Q
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M=%A():!VR1@_#*IDD^&!4N@%,TX<CZ7G^NUW:+ZWU$D<.=/1Z=97&%B%R2+
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M,0!HK@2U;\.AE*>PL3_$E54QS'B'2=N^25OPXD?>S<UX(I;3; 6-\"?&+DS
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M33#YJJ8>#Y$$EF;A>7#P@C245=FTX$P&?*6)C)$L(C-T>""KHF*#C>2ZLJ+
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MP4^S&8S08SL?*RA+H'BV'S^O]S;X1JQKZ<K/I07LA9Y@.BB:M.-X7*F*V"J
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M6'1D^#>^B:KQ'JUZ5;Z?D"RD>%(,OTID.%AQ&?1%T#S.Q] C0FL\:\-[^!I
M@AJEQ[ HE@=) /D:-B4R$U<0"TK9EVJV'XE/SHR:RIYFW:MGI85=KE,L:CUO
M#H]:/A;&7XKZ(>6'4S>M_%#[ 5!+ P04    " !F>SQ72=_1'U4"  !0"
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M3V_-^32>DGD:(:F?(CI/J-"S/]M)R?0RML33$KV"-S:R"\N$ 6Q9X8;I*<3
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M*H=(?UN3I39.'NVI,2$KAH["N##.6+: 3GS%$I( >5K5^N9#@']ST)H;EUU
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MWS*VPW^Q]'M',PVHY]Q3/1F+)F*HS-TX68@[9DQ8?E#CTM2RN=#TID&BB.Q
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M-B9^:1V\DB_.P>1Q@H=# 6W)$R=VFZX2:Y&12W?+^I>6EPK?F9S09K\6'0L
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M)"IP>Q 'IG1*1>=+M%D&V1<;KY+K&X$$OG,)1*SL"V7S<&W'NPJ%]."QR/+
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M, 9:A5AOSJ9T9/#T;^Z>DB :.SY9+DY04%>QNGC2.OKJ?- U&@0-='Q^KX&
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M/!K4G3MV3F"*7'.>@WG.JGYQ]Y4&[VUO+E:SP,',,HD7B@T$A'G397^S:81
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MHA\\/USH?"*PA:AH2!+(5;OTQH; @2NQ>_)E$YN_+^.XJW@GD#'S$L'_5YZ
M]\-'$NEM$V"YQY[Y]).[6^]7Z[Z#Y_*1QV'J;,WS19S>IU#K1BDR6*F-I[$J
MI-6QRB- >" (;WXO+2,V=X6IE;E:IO#J8T(4YL;FF#<&]%*;G(U!A[+GH-"G
M$YG/NKBW\H<H9PT8M&AG0Z_52D6O"UD,' &>@\/D*_I1SGBQIC*MRR?/C#J^
MB,C<2$$O6S2^G._E: MZKV XN!FR*[//*"$/]\C4.Q@-68'C[H*#_=Z5R9(N
M.CH(ON5>WW48V\,Q .Y7N*)T'&)'P7-1F8R[0@96 ?.G^#4IUC)U,8[A2XOD
M!0A:@'+ )NIC7)&V>SOVGGG@-YO1ECVA#D$#M%6&W8P?W,>X?12$T[*P:0V+
M#Z7(PF[A5F4O-* EE)">5Q3=9M_NY,3OL9"S&DXSD 2. !4RA9]8)HVJDW44
MC@"?$YX3K=BA#[*FL_5@@QRC4B=]0/8'V<HU.UER N "1!0K)G\]'0,P O$0
M3K;IY@L+!0NX,:C ^Q.KB1JK,RF4<T> ]53,.#@ AVZJ:[N*0]-]$_BF\.K^
MHCO5YR8)^_H1KT<?Q-V,WU;-7M>]S;?#P8Y_BJQ&HY G-.HMR.\]NVM&?]@,
MYB?A EQ>WW7=U($0KASGX^-N,,"E8(5>?+TF3OMNGS.QFVP/+W< AZ/[/R;;
M:!>/=A*UW6+T:HT+$*^D@01QAA9>4TQV?42[G\+%BXVC^0*.?/G?O.5*)E6I
M;GPNZ?1HQQ"^36: V5KBLU.6@/(FYW&_5YI\E>_*#O'#S6F?/1G*E:-FU;?7
M+1]F!TZ &7>WST^0-'%FTF_'XC^;=:Q!'#\W+>%*9M4(81\('P43[PU73-^2
M%3CEZ)80VN%7J!1)6N72>^<=?<,DRME.P(<GRKE;5\/C,[T)/%;IF9&2J\&W
M7D/-KZES2)8^\%QA)CWA")#V9^;Q5V(/(B/PDJ4&Z!=61-^BX2RN'!55*]=%
M&<'9H48!%,.=L[U)JP/YR:IHOODNKMS9J)BI"PM?V- 5'S-,7#<??!Q7'CCI
M!6D,O:#H_K NY>5SCP)8=U&WF<_0V=XKGX)H1@M+H,;D' H?P<4)B4>_>#X4
ML^CX9.:JOS?<WCXFH^OU;J2WANM$G%$#_ 'YJ_+IG_T;*5B-%T_7(V]P+EV^
MS'-<,.V')X0@6MWT]4(!G%?M>M?^'7G/A08_4BF+*8K!8IUCGV5W16Q=X&=#
M_%UUS^-N]#Z(A%T$X0JJ^:LXWMD=*ZZ1Q!5Z3_0FUQ$@.28I"CY7,4,[+&BR
M V> W1KF2N_63SX3YJ8!>/+$5]'CDPG3YEHJW+;_)[H\%-_+/(Z(6J"N8 &A
MU23>*Y0()MT99@\G=$4]->;=KF)H!D'ZWE$=+P1JVJ5L>;:\I-2^I_:VKZ?0
M=SG%Y'!E5*YMV<2L??=BI&^2<@HQOJ+Z-$G70L/S" !>&&W7)_F2OY!4*!;Q
M+5!ZNZ+,-.WZ(<><'=2AC?,^! ,Q@3L"V7D7(1$9?)L50?/+K\J(%(\1RSVW
MJ(-HHAHX7)P47T'U41ND=G-E19'M:81B95K*F-].SW[F.1AOOOK4%:,]S1\:
ML"/ 1Y'U#A,*VQ(YF*+D$^,TC+3]ZM7_ENVQE9UHB0(HP?9@5WJ$*<7T9<":
M-J_>.GU UKXP<$9O]P;S88X,?B/!4(WW81P#Q)0P!6\6(QE\,JOP0Z*0+\_'
MOP6DD/D?"3915GOFW-?LNJC&P!#'EWLAP*P#=.:&>M\BT/]8Q$TE=Q8ELNUA
M(Y>X/70!_/F)=:4"#/WI!CRFD15W6 [U25$IXX$CAB[&'U2ZRR^MQ^+R6]>Z
MO?'<S5<[&]X> :H<)U0W*Z3D2&(H#P1! -[LSP4>D%YWUZ.YA5TR2&2@$":C
M?E; "9>@3;WGU%[#V%*NW*1?TJM_ZTKI2G%>OAUW*J PH.F3%6@<ZMOW"W0J
MI!0F33#+59_A149W3(0U.4N<DG_R!?%M4KNW(N8<P(5S+C$NM8L )6KY>.^]
MI]*_@+'B@1%.K ZD*_B!Z0DI/L\W*$.<G>V4*]IEFM--C':OFDJE\I.B&#5K
M0'B6YAQ>*6R8O-AA\\IT)C8GW*CUFM:K(M1QG@7V5IO 'F2I5R*1.@W51N R
MQ7LOH_X33!)?W%'HI]&YI5'DH_A1O8;&*J8^R#7Y2MM\D+RK7E/ 0WGQ[8.W
MCZUC#UL-]7\H$SY&B74H_1UR-V90&QO$JR:M;-=<3G45#;R_TQ;\2I5+5#D)
M!?_JX74$6)B&47TGZS\KDG]YB+^[__L4A-]=#/]'%0A0E?_VA0!U-:'9%+:*
M/]^LAE[[3Y[9+'Y-K G\NV3!+/JU@Z\%3_/U]%-<.&G0=YFVWWGD]T.2 ,,+
M'FR^'BLB01V<BMM:^BRO-:\I"=,$,<-CN=TADXF]=-YZ3WQUT5>N+N$*%BJ-
M]65$#J/2!8:^*^=%5WZ14]N(D3P#4_A.,G/^85^GDUYX1YW)PC2G._[>U1MM
M#IFE-BUPELY>7]QF<]S6,=Y!S1#9YS$\9067LPZ-/YVW9<]Q91>HR)QY@JO(
MP&OT':))9U%S3HV]2S[G9RY?BK2]P5VCKM6E8*0K)]>A6G*Y#813BP\];.@9
M06![+WNK50X]"+NYPORZMD]N];OQ&/?-K#P(/M SQW4XNR+UW1=I2[Q&^Z\2
MQ/AZW*)9RQ& J_'B3Z?,%7<7:/?F$>#*C#(!'';G"/ %BD(PY*=^I/3[#>^\
MBI\NR;<3*UP"2_GF<J)!WGG^KE ']GF"70G@,H X>L===-8>/2S 95TQV^H1
MR!XX"CZCK.1S<N^08.:,/VDRS-INR8?+^^J:C3[S4H;1:>=)Q_5CGSI/MS-<
M.0)<2[K99+#GW01Y@:R416U&G(='2@:*F?M8#AS<27:Q>)A56QL*R(DI.M/D
MB.+>NANDN7!^'QRC?'KPUV^3='<)?)ZGE#L.*JC^489<0Z7#6R-HN4Y:=6A+
M-]^<5]W&(TXWFAL[,;J^M@S=42O%[RPSK]BU*VPZ"[KI=TW9N]_5F6E\3@V@
M>2OQ#B9N$_GKE^;U>;TXU[-K(D^[OXO^;/,SBQCU&C[WRFAB$-ZNBH=BE;_D
M1#QRYEATNC;;L,V >+X]TC@PN;67-PK:BW6*#>A<>^@HD=]Q:$-B4<#<_]QH
M/5(X[ZBN ;]V6VF'UE?)5Y-M7GEWV Z.TYP-.0<D;C+/0M<!M,JEWAU2\?7\
M.XK$9XT?']<8W%WP8$]'/0%-2,=!53T405I_M%!FZQ^_!P7NO'SH/Z58S<"7
M^GHR:D4:,3:+L0P] O A3\-8N6T4.J*=S&834I<W+3^,YAZW*>BUN6)H)_Z4
MLC4?^K$JZN97#HQQ.$SI7"^X]5 \!CY=71IU\4 T:CQ4)WSB:FE'%*")1H63
M)-J'WK=K8WU(U*JLS;%5];@CYAP7?<CDG1(ZN55X-6LWB\\OS;RG_Y985GNT
M]%9ZA-Q^OJZ.B,.0UVW%AC3]M]0_A+^L:>B<T-B'BWH)9]$G-7=FOWOR7DV0
MELF)C[*[?01H>S!)73Z=/X)/!"HS@G2?Q U5'?U=U^ \,8%?X'+!8?^6'W7"
MU_1I+&H9XERK=Y<1^M5 O(3A#<R57-=XBM)#4<+MAU$ND'1P&J$D-6QM6&-J
MOGU=@\PHQ_&<SSQ%5Z7:8/FJ5]+U<D0X'3>B9HKLW*I?Y;PNZ^:)8JI[5T3;
M>2'N)J(=-,FP)PL=U]Z;:\1[MR/&JV;WPG'Q;;-1HS-"T>VF2I7YD8JWW?.[
M,--: KA5.V.%2^W9ZD[L<U[J<2,"P=*NA61]<A#5<(<K7R+'*?-.P\[7I#F'
M=6??9@@?<4A/?RE>;-7C0'NC6QKS4;B?_?7+VUR648 2L];4,(B7O5CIZOF\
M0L>/=N66EN:W'>P<N.]+#\K%R>FI/GOV1(4)()C8=*P!CADEL1GO!1"JY[F!
MIWV,YZN;D:P^$8:OVJUSEY6E!YT1SB"[)Z6M/.U3<ZQAQ^>>%5!UMZYS@QHU
M?FU6#)2&MPA\7,VXB+^/?G%#3.DRI'\M]VMC;6W&-"92C<V^;^V\BDO6NV,.
M<]"QHK:,L^38P$LDUO[&RY2F0!#AHG-);S[!H 7$;CK;>AA>Y%FD5!#'6B#^
M&6XWN%1[,452K#9!73]PF[FPJ[;BT$2PF*W_T H/W2L@6.,$VDR58^?AD3/T
M.*=2+,?63A&O.[1BL*12YDIAU8G%UZ;Z#Y-<@K945BW6ZXO"Q,+YL@<GD#?@
M5B!JL"-)8@-A)=<-YQ$Q&<=PLVT0EI5,UET$G9G%ZHA=@$1L[O)+]MP*F7OS
M,C5\5ILOLI-AR9=4$52_/H2#@#+ .Y-8Q3 ]IE_)BX6>F'%/YU.WO3TO)MBM
M[TP;;;5,E7L_/E5A-1J77^S 6[+/?[A<N1;@_Q>+I_4?%L^/@R3M'($BM9)\
M?V'!42.TSJ3Y(T I0SSKW'YSK(,6_ESH_+2";@,A>-["21B).36<-VM3X%-D
MB"Q/\?#J84AU<#^>KC55O_?%B#GKRJ'_S1Q!6O,SY&Q%9>0V$+_T']"5:. ?
M",F9_P#A_//;3*OZ?^"DFOZ)] I3!B_^ Z470;GSQS='C75>#/447?T#;?4/
MG,S+OQ!>CP#_0//=1?ZBHT3-_1V5]?=TOT,N!OT=UCE(X5 LZ'^$DPG8_%E"
M^S>\3;W?(&8*TR(_U@#_AA>M\>_HG?\;/OLIH#_X1.(B_A.;OT,7S0"A2*$D
M_W\N[1N:)>1OO99N\!=H.S<\?)9VMU?!$K??YBAQ.(^5C*LT^9#>-/'=IK(!
M[X3P=1 ^ MPAEDVBF:-7RICVX@FVF_]8U%]8NG]95 V??RXJ]Q^+"OF%C_PO
MRE7X+THR>Q/\;RBY!D0-'QB\YU]0K7^\\.]DO^" _[7.P#_$ O#>,:;Y#5*O
M\&_6CV:VWYSAOX=+U66 J[G\9EO$_T]G\U^P2?LGFNT!CGH\6'[UH.+7_R^W
MU+^!V>K];HJT:.1OJTB2X8^04>>H3S0RK*9Y?:4^%CEAL8MJ@_+:E]Z6#?;,
M0COX8J<MMT8>4U[N6U=G<'&04^G\P?_%D?G;7'Z_$X-!%=X1:*H^"?C7IH/_
M[90#-@M*&'Z!=?]S<A-_2N'?1?A+"K\E_'_T!/X?:(J_3V@YW0T5VNMBM?<*
MM__G<?T'<>A>/&X/0M+^RRWJ<64)A;<.*I_:.0(D&,[WS>YRX!P#:./>&7?S
MW22\I\^FNA] @ADV4E$!?QX"_'D$.-U@E6LY*QGLB1":6%DUP%54X:6(DC.O
MKVRD!F3Y[?UC\_X"$=[_)XBP+>UWX=\(^7>@R\*TC1]K0/]^['\'H?VGE&UG
MJ93H7UV,(__$AOZW471_?7O_^TZ*_]OZ_'G&_B<@]/_4!7];^=\IR5_* /C+
M!OYKR_\#R_G_(I]_Q__^4VG(_JG;HJFZ[3>I\3N@OVD72U4L!*2!11!$+K=8
M>*%5\=NVR6 @R>*CA3VKSW6CD)&1K>T'N*))-<$R,U&-Q4OO!^F?L)W@20!D
M ?,+_ODI(/OF?^3ZGR$5Z?8T/B&O7=T 'AQ2V(4A?K<BV*\9TVZ#]PK)$7!'
MYU.4@3J+_6;$2R@0]GB.&\$[36C5@4<Z!KA^@BG5U XXK^7&G7O(Y22]PW&-
M\['>VQ_)=%MM(F*99?"Y3'C9'? 7U%H*!A1N5SSED[:J&H<-N&V<<?&D?<JH
M\;7I:<B/D#OVVV@QT6->A;2",9G&^-,5&=PX\N('V;??QYKVSQ[OP!;D1G(U
M]=&LFMNLY1,U?T(K]]>6YF9?-G)5#E_Q '';N:R,7+5W1;$O2&G6)UF;3'^7
MVV ?\^]G-%6,S@W)*1FT CO 0TSSU[F)-PGES7Z@F 8UW+;YZ)48/^>7TF*U
MXH@*_USK!*ZD;.MG>OS"/JV2J5P>@O1"C;=PT#5MHGG@ (B3P@><L$$ACTLH
MGR>)C8J3[EM;S_'*4)0,VB>2\NZ_JPN=%HZ;$DQ_9EW]K3RV7F6B^Q#@4C2Z
MO:YC*?^_F/KR>"C?Z.T1DJV)R+X44M:R)LLD(222R*XD6TQ"R)B)LF2;(A0Q
M92];LF4=C*4L*3N#V8KL,Y;Q,(MW^O[>W_MY_YEY_&&>^YS[G.M<USQSG\-*
MA;*TM%6)D;X.B##Z#G2F' _M0[RXF+W:1^$E''V%]TB9>3L9AH5(^>V.>D3<
MO)DNBF]J'1GZ?%;3LJ8BWVWXFQ2(G:^W_2,C$>$=K4E59&311<@8RS&UG2@H
M]U1TOIO9W[O1EH2YXJ]-P1GU13D6,D'7=4F*8D9E+OQC6U='*GQO_SXC)K]=
M4D2L^/ZGK<*B-NV,Z*%V7@J:+JE,#N]T/S>6"0-3L,X M& YL&C90U@+Q6$=
MCG<1*\S^_J8>B/[QJI]'L^]X+'R=;&S40_/Y-TO12!K>D^/Q[,2&):6O&RE
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MS<P[.^\6J;ZJ3[N.P-R'?\.!X4H'H#LLU:<%BRS KLA,W]]:0]W9<@S/7'R
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MA)^U'[/ +?(/@GH5/4J3]9<&3%7^\XRI<$?CS7"%4;=IL_[ KL CV.^.'3-
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MMA3#_ ]$*QEDSN.\8J#0 IUGG83Q8L> IUOK+.["].XR[W@N5\3Q)&WBI@]
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M=#:R-!VJ%YSHO)ML8$$.VV%II5Q;E/U8%;9G?_7^\D*DN-.]F>P/CB$MDF=
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M^A.@AS@,*!L>@)+:^6!B3MOJL2O!.C&L<"KZ)LYOQPE5VC7[F0%9.GZ5[^7
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MZT)!0L_5(H7XZUB+4SM;]/2)K<)AY#FIL1O6'#R/&DQ!0C=AG1M[-UJ#-WI
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M15G 6S5O[7.ZSM7$%,MTT+'(XDOR#>-^;FII5%HVWK>R?7U@:RY_*9SES0Q
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M')2/1_7@GB"/!WAL6:*BP.K4";KZ <#/3\''$5\1<N@B\W[<@Y(.^"@)AP?
M3W"T_WU$EV1A"Z614UN1ZP< H1\><-=F!E(\71LJZ%:0;!'&](FZ'V@P5_P5
MX_2];?=8/&^=8^PF\2OGED-6 03$HS"(!YN7,_A;6!].J=>EA](4>FMX6+;?
MM=62YX$[QUL^NLE/@6;UC]J@!;O,M;R3=(X:8>6"UJ>0ZU#.J!_NOX&0BF24
M)QK4$B B#5@Q6.LUD%_+N,?@CG7;MM&QL1+'!SUC[U[8XDYYVPWR224A%0X
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MOD$U8DGE(!#<G7D%+DKUJ"7-N?W<2ZJAR77AN7\0[R<MC-1U3-YI;DD7+OY
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MSW_=.MD?Y5&/6KNL3CW3:<R:\WI&TO+2V\[%0 O*M(=9'/7SI)G-^0])Y/U
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MI :N6"RC'G"5AQUZ?,X2,-U)I'K@CD05DYM1D/NHU"O C'!( A:($&^J"/[
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M7M?W;?Q7Y27S;_>/&>TZ![DXGZO860TTU@G$I$-[F*2!LLL+1]^@I["GD7[
M=*@XUJMFUI,^R%" T=#],AH8AM5[AJ<;%9K5*&V-)5\8*YI43;@_2-^6SI3/
M+H@(.7MH_C+A =[>O#9*@1S9@YL!LH_=I>H0;^V_PRC#':A;_8*:T/2^DS):
M$W<*K.L[:C^Y#FPVK$51+-;/JF#5S4>O<K\,NVX5LUJ*CJEXNA0HL[?_M68'
M<CWN]RJZVJ\S[O?OFI4"#DPV5&AK9E2Q_@T0"2J-F 5?K!L/9P0= ,BJDUN5
M!N>HF+TN=TL5,@PJ6#\<$@J3MY/W=>[&+.4VH9\CXAE69)O,?[U4&,KF?>F&
M5@OFO5A^A@CY- 8XK<51S(S0'F&GF5]YH<X&STS"> -F/Z5L/=%XXO"\_IF]
M;UJ;XUK,;L#MQ7<;?Z/78*!P^%U&-QG]&"30B).,&G*NIVXELC3]SA>5^XO?
M<%#RM?5^N7 .=><CO_H91?G'"+5Q)(E<D[!PNQ8SC1%GC\D<8_B56TFZPJUH
MP.ZV C6>&\^>GBG8B/F6+EHY*#9_ GS'U7>Y&4)J>>I7Q^)CF!P ^*X3FKM]
MV9<8SNTA]+?6+\<P$ZP?*XLG8BOQP1KPEVMXS-O](O,XFW4FA<YXGG\#>WSZ
M6BM2J+H4].I^&)E?*EZ6]*S0*2 N)^OU6.:?F#68V.2Y2;>-0#4Y;&-6E+-7
MDO?QK(03O\R,>#YKZ^;S]9<B N$.&"R'<%,1TU @XAA+@]&QL/4$>R0 (>0,
M-VI&?\F:/SW-,A$<'FVL3>-32!YI;'JBF/L*_LGFM5!>KM(B5HJM!7?:S_S7
M8I;@2MIBJ0*EHNC(>##H>[L5:4O2/S\')++ZR5^57!D<?'8;;VE+$'<&.T:M
M!#QM,ZX.5,58#:XBWC4^:\-,__%98T!TF1,M>!OH(/8B^ )[A"@-YD;@T3PL
MM1+V)%I<K63_?<"?=(B$U<>"F#8(L,#*8LLE&(@7%?*KOAIU2Q:JXO7#JK4Z
M"ITZK\4H8XHBAHC--=TQ-IE0T?9P4"<3"%P#GZ"II?YI"3*P>H_T-5T>%B'V
MV9G;CK(^SQRN!0CDEUNJB+1-;SG8[)R[3M]I_JI)UXP EIZ]B_9G53!*F0;P
M,(88$P:7H6)RF YPCXX\>G[#E#++Y_S'P,TJ W"@BER'']S0UU/(+^M_!P3O
MM\=I5L*C_G7WY2(R3)GWHXY8<F89FO(,KMM&?>UQC&;>HS1:X=_*SXA[AG<.
M"G(/T7+8[+(7B#OZ0ZQ3RUU%W(J%][MD9Q/4M'L>T;$U\//1GMVF5!,UMH)#
M%Y3D]26:')O/9@$8_^\;%2(>MA#9FTN+1(5!>1C=76S(M-RD5H>_RLV0@#&_
M%Q1MG5!3^:2P:_=W/?&6]G?F_2@V<4@)B.\6-V(6*KS!21U05B%_<#STA,%-
M-L]W+968]3W[^AF7WH>R[0*9*KT5TBE-G5.*N4Z)P>J)8"@.*EM=A<AW'5E9
MOW5"M/ Q0HRFT(MFJ#9W8P^QH#2%!(.S'$I)94S,\T] S6GGZZD+7QZN/3)+
MC)$Q(/AM"F2C-"X][+I$NK-M(_8[<CV2IFO+&&6>A:O3DIJ^GJ^AU/#Y/6ID
MON-R*(S1*WV::'OXR;<HP*'Q1CB,J<]28U241/%XT)K7'6FA9)LTL&C4>(_+
M^_I ,B05+#(1*&*&?4&_]:%?<*/-)/(4T_8E;W7@Z][7WGF!UQH*4%Z*#12T
M ZZ\'<@IL%(,0YHX'4&-[.'HX]&O9) T+*)0<BQ(<B3\3:-5 ;JNWUM>WV#@
MO<C2J2N//\L_;9_^++>;!AS.0(0SVI@!3>G,"/:0S"'76,T>=/U61KL4\\;J
M/"]M))4D[2&E+]&X5L'T;IFTHRC>=OO!%15TIB5,V%P^L\.MVJ;5#8&;O[R/
M10;:I*&/!4-\<5EH 3:(/=+JD]QN6$9@R/5DKX+/TJ27^O+S-/SS<[>>X53_
MW(E[((;7?2"Z.6=7EZ<&Q5HI/,0,YCQ"-#>BQ@_/0DM#D>*8\S-P<<9_%*2$
M_]-YZ_>,6Y:M4T&41M/HQ:1YA5=3EWIOM]S6XWZL<#JK<=<+Z8_,$D&,3(,
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M)+TKU<1G-GOWRV9]Q'E'Z_6$]N<R7O_YH5=CSYPHL9V<VX<,%,!"=U ]2&I
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M.;C_/Q^L&D" $[93SK;G!+!78 ^;P!Y6 X  @#W[_QW>'N"_CCU[V?;M9^>
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MCFL>_^UCK2?VJ^EV?,YDXHB^4>O9QU:Q)?K8#*OG-C;EL;E'-W'U:_#:U7J
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M/>2R(8/YI28^JV4:\27>%*?A'F4R=*:XO?/2=M 0+FX9)*UU#C;G,I3TPE@
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MB7)Q7BM*+-T.0VM"OIR#LM+,68#^/=SL+%X-!M6M9 01_, ,H=C":6'I FF
M.S="JW_"=>9\,"?-G'X-/:"&WD.K)XQX^NIC:@>2/%S\K$]_.%5JX?TV[(T$
M7F-;H1J&]C"TG?=*'XC=.>C/SSS]$_?NMR/WAT9.?7MU1"DMXU4#@7'I3][-
ME!=3!D8&9W/2DW.*3?XR3R%)!IC!8RR@O6P>O[7N#2E@:/YZR[#FT)V"LW6B
M!4\KWQ%KEYQ(DW2E,I:HB>]F6,#&(I+&C>S ;39'8QE_Y&#H',8RXC8Z&1J9
M5 X6D.G3!:Y-3S#LG6EXB(N+OI^&NY:B:_+\79"O0=;9V90 >5^=U:SOB.P0
ME5F,=T=&9>_*M[/CBXNW7BN+N 1P YLG*5_>V;QK/6L0XPD=ME=0GA+U/YSQ
M?J \"$T%&7$,"APK5_!.,'D<Q%!CJFBZ_GKX[M4'F;T_>88 _K-9,8ML4[3$
M*7_D:MAXI6IU)3R1_>AN- \3=NC!C>!+O9^JNQG2'QLSQ>:/*ON.RG>WG;&$
MI-G_^;#P]J0_[LT267[XM1C_A[[<2-IA>!6DF @"KY?/>Y(#AU"R(O55CW&
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M=9*5;.V"1;S<;8>[N'2*$@ _[@(0+=3E!KOM]N(=M0<_H,P*)HDQ=:TD :P
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M8,L \B"Z]T1R#(._$BEQ'!$(]N7$8[X81X%3\@G&5T+MN9P&;)]):4Z,8%H
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MQ7EO2I;]$C61*RT E^6/L?(3H0-#SGUA08/-UJ'/8#3WKHU9-JJ ?T6.'SN
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ML.=0CNV^?',A#9X*X:M+LT?#!JY=2R/3]*\N6^@C ,[,Y<02MQ/"C4X?F'@
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M"U)^&*G.S0CAAF%-G8$4LT;5IF9;  I4IM.4N$(QPIR0O- C/"'X(<U%E"F
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M'S<V\I:I,K*-*>+DE5JO>"E*EZ1"/3<1]ZU65GFU"VK!#?XC_RX;PRL4H^B
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M8)[X]9^N$P9@/;2;E[ZSWR0FW)2>,/$:\I*+4GSV*2,K[2=,N%KX-CL-:*_
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M[*ZI\B^M7J?ZZ"]S219@/X^J5Z 7.\H7YE/$;/(%3>7,S>F*>PHZZ@]9$3Y
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MH<EIJD9/Y4D6Q$!?C?,<"'36&L^ 25&UJ.'67-ON>F NZ2WF_',:@EZJC@/
M,SZW4!1,.^B[5IC\Y-*R_%%,>V;[7V^>;Y"[W&Q-3Y!?*^[9NMU%5AC5A8)K
MP"\A6)@"*NRI9B.2!D&$7;X@=-JDZ@-/YRVL)H U=6_,30?Y\9FD,1)6<<MM
MKBHR*/U.84D>P"BA3ON?V);B=OH>=CVQ;:4L329#K4P166XG;;8Y@4(OP;G6
MF]N90+5L2RL/IJ8;6>(?RU NZS$$.FJSN0F+\LDP NYPU3JCA+<\4+=G3"X4
M+&=W*63;M6?_ AB ("B;RU<* >INGJR.R.-=6LUIWOS]/!RA8AF*&]J+&D)
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M;'>F"P6P9;K^./C*2T,[&XI+>F>ULAW;#'C'L"4'^#$F0QF95&U;02_[OB+
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M//;?"-@_?I*!5T;\+&/_L)08#/H\9?#'V<<$[Q4B:[=%6G1\'P4^>:-&MOE
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MW!S:=+;4$7%=="K(C-GJ>2#-(*A>B5TV\??T?P]D5/+-_P=02P,$%     @
M9GL\5W_$QF4GAP  0$,' !4   !F;VYR+3(P,C,P-C,P7VQA8BYX;6SLO7MS
MXT:2+_K_C;C?H:YW[XX=(8W=[1G/V+-[3E 4U>992>22;/OX."8<$%&4, T"
M'#S4TGSZ6UEXHYX R:K2W-TX9]S=S$S\$OA5UBLKZ]__Y\L^1,\X28,X^H\O
MWOW^FR\0CK:Q'T2/__'%Q_7E9#V=S[] :>9%OA?&$?Z/+Z+XB__Y/_[O_PN1
M__OW_^?R$MT$./1_0-?Q]G(>[>*_H'MOCW] 'W"$$R^+D[^@G[PPAW^);X(0
M)V@:[P\ASC#YH7CP#^B/OW_W_19=7FK8_0E'?IQ\7,UKNT]9=DA_^/KKSY\_
M_SZ*G[W/<?(I_?TVWNL97&=>EJ>UM6]>OBG_KU#_]S"(/OT __/@I1B1]Q6E
M/[RDP7]\ <\M'_OYV]_'R>/7[[_YYMW7__ON=KU]PGOO,HC@O6WQ%Y466.'I
MO?O^^^^_IK]6HHSDRT,25L_X]NL*3FV9_!I(Y%M(TN"'E,*[C;=>1C^[\C%(
M* %_NZS$+N&?+M^]O_SVW>]?4O^+ZN73-YC$(5[A':)N_I"]'@B5T@"8\$7Y
M;T\)WO'!A$GR->A_'>%'+\,^/.A[>-"[[^!!_U+^\ZWW@,,O$$@2?@C]^KYC
MJU3ZVC38)4Z"V)]%XU#WM2W!)VTGR8YPH*UOW(5-G'GA*/!M3>.P[_&X-][H
MF7_3),[C<6^ZI7D6V!D+>?#KY;_7$/[QEORI Q&_9*0#PWX%$DQ((C!] NT8
M2MNU]7C;L1M"-(\3UG?H&:G-G9<^4,-Y>OGH>0?R@/???HW#+*W^Y1+^A;Z$
M\A]^@[X1[W&434,O31>[=19O/TU>@K1Z#G7R/[[0D/^Z[P!H3I+*"R_9*EY%
M*?'U-B8=V2&[#(N77JCODGBO!:-\9[&&\&_A0VV_>,D$@L"1CEB"TSA/MGC0
M-VY[H_M62X3[D&C @ U'EQ_77_P/*H;B':*"Z%<0_>N_?]V8ML(E,NS;QQ'%
M-KG#^P><"-SE"9IDCQAHFS:LE#-\$4)CB$(%4<&7"?JU$':**E>Z5+FR3)4K
M+:I<N4N5*WVJ7#E)E:DN5::6J3+5HLK47:I,]:DR/1E5=G&4T.__S7???D,Y
M<+.X7_U6A+G[./HISH+H<4ED<9)@G_9]7$;HJYG@QU G@"VZ.M:Y,Q H?R S
M0407%<JHUJX&-ZX$(@WBR45-!B,5P61RUDFE :Y/)&=94\1*-64X<N8[+P59
M&"%GF")")NBY'.-(/?V;_3T/LE=8/H\C\M=49R+.U[$R&9?!YT[(>0K.<$H'
M99]?A2AJ9$\T-Q\X-!H^*G)F0#1P+.1('-+'*!H!17%T^=P? 9D864]5/91<
MU"QAQ&"[3&'E'**($!R?&U/D9J\U\?T MA>]<.D%_CR:>H<@\T+I*$>A8[+7
MTH+?[K6D"M;I-01EGV>-#@*ERX#,[0LU=]BVPID71-B?>4E$@F0JI9E(V"2_
MY(#;Q.)+.L,H*;P^E2IA5$F[PZ!-@KTT3UYI&"U"JI1$$GF3/%+";E-)*.P,
MFU0(^X2JY(O>[Z+J"YUA%1GND8^8$;^)U<=YE&'RQC(IL>0J)KFE [Y-+YF\
M,PS3 -DG65<%53IG'W]K$D<E;&X,KD,6N:1UFFC!8]>-++"#[MEQD/+'/IHZ
M9N=K&O"[$S>)@B/,T4/)G\I=(1Z1SCU&2I.LU9.1OS6]&/G+;Y#+ZN<A7NR*
MU:L[G#W%9.;P3* URU_M?\48$FLYBY/'FS-!SU,Y#<P]UI9U4I_(@3[?&^4+
MFH7M2H[231 %&;X-GC'Q)".(@X<03](49^G5ZYWWMS@I5O'$"^^#+)@<S(UP
MK3VV&Z!NG;3C,?=Y6EBXI"908P,51M##*Z)FREP'1T@,'4<8XFV6>^$RB0\X
M@=8IF7'(%$Q25 V\S4BQM#,$5$)DXV*C@"H-QV:S^P/.\.0QP73W2[[2)E,P
M/I.5 F?FL5QI9YBEA,B=PU(%U&BXPZQIGF;Q'B<K'-)#2>E3<)!32ZIA-#="
M#;V3)2$6=X9=:HS,!*;40!T5=_BU2;PH];: ;$,>(QG <27-KN@*H7;7<ADQ
M9_@CQL:NW]:2"$3/FQ!Q'7B/49QFP7:^]Q[))/O&VP9A(!@>Z:D86S'1!%\O
MF"CDK9-E ,@^:QHM5*JA2L^=D#.%[QEE"0V'JR#]=/5ZA:/MT]Y+9$>HU&IF
M$__TG.CF <IUK#-O(%#.:F^CAD /U6JNS '77HC3%7[&48[OL7S#22!K-$=0
M!K>3&\@3=(90,G3L5C@5:U/'X<BE&#1)-2S'*]D@2B+N#*G4&#4"U G'5B>;
MZS&.:<WWA%HVYGP*%WCS/H&*.W33PBF<_W&X9W7[JECF+='Q%NY%0J:VFL0
MJPTD5L(Z6:2PA-PXZ]R.+CQ@?^DE68 E>^!\.6.S.!G,>NK&$[+^S57(V $.
M%46E[+GS(?K(_& +B^ZPMK =P@>^GC5^R-P0\H6GY"9_)$A5?"J54:UMMZ-9
M$:RBI(?6;Z:Z%09.U9O4/U@G! ]-_Z/#*:L %GK(A[ZCJ9YTY^*L0UG5B"*(
M@GV^YT84SN_&QA$\6/40HOVC$Q^>AZC_\4L9=R;&U8[LDL#,)I$/F2\'X*-R
M@JRE:?8$N+8KW0/A2C7K]!J.M4^\VSAZ+),^-IV4#U/;$S54G8T)1MC"EH0
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MR!]%7<*/AOO('[E]Y(_.?,@:"G-&]N?YYO_,5K>3^VN+'_+#E0 W_&#R0S9
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MJ(I5POR"O42/+BU).V1AH/*I4HLY2)0^-A5-0-X*2:9YDG10BWL<L:@IFJC
M5CP1R3E!% 4XYG!_(=XABJ4>:$;K3]\$(;[/.1E"?!%3W!"!JSC1_]T)+@A
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M+^9WKT^A18,%;G,E[5UBTX$JOKB&BCE#'3$VQ04UB,I:9TOKZC$955@QHR7
M!2 [E;Y[,LXP1 ",251HW>3F"#<FOD_O^O;"I1?X\ZB<^@G\%$H;S2F70^XD
ME?-%G>&-'!\378C,91#5TVOR1_P")>A@2>?@)>C9"4JM<.8%$?9G7A+!W9B3
M[3;?YW21_AKO@FT@&OOH*)HDFKXC;<ZIM9RAGS94S@&'2A#YA:1UVFT2[*5Y
M\JKLYWB")FDE!MJF$2MEAC;?%[2)\"-\7=E\3(B0F9:5@B@M;NWS,K2-TZ8N
MQ;MW%W_XKJC?2O[XW1^^16EQKQ^L5!==)M5\,R5?V;F&]J3$]BQ/;W;GUL*
M$!]_?>"&]+?T#C]ZB2GI?<O978K$4S[KE+H+HC@A0.91ALE+%'6AK)A).HE
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MS39OV4(7!Q0OEI]F*4N0(7J5O\9YMM@)]A9Y*85*%6.9GIK@ZVQ.A;QU8@P
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MYSCY-(_H%>5I6O!<X*A<Q4H).0EX;@DYCKQ1'CWCY"%.\:TTPU:)552N,'"
M5\*"3WJ=FKZZ$Z6[-#H[75UGXME P*)B<]TJ<]9Y.=\?O" !*(N$3&8/<>J%
MBQT<]+H-GK%?E)F81^6E1_WZ$X7K>A0^RY.,1M?SO:I.4#[]8YQI0^?SC7M4
MD1HMZ^]8;VF2$D-Z#6B( 4=*1FG075_;&18/ALQDDT,Z.ELBRF6*5C])1\(#
M]!TA*-\M37YVE5T;, \%+BIG=J93W),M&0,E5<PG@R+RAWS?.;@A#XNCK1@[
MVSW>Q?J8]W 3UJ/D<;C9^[D*0\@KJNC!Z-DK;*&P,68]=*XPF6OF>(6W\6,4
MZ*]6:NB931;3=*.;(J90LL[)H4C9)$:JAUJ*#C NQ>0UPLV*UP1>&-,)Y>SE
M@*,42[MI+4VSK--VI<L[I9I#S-/%RG*OT*2AKZ6+IK$+%]]/?#(6R8*4S-<H
M(+VPI]0R>O16SX7.65JYBC.TT\/)=+J-EB,LJ^LK:*XU"<6M5+K06?41R#K#
M) 5 <0V5L]6!FN9I1IZ1$+9ZY%OH3!>4*N8JA>J!;^J#RN6MTV0 2.909ZF%
M*C7KT6;F)1&)?>D2)^LG+\%Z04>I93+V:+K0#D$*%>L4&X:SS[)*"Q$U1/6L
MTZR\%[UW&[IFEHN>KND3F=KN](]C*A6=H=\0M&Q1[;08Q],_M-2M<Q'VRM-,
M?T-:(F\ZXT$*NY_NP!5VAELJA$S"WE.<9)<;J,C9J-HGTQ0^7)0E-,5K%:2?
MI@GV@PS^),XJ$VL8SME30>^E[(G$G2&5&B-;.::E07/VJ 8"%>ODNO&"!)+R
M\6)77D;EA?,HS9)\WP1BP:O0U#5)N$'NM*FGI>@,"8>@[=,1=.F!(9HK6*NC
MEKYU5M[CS^69$#+(7"9Q1/ZXQ2W?]+K5X6:,7C,PTLG.Q0,#;3C#X)' >;?5
M1QEJ3*%U1D:$7N*?:YVD2J[U/Z9XEX>WP0[/HU^PEZ0W<5*EI;43VC901T^Z
MCG*T26/K+"=ROEZ'.=*>=3:?T EFAEU91859!'91$"%J&>WB!#F:!'D=I-[C
M8X(?Z8!GL2NW^Z3M8*"NR3 ]R)UV;-92M$[A,6C9>KE9 &'X!L.F;K&Y>XGN
ML7TN-B=/^^M<5UX:;&'_, ASTLJTV#G:FM%3=\>YW#F3-\Z4,YP^#K]ZS1-]
M651>S+'_E4-4+^:7MW&:XK0LWK.)ZZN&8<@4/-/ZUG"U4UFQ=QC]3_ $.TWB
M9*^&WTR.-N]:VN/I76-VQ\LC^V@UF\[F/\$M)!?H;G8]GTYN6_]&2ZW<3>XG
M'V9UY96BC/3-;-96/M.P?Q-G7GCC;<L,N<7G"/N+Y,Z+O$=%YS%<W=AP?H13
M]=!]@*[U_F DX#Y5J074F' HY-?G^::CXKE*W4ZPUG.*'XGENNZ&62W<;_)H
MYNA#F:X=QQQW$--9[FDC?B-G,&\Q&:+@!8'FP8(@O1^M2I1_O?.R'.Z>U(J/
MHRR9I.@1KK8Y.\*,]2[]>.S,,;+E;#6!^O?HW[S]X2_H9GX_N9_"WXN+\-!E
M<1$C7-%XDET2P4BSZ0M^QL'C$QEG3T@K)H.4%=Y[050Y"=O4ZG'G$<:,C4*/
M=K@>DXZV9)W.)X'?9W1E!95F4&VG9#)8<B!>$RB0%ZT9DP729N.N%'(WMG)%
MK1-.#Q_G$IQ#'-'R:/&N)%%YZN)<T9!SI\0\VL7)ODC J%8BBCMR-0+B4?;,
MQ<03N-V$Q2.,62?JJ3R0WCBRA03"'=PX$C1645(6V\]B%)[D"N:33OB[AY#)
MP+TZ8CQX[J]MR=8RP$!712L"FF:L4_YX[)HE$AS;I(LAF2G(,"TTTG?Y)L_@
MDK8]E.K^!VV?9<<SB.ZG>82-=G#*E\-K(*>P[US+.:%33/]1/@(M=LC5"B1-
M )&\AH'=Q0!+=KJ+P:[RNPMM,ZZMYXUWX:T4UEEA'Y.9+$$$>XUQE)%7$Q85
MKC!YJ7H3R:%&S)[@'^-@]S#_$ O.Q.U1L)E):NBE*9K09>DK=(?W#SA)?T=7
MJ+-7Z^1MFN<U?ABZ3\=3L1-EQ>#YX925=X9T&B"Y]? R."@$*A?H/LYPBLH[
ML\LC:8< 9I:WKDT<RS5QV &GI0)A#7 $$W7-V&'G,"?YC-6SX2"+!P'O,[M1
MIBM\'9X[Q.)F(1(FQV4MA7+X?H4CO L&I[0-MV@IA6VLZX*4M:'F'&3\6!^$
M<SI"_6UGJ9N,A-$AB9^#%!8&(?D^*$IR9*<HR7'*-.?=#F\S,N2OW\/*RVB)
MK@C2EN@T=VBN\PB3EA*>1SLOR'H>;,_!QC':"5GK2#KJ\"\[,G1/R( GS4@/
M @E,K1:"$O)$6$:'1N5%K__V+W]^_^Y/?TD1KK#54@XUI6N\PTD"N8$O]:IK
MJ^+BX*'[(&NV1O4C7!8-^ >8<K#9C,&OWY_T&X)?/HVV@U9Q3I>*<C;OIKJO
MK9SPD#=#_B7)\1'-8XQ).VUDO//\AC+<GH.M9;03LB83T_7'\C"!HTVA?X=L
M:U?ZZK7\4;\5#+1FIP&,<IG/_4&F'*3]&/PRQJ?Y?N\EP3](1Y"6]USOZ@(-
MK=2$<YUM?P$_EDGLY]ML[84Z"35J'7.GTS7A-\?/%0K6&3<$I8Q7F)J &2S8
M0"D8.2N'UCAY#K:X/ RL32.%FF$F:3G1(Y-4QR4^Z0"548K$(AP\1B1.43MT
MM)I@N)"&3 4=Z*(G81A_A@*8-W'2/KNXB'B'%K5&J\>9-%J#^03.=PHT'V'/
M.NE/Z(2Z[WZ%/WK5D^A*H1_G#QE4\/#*0?*9(N^/^ZT'IQJ3]"DXK,D@8K&;
M[P\X(6.'XI0CC"?*9@\'X:%R#B\^C+-C+#8?XV8=K,<8L4[D8Y$SYUF?"'$K
M4V1X6>RQ X$KBZ@QB2J;R-L101+K"6 O*C.G0"G"G\-7&&J0KH ,8'^\OCL3
MT6OWJ[2 "2!:=0"1-OXC]L+LJ?%@&B>DXRO+FTSVQ$'R)G?W@'I6@O[1WTL:
MAIGG&FM()E]CW?!,/-2-AFK04_V&73RMW:Q;SP.!\HD.-O+%;I$$CZ2G#HOB
MK'&2+G;D56B]>[&RO>:F<DC<9D2:CA)? 5>?O; +&Y>FR ^E+<KKL_'P.DCP
M-EN2M_/DP1W<_,2T_EWGPU2-<7"@,S4#-?7<X-\PL,RI]E(/6%5Q+T7P#E&5
M6/CEO]JO]E1D,][A["GVFV+5==,K^P<2Y 63H0'Z1B]:&.I6Y\H%767K/!V+
MN$_6@NJ\:'FH5<\4%YM0W@_WO#8IDS86_=20ZX G%K7.'3U\O!(Q96]Y3K*<
M<&=-7)<$5F:46S,J=3M[9WI.\3?+Y+K6>3D2L*BJS 6B:MWB,NA7JOI7ZS05
MNG8;1'B>X7U_0#A$T8DJ1XPC6E6.:BUGZ*@-=2 101U1?8?9V%2D'OIVVII.
M\)%U18N0C9K[C&2P#J+D1;M0N'5*RLI)"]Z+7,65DM\\]LGDG:&=!DAV>M%6
M@1EQ5=W;E7Y8X)2J%U:K.4 W:0^LTG&==JK>5T*]$_:\@KGM/<[*DO8WN,J0
MX,W"^'+&YK,RF/5,EB=DG1PJ9'TV$%'$N63 >O@AN(I3%9!),'GV@I!F#<33
M>+^/HW46;S\]Q:%/YMMEH7E!(QEAQ^Q-12/=[%Y5--"(=98>B[S/8GKI +K/
M]U"L,DY^@.([J+S:N38+QV0*PZAM^4R1KE=HD-YJD"[R+(5;E(+HD4+F-5Y-
M16.Q<) C=7#4TK+.P\%0^<2[QE&\#Z*">DQMR,(@:EFT'EV;1G=#/G1YU08!
M5E9[C2/(;Z&^4?""UCO8BOE+[0>[R-YUKVW".IN/P\VG=AE$X6*6*G8Z<2=U
MK]$VWK1;+IG5WT!BO^ ]#;1ADKVCW&MS=Y !9Y@[!K6P-J]7QM^TB+_QZ>*O
M<.-NFU2E-(L!#'WR),N2X"'/JJ%-1'"E=,;6&N;PMZ*.L6=P\^]XMUO;@^.-
M6:?QJ3Q@K\^F# ZB;9A#;EA^('%X6YN@-Q_3#(II%:3A1+@7;G,HLXH\Y!>C
M9S1;KJU'[L'O9YF41WAY#>5D5@V/34[Q"GICE6-,6F\ZI_6#W:.OK7:&,2EJ
M&X960^>94#:A*.Y FU:GH=7/*R:19F:/9&;[@)/%KIP%]^_<TYC5*"W8FD]J
MNB::6"K4K?-Z/&;^'5FMJ28] G-=17;F"D7K@;[OEWRA3BAM-$E.#KF3$L<7
MM4XX/7SLID!!HW*Z=W!MNM=)?8&3MJWSX-I92WP]:^E*,C>$>4H\)6<XIXM4
M=MBOU$0M56?V1%FO;M5)26(-P]D?*NB]K ^1N#-L4V/D9'FPW+IU*-T(KHMI
MLOM6]- WE$>Z\R"C%([2B@*=EJ9)P@UPI4T\#35G"*B/E:T%6DNTC_?CHK"B
M_2/^XOKFRKPW/5633!SB3)N*.GK.<'$ V#X9"]5+JLO4I#]I[IM@LMN<F9P\
M)IC^(?TYR)ZF12DW.O&YPWZP]<)EXFTS."O-FV:-LV-LXGN,F_7T=XP1ZR0]
M%CD;/NM#MHTM!,90:0T5L^72'JH-GNUF22^"LQ\ 0>$GO1W[ZK6\6&OID9Z#
M][:.M6CPCLE3N-ZZ:/(8<VXP_20^L'.DPFA!<XT60$VCJU=4&D?4NM$&T'+T
M%HQ!WW2//_\2)Y_6&?FK_LM36[),>%U7%417F7&9X)K8M8G=87-ID8Q/$+&)
MP"BB5L]$:,B:@$XC]\(;C-.;.*FJM*QPY.,$^W=DV+3/N442!B@;H^U@AVJF
M:FNZ0<ZA<-F;6&M]R(A-$;'0E.BI;*#2B#WZ>2]'T*]2=HE^78>&T*_0?#/T
MZ\ =2[_"B/65@HG_C),L2(/HL;P60C!!Y0D:+=PG!-HIQ\=(66>5$EJ?02W!
M,U\A76UD%GOI'P]QU,EK@924:;&--"]35^91M>EY@*;1VN(OL[%Y3>HLCS%W
MEN1\+ZDYBG+Z9UCG_9D=8P["T"?!G:-E9@@\K)W[L6"2K*I'PJ"TWH<_%!&[
MO7MZHH,&Q^\N>.F3:"F;_F1T?Z %IK,!0/[=.O<X8)A^FOSDQ!>]N9Y/YU&:
MDU'!9 ]54"6^<&1-?W,AW#X)&$&G6"%"QZ/)!0)I5(JC0MX^=^![P5@3MD%7
M0?JIJ8GT3KCA)5,QN[NH!M_=5A3+N\,K-4C.;*%10:!S@9;NU!RJ)C--]>?K
M'&\^QYMX0YZ ?\$>,^(;IFJ8<]K.]+BGU'.)@[I@^UPD7_^/CC(.H&_B&_*F
MAE..T;7/.8$[:M+U%!UG'1\MAW;?6:===4M3X\!5$(;8)U.!ZJ+8RL=TD2R3
M^#'QA$EC8XT974XYRN'.DLLH2\Y0]RCX_!SO"$[WE'=S)<V]"6=:Q*'/O/&V
MY0U@=-MPD13[,/XDN\*/0029Q(L=M$+>)'VH!6-++^-<JU=5AJE;9^1XS'P:
M-E;*O>0X*;?G?/2EEZ':%J3M@K6C:_=*\X/\!L_$]V'7G!;FC+SP&C_C,*:E
MNL2))YKJAK.!!CG52P+2TG6#E<,!LR>X"DGD-Z*FZ#8-XQ3[UWE"N"Z*@1I*
M]J@E<D!,J+Z&HS02P.3GB_GMB%9HVNE29Y$_NC-MZ;K2C3+NZ':@M:(;[!J(
M=ERG2:R<N[MLUG\6N^4VO<=96=3K&B>0XPM%0>[CG9>'4".32*<QO4#B;WGR
M2L:G&=P;'D?3T N8&<H9[!MC\3E>2\WT4QIWHS6<P2/F.$[]"-A<(P^A9;NJ
M:H3E<Q \"-W'B#X*D6>AZF&H>!IJ'H>*YQEH6&1.E\9AX$-26O-N &N3P0;I
M&ZI7JV_'2D,9ZB:W0>@:<8_X Y'+"=XVUF$Z97@K\?'&A5L^%W!%.-QM$!';
MK^O\< @#ALXJ89,K4G+ [14GOJ1U]FG!$UVJXZ.#EV3I!=K&^T,<T71P.%F6
MENK6^50[]'.<?)I')&9O<2KBDTC8;)$6&>!N[16>I#-\DL)CJF<1F<L@NCP4
M4C+:F'CW<#8M?<+^ASCVX6BE_K>0:O[VWNC7R6!J<*OSB?10\ZZ@ 747VKFP
M!O^')!:V=Y62$_<D=!S0NB*!:C@3![1@BBY&0(?Z7@3<W(OP")K6*3?9;O,]
M+77F7^-#@K<!38<@?PXQ_('X.MG'259>MBE\#^(=GA.9-[Q!=]*7TMNR.XEM
M9YK&B1WJ-Z);$KQ_0*V'(+_U%-JHO)9Y2YVNT"LR5QD4]HB\X0[V&2</<8IE
M7:P6VF'1+\+VL_C:=.VQ5/ BI!I&+^=00^_<RR$6=R:.J#$RA;=:&A>H#CB4
M:FWU"W0?1X>B?HTB1!QS)6^%!ONT^D/Z<Q)D.-[M> LE$F%SU^ZJ #<7[8HD
MK9-'"YZ0-U#HF"J@SZ!Q252L!R7H[S NRXU'C[?8([$Y\!Y@9^1UZ;W2T^K7
M.;['+]GF,PZ?\5T<94^BV<%X<R;#V;%.MV/=6%O6N7PB!W@#*(PO4&T048L7
MJ+9Y <5;'S!:>H%_0;?7T"*RGP!-YO-0Y.G8%C#<C.$"2Z.<[!5;&F3#&::/
M!,XIPD2K@;T17NNV;P"\^1P?&25J*R[&\YZ+8\)X:<(93H_#?9*@3<Q9)[>J
M2<M)K:WM4HB6D%A3U1GR#L-[1!QV@:J#6BJ<ISA%BR_L.!N+VVZ.CL9@Q!E*
MCT5^FH@,!JT37:M52P@^0-^YN"PBM+:R,T0>BOB8Z.P$;8>T7#CH=H( 4)AQ
M-3JWG1P;G,&&,Y0>"?PDH1GL6:>X3IN64%M?W;6X+**RKJXS%!X(^(B@[ 1A
M![78X/D40^;"C+,QN>7DZ)A,;#A#Z)' 3Q.3B3WK%-=JT6)JZZL[%Y,%5-;5
M=8;" P$?$Y-=(*QNBYWL,IR<*##W;+D8G;GNC@G1'4/.D/P8],<&:P]L.M0"
M5 U>A_D#;;@4O)5,'V3 &8:/03TNEI^8SZ(C<.0%$>@_>6&.KX-TRZDW*)$S
M=X1- K,YHL81LDX<%3(V0Y&*(BJ+_%*8"8,&Z5#0M0KGNN[UM:Q2A>^"E#A=
M%7=IQ,6I2ZI:^32D.OZ,(G_D((C%0FFCIQ3ED#O'%/FBUKFEAZ_/*?&XS#J-
M5)WTR+[=K0'6F#&5,U33!#IFY&3XL$61[$LB:AA#->"Z573C<CIY2&G).*;O
MT5=UYPC&6.#B$-+KB%)TB:H[UE%YR3I:X;T71+4,@DI\UD---V;V[H6O$=,?
M :^H$/-P,_;Z.'TGQ9V?VH8SH6HD<&5W^3;XW0[4H]D]U(BM;G8<LX=9<(;7
MHV K.N2WP6EIBZ[F52LOPV6YES&!@6O&F9@M<5([9G-L.,/MD<"'Q^S*%@)C
M=:5^ZPR7M&U]?@\UXDC4UN3V, O.,'L4[*%1>SBKW_;$ZENSQ6-P<IIIU;=C
MIE73IIS48E?VRB>Z5.[$'?,T3O6ZWD+07N?:!BKN/D'*F3 BA";F4DBILB6B
M9]I[:(<V0,0T[78SD0@;VVE0 JYCD5#2.B&TX(GZCX82/YR[?@&]'I "%);W
MT5$P7\= !IRM9<"3=H,C.A!EM3"@2#+E2ZOBBO4.ITU\6I >IYG\UENIAJT1
ML "Z:+C;$[?.+WV,W$L$B!0B_"J"45AN"9R@<IYF-Z434"UV2LJ^R/KGEZ'B
MUV3?,?W/F;YU/?JA-T2&\><42OMV!T_<BM":BL98,<B1FBI:6F[P9PA4\1AW
M2Y31#K01O#P4=T>_YPTI??"]:9^XU2@5#0<?34=Z$4FAY0;-AD#ECYIY--O5
MOYR59BM8YHEW>8KK@5M1FFKQD'E!!%=MSUZV3P0SALO. ,KB(0P>Z?A-.AL[
ME65C1#WMJZB9?!JS;E#]I+[TVP(U?AGO+HGY;A7&JOA97#X%!1'"Y7/0+D[*
M3C]N'G6NN>>H%Q#4L#1&":=^@MO-1_EJCFM&0O-ON#FI?%*LUMFOY+S>/F$_
M#_%B!X70,WP+-\"061L!'3R$N'@#&[@-4S G'&+ Y/1[N&/MV;B^MG7RCH;<
MYV9E !:""A.7U 9JC*#""OJ5VOFK=?9*/+TE37:>8>&5OWJJAA>,M)WIK1PI
M]9QAZ0"PG.&YE).@CZ@!IXDINY5!K>8((84W,ZATW@(19;<ST*N"R)"W9E\Y
M&KYTY&8&B5NM:O@:1<O'&'*$G I'->DJL/(6""R'KKXK0?=J!)/7HG4];%V0
MT-\X%XI;N!I-")IS.1HCZPS3% #U0Z0+US?(FDV+]N6VEGZUZ*.,NA(X]5^
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M4R&4IX-0#9IX3'6L<ZK=7&#UO6 \)?SB(0P>Z3I]JA^V-&S8"FC:[HE"G=*
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M+MF6ONXJBHOY69PA[/;<Q4V_\MCD7:2I6+ G&3=ORW'AZ.^X:+*#"[PK:75
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M;$<"-A)%ZQ3W?9=NIQNWA<[^KS[SG_BO]:_X_ZV2BO+?_!]02P,$%     @
M9GL\5U^<?:$.5P  Q&L% !4   !F;VYR+3(P,C,P-C,P7W!R92YX;6SM?>N3
MXS:2Y_>+N/]!YXO8V(V8LMW=MF<\C[M0Z=&M&)4D2RI[?5\<+!%2<9HB-7Q4
ME_S7'P!2$D420((/)5361.RZN@H)(O.'1V8BD?GW__NZ=3LO) @=W_O'5^^^
M_O:K#O%6ONUXFW]\];BXZRYZH]%7G3"R/-MR?8_\XRO/_^K__I__^3\Z]']_
M_U]W=YVA0US[KYV^O[H;>6O_;YV)M25_[7PD'@FLR _^UOG9<F/V&W_HN"3H
M]/SMSB41H7](/OS7SO=?O_MQU;F[ _3[,_%L/WB<CX[]/D?1+OSK-]]\^?+E
M:\]_L;[XP>?PZY6_A76XB*PH#H^]??OZ;?J_A/SOKN-]_BO[?T]62#I47E[X
MU]?0^<=7[+OI9[]\^-H/-M^\__;;=]_\]\-XL7HF6^O.\9C<5N2K Q7KI8SN
MW8\__O@-_^NA::'EZU/@'K[QX9O#<(X]T[\ZDO:9D83.7T,^O+&_LB(.N_(S
M'6$+]J^[0[,[]JN[=^_O/KS[^C6TOSH(GTLP\%TR)^L.^R]%[_C5M>]9 4/K
M&_:7;WH^G8UTF)SF.2#K?WQ%6P2TZ_<?OOWAP[>LX_]]UBC:[^BL#!TVJ;[J
M?%/MHU[HNXYM1<2^MUPFJ<4S(5&H'HB"L,W!S:R >-$SB9R5Y58>:6DO#0^;
M+3&RI9\)I^L1W5ZV1&>X8NH6A[F(_-7G9]^UZ18U^'?L1/NJ0Q;WU.+P>U;X
M/'3]+UHS6-I! X/MDW 5.#NVZ4S7]W'H>"0,NYX]=JA8;"H8^G//VCF1Y<Y)
MZ,?!BBC'7Z?/!EA:Q-NM%>PIRL[&<]9T#7E1=[7R8R^B1^B,2G;EJ)G0ZZ6!
M8:>=AW.R(LZ+]>22!V*S#>#T"RJW!\NS-GQ"T'],Z1X1# G)T*C8:O8K#; ]
M\E[H9_P  $E)TP8&, O\'0GXI&1;P8YQK1J)C*:!(4UW3$VCTVSH>/14H#^,
M"3W+E0)2T34Q-#891A[57#8.FRMA"#B2I41-[+C)9L)W=>7F6M*VF4T_HC]0
MD@V=%!.?GHG'7U#.24!"D.H"[Z2!08]];W-'N]WVR5,T\2-"-8]]N@6D<H)-
M/.V.&MDXF-JQM%XA&T>A:5-+H1<'3%<;.]:3XSH18!=3D#4R%[=;)^)* Y._
MST\L:D("!@<@;>2$WE%B]A7+/2@US/P+MMSZ41_-(/(&!CHG+E/"J#X>[9>!
MY876BGU!*48571,R))OT?$X_IB-  &T3&HU+@6%6S= /^G[\%*UC]Z!_*/44
M &TC,_$I)/^.J3 &3+< :(7E[2^FMC:KOK:@QL(^O&2'0T-,G/=EC"8.8[&-
M;S6KE</X$!*TI*'#1J6F;%%;APT11MV6Y@X<HYKT4BHT;, 5NKJD.@UCHF)W
MS:K6T-4O(&A/S=:8N2KBEK4QX%D'[J%ES0QX;H%[0')2]DED.6XXL0*VO;XH
M'6--?N-B:M3=8TBHX,?.FHR\7XD5A'?IF)I1K=3]7X[5&14Q72!4\9D3JFO$
M]#\KGQ(PQ ZC>M<0VUK?:D $ ROPZ/?#&0D6SU9 $L,[)C8032C]Q=#277WU
M>C5&YP?"U<K'C!'"W=*GF^306J6'[46%HOBX,4+272#M?K59B_$N\S,0?!AU
M2[;D7=DO@0.OVE]+K.A.*YT^6C25[_A_J'G#/<] T5?JK$TF?B'.YIEJ[MT7
MVF!#N]I:CG?X\Y(;<O48T_U F\RRB#'?2P(3^*\&KSOBA= CL&Z_;;*6&F!+
M/_EW78[DW;7EV;D[_C;SRPF)INONENZMD?,[-RVAS#7WB=889A%^=NR2Z;K\
M[[58U>S\ DPF?VJ:.WFO;;&E>VQI==)P@('N6"&TE_*>WGVRMP]D^W0,>P/.
MFD8ZOQ23V@#5Z?22;N,[>$L@KA?X]$4%]&!%<<#M/JH\9*FF5&/Z7LM!UNI'
MF_71G^E,5*-_<5@$_] /,FW =EB=7AMFBSG=/&;(6XE7=DALJF*Y_'$ M0_W
MQ[9SJE]58+!._RTBR'ZVO#T5[IH$ 54<K=?D@./>Z.,=!G0B-_R99AG7W:L!
MI.U=.=V)?J^C>U7OMMW(,/U34[NK]B/']-W.E;IK,;),EP/=?EJ^Z[Q;Q%LK
M<'XG=MH*?B%5J]>VV:+''G$V'CT&[7@5+2P7ONKK]GLAUA8D>'%6A+?960YW
M'#?)(J3_EEG5WATJ]-7RY?R=[(_0BY:&^F\A_%)__X;1RX:ZH_8=.P 8JF/Z
MBS,2\AH1SR;VH2,V:M SR<B)6,OTV>J[SAU[XQJSZ41_3%JFHSB,P_579Y]V
MV5M0/_?N\O"NEK_X#,GJZXW_\HU-G&^86-@/7#Y<-O0?O_$/=9_"**#'PJ$G
MUWHB+N__-]HFU^2;VJ-:6^$3?XP:AW<;R]HE0R-N%!Y^<QIC^HO?CJ_<EMG7
M19F!I@WS[?*CS6+9#<Y';@6K0\?TQS,@BV]HTQ;?[/A+S+O5L^,>Y\ Z\+<B
M\:4?]*6C]@-J9_SCJW???HLN;SKAR8C^& )DGFF++'>!7.7"SPP_!>"] 0#T
M7"L\/$CMOCH0'(HDUPA'D8OCLL ")3NDOL_NUL1HE+4U# ;1U,HA4L9)"@4>
M$M2X]#T^LF[B4I8@4=)6A43*WX=O6\) /)/RPA<RFIDFZ!C<:V!PKXG!=R9A
M<&\N!CT-#'J:&'QO$@:]9C$H&@W#Z62>[/7=B>_][/,(PR#U@O*A"D7-2$&4
M0,'_@"=X,"LM+ 6UX7(PEI:TQW*[Y;P%4-YMB5NL3Q_$71@QBEB[]/LV&\/0
MM3;E<LTU 0KV':ID2]G"$FWF(8%"PF<M@8)^;X:@2YA$VB'F9.,PZYL-Y<B#
M?,L0D& KC5J;B)1M)"BZGA>S@.2='R@0.&^)K2EJ";Z,221Y_Q1;040"=P\1
M>:$QMFZH)74!JUA:";MHXX^!()(OML;6#O74%0&S2+)?/!/736,7(-(O:P^4
M_Y^-D+^880,0X-<N?<H-'(0,"1"'OQB'0X%M)"AF)'!\EB,P (!0: P4_X]&
MB%_ *JK@!YX-%?NQ*=B@,DCJ.3Z19#YTPI7E)B,:TM^5W95DAE[2'"I[7&M6
MR2^J_%D\*UCZF<90V>,:N I>+RSY-";P-!CIAB-N#94]KFFKXO;"PA]XD1/M
M67KT22QP!]-FQ5908>.:LR+N4(1\<&9X$4O_+A-TOB54V+A6K(Q+%('WZ( #
MRQUY-GG])]G+)%YH"A4YKO4JY1-%YK/ 82DN%LY*O9\4VT*ECFNSRCE%$?O2
M>AW9=-@\J0B3EEKZ0A(H"+@&*XAO%"S8ZXU@YV>\UCT66!KL>[XMW?85A%!<
M<"U9#1F@H-.U[8#EO$K^PSAY)\.DM#GX%LL )"3\&B+_]WKR?P^7/ZZ%J^37
M$/E_T)/_![C\<:U<);^8\N_1'Z?!TO\BN#X7-H;*'M?*5?"**7D^_FG W_HF
MA:E4XB]00#$PP?B5<XVZ!!*- #+_#RVA@C?!$"[G$E/@,S^,+/?_.3N5(EK>
M'BI\$TQB&<>7=F\F$X#Y142Q4KDF4$'C6L&E?%U:M@SJ@%CB"7W> BI97-.V
MC*L+"W;LLTN99]^3NH6+K: "QK511=Q=>G-FSRY#X:Z0^3,X: ]WZ\WS<V%Y
M_A(X$1T!B[*/O=0?)+C $S2%RAG7L)3R>6&9+WC28A97_T!''CBG2I[G B]K
M!Y4VKADIYO#"HIZQC-=;.MQ5\OZ0/=D.INNU:'>6M8>*'M>*5'.,"\$H#&,2
MZ )10@6% ]>@A')_Z2V(K%AFLOV[]T]+EH] L $56D&%CFM,BKB[L) G_C*P
M6''VQ7[[Y+OBES6E#:&BQC4=)3Q>6-IGXRB7<ZX)5,*X-F,I7TC;Q>!U]6QY
M&R(.QBAO"94TK@TIXQ)M?]Z ]N>-YOZ,:TN*N$,2<A([3]?8],EU-F>U+LOE
M74H ?JMDA.@E/%_Z>21_-I5)H#6D/Y3+7] 4*GGDIZ@R/B\M\]AV6+4 /J0T
M*WV2WI2S(7  J*F@2""_505RCW+O\ MQW7]Z_A=O0:S0]XB=F RRJP<A"10.
M$^X]%7RC8/&S[\947 &/A@T$JT+0%"I[$^X[!7SB!* FL=['\XGG7):*7D0!
M1<"$BT\YUT@A>1%AJ>N<%]*W(BL=H0P($044"!,N0>5<HSTT"'J4@XTOO_G/
M-82*W83 X%(>4:2]V%JN>ZCR*9-VKB%4VB9$ )?RB"+MP98$&[K??0S\+]%S
M^H96)G4! 53Z)L3Y2GG&0>'U])0_>54HA:"D-3AEA GR%W*+E1WE6,Z4<N'9
M5B 0OZP]%  S'K"*.;XP!+S 0E;KXH-APY?%<*BIH'#@&L)0[G$.XDQ6!>DY
M?-8.*G@33-XR#G$>H,5/KK,:NKXEU>_/FD$%;8)]6\(?BISO+>]S$.^BU7X6
M^"M"V+U.>%Q_  L+V $4&Q,L7RV9X'@D> 92GOF2EU /IW$4LKV2CD_JEY#2
M03$RP2B&2 !)=PI/K^:(?;^?LSRE+-AB25ZC>_JASW)5"D .!<J,G%!@>:!G
M,#[/*0M962FEDA"*&*(I#F4%=6T-';KFM]$@"/R@Y]-A\@)2XC 6"!T4&S-2
M2ZDE@'%QYP?B^(NS!N!L@OC7<><\X4AUZ 3;D<#VSC6!2A;YRKF,+QS9COV5
M)+"BT @J7P,NDHN\E4CX[]\4V* =?S[\M?2/9[WIE9OR0M]U;*X"6"ZKV45-
M39*YV#XK0?6^<]<YLLMJ4$TGB^EXU.\N!_W.?7?<G?0&G<6GP6"YJ%^9JE9)
MG.GZ>%L_\Q,'GJ2$51Y)*36.#G2EU:VT)%NJ^-P*7[4,R:WPU?7!<2M\U38,
M>(6OC"XV@UCM"K/83'VOA:KR4BU4\&LO&8U$QBD)*X!5!8/6G'J:]:_,!:#U
M,G"M>8)N9> ,R'MM0!VXVB!TPY :U^E5E=H@%30'0H'NLY9RBXY%SPJ?NY[-
M_C/X=^R\6"Z[%!E:3O"SY<:D[X0KUP_C0&)L:W0!3MG?$FAR+/RJ;!F"Y>+9
M#Z(E";8C[X6$D>AERF$"E[8&IYTT "$9OW7!$-@?:2!6."<K0J<$-5(7)'AQ
M5H3.E#G9T<DQ)*1,Z(P:2HQMA8 PT&&H54@>B.VL6!VQPQ@$TB]I!WZ"B"UH
M(8]MR=3RK U)BK39/.I-,JU%C;'--KATI=RV*>+\-T\ SXG+KB-2X&?\B<6*
MA!,2=5W7_\+N**1XU.T9?!5J!'C-R!'] &?GF$>[W0\=SPF?B?W1]^V0,O:+
M'WP>>3S@J_211=H!E![;F-<YY/5D@@[A+&#GGCUXW1$O)(<Y><:PU/VE)@:"
MUUJPC@YX&M) 1PZ(434T6G/*Z*"ADOONX+X<)UP+1\B'%_F1Y?*6;:O8=+,>
M^]Z&:?I@S?J,!FQVHI]F(.;1ETH_G2=+ZS7A[/ +%DQ9&FF54BH)T?UK.NL)
M* 9TN.@9N2-!M)^Y%E>3F#MCQU0F.K=DAY&,"@J4$8X"B #049K2(5KL/F],
MK)#,G<US-%T_TE.3,2J&24$&Q0G7F0#CQ1"@DM@=H@>3E @*$JXC L*)(1 Q
M&^&+XY:EM4N;G%I A8_KIR@,VQ!)CZBDO(U#%96$#;JC#EY7;LS"\=4HP*BA
M".$Z([18,@2]C#DF.6&RC:!8&.$[*&$/7>0J:>L*V@@[7RCC"YN4M=$9.]:3
MXSJ10^#WTS(:*(J(SW< 7+3J"#]8MWWR%/'[UIW#9@%3+TZY%L5N&=:'7A?@
M*\ZV, &(VJ_*G"F[7.K'F%E[YL10>]4$[:%8M>8/@&.EX,008/B16&1*<?J7
M$4"A:<T#H V-@G=\;,[,W\- ]VJ(%'10I%KS >@C!9($.F!94Q@.EYP*"E9K
MO@!ML"!20(?JX)J=DQ?BQ>H#2=0>"D]KW@)M>.2<MZ34]>(P\K<DZ),=>^ F
M"E4H-H/*MS5;7T\Y$_&)/M]UCO@ZIWMK=K[V/ <=[%=LCTY\;U7!)"TC@X*+
MG_ #Q#_Z8LMML:>1@L^7+ D4G=9\!C"A2T^9H@@J+\(7$CSY5+/ 7(;G%[M+
MZY6$AV"64F&I<8?W!(X&-G$ZZ JL)76D'Y.EGX8"SJP@VN?C 07Z"8 ."L\E
M/!1J>(!,&;*O"LQ R#H#D$*1NX0# [RPP")!!Z_4+(1 IR2$ G<)?P88.* X
M,)WL=;SK<%0NX;B ;81:0D%?3_G#$^ZRA6-S":\%?*L3,(R.A*;*5U.ONX2G
M XP)5'F[8CL;!"0<ODLX2*K ]P9 XX_@GWV7"CID(9W1'I+=3$P#A13?+:+F
M''V3/,^%PI],BU$I;0R% S]V0L(K.@Z9?"@*$(HMP>]CT1$0<8DN_JYM\_Q^
MU+RV''ODI4JF)!)"1  % S&%JHH%0S"9D\BB+-@#*_!8]OSN:A5O8^X/Z9.U
MLW(DYP>$%HH48C)6#6X, 6T94+LL#O:0G:RL+104Q$(GDM%7U=5^3'0UCVP8
MIH9I:SI:&AQ Q (JDM%?O;+]X'A^<"CX2$+)%EEL"84.L;Z*<.R&;'_%.37R
MTE<%,U;ZA0HRB@+G*8Y8U.'29R:A[T541'04&S5H3?4/A1JQ3$O#'%_]RLXX
M!;J>K;--JRFATP&Q& R8EQ: -B/-_8P+\IE$[!;PR.=9SOL/\)SWG?\\Z^^_
M;CGP6^+LE@/_E@/_E@/_E@/_E@._51AN.?!O.?"O)@=^:\Z/6PY\_(26MQSX
MZ)D+;SGP\1,0OHD4^(?DHT,_Z/OQ4[2.W>/+X8!LG7A[#)@^Y8*3I8VHVN'5
MI-&O)[&+)4H^??N48+9DR (-K49_V+GUU4C69+!5(+/Q\/4@K-03=MI]&'@U
MA(2^XY[KI92%:<"9MOD-ZXP$O)HT5"T7TV.;3Q6#EE0",0R_I/1W-XZ>_<#Y
M_>3_AE4_S])A&U:U:I\7!6 D3I<M4V\D4FU7J:]I#>OOAR!B["H"5>('C=\)
M,V.%;X-2(FRKN@I,QFZ A3&.PC#6@N9 @&UH5X?EG&7S( $=2'(J[,3_U<$Q
M\2@ZBWE,1\P'*X9'0H*>[[]:K&<9WR7(H 6-'+D*I^M<BONS8)'O9,$BBR7]
MS\-@LEQTIL/.:-*;/@QP0D02%HX#54>%" FPPMAYJHU0/?!B2V2OGT+TA2CU
M<D9;<@7-J!3HH(:$')*9D&BZ[K'8/_KQV')/#H^N9[,ZD#)W4.7>L/UY0JG[
M#3#7+H"!;\>K:&&YO-"7")A\*VP?'$C@Y:RU),BR:HYB@0I;8[O$(()5L'I!
M 6><K(ZNN$MHL?U;584O%,/%;G+DLUW2'MM1!1&YDMV+BEE<I5%+^K)NL%U1
MU4%1"P?=?#LPIU9!\9U-*B * R[(^-H>>/3\,&+Z5UJ&$6 PB"FP?5)ZEH.*
M\[:RW[+/ILMVZ6=U-L%V)B/ =C0I9>C#^+B@Q#5JLD,(T=U)U2% J,>N'L"Y
M:E<9F'PW4)A:LYB;A:E<2NA'/5=+V.BGZV,NPO2L%)\G4B(H;JT9WE#<(,Q<
M<&G)R]9+EY.(% I%>\'_E9>07!J(@ C4]QHX"7N$PM?>*X&&X5/(#GTSG%/Y
MTL\_,^<FW0%<GU>53;F7&4-2,BB,[3TTT-L005) QVI!^,/]C\2C>[9+Q]JU
MMX[G,,XBYX4H08/20]%KS=.@B9Z>7-!AS','-V+AT+3W?$0/&A&O5^R+2.SW
ML1^&0RH<=E/D>#&=?JDFY7OA/5G[ 3GDUTA9/_PS(<]DE1^\4@%2W!S/"O;\
MIKT\3X? EWCF5< :%71:&N)4,0'"*UX!7+F!N^($S:%SIC6WD-Z<D3*-?J;D
M9JILG\@U!-\9FP&#@-&KSBLW\EXH1XSY1!:*C;ZD,13$UAQ'NB *&49?27R=
MT^W;/SA&DB$J%Y:*#@I1:SZB"MN=4@SH:,%/<NW#N@E=J\)'H?.D-0=66ZI4
M90"N6%,Z<IVNFWMJHJYER7F%!-!IT9ICK,JT$#)^U<?U+/ I*VS*BW',MH%"
MUYHS3 ^Z(GM7O "I9G':H>KE%ZW0%13YUAQI>LA7%M95+^<SKH'PPZ%MS1%7
M ]I6UK41;SHD24_/WG=\#W_?L5A.>__\-!WW!_/%?U@[/_Q;9_#3XVCY*WI6
MT&K%8T#DM[R@M?*" HK;W!*#7A23*TX,FDR@GK_=^1[;Y8#)0<O)KA&6<D[0
MDX3FAJ7*$RIH;A@@LLF6PT? 4"9\]A(I0RME"]7, ]=^PBF(V"$,&>*5NTB2
MRO8S26DLAM;R5<J60P\BY^.T*6N-_:ZMV@(0\XT^\P6%PU2K0$&&_0*NRHH
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M![*Q*5)5BF]BZDS7?8?)S[/#?+H=]6R1$D,G2&N.R,8G"$!65STGX )K0E&
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MM@Z@20_5J,_D@0Y;=[6*MS%_X=XG5+8KATN6_NP2+F*//:,)(N=W_GLA5V*
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MMJ>E]E9P 3S0=Y3L().A,5DE/QSSEJ;: I5:VIBJ](Z=.)\^$<N-)#?GC7T
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M)]H5_<W_!U!+ 0(4 Q0    ( &9[/%<F-E(A?G(" #6J'  .
M  "  0    !F;VYA<E\Q,"UK+FAT;5!+ 0(4 Q0    ( &9[/%=\_[A^H@$
M -L&   4              "  :IR @!F;VYA<E]E>&AI8FET+3(Q+FAT;5!+
M 0(4 Q0    ( &9[/%=)W]$?50(  % (   4              "  7YT @!F
M;VYA<E]E>&AI8FET+3(S+FAT;5!+ 0(4 Q0    ( &9[/%?-D$QP# 8  %<?
M   4              "  05W @!F;VYA<E]E>&AI8FET+3,Q+FAT;5!+ 0(4
M Q0    ( &9[/%>RV.ZAD@,  !,/   4              "  4-] @!F;VYA
M<E]E>&AI8FET+3,R+FAT;5!+ 0(4 Q0    ( &9[/%=EH_K(&/@  &T6 0 /
M              "  0>! @!F;VYA<E]G<F%P:"YJ<&=02P$"% ,4    " !F
M>SQ7C5V:</<U  !H.   #@              @ %,>0, 9F]N87)?;&]G;RYJ
M<&=02P$"% ,4    " !F>SQ7VGK[]1P9  #*&0$ $0              @ %O
MKP, 9F]N<BTR,#(S,#8S,"YX<V102P$"% ,4    " !F>SQ7*=7KW:,:  "?
M2P$ %0              @ &ZR , 9F]N<BTR,#(S,#8S,%]C86PN>&UL4$L!
M A0#%     @ 9GL\5]TCO_B&/0  U;4# !4              ( !D.,# &9O
M;G(M,C R,S V,S!?9&5F+GAM;%!+ 0(4 Q0    ( &9[/%=_Q,9E)X<  $!#
M!P 5              "  4DA! !F;VYR+3(P,C,P-C,P7VQA8BYX;6Q02P$"
M% ,4    " !F>SQ77YQ]H0Y7  #$:P4 %0              @ &CJ 0 9F]N
H<BTR,#(S,#8S,%]P<F4N>&UL4$L%!@     ,  P " ,  .3_!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
